From 621b1dc907d6b45fec20019435810e5b892be059 Mon Sep 17 00:00:00 2001 From: Isaac Zhao Date: Mon, 15 Jun 2020 22:47:41 -0400 Subject: [PATCH 01/15] added more dplyr conflict functions --- global.R | 104 ++++++++++++++++++++++++++++--------------------------- 1 file changed, 53 insertions(+), 51 deletions(-) diff --git a/global.R b/global.R index 1db4a7f..df772e7 100644 --- a/global.R +++ b/global.R @@ -1,51 +1,53 @@ -################################################################################ -# global.R -# This R Script declares the required packages for loading the Shiny App, links -# other R Scripts with global objects and defines global variables and functions. -################################################################################ - -### Declaration of required packages for running the Shiny App smoothly -------- -library(shiny) # version: 1.4.0 -library(shinyjs) # version: 1.1 -library(data.table) # version: 1.12.8 -library(DT) # version: 0.12 -library(ggplot2) # version: 3.2.1 -library(plotly) # version: 4.9.1 -library(scales) # version: 1.1.0 -library(shinycssloaders) # version: 0.3 -library(conflicted) # version: 1.0.4 -library(dplyr) # version: 0.8.3 -library(tidyr) # version: 1.0.2 -library(survival) # version: 3.1-8 -library(survminer) # version: 0.4.6 -library(fmsb) # version: 0.7.0 - -conflict_prefer("first", "dplyr") -conflict_prefer("filter", "dplyr") -# conflict_prefer("layout", "plotly") -# conflict_prefer("hidden", "shinyjs") -# conflict_prefer("dataTableOutput", "DT") - - -### Source any R Scripts other than ui.R, server.R and global.R ---------------- -source("volcano_plot.R") -source("GetStatistics.R") - - -### Definitions of global variables and functions ------------------------------ -# Check that it doesn't match any non-number -numbers_only <- function(x) !grepl("\\D", x) - -fmt_dcimals <- function(decimals = 0) { - function(x) format(x, nsmall = decimals, scientific = FALSE) -} - -reverselog_trans <- function(base = exp(1)) { - trans <- function(x) -log(x, base) - inv <- function(x) base^(-x) - trans_new(paste0("reverselog-", format(base)), trans, inv, - log_breaks(base = base), - domain = c(1e-100, Inf)) -} - - +################################################################################ +# global.R +# This R Script declares the required packages for loading the Shiny App, links +# other R Scripts with global objects and defines global variables and functions. +################################################################################ + +### Declaration of required packages for running the Shiny App smoothly -------- +library(shiny) # version: 1.4.0 +library(shinyjs) # version: 1.1 +library(data.table) # version: 1.12.8 +library(DT) # version: 0.12 +library(ggplot2) # version: 3.2.1 +library(plotly) # version: 4.9.1 +library(scales) # version: 1.1.0 +library(shinycssloaders) # version: 0.3 +library(conflicted) # version: 1.0.4 +library(dplyr) # version: 0.8.3 +library(tidyr) # version: 1.0.2 +library(survival) # version: 3.1-8 +library(survminer) # version: 0.4.6 +library(fmsb) # version: 0.7.0 + +# if function conflicts, default dplyr +conflict_prefer("first", "dplyr") +select <- dplyr::select; rename <- dplyr::rename; mutate <- dplyr::mutate; summarize <- dplyr::summarize; arrange <- dplyr::arrange; slice <- dplyr::slice; filter <- dplyr::filter; recode<-dplyr::recode +style <- plotly::style +# conflict_prefer("layout", "plotly") +# conflict_prefer("hidden", "shinyjs") +# conflict_prefer("dataTableOutput", "DT") + + +### Source any R Scripts other than ui.R, server.R and global.R ---------------- +source("volcano_plot.R") +source("GetStatistics.R") + + +### Definitions of global variables and functions ------------------------------ +# Check that it doesn't match any non-number +numbers_only <- function(x) !grepl("\\D", x) + +fmt_dcimals <- function(decimals = 0) { + function(x) format(x, nsmall = decimals, scientific = FALSE) +} + +reverselog_trans <- function(base = exp(1)) { + trans <- function(x) -log(x, base) + inv <- function(x) base^(-x) + trans_new(paste0("reverselog-", format(base)), trans, inv, + log_breaks(base = base), + domain = c(1e-100, Inf)) +} + + From 79455f540cb171d000e012c5dd656349574a0749 Mon Sep 17 00:00:00 2001 From: Isaac Zhao Date: Tue, 16 Jun 2020 21:03:31 -0400 Subject: [PATCH 02/15] ui two column format, added test data --- GetStatistics.R | 1156 +++--- data/Get Test Data.Rmd | 57 + data/ae.xpt | Bin 0 -> 474000 bytes data/dm.xpt | Bin 0 -> 79280 bytes data/ds.xpt | Bin 0 -> 132880 bytes data/test_data.csv | 7519 ++++++++++++++++++++++++++++++++++++++++ global.R | 1 + server.R | 1654 +++++---- ui.R | 110 +- volcano-plot.Rproj | 13 + 10 files changed, 9030 insertions(+), 1480 deletions(-) create mode 100644 data/Get Test Data.Rmd create mode 100644 data/ae.xpt create mode 100644 data/dm.xpt create mode 100644 data/ds.xpt create mode 100644 data/test_data.csv create mode 100644 volcano-plot.Rproj diff --git a/GetStatistics.R b/GetStatistics.R index 1f9acd6..ba09c97 100644 --- a/GetStatistics.R +++ b/GetStatistics.R @@ -1,593 +1,563 @@ -################################################################################ -# GetStatistics.R -# 5 Functions: Obtain statistics for further TLG outputs. -################################################################################ - -### Hazard Ratio (Cox's Proportional Hazards Model) ---------------------------- -GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - TDDT <- Sys.Date() # use today's date for convenience - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(STARTDT = RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.extend <- NULL - if (soc == FALSE) { - ae.list <- na.omit(unique(data$AEDECOD)) - } else { - ae.list <- na.omit(unique(data$AEBODSYS)) - } - - for (ae in ae.list) { - - events <- data %>% - {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% - {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% - mutate(CNSR = 0) - - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } else {} - - censors <- data %>% - filter(!(USUBJID %in% events$USUBJID)) %>% - mutate(CNSR = 1) %>% - group_by(USUBJID) %>% - summarise_all(list(first)) %>% - {if (soc == FALSE) mutate(., - AEDECOD = ae, - AEBODSYS = aebodsys) else .} %>% - {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% - mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, - AEENDT = NA, AEENDY = NA, AETERM = NA, - AESER = NA, AEONGO = NA, AESEV = NA, - AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% - {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - - extension <- rbind(events, censors) %>% - group_by(USUBJID) %>% - mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% - rowwise() %>% - mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% - mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% - ungroup() %>% - mutate(AVAL = ADT - STARTDT + 1) %>% - distinct() - - data.extend <- rbind(data.extend, extension) - } - - data.extend <- data.extend %>% - mutate(TRT = ifelse(ARMCD %in% treatment1, 1, 0)) - - getHazardRatio <- function(time, delta, trt) { - fit <- coxph(Surv(time, delta) ~ trt) - S <- summary(fit) - - HR <- unname(exp(fit$coefficients)) - HRP <- S$coefficients[5] - - output <- c(HR, HRP) - return(output) - } - - result <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Rate Difference (Large Sample Approximation by CLT) ------------------------ -GetStatistics_RateD <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - TDDT <- Sys.Date() # use today's date for convenience - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(STARTDT = RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.extend <- NULL - if (soc == FALSE) { - ae.list <- na.omit(unique(data$AEDECOD)) - } else { - ae.list <- na.omit(unique(data$AEBODSYS)) - } - - for (ae in ae.list) { - - events <- data %>% - {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% - {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% - mutate(CNSR = 0) - - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } else {} - - censors <- data %>% - filter(!(USUBJID %in% events$USUBJID)) %>% - mutate(CNSR = 1) %>% - group_by(USUBJID) %>% - summarise_all(list(first)) %>% - {if (soc == FALSE) mutate(., - AEDECOD = ae, - AEBODSYS = aebodsys) else .} %>% - {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% - mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, - AEENDT = NA, AEENDY = NA, AETERM = NA, - AESER = NA, AEONGO = NA, AESEV = NA, - AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% - {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - - extension <- rbind(events, censors) %>% - group_by(USUBJID) %>% - mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% - rowwise() %>% - mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% - mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% - ungroup() %>% - mutate(AVAL = ADT - STARTDT + 1) %>% - distinct() - - data.extend <- rbind(data.extend, extension) - } - - data.extend.summary <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% - {if (soc == TRUE) summarise(., - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - na.omit() - - getRateDifference <- function(count1, count2, saval1, saval2) { - r <- ratedifference(a = count1, b = count2, PT1 = saval1, PT0 = saval2) - RD <- r$estimate - RDP <- r$p.value - - output <- c(RD, RDP) - return(output) - } - - result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Rate Ratio (Large Sample Approximation by CLT) ----------------------------- -GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - TDDT <- Sys.Date() # use today's date for convenience - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(STARTDT = RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.extend <- NULL - if (soc == FALSE) { - ae.list <- na.omit(unique(data$AEDECOD)) - } else { - ae.list <- na.omit(unique(data$AEBODSYS)) - } - - for (ae in ae.list) { - - events <- data %>% - {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% - {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% - mutate(CNSR = 0) - - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } else {} - - censors <- data %>% - filter(!(USUBJID %in% events$USUBJID)) %>% - mutate(CNSR = 1) %>% - group_by(USUBJID) %>% - summarise_all(list(first)) %>% - {if (soc == FALSE) mutate(., - AEDECOD = ae, - AEBODSYS = aebodsys) else .} %>% - {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% - mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, - AEENDT = NA, AEENDY = NA, AETERM = NA, - AESER = NA, AEONGO = NA, AESEV = NA, - AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% - {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - - extension <- rbind(events, censors) %>% - group_by(USUBJID) %>% - mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% - rowwise() %>% - mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% - mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% - ungroup() %>% - mutate(AVAL = ADT - STARTDT + 1) %>% - distinct() - - data.extend <- rbind(data.extend, extension) - } - - data.extend.summary <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% - {if (soc == TRUE) summarise(., - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - na.omit() - - getRateRatio <- function(count1, count2, saval1, saval2) { - r <- rateratio(a = count1, b = count2, PT1 = saval1, PT0 = saval2) - RR <- r$estimate - RRP <- r$p.value - - output <- c(RR, RRP) - return(output) - } - - result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Risk Difference (Large Sample Approximation by CLT) ------------------------ -GetStatistics_RiskD <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - N1.total <- data %>% - filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - N2.total <- data %>% - filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} - - getRiskDifference <- function(count1, count2) { - r <- riskdifference(a = count1, b = count2, N1 = N1.total, N0 = N2.total) - RD <- r$estimate - RDP <- r$p.value - - output <- c(RD, RDP) - return(output) - } - - result <- data.summary %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRiskDifference(COUNT1, COUNT2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRiskDifference(COUNT1, COUNT2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Risk Ratio (Large Sample Approximation by CLT) ----------------------------- -GetStatistics_RiskR <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - N1.total <- data %>% - filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - N2.total <- data %>% - filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} - - getRiskRatio <- function(count1, count2) { - r <- riskratio(X = count1, Y = count2, m1 = N1.total, m2 = N2.total) - RR <- r$estimate - RRP <- r$p.value - - output <- c(RR, RRP) - return(output) - } - - result <- data.summary %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRiskRatio(COUNT1, COUNT2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRiskRatio(COUNT1, COUNT2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - +################################################################################ +# GetStatistics.R +# 5 Functions: Obtain statistics for further TLG outputs. +################################################################################ + +### Hazard Ratio (Cox's Proportional Hazards Model) ---------------------------- +GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, + treatment1, treatment2) { + + if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} + + TDDT <- Sys.Date() # use today's date for convenience + + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY","AGE", "RFENDY", "SAFFN"))], ~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% + drop_na(RFSTDTC) %>% + mutate(STARTDT = RFSTDTC, + AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD), + AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + if (ser == TRUE) { data <- data %>% filter(AESER == "Y") } + + if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } + + if (period == "Treatment emergent") { data <- data %>% filter(TRTEMFL == "Y") } + + if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") } + + if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } + + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) + + if (nrow(data) == 0) {return(NULL)} + + data.extend <- NULL + if (soc == FALSE) { + ae.list <- na.omit(unique(data$AEDECOD)) + } else { + ae.list <- na.omit(unique(data$AEBODSYS)) + } + + for (ae in ae.list) { + + events <- data %>% + {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% + {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% + mutate(CNSR = 0) + + if (soc == FALSE) { + aebodsys <- unique(events$AEBODSYS) + } + + censors <- data %>% + filter(!(USUBJID %in% events$USUBJID)) %>% + mutate(CNSR = 1) %>% + group_by(USUBJID) %>% + summarise_all(list(first)) %>% + {if (soc == FALSE) mutate(., + AEDECOD = ae, + AEBODSYS = aebodsys) else .} %>% + {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% + mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, + AEENDT = NA, AEENDY = NA, AETERM = NA, + AESER = NA, AEONGO = NA, AESEV = NA, + AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% + {if (soc == TRUE) mutate(., AEDECOD = NA) else .} + + extension <- rbind(events, censors) %>% + group_by(USUBJID) %>% + mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% + rowwise() %>% + mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% + mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% + ungroup() %>% + mutate(AVAL = ADT - STARTDT + 1) %>% + distinct() + + data.extend <- rbind(data.extend, extension) + } + + data.extend <- data.extend %>% + mutate(TRT = ifelse(ARMCD %in% treatment1, 1, 0)) + + getHazardRatio <- function(time, delta, trt) { + fit <- coxph(Surv(time, delta) ~ trt) + S <- summary(fit) + + HR <- unname(exp(fit$coefficients)) + HRP <- S$coefficients[5] + + output <- c(HR, HRP) + return(output) + } + + result <- data.extend %>% + mutate(AVAL = as.numeric(AVAL)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) + + return(result) +} + + +### Rate Difference (Large Sample Approximation by CLT) ------------------------ +GetStatistics_RateD <- function(data, ser, drug, period, residual, soc,treatment1, treatment2) { + + if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} + + TDDT <- Sys.Date() # use today's date for convenience + + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY","AGE", "RFENDY", "SAFFN"))],~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% + drop_na(RFSTDTC) %>% + mutate(STARTDT = RFSTDTC) %>% + mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% + mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + if (ser == TRUE) { + data <- data %>% filter(AESER == "Y") + } + + if (drug == TRUE) { + data <- data %>% filter(AEREL == "Y") + } + + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + } + + if (period == "AE during entire study") { + data <- data %>% filter(STUDYFL == "Y") + } + + if (period == "Other") { + data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + } + + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) + + if (nrow(data) == 0) {return(NULL)} + + data.extend <- NULL + if (soc == FALSE) { + ae.list <- na.omit(unique(data$AEDECOD)) + } else { + ae.list <- na.omit(unique(data$AEBODSYS)) + } + + for (ae in ae.list) { + + events <- data %>% + {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% + {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% + mutate(CNSR = 0) + + if (soc == FALSE) { + aebodsys <- unique(events$AEBODSYS) + } else {} + + censors <- data %>% + filter(!(USUBJID %in% events$USUBJID)) %>% + mutate(CNSR = 1) %>% + group_by(USUBJID) %>% + summarise_all(list(first)) %>% + {if (soc == FALSE) mutate(., + AEDECOD = ae, + AEBODSYS = aebodsys) else .} %>% + {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% + mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, + AEENDT = NA, AEENDY = NA, AETERM = NA, + AESER = NA, AEONGO = NA, AESEV = NA, + AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% + {if (soc == TRUE) mutate(., AEDECOD = NA) else .} + + extension <- rbind(events, censors) %>% + group_by(USUBJID) %>% + mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% + rowwise() %>% + mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% + mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% + ungroup() %>% + mutate(AVAL = ADT - STARTDT + 1) %>% + distinct() + + data.extend <- rbind(data.extend, extension) + } + + data.extend.summary <- data.extend %>% + mutate(AVAL = as.numeric(AVAL)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% + {if (soc == TRUE) summarise(., + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} + + data.summary <- data %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + distinct(USUBJID, .keep_all = TRUE) %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + {if (soc == TRUE) summarise(., + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + na.omit() + + getRateDifference <- function(count1, count2, saval1, saval2) { + r <- ratedifference(a = count1, b = count2, PT1 = saval1, PT0 = saval2) + RD <- r$estimate + RDP <- r$p.value + + output <- c(RD, RDP) + return(output) + } + + result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) + + return(result) +} + + +### Rate Ratio (Large Sample Approximation by CLT) ----------------------------- +GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatment1, treatment2) { + + if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} + + TDDT <- Sys.Date() # use today's date for convenience + + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY","AGE", "RFENDY", "SAFFN"))], ~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% + drop_na(RFSTDTC) %>% + mutate(STARTDT = RFSTDTC) %>% + mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% + mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + if (ser == TRUE) { + data <- data %>% filter(AESER == "Y") + } + + if (drug == TRUE) { + data <- data %>% filter(AEREL == "Y") + } + + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + } + + if (period == "AE during entire study") { + data <- data %>% filter(STUDYFL == "Y") + } + + if (period == "Other") { + data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + } + + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) + + if (nrow(data) == 0) {return(NULL)} + + data.extend <- NULL + if (soc == FALSE) { + ae.list <- na.omit(unique(data$AEDECOD)) + } else { + ae.list <- na.omit(unique(data$AEBODSYS)) + } + + for (ae in ae.list) { + + events <- data %>% + {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% + {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% + mutate(CNSR = 0) + + if (soc == FALSE) { + aebodsys <- unique(events$AEBODSYS) + } else {} + + censors <- data %>% + filter(!(USUBJID %in% events$USUBJID)) %>% + mutate(CNSR = 1) %>% + group_by(USUBJID) %>% + summarise_all(list(first)) %>% + {if (soc == FALSE) mutate(., + AEDECOD = ae, + AEBODSYS = aebodsys) else .} %>% + {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% + mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, + AEENDT = NA, AEENDY = NA, AETERM = NA, + AESER = NA, AEONGO = NA, AESEV = NA, + AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% + {if (soc == TRUE) mutate(., AEDECOD = NA) else .} + + extension <- rbind(events, censors) %>% + group_by(USUBJID) %>% + mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% + rowwise() %>% + mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% + mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% + ungroup() %>% + mutate(AVAL = ADT - STARTDT + 1) %>% + distinct() + + data.extend <- rbind(data.extend, extension) + } + + data.extend.summary <- data.extend %>% + mutate(AVAL = as.numeric(AVAL)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% + {if (soc == TRUE) summarise(., + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} + + data.summary <- data %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + distinct(USUBJID, .keep_all = TRUE) %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + {if (soc == TRUE) summarise(., + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + na.omit() + + getRateRatio <- function(count1, count2, saval1, saval2) { + r <- rateratio(a = count1, b = count2, PT1 = saval1, PT0 = saval2) + RR <- r$estimate + RRP <- r$p.value + + output <- c(RR, RRP) + return(output) + } + + result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) + + return(result) +} + + +### Risk Difference (Large Sample Approximation by CLT) ------------------------ +GetStatistics_RiskD <- function(data, ser, drug, period, residual, soc, + treatment1, treatment2) { + + if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} + + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", + "AGE", "RFENDY", "SAFFN"))], + ~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% + drop_na(RFSTDTC) %>% + mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% + mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + N1.total <- data %>% + filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% + tally() %>% as.numeric() + + N2.total <- data %>% + filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% + tally() %>% as.numeric() + + if (ser == TRUE) { data <- data %>% filter(AESER == "Y") } + + if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } + + if (period == "Treatment emergent") { data <- data %>% filter(TRTEMFL == "Y") } + + if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") } + + if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } + + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) + + if (nrow(data) == 0) {return(NULL)} + + data.summary <- data %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + distinct(USUBJID, .keep_all = TRUE) %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + {if (soc == TRUE) summarise(., + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} + + getRiskDifference <- function(count1, count2) { + r <- riskdifference(a = count1, b = count2, N1 = N1.total, N0 = N2.total) + RD <- r$estimate + RDP <- r$p.value + + output <- c(RD, RDP) + return(output) + } + + result <- data.summary %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRiskDifference(COUNT1, COUNT2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRiskDifference(COUNT1, COUNT2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) + + return(result) +} + + +### Risk Ratio (Large Sample Approximation by CLT) ----------------------------- +GetStatistics_RiskR <- function(data, ser, drug, period, residual, soc, + treatment1, treatment2) { + + if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} + + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", "AGE", "RFENDY", "SAFFN"))], ~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% + drop_na(RFSTDTC) %>% + mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% + mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + N1.total <- data %>% + filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% + tally() %>% as.numeric() + + N2.total <- data %>% + filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% + tally() %>% as.numeric() + + if (ser == TRUE) { + data <- data %>% filter(AESER == "Y") + } + + if (drug == TRUE) { + data <- data %>% filter(AEREL == "Y") + } + + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + } + + if (period == "AE during entire study") { + data <- data %>% filter(STUDYFL == "Y") + } + + if (period == "Other") { + data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + } + + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) + + if (nrow(data) == 0) {return(NULL)} + + data.summary <- data %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + distinct(USUBJID, .keep_all = TRUE) %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + {if (soc == TRUE) summarise(., + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} + + getRiskRatio <- function(count1, count2) { + r <- riskratio(X = count1, Y = count2, m1 = N1.total, m2 = N2.total) + RR <- r$estimate + RRP <- r$p.value + + output <- c(RR, RRP) + return(output) + } + + result <- data.summary %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRiskRatio(COUNT1, COUNT2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRiskRatio(COUNT1, COUNT2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) + + return(result) +} + + diff --git a/data/Get Test Data.Rmd b/data/Get Test Data.Rmd new file mode 100644 index 0000000..907353d --- /dev/null +++ b/data/Get Test Data.Rmd @@ -0,0 +1,57 @@ + + +```{r} + +setwd("~/Desktop/volcano-plot") +library(scales); library(dplyr); library(tidyr); library(tibble); library(stringr); library(ggplot2); library(cowplot); library(ggpubr) +select <- dplyr::select; rename <- dplyr::rename; mutate <- dplyr::mutate; +summarize <- dplyr::summarize; arrange <- dplyr::arrange; slice <- dplyr::slice; filter <- dplyr::filter; recode<-dplyr::recode +style <- plotly::style +``` + + +Make test dataset +```{r} +# https://github.com/SafetyGraphics/volcano-plot/issues/7 +ae_vars = c("USUBJID", "AESEQ", "AESTDT", "AESTDY", "AEENDT", "AEENDY", "AETERM", "AEDECOD", "AEBODSYS", "AESER", "AEONGO", "AESEV", "AEREL", "AEOUT", "STUDYFL", "TRTEMFL") +dm_vars = c("SITE", "SITEID", "AGE", "SEX", "RACE", "ARM", "ARMCD", "SBJTSTAT", "RFSTDTC", "RFENDTC", "RFENDY", "SAFFL") +all_vars = c(ae_vars,dm_vars) + +# https://github.com/phuse-org/phuse-scripts/tree/master/data/sdtm/TDF_SDTM_v1.0 +library(haven) +library(readr) +adae <- haven::read_xpt("https://github.com/phuse-org/phuse-scripts/raw/master/data/adam/cdisc/adae.xpt") %>% select(USUBJID, TRTEMFL, SAFFL) +adsl <- haven::read_xpt("https://github.com/phuse-org/phuse-scripts/raw/master/data/adam/cdisc/adsl.xpt") +ae = read_xpt("data/ae.xpt") %>% select(-STUDYID, -DOMAIN ) +dm = read_xpt("data/dm.xpt")%>% select(-STUDYID, -DOMAIN ) +ds = read_xpt("data/ds.xpt")%>% select(-STUDYID, -DOMAIN ) %>% filter(EPOCH=="TREATMENT" & DSCAT=="DISPOSITION EVENT") %>% select(USUBJID,DSDECOD) + +test_data = ae %>% + inner_join(dm,by="USUBJID") %>% + inner_join(adae, by="USUBJID") %>% + left_join(ds, by="USUBJID") %>% + rename(AESTDT = AESTDTC, AEENDT = AEENDTC) %>% + mutate(AEONGO = ifelse(AEENDT=="","Y","N"), + STUDYFL = TRTEMFL, + SITE = SITEID, + RFENDTC = as.Date(RFENDTC), + AEENDT = as.Date(ifelse(AEENDT=="",NA,AEENDT)), + RFENDY = as.Date(RFENDTC) - AEENDT, + RFENDY = ifelse(AEENDT% select(match_vars) +write_csv(test_data2, path="data/test_data.csv") + + +``` + diff --git a/data/ae.xpt b/data/ae.xpt new file mode 100644 index 0000000000000000000000000000000000000000..c60282eb9c327ddb29daa2a80f0b1c0275660e72 GIT binary patch literal 474000 zcmeFa+p{Fec^@`Q`9eyxyx=~Q*soYUAo-L1aN?pfL5SpWlK zL|}F>y9)|dNSr52G(~!;ko~--Wl5w$^76r?!wxI3bl8tFBK+V-@0(xoC-}?!@|Rg% z)mdFxofC7;OdVh&t9$a+`K#~CFTeaQ7kN6(*TFiUEZ5Ut;lKGTTc_)*;G+0%pX0x< z_AdxF=_U|=g_61pg5j@)q4<6sB)``CweXI3KJ*t3Hu)+VejyIO5GP;gC*{wF+PHkT z_nXx3z05B&T7zc4HyU6Cq8|OCL;X!Rll5x5-v2kp^-FX9RkV)NberDj^;@Ku`R2&) zO@>&uVi^Q?zVFVRJ3n~mmCbfHy_!vf&3o^E<=esRD-RyM_wcI^A3QmREwz?^sE5z3 zN->x3yYqe1*3q)J$&a8hB;VbO#Gwz{Db)3sT6bh zD|i0VZnMk2Nb9nD^zfVSKL|GOf9dZ&`0{(l7YJjO=JHqZy;J!L)&BlF|3R8>^1nqL zZXVE79)0;iuz3F)Upfv^fU!z*`3ZdQREl-^OLzW5n#+ooCD=TE=h3_GJh?l4@YRQp z9(?8K!eFe@Tt0{Iok}s6U%T@krTI2rUlMP7@c5l4@6jZ-51xD@`06`Pg7?1mAV|OR ztp`uueGuf|qIVj@$`WJYOZEBZ@x4>YbNP?cd_Lb&hx2!S`@y^K1@i~rdhm6g4@Nm$ zVl4ct`n<;XP9?uD-!JDfnI4$Sy155Fwv z`0Xd(rdQ_4!*2mCj8!f%7QR=X|1rLIDtTT0a+x8Hs5!8Zb8bjv5d`Szn=^7XgheHWwcmlzA*s?Yx~ zzIQ5lU0$WR&{QVVnz(gP04JrscZ4@+(er zKxJN+AChw+I;xqA%es66-8+?HUB3U$4-1*$KCR1!HlimF-~0CGXOG@{@aSE7!s;I` zF&6%nKfm%mzIQ6cTwb~JBVsNj=F?oBJbdTc@xcPbg9A4~IfKBo>R zZ@>TU+h0El4TiSO<#(LsfXZSnKY8cVX};VE`DOY3dtZL%8xMkazFH$d>6uv9{8yKjH#p?HOe&cFQj>LFwqFwrh2ES; zzlmWEmKY2F$e&;N7x><()bIBil#bG8^jQ$UF?^M1*wZH$)&k;sfVx3tpHGP}d?N@{Q4@rReyg};o`QLl{ z8$g3gjD>Ic^DF-szIQ5lElUi;iv+^YQ0;}w!89z@Mx9Vv+d+!MiSh?Kg^@js&)*tk}xM_n3H6L3LVT0w;kq? zE9Bu|I!o8?S_>D;Ndm~T1l9ro<>z@sD2~tkMtMkDbeh5w%F2UK3nXO zb$Q;l<NSB9F``Q?(>V}X*_BpM1T#&jA`^B8m;MVgwQGJ5HUTv}j`lN2yVVY*$< zmiLKatY?$mJY5Ibd^veN*pQZ(IN&rtU*|Ma{H6En{~h(X#3H(lfmRacUeq_A1u zm;^R1S&+c51!Fm2-4VMI^EyK!WwIsIfGW-PBA=71aIVZQ=FtrT3T-AUSj0gGPP zo7)_yB+OBdVJ5&w=syUu&oFA)k8+6-EiflNL(ScRN-mklv)PF-)46$kH|`V6^dy9_ z0?cnHn7_~z=71}bdgLBy5za|uY4+z<8?RftR+4Fly#&4RfhrnB_`)ML9=j^Q+=glQ z?na~@8A+JwDU1y;+3zcu)!io6!9vZwVR{Cb$JuT%o#z3WjxI>U&Znt)eotKH9r%;~ za;V9Hx`947A8KG91G85mm`0Uh9>)5Mn|`2LEEke|oU~xXv=h=)GSe1MW@R=QwEIJ?)Aops$F2(0tj^6&dvlqZg)qk7#hRKECep0WrJZT3 zO*{{KwMwrFbZ)f)Si4qA(!O;%?TWI~X>TS-=|H8<&2*qTblt&kmzaW*RxI=z5u24%U0ku!wGBpcTWMl$dre)HhTfvGLf|O@cX4Fo%6DSgY-6 zwlTNfdzi@&s3fi;b<1is^$h^iHPO6w476gHbQ!<^^?6+J1LTRdeuMlDn5p|rz%tzeGg4rZ|w zH;S6g-kjV`G|Wk)_vW`4y-byMnAPS@)*~IvHyGwU5iHa&Lj-%oa36*_BI7Z@91YSn zNmS|lyn#ZS_*9W;e^FT5)e3CjV{T)hmE4_M#gue;(_WTh85^x@^+Y?a)Ue?PRKWY zHzy^qaW-nnLL?sa{9BB23M@6*9uFT&2{9!%= z%$<5fu7uCMS*u3?^HE8gBH)k{51G5uX}LtrunHsluwkmG`QsI%SARn#n0BaO4hL+j zDNZ>0jXp$T>N{iE*`zk;(rpa1lGNNwN=&=o*KQbk3ODP9%AILjVIJ-o2?6H6`0I=w z7Rt`FuNBPE=yEpM3O5U(0Nbr;@1010EDO|Bb0I=k9j_@mz&zZ>Kr0DzJT56adn3)o z*SWC47dtYhW!!8m^Dlpmu{?HFRgavqHx~_f0W+u=lefdH$UcvZdZfGp2S3+Z_*Gh9 z9$K2O)Hw77T1l9P!;-RdFxKSlk<)tYstWV-V%q)m15k6-fR}DtFX?XnuuN9DYg(rp z;kzQK4=OIu#@WeZO`H9rN+aRs zZ!S2#4kpXpx&7p8#^5Kn+Ik*NW1y9UnS$b&&q4%?jj5+c%N~zi84(OR?V~Ukm7Qer z$IdlHV?SQ}j{_!7EC@;q%n6Ctikc}}!Brll^Lf5LuTydYZnxT)N4r)M=D4o~Yc}}{ zhZ=X$t+RR)zl6);3_W#Kh54u!tQ1M8uOkWd$vu*d|HM=Fw;8o;yIHFrJ4s$D}P1HP~+bDn=7d;|j+4(l3hlR4k ze5POyM`EouZ_uT)_4Hdrj%shH`jW{1h^en=g?YG*fmXaXhb5hM&)hfPbeO@kpC2_p zRWL`fn+>&FZ2;D;m4rFE#dg}ypPIF#9W`gBf^25kNtkc* z4b}69IRMihuCCVko6QWt2RF1C*AZ6d1L%=-1jeMQQvBA`>HUMkaikWs7jkMnZ`R z=Gei^1aYI3ouuV7H&jKKpD1c>40FH@y0~Dx4qn~ZHPb%fzS$EspLH-xfdkURi%88q z3OJ%*j;i;~ZhLcWZ7ibO{*P8t1iRJ299!F#l{*n6CkI zQiY&PX>w8$9CP2?_CV!N1bf=Sd~**}MW($cX@i;@<+>1(_J@GE8aBN)G+TxCYinDX zcB59T(>69iDqz%&5C5iZ!P--^k+e_So6i7qJyva&aK z9+BX5Sabt(+r60rPzbXEqG8H)(MSK3Bk~hQt)Z)2ZH;5O(WahK@3C&w(dhNjE!CNq>bGTvyi3b(I4TXeF6;zpr_;V%m|8 zQsFU@gvYLodZh8*Tw>ZHE3c$x;S?$CNXVQ-Jn57s?=yOtD(y@gTCjL9%~#}dAVSPs zE@cMu0}F4ya;pu%+O=X4tdcx1)-u^@b4BT9MFPs!c_J}Gk6l$^KDsv-MKBpVI}~OG z#Iz~hSTS0`pD?_C@e^EP@^+Y?a>YDMrdOL)zS=Z2`kPT6GbbRvIl@Y;CWZE)-y1c7WPnv1}myBMfN;}Le zz}&kxPZzJ(hGaCbkpZt$Z2;D;m4vxhX4-wDFYy_H(PLaltpz&~X5Num=HB0%-&HUl z-J8zHQ+rBW&)Q) zFeP|}Bzv(4Cd9Jr4FxZ9T_|F;P;tvnz9;Y7={eVP+95BAD60K%@~I z=&0E1K2A)c*0A}g(G$H43*%!%RAOwCE6 zb=n?v8XmhclJ@h58Itya{LQtOgcZQLJXCnW@pj%Mn9o4Xy^B1ZrX*Qmw)Lf3ZT#|< ztwbu&a8NooC*~l%$k+Fmq`%u-QO2{&R)GsJLyuhmu-0$N`IP&dp%jPHyabdo!sx)g^}5r8BiRBQ0~L_GmlI zI5&q0xtK3io+wK=*5VIpdX(Ze_~mY6pcNme60P)7lD4^-yrBmwEopz} ze~}cFpN61j?GgFoOssa815k5xe|bsp+QKmwAr{YWwEAqRfFi~^s{LK_uOFO<&N|SSYgw8U^bmi$(8!)$PC1H+CL>Y!T8tN-6kM|88 zyQ=QZj?^qPUP>tt~ie1K6UI(w~ z#`NCY9%h-ygmz@2>!R0%LM;t=*2iHExnc)1uY*^ZjTWq>^$1DTO7JSdtb$Oa0nhq4 z%&H=}vDYf3Dw}hy(yLM%^Kcsjtt8XF&5?wjKQ*86`_RG6>+qsdvpzRdB%vCKt3sa? z4scr=3T&?h=+bQrw35`^i?v{lbF+4p^JsPJu`3@U7??I~&&3G5ifLy*#4jfn$}WOk zgPJ>-;`Kf|A3f(BJqvkz!Rr~AqPe_LW9LAze>lN04QvP{XpKv{Um39n5m&uu{*|PTLV?VdzKaNGi%O?-(^q z8l@fPYrs6NmALj^Ch5A)Ei>Z_}NMJsu3j>~r1(O6sbdOQVr?8->m zpk}AN*-$e*jW`{G{4VNcXN+3*DOIXWHg=dl;);0`u}yor4&KPq*B9hXRSSh%Z2;D; z6{|;#O%SU`;z*}7c_Gd5X>V54EWwpoFXU4aW{R4#P{Dl8r5)y170ls)6BJzTCd*A4 zWV0pRyw(8iRvR$4Yb9YGlw*%1=4NuXAoIlS>|7?atbaXiKM6DR*wyLOY-pICIQOfd z>jYGc<1k7)%pWS4qj0szcbCh>;p^qf>bTX$BDQPAOuMg%m#KMR5)|D~BcX~2R?oDr z7K@^t_F-z48+C=6FOO043e-H>$E-E z0(k7|bZQ>6IsS=za~u|;g(*Id`JY!bnoY6IqWtt8AzU!%$}M(m}!#` z11q9KVbg2H;!fE)S(1yl;C|)T2ycvm83w#Z4^$cCDQO=22-?I|f=YHQzqx8e=5XCN3C*tCAp)+Owb`(II96h8qiIhxxJE zo1>WC&U?EJy`9AT$e+F5A(C8PRqcv!cIXQ|5437D23qmnTn^2e#F}Y)G{^MVRn@Z7 ziJFON6SzV>!cUP|*i7ZP$iC1N=BI#J2Blam^VIZK_q4fKuD9}Zy}TD>>4#eM_89)hV^?Nxh8E0;noCT(ml+BRR*RrTh z8^mOJxtf#weMn;BpNX+Nc2%Y3`g8N5a&9KUOYhB6(q`x*4YS&EVQp`RS&8Cgz^j3) z4S){p-D+bI+qGh9HmEA5J<|ToH&ofFMKCYaT-ck-Fk^Y`Fkge32U2N2PbVT|CkbM} z(^3{H(&kL}7qyHY^Kcsjt(cmPHbkA9O$u0#BWwt>gQwOT7QCu)_ zZvH^Q97UVmbV|9Hr$?kIHJDp%0M@RRgqdVc^rEPFsK4;2y7Ji7Mr2E+w|^0UnkmjS z?I4H#h+$vR|BC14vZQTf?w*#kA#tnHLe0rot4E@$Ets2;P;G4hR5>>{YQ@xCP6e9u zv{RKwY&>>ls2S$?PJ6SA@+X5i%4lFF7H>F0Dp15vMg~|r%&%%{u2p(f-axn7fVo{O z3G;2fZ*HXpV{nD5oO~(+T2)84GI zHj|>H5YJIZD`*U}-kS$*2@2e51Lk(Em}#4!eo6!z>6=N9oYrGkhG{p>#$Jp)LNrYO z7yivuBzx>MTklgbme)?rAA*{Pq}H0|%lYnduSeU5&6cjH8vkJ)Ze!?HBE-xfEQOef zO?3Pldf)7Rpen)K*Dx16YiQB4$F4AkfH|(cMW_H;ds9)V4Zz&SKr2bjx7s7J&DDk6 zk)_v#e2NMLt@mby9u~?@%>iKU%QNkAy4z@*ZI7`xXTQwo;T&y&dDz$Lk#Ov0VDDBN zi`cFeGwo1ITu^pu@-DoauLWBY0LZ9#qD@IsvIZ2ltF>`jF+-1Cd4X9Ss06r57`qz} zaRHgB9FbYXaNA-2j-uvp;C9$?tBpl$*Gj_tBAlCDshM&_3f-3=>btReqVMADDWeAe z=IkHxXFJRva)mq!*|?T2BOB#5aH|cN+qIG~M@EIs)ZFiBvjUGK=&`GtM9m*5n8V&8 z-EEp06_BFVskVXHWel`prd`%)C$Uj>5?@}6dsJbqeUv{Jw`Bc{v7SlzH>gKWp=KFR zo9LR-bSI!@TtL=mu8C=H{sb_OR_S`Vxol{rO=d*vl;}R#T;_8!D#{m|x_d1wqT3i~ z#Z0@e?;V+%d&W-NV?0%lT^VZj0kdJ+24>B)Ym*=dn7;?69l4!pyK}Q<1my?3ozDv9 zHhc4TLCwQWI-lK7$vpewicVI>aK8L2_%m0MO&Z)zB?E8G+{|w_)w`QTs*>;3Z+HT9u1L9 zl8l5Zcfqx%pGxg6_6XP>-su80w~6vckSbpb`Lt&}GGgM)UgHuY+F{nzTs14G-K;Ax z*KXFBN2OKm7-+>z`(-o7XK+O@N2cL|vQulne!3~lE3Qb+HS3ERX|mTB%}lk|J2Gn_ z>lex`*WeF;xs8EV66QhKva@F_dOaR?J$7ZNxvjF3GD9kuha6~`03QnV$e%N6*}qWb zA9HD^=2ro8>?R(Wj8fdLUJe6bZeyU;trx)nvy+{+q+x0DM^9wRTX3$yK`IRxJuH+3 z=5f#L%~c<&Zg2J-Fv3+BXgxyUlBBK7cIipcH9cvs^p69E`(uToooTCz z`GMqtwNh|JX6__yh@xPjMg+sT`S~&JGkzaBn0X!UJR7Fn#z@F3)4m4G<8`{Z(BZze z!pf%Z5AvC;D4W*R#tZH?23oPCUCl$K?F>9x_IT{dxXQsC-<6up-b_!SS>OzN^ODiS zLLFw>6xbre-W;Er@wL-}0R}93foZoB!6<5w+L1+suwn#W748jj!7!o~W}SyBrZ6Ph zH#FFY?9Ji=V>Pol&bigbJleIA)EtkrJF~ioH2%#VIjzU83NW{1+GCwEaCA2*QnLz| zo(4^+S%m}4Fvp=A1oPSX#a5(a&ZiAt4FKjg23kpKzJ)Mr=bE#5~-_Kr22_jkJZIvg{n{ z*drdVl{|J;W!jDhDq`B9h&@6l=<&V?1~dH6HH10)Q3Z1n-OKa2jLvf0vxX48w>&?; z3eaY@2n1zYkp^I>-@to^`a&xSb3ZN_2@Q<_uSfCNV^;>|mefqK{mhOW7pXaC)S6vg z(772Qdh<9DIHi+|M)${oM74Qs4Vcpyx|Q&V3R&d zo7I5|%o_`3XWD_H=C~(~_%3EsGUIK)xc3g#`I{3G-DdZ#uL$PhHim8`VD67Jk7lMF zhB|_jN7a?bt_;jAsks32spsZTgJ~!8SvH$4DZ~uLTc$v~b`C6Avs-Nd)~*%r%}Lo# z+l2k|7=h7aS0}^lk7;K=2AJbHNnrD)=cxd-8;IG3T^6mZoA};8;N@URyI-Q_$ZXag zvGLf|4T2d5>^vHfKXck#EBYIkN9!J=4SMBemZj;D)YC74~Q8Sg_LC2mfsZnXh(yH*nB7s2uMB&J=6*$Ez; zo-q%?@>-cTD&}$AC?cyCk%WioxzMIG`olcj#y~3xa}t%#&Ar>RH=j<;bf7u}bJ!H- zYp$3_y%i;^xmuhr=d#EtibEYJn9zsT0L*O+v|?&bN=&;K>X@A#HIyE^ zG9s7{^~m1d?98;4@;i_EWXUq!O}0YG(I7;KTWtW=u9bwj-_zO<-kS&JBGMx^9=p0h zFlRrks5u@NexQmWR2QJatu|n8*NT~Tg__N|xzO#64l(1nHycS?+&mZJf@RQYE0;Me zuXS(Eeni2Xgu=gx67Dp+pdx}_U%k~ZFNV2ApFMHPiMO<;i1LCsVUO zn6-0FJlJfPmvk8+;wn+jfP0j&q;Ati?cHjV*H)CB05G&_HU?Trn8QJdX-CF5%%ktQ z$F2;_UPQ3=wqTL*Z$1!D8#cNJ(XJTpb(Wo2C%l~}!YsWXWdcxo8tgOeUu7PgHM?&n zn9mf`j;e0#oyng!lfO2WonB#9T2Yd;EA+WrZz1k!BM{GQHWngZ6ZZ5jY z5jB(JYsk?G$nmuxX@9Ix`}hM!PcN^Kc~-OeavMfzPEOH7k(e$arhUy7>FQ#dujpVR zE}Acw%OkhV0bNVG)W$s8wPKh}z+LFHwWRIw_RwQj2If{Gm}J`0>w?*LPm@@X{S8K~ zS?m!3vsRCEFw3R$3A6EUZnrlJlRuRNfr3&LVg7wrm=)R64VB2>c+of;`^7S)*kR3# z3e36LZ4B@LK2QxyOglD#!fv{Hq}4@aPo(n=IrfNnDlqL##Tr5E5iFENJwnv{l;4Xy z8oK47*v@KCP=>+CC(Ofb476gHUxr*4MXw8j*-$fCY!}T6K+R7WJuH+R=2ro8v|Lh+VZKG@l{9pQ&#p^2MaY5%z>iju!}t+ zSK>y&Ou^EHgB-z3IU?C23GqJaqqISI1_oZM{aAUw#vsbB`&zr~*| z)ZB~GfGbdR{0aoM47F0bRw4snl~%Q5pw(?<+U7vjE?NPlK9HeV8QfyVSC!)eVY0DM zc9_oqbL<8|rFI81_!t)5IKH;pn+e<^%zIJ(kjg|^*<(aI%qzfL4b57cjkN-Ewp+_Q z==iaFCFW6SRXYY+Noo#nU&hx8HM=tHeVB=TOS(=%ov}v2oc$!DXondGs*rO0mSc~s zck3AiFxUeOA1bxGxL{Zsyq$ijc`wSJGt&-1%?CovbTCtp9huH5onDe@jmYmIL(s|y zJY+&OC2O1IqD%*Nn4c3h4?=Tpu7;SY6^|;^Tw5Ezyj`o8Rs zV0kS}n_vzUHFr##7sBU(sKCp8DCpVk*vlSCzlV zrEPCc(ts=EVHbNuu7uCnBW7=IYF1D*5~3YhP;)dM73i2rEi0MfgC6WKpLHT9jtVbM~wy@6T5RQd( z2o!R;pM8d5M*QUZbYscLh+qdUB5O~=6@jg`Hehbo>b9PnE7a@?GuiqTQXjCglae3| zbee7@f@KNAZlPv^c?G83sYm2W_&hgPV0Jw>_t>m}c4@L0D&9BWSJXV^5>#Y|`I;-{ z2h=0A*9sN7?5-|w62YPu?wgy6U`1On39hsr@c{GF4(2@(%qKOwOWGxv`!;HRk5S7S zQ*!{AtJWiR!3u&3HP_b03*N4k+?$iK2o{d?LE0lW9=j?~vr><^?#*O2BJ8w@n$4A@ zc!KB!4>*)|rmZFI&Q(sn@GmILXQ1Y4N|R36=}p<$dT%aD+SvPppe$*FS=y=jaR>8l z*qcQzxdP1Co7I8pILsd?m=BozbvIPLso8aJHX>MG8~>4)WG@5E|2dt?%%^w2h zh(c+T=WDZY5kbJUrB~#RLPs6>)32M;7-%I$u>QE@L)E)|j<2pT7qwuxtD^6E*&ir) z;bfyqJIvn!%t?bNQ3WvFY6Gx#tytL^YIkPkTw@HkZ>X!BK2Wv1p`xn`oSW$)a>z2b zNZpIh>FZ^t=Ke^3;W7M=$F9t|xz*JLDYQxO5?2@UDH6#| z)KmHi6DPdWQQD|^mN3k12?U;7) zCE0t%8)IN@C4w=7Rv~5xUlpE0Jn3i!Fcwm!9cFdFCRe%3*<>r+EXcq-*sV$FH>pbw zNHrG}s<%N+u>|IqyNrQWlA7ajInc6+^0&?x6fihlOldkiEjkx2*YeoAhk*S9#`4%z z6=uhaNOFaYBT2($$Je(M6`ym7$=hKL6g7uqH-=iRt=ZjywZuHCtzHVI-HMutPm|-T zf|)|Iswav<(#w8b!Ti&zR8jxzFs~HMQRD_ewRQ)ydcW~b8)|MZf<=mHE5M17i_is{ zX@6V6T&o`G^!)Gzr?6Dhxr;XSFJ}nTd)(Ewt=|~)82!bY(|Pv{uIpF&oFwR zB0Dt)fVmo!qT8EKgxOejwuIRq)7Fx92eW+PeHsaQq~_Az?98+ugPN;x!8)^o6RFuF z%%?K#r+~S)O4li=g6ZP_aG>;kt%ta_kjdNkzqWkB=HWI5T1gSCXYvuL8>&RB#XLGb zdF;xZn_H?!3L+T6ERI%kzYa$k_U4~s^fFc2_hzl^Og8C!c3Y*icFN$$ zn+Mrkq^+6c^CLU-8`-3O^WJ+q0JGZ|XeD9pmBXg@Og2G}*m&&fbeKKt%_2Na@glO< z83_rJcqV%@4pfdzo9w<2{*4aIDs&V*_0#V%^&;F?jYp({Ip79)*q<#n%gaR*)rcTe zx7wh~cC92e$KxS-QRn7?Hu>|IRmfvkhMHTM6%d|#Fl*yKiXQ@)&lKE>Cm&$i0_GuU zI017t0xzlhF6oGJIM;9G1iVf+7kiAl_yGV_TGft$RubmKWH4cvDV7o{cvM7t?8?C0 zGM=`u0Am^!=0ZhRxnE|~vd?mfb+E&H2AHd{N4guT6Ls1Z^@zL4pD&mncQ8w~1A_2L z&8J>nh$I*4KvkmV0i)KOnghTbW%*)uz6glHNK^I+>$X?(^x##-;o4G-cEIizi+H$| zZ49*Hy}1(1aiE=R)|9YvIo(aRv-^3lp_Hcir8MWw)_KZao<~p47|UZ<=G=^{3s-6; zaD~Yq?XTj=?1DNjm@*c^%-R`p}-!5kV?Sp*w~TKjpKZ_{i^8IqWY7o?nLw}NIGFhM35%V$>=n2%EPzIsH7 zVByfvF+XKW1jD3J+F`y1%tHym#cWDUo0MS3{yJAV>k47f3zBv_%g%jCyAV$sFlPay zhY>9>j|Qo#NI9J=hn-sewp(q?qg^Y>v~S@>q^9Op2P!&EjgdT%o{WuW7$bRL`W=Qj z`}M@f5=-_J$74k^}VDP86rW!l9XDsi{O;7Y*vVEz?`wK>e!+@Pao zUWYp#VJ>VfLZO$PLj5y=2)DY<&(4?VG8dfYsz&+i_U03{V5jZP z;bvon2+a()HhU(VJ;r1 zh?)(|Cj6WD4lrlG(-dYcX^*P$2kHVwRBLz93KaJO6KX-tC71_V@S;ea%7B-?OES2z z&lSuYE-lm?jbY(SCVy@kD!1DB*l9Z{JNIBFnY-x54w%2laATqD)O^Mj$>h%sf)3`&yNoZe=%-UNr4~~`DM~Ou zQPkWF=3(FL%~491w9EVXf{Mv*p00(-HYEoo*GNh`9!&G|bzZPFpjf)=ZG9E|Y%1}~ z-NryGJ~x-GM?$0hoTO_qKb|ynuqe#SJYp=5T^X2RR&bP>_YYJ;%gM(m`D7;halkO6 z)RPy{&{wnha!VJEbWL%W?&L`eMjnx`as#5~ig;8T8>muyolj-pWiy$=6XsEARXYY+ z@wvHdjvw{4zQp5U*JD>zo%T_f_a$xVNW<16!llNnCqm1h#6nq^Ho+WpFw5n`O8JD@ z=(Jm!6_5p(qUL>=;TqQ*W-WpZg)u%^2rVWB)@)v&@)H@Eys;sttBso~(P<1Uy`<)7 zP>R4C_is(K0;oq^soB6xPsQYc&}shy6DbzTPR(ba<_>1L5M0A!ByRqt)JlN~P(}Vnz?kdzhL9%$jL;Fv}(L`Nn8!ZVU5BUqqG;RDZN2AVF4qF`FX>)ba-m+6(L`qvQIKI*@ZSI>tui*Z7 zTw0hm!Tgvjes5Izr7W^Zn3J)$J-D$E}%cpJkU0OrAT_SRdCPe{bHU25Y6Z`Vqx zM@me4*w-SMNAcKWSB9EfX~8tOVL>s%93xZkVp&nzsd?4GESC-|Oh4_qqM`UCGBC=P@pp_keQR(<~lMW7+`j?1=G|l?6gOunr4e_dK!b8Gq}pBfXfz` z$Aznl0bNC02oJMHYOTPnHeR=Ott8V9qY~3D zSJ)UKg;_#^h}Hp;_~*rs2P=zYR0=*wu-9v$P%wqi8%X9Hn^v*}vwk7L!J4 zhxrV9vv7P}Zu7;a-V_(>0%ufN#C^30E%-0>va`~`QK4I2OyFJV>D=5MI=Zso&n4bdX;pNqm z@6_i)@JQFRuhp2?yVb@bwrj-)s$OYt9+*JO9&G_Uc4e5h516B*K+S+zl~`UoHJby~ zHl18t@vk%;TA$o%V;=2Vu?RNOJerlAg}V%o*m&&fCNXWT1sk|Q;8y$Pg!u+B?Ep+W z?#|6(DYR3;={bT8HRC|#cy1PM>>`qoJV6&+Ut|??;Ru)a*6}T1lo&S%}T&a}vF8yvbh+n2RQVbZ$;KtDJly(>IlkJqckP^szz@ zVbl-9+zS%~^~}R$Ldi_F;z&Y==X*;s+pPWL+7yxgV%xw{2mrZ_fmVEO9_zqCyf^o5 zUob~kY9{Luk@`Rwk=&Iq^V1-G%ESru5R%glvw9zhn!5iNU0 z4^+c9a>0Sg?j9y#8qz}#sx~Q-o9Ms+v)dSGC1H+?*E%!pg13#wSmz$QGBCFi!GuPH z-PoCih4CLhjWcCE0xNq^w}qOMf=6T*FiP-jpRRI71Oqj@UR{s{m=e51cnU*p*-*~) z4x$u*9_%m&+@K2>#p~b|=E~me3iE)&zmcR}g87}sFjGVtI+K9xNz!f^%&|6G6<$ER zZf;}fR^sZSaPP=WI}G&+>xOznYO{j2mYw3jOsrb6@1z)kx4Frmf?11Tee$88tUlQ~ zoijqOh51au9EFrYE}dHD4>3 z!_gw$ZSsbeU=%&rsWxD4*Gj@X?3M1D6O#hgqw30ISAJoRHT#Yez^s!YD9PInvzD}z zTJM+&CwHq2nA^2tm? zM6kq&V6(*+ck8Ryg4L3e_%6iti%88&Dn=Qbl?=D(Zgn-MfUUy3?cj+|--vtc$}sKc z53`oEqY342YHW>9HU;UFEM=uzLcMXIcm)8M+ZbrYFefFGzbMvUcr^L&*i{u~ClO2< z6Uc1r^hBp+5zLXl8^CG=j*c~E1wuWt@5Vk$DGB?sp%liq(+w+YnBDHQ_h62CdMj31 zFk{*2QEu|s)#)(rF>Q5;LEjBBFztV|&%EtS`wUFGpT9X-u4j#W*oi(<(uztBzgQmT zf_r=%fVquye72?YcMnV%kF(jpY#~ zLD-LoXroO2-mNxZZr4h}+&7^{l(N&PN6Otc*hb2~&Njmnx;l}XMHoh0M2e@P57o~x zaY8+!Coc>(_k%e~5o`!!u{=sh#+>i+#aqo3VN|!gQZ=7354SPUO2QnKb3}&41Jym@ z<0=kI;v^-c<+e`AH%HR0z$|aA1mL5r1atPY47*JP8)~zHsORS27Gt8p!Ya^fDk{n@xT$Y*q;H73J+J zXuPZcM!`O?ArZ35Z!76k9Msj%)PP?Ro{GZLl0EifEU&yu6r|yV9ElF zj0tqQG2jwsnMSqUxoz_fpGs|}djwURK${nABbWSF*4#)*^EJk74w zv&HtJ0hccQG|bRrSH`llEj9at`5G_}-dN7>-MhO=*RRhObe(tijSCTLd2_X(2j!HehboO2SMIMCgV0=EUR%^?0r1u`9DTgK4{-o9P(Ex#Z~F92d+AuqQ*g zg@v)htlo<}iYqa7-SRhQyS2Q~FEK;@h z!{OMhZ1y=t&7a~D3uT8{9jtS@dR}P*i(n)8b*;XnQoA-W73NWCRXYY+Ntlyz=9(nY zH&h<6@z_;iZ&v4KcbE&*T(HyD)U1dU3uT8{t49Wti`jhMSX1v-ThGI3478Fk_f6U< zb#-CL+aop}yE4=artK|Mg0 zdXm@gl;ySZ4+p=%Jlw`WD+zNvDn%tKiZRlq!|)l`@v)KjfCq*5F6a2o@ym}wh7S3Wo2{A}!+n%lxmBAD=lB*4X!Syh;J zp~OO2U>+xinq$h!y_^Q;bIOE3&QZrA$26_SbHhB`#y~3xbI(M3Q|b}pb>Z=n*kf0Q zn!&Uk)gvOS9P6}2^iDoOi|-Pc_`%60`z#Zy9p*Do^T3VLI%+n=ReHkPX<%+e%@ksW zQh}=b=2DJGs7De;44>-Av^>b9}tQ zl@f2KVcKo?=E2=)z%UPR^BmH5N%n^fE8N(#KR5=ndJibd-!h-(O|wu1fm3De`06$W z)=N_Jpd4Z*OkVW+W)i##)SQ_2NmH{z4+~|d<}-c|^042DU}7n5&bgUbbwV~HOwIIE zg!ykWYT2)Ic^qafg7w_QBe&X^N4r)ptqA4`=C}}ICSIhQea%QnIJd~#U7y0GH z*=Rf!QTF!!P~ z;0APcF}>QX7EMET1{AwMn`x6<@v`154D)as1Fa-A$76j{!PH!Ec*bOwA`I{LV!2Ky zA|DHRJYVMI9zr2!m80i!P2prWX1&Z4#`4(Ji7=Dyi*jA41VzG)-Ap!9vqj)2Ox_N& zmb5#awtV4zO4|BBg^S3e)LcyLy9e`VKWw_f_2ZA2NRPlg7^L4-)J*=(l)srakNmmSF2mex478Fk_l8>HVx~Qa^%pNB%tX!P{is~!Naj|G z5*g+1rx`UkzyfYN%%1?}K{lUl8sMwoSG5}^0tR4iW1y9UdDz!x*=lbdXqY{6T8~|s zy%{>~Q>eM%5!ut!tb#aZ>i*dda{!n_H#;r2+5oIwD;B|CHgkNrH-m;L*i1p~2`UCJ z&Mp{5JIvqdV3zy|FQQLs)*{&H)VvQfsJSuBFz6;Xb~j4vEIX~j3*H!?Oj`(E<`M%i zL-aaM%^!lAJO5_65FD@ii)B-!x{vKc+cGe?eDV`0? zZ9=n_4pc@2qpWf`P(cJcx;MWHm?O#@NKxNJOw;*1U!PxDnUeg6i}Z?g*%Y;}zMA@1 z@G-YB(26DPsN@kj9BI*ec6qs5h){KORJe4H@FymTu{?HVm^RMM?&=X-M3O$N5Ety@ zfKmJSF_)P9VQNm|MB9Qzp_>hLXQxfEdZ%O?S@*1Um|IDSz`wUs#AILr@u* zwJI^99p;eVhddm2Oj|6)GiBP(59R89k)@T~FKLe2fi?9ItNG7Q?y^Tos(V717mC|N-9 z^L$IuRyVuZWHzk>IcQYJpa#I)#y~3x^PrNy z*}%NoTv6@~VQktY9i*97;R$1T?8>;xftv57BJ<{FZ>+AGr9R;nn1|aKXvNfQ1Zx(-hLQH2 z^LW_x*p-2~rOBW0YSylD2)Qi2OFv=M(m<7;aCsQ!coZ6Hj@)$GZnXheyH>n6m#O(S zg-vg>HxmsL#}#I~LL)*MsSJ%}e~)3!{tlN|UK`8>$Jah(8CsHRL|8YO4y{iqCA$z= zyPN64Fb}se(28L;xdN4XB#KaBw)o;s_`I%`GqPF~4nM-_m3G8QKHUjp2`S;vCi2G} zp7As2szA+ck_SqrjSGv2%nA$^+OqSkDa`un!Z9vbJGyMw>ZPS-(qyZ9sZ(Lr%FYgE zNf|zGsEnlDl4+B$Ewo@#1lyzLM@+@p8JA#17N$Lp(|{|IPTTFU<5nBin-VOCIoU14Trjw>%K({8gj6DiZZlya$| zr(#eFg&OXi>tRm9#6%Kuv>s^(Si4p)%-(D?U=-p+YQI1W2ee>PzQ(zkZZAZ(NJZh< zHx)JaRJq{tFf|L91Fk?JX518!Zng2cwQI#N-)1}QmV0y2m|zcP*n%~N`K*IkQWRdq zXDWg{Cu)ug>Jh%WV6I9RJ;(lZ#YO~*MU<6w(_>?xm89m#gc?y=u)e;C^oWhet_tVo zHqOHL!u@nJ+0D~+J9W04`!ne3M406H!3Oy}pKM8Sl&+_<<@q|j3^vJai)}E?S0ptEwU+|4`fqhY2sy=llZ1zUFc{9fZ1tpCYZ^dfCI}2Lq9hDlTV1ei`qHJcQ$9&Zmlc2#BCr%*GJf(qLq zP0gQE%v+TfYNo`#nrTOAHYE^*CG0AlVGGtwy8K{jPiPxo9lrL_jR2Tw)np8`k}$`S zu_BnClc{Gf($wq`8;@O`2s3F!bQEoRk^$8DyIxk3w6h;#xa}|-rcIfpNWhw;WRKq< zpom*-0M@RRgt~ms`8&4gZYdrIOm~ir?za@O2Rz6&1MBnBMFu4w8@x2s5pfkFDpA~zZTGE{~x3F zzkg~a9{~GdYVMI`XTS{z=5+DqEZ;W0j-ZJ6GC00ywLI!Z30iR*1Fe{vjl{)!bAPB0 zR35EvJ$7Z7c3UH%q0aM4PbxY-Jq>VWk$#8KgVB&3X1zCanr_?_ZjV8?SMjJO41mds zdrkHBec%DDB+Q9P@X9a`Lv20cQFZ09s{+hTZ>UPtJb*_erSpvomYtBOK33>qp$@=I zd4NfZK?AyPcB3@ZPPf~1^7;Xc_P)YA&}#1=tsl_pwoFlvAor5)w~Fh`UWf^^wUlU;D_rdl)1 z!)*+-lGGgabl@PhH;?oe9#26YyE050Fxw^V!}rZ3d#TtXWR9=Rg~Ac2Iep6LAyJVX zW){^bN954W>aw%!w3@Zz?KCjMhsqu1M8zm50v?YtWsVQH;cR1vS-lTrRxn#r=#f;o zE;JFh-D=~Pw`(P-xsdaKskvtoQ+edH9=odEP`Sc9WFsNorIq!F_%8dunTio68=vhk zf4~j$aO8HT?Ly4#2}Q*Zc&80Dw>nS}xCUl%kHJPldoZ6VxE1U+mq92ShPD%zAH*+#qnP{gT7njGF0CRl2$mx-X(;23IicGRz9S<1jx3)9zg5 z@`zvVHU?U;q+PZJ3yWdX@8^`g_q@h`*)lQxHOBI3*{P|y)w!9hvrWuS5tKs8+;V%? z0i!<4=t1&6Ac85Fp8{qI7)8$Di^+C&pG?AzGGn*eSj2X%B+UJ?q@5%>1#EtmpJ1Xb zp~eh7c4er!txlVeR?!Mb_EMhC1bv(-Ymw}03g&NdX@_|QnEUj~ZHaQ}C_G)yR{Ax! zJh;`yBDQNKVJ1^n^up>9(ih+hkGZuyc4f3+E%)XEH51H*SiG8=e?h_g+A)}~0dsFN zTaXoqxTU(DLsVGaOupMYCaDu$F~Y%-_L&t-Iq0-N4{l(jRuwA?hQjd{3@p<4+p*l!;`BbWtl^7k*0MRvW*(T`S473&hKkc659E zn;~gCF>O+Ds?#z*6`UfG;{w4bu)KDd15oqO%~sQ`Hs;Z;m4x{g8u049xs`f^z@@Bm z!m_jS1Z$CUX@Pk-f-hYjCFy*!yjacyiVjvJTg$UsZNS{F6;pFL2?7OR%+KeRbde;t!l?WD+zN_jwF;A+&yY2J$7YaZcEKYn5909z7XGOn9mi=3U)ip zj}_CV@SPO=jY#6&EL+bg_v?{e+O0MKYuAclE=$^UGly<(rh3HnhN|RTqaf8x+fcKC z8PxnHqiBcuDPWF745cQbQBhyx;WP$XNtlNwK9mx{Vy*qu zli)iG@sU`!m{numjj=p-WvCeKXnDDL zog(}S%Ow%=jjkLQg3sK~1F}cn?2efDVun7u(vmhru%id6Vu%@O5TukMWat--#j^9? z#~(6rqQvCwOgjKI_sMvdLa|bk#RVOpj~Z%IyuPER2bh(iX16ggdkJ$`4H$K6m^NT` zW!j_-5xOthrRhnT{L#}WgXr})8NKWtmv)%X0Q0CA9e0zj1XWCPvGE$T3Qume0a&|M z66XF$qsn{pu&1Lt66KPFOxm6KYr(yg_Cz5|3X&Fb^R`h^XUx!JS7vVp%txuY=n=`_ z8kh^ztYKDg>&cT{#bh;`FSlWo=43WDq(IzJOo!zFFeh$Ouv=}+qg^Wrb8_n>Z3A;F z170FqV>2RrEm-X-o}m3gbU&1bsX2}cK2%jBp<0zyOAWV%iL@@SIXGqyHd41R=nT5$!OCVA^p7xXl~+T!vpY{hKGZ+L%YX zR+5^duyhd_8=1@_33}|x2h1v30a0@?W+##!pv3Z8VD2Zzxu!?LN9PfF=b0GrLIgW1 zY40DXD1S4eXsfV}#K=WXXPEdQG;8`{Ez>5L&p^$|WVt)PFywmV$*s12-JHfiD@o0T zfV(VdQ<8C1@aV?qu`5H(&mZQefVuCcp>nGYJleHVB3SuA^@6*~5#3Gu+DNDzo1jYCZnXh(%T~fjXwcKv_e{-$q1J+VwCwTNm7(Ug2dX`$ ztzagm9fE1YnF2i7vNsQ7RLG;Mq)j&ym!$tctP!gSQ?;Sf0du8Q?HFh!sW~yaO~tg0 zQsA|pwQKeA?9HWfGr_Ew zHa!VtClvzvEKuLhxtRUm`94u6dcvr^^wACi$R$I@*X$-WI)Z7cT6@gNAnwXs)54#?_ zGBCGd+Fq$S0L(qNfDyu;c|D^zVvU*sutt@&G=o+W=D`aPl;RX>juX8u0n7>GNYhjGo_b7XZi8I@%@@+2dFkf?pJgnM+)dq8_ycAu) zC{P<{%P?*1&5r63VKc(IF9A5q-1L-$S_J#1g8BE3!5jc)Sax1qt@8DDO(xql2c#gF z=l3YnIlEmQZ-QUmxPe?Uv|>qnSc>u&4zybAMLkea%yXp$qYyJn*(si~&oF9W+9>VR z{1`9~SCl}ET%rPTo~2{(kqm;Uy}ckW8@$KX5`dvqvoX+09jNs6vQl;qbZDWQsRc9C z+)4yvuM1|{Wc8=6B;`}~XN+3*r~9Q1<{>VoMgHdQKt+r8O!sD25sZRTs7OLW>^4M{ ztrfgeE4e7PYU5b4G}eb0&P{9wktK0 zJ*T>`5Km@!o#R5~y1@*(sqKGRh%lFFWpNO zL(G)+WQ=HsSt~n5T(Hip;Eu<5+69qh`G~J0>WSu}8#qUgz%$p+tw6>AWtM z_j3|fKTke9%lUm1wuQ3Rh`*vO7)f2qNJu`(`)2i|&GEm(M4GD7PR;s2)h5J@wC`+! zGh~Dg=H@WdeKWzVjqq`aLHe**Us=G4M3okpdqXXPh24QlQie~aZBl`@^tu@78>#_0 zuk&3M>9qUVL#E4#-VnawVn>?meuzNB=QP2xo1=VCPjz;ZTNou}*F*}V;yQNtH8Suh- z#K0`R%W@`8BqqXVJIpvYlSky$YProR8)!|EF~c|J%Qu2-zFba&6&>|AyLGK6C8*hL z4Bd)Tnv{%$dM42FO?Q=RPt6AASW)vH%p(Q2g53f$`A}&sn6w3>!#inWW)$Z%T?-T^ zuLql)OtPmG*YSLv7obe<*Z;eDA;c2^6SiQ@$3QDd&Aq4;Fe)7BC>1x<7EB+g;3{`? zZ!Sd=G8Y!&$t>x|iU*^_LLG*=N3IsCK_2#&`82;w12XuVtuAC{P1A4nNgt}0_sIP3 z{7Bqt%)@OAv|^?`C{c4{JYhZRG(2`?n08~Bi^@*AZziRPN`fGs3<%l3xg-BjVxcTB z#|25dY716-$gRlComl~3z@k^r%}1%Z2s4}fv1KPo+KPQkJ+}@@p@_8JRjx-cU-Nr$ z$mFks`7|w<@o#Qfp^G%}WGcfI{0q+~>`f_VCwXaZfZEb8gdtZqnZT zxPw_TTfB%KVZKS!tk2E8d^Mx2K5rh)a=}~Bf)t%}a?Xtb1h%F_B^J?b478HeoS0*> z3Q955K2#p#se0_n9H?4q!Gxowf)pLr{L#F#A4GIh~tJFvrCkD!{B_cH+gd!+gf?0cpXyV2)xb zo=H%ORyyqx%!yExNV+EfX2AS2j9#Wn3(Rq7?wb?0C_iqs@w&BZ#gcY8rAaT+0k%D2 z+De3g3)&ov|c){wmr%pUvinNi|V<#W7?-N?E=io||5kp^nB05Erf zmgP#kkW71=YM84&RNd9Z4WMQfsgtO=$h3coi8E7S(~nW}7_nO^34&YXdbiqo9$n^| z#?CdwwCR>v*@97q3-dJ2{zSp7A_!&wlt0_{=CR2`HFOJtEQ2f?q2S09V0Ie=t)!%V z`vNT+5v-*aj1nFoo;K~$CP?crLwar;sM2FFpK%2W=ICa1scbqMHUeM`tE-m=tt8C1 zIm#cbM_dn7MVOKGg2e8zhFPhqGbNJQsrjjbISSn%=wP-oFua|Hn%lxmtXlau8^A@_ znd}c3H4XPS`LiA7?*QhcgIO$vN9#cYGnls1xtaE61G9KC@0EsG!HpNo4)Z5~IaZn2 zbINdCD`WF$Wcn3sFV@TSa29VfCHaJTxQ&5Ul4|w$$uR z1VeoFJnGeILrSm(L9Ie;UgY>%o6EC|Ti{k3^Jv$K_vV52T4xa~G9s8q-*b;$ooMn$;PyCqpnM98 z%Fe&T#F?$Q#PZr;9vPUcUKia(YuD~x}L za+T9YLh{KFQuf0NURB~9wZnYf!7P^#E9DbrEorxf*|^FHzzZ<{O;?!D0CP2SO|8nR zVp3GA7Q-S|TGft$R+4GIj3H+HQS;*t=9ht*L%>`$`E$!dRa+Z$S)t}ett2%^qmrv! zf2e~}c;vJmyShnxvpQgte{+lc&6}&s)pmJ#T$BaOZeyU8ggHz!sw`;_LoIrXOokKo za}lz(_(<+xha6wb{#JUzSRT7FFylbwsM8kyQYzh8L>5D&4`Z=x2>Wc9c)=#@un0z) zG@~Br?6f6cyGhhc5qRZ+O2*=iiq17K`BNp{Q9I0#^{sW_+ ztTD_1_U7ujxmF6U?6RGt4H!UMhH1AvP0vkqnn53upcv~LhKUjyb-CG9Tb>v3v! z6v2pTC(0b3RGi9=gr0`koKefpRe8aseQ(y1cHb?Yrdw^$O1oC9(>4x}O49CY<1mlO zqdaz1VA?G`BKKfcxnBj~8fImm4Y(~Z56Ghi)ST3A#duS7DYoL;%)h#(cmT|9W1y9U z`4-xORhYITHPeAgMk^pmo8lIz163#-U;i^j#Xqk~Mb&nguK{zV{@0`(N)4@S4Pr?PTSF}V4s=`@w7EHe~Qu5%R8NICac+e zxup=SbWL%W^!}tsBc`pmJ9$L99d_JmV;=2VNtkb85(Godtq)X`g-Kjk5a3GEmQV1N z!Iq2C&a}@!%|kZ`+-kp^FdGr9HOz&*S&3j$Jp#*46|JEDhDuQLW57Ie1J12>2lHk| zkuO~(ZE|u|k~UfWDSa4y7iGW9s3C(*_KW=4PR&q{L`goUJ6p1bOv#C8dA?3BgKh9e zdOxS@TMDF5w(~6h+xBSSPQdIo23kp`9gp<&GVje%qU{XC3^&`^x!V$dLm12I=LvME!kU#(g(NNm`BT2B6CeR=;>bO=k!I=(_eVh zP>65nvA86p^*}j-^+kQ+Bq@_-YPR z1h|4(o||!?+9{ap&&^4}>ta~BLGI4YzR%6B2P%S8N!ooxueSVOQyVb@#+O^`nIn-M*@6Elwj;HPMlGtNcC%VdsGn6-& zL%>`O|5nSzD}dEz6Q)aHw~3rZ2;D;m4tbC`?O#h z=C)ceL(K!ai#))zf0EJD%X?T0Mojxvz}&^`lq=ygW@iQF7LvB!n~@`ugt3uZ5`>sw zUIFI*#cUPaTc?xlk+h!tQn}T}>(;WBJW!4GR*ZAAwjP-+zPMXoy%wyNv(0ibTbxVR zNV@)$E|KIZIayw6!Q-%1IcDgwE3-F)nq6Tw)J!6nQjdryErKbXHj*LOMX;v|<|vex zw)0%-K^i)~Hm;3DbQ=S$B-8Gh-~9)AE})mC+5 zpp}G~Zsg2op&scOwU{276Oh~#uZs%PZhxRUX>aZqLbHytd@(y;P&($NbWE89lx#U) zujc7ymR6C=7nJ+=oV1*({=rk1ZU%td#y~3xb6igB+aDCdztJqFJ9-&OH@msoZ1YRW zwzGAfZngmlCghz@3R^v&>I24F=ia)iQgc1bR|`t2oTuAMO0JB1DV3mz?xmmw6Q%~* z96wRie8#1PnhEA>u8@Zv%yK0>!feuwHDlUUm?^}JwjSAo8QQPLFza(OS%r$+>bv!9 zk;@G0^iEY@di@R8o-I@Z{r%ww(2Cm_XvKSTUlT9y&4s%RkM|88yK<%GMLjk5%+hLV zR_I}&?9_Y)Y93CA*)2Dd<*Jcgu3K$A52rEEieWB$M25YBqW5W>wl@eyU)O;%R=P&2`N4VbIWHMMua z-F@@3&fiS;&HiA16)-0k`QgnRcDBljQ7*dc@E$Jr&g>pyEdPn`5HpGr-(M$CoSdOrqoC zKvf5`K)I~bCM!g)DW1%VYRA`KWg^8w*TX-->s+aw?bh-_-%O_Pgn3k272Ko?)zu?fNtna3dL-%TcyJ!YV~<@Kvw~J4 z7&%%f173Qfu<0UsAb*!+|23nQ{cTnLK9_cw1Fn!$B)GC=XD5RBmb9IynIP>kHOnV? zZU)S6D0nYbc@*ZS9n6wTTS=vVm4)tqBWpJf zC4xnC8w0I)Z#FJd>LRkQ?=o(BPzvnLPB&BpsW9(jR!vVjhYdx?f0t3qeoK{)xU@5E zErLajF_U<^)dpbgT1l9Pw=cwu7QwJLKR>4Z7}VUsELXxKWAG`0oyN4s>30;&QJBuj z0hcm^1myI(*v*%hWcNp>s&sKaqs!Z}qU2ERO{EqXJ*fFmEBhE|C8;@z%2yZWhN@tv z_!=cBU6QFH{SM?eA#leFbZ_!PlTW7-mCSZ5Dumj=xQfj&3?5~GKA)DH7g1#>vgX3N#4k%5pH z&#gA*(XN%G=E10R-%N%E=+>hFm&dMrP%~l_&c5{d^1myYyODD5zR1em*^6mlh= zsZRSOrmeg#h-pV)+8XZfGKzMXzo%f1l6!eR7k(*|<$P-RgYC(!Hps4BD@n~suXNu$ zjP%uoM^5Xpt12}+N!rA;DcX|)SH$)+P-t7Q6{CmcwZp6`QdT+2Lm|D5$mWM+7P6PC z{d230d9-V#M6i+pZ@;IntUSt19=kFyw+%`mD3?Vr<4r~EJJeMCD#M%xT-ss2<_dW@ zB%h0m?PXeTyQiUdtF2*n8Uw8u=8@itSv?XOm`SFXT+C9k=bY5b(|Y=q2aM&htD6M# zhk!Yjs*B5%OeB|gSLsSxN>)}wf58<|@0i*Hi|956T1lAu*GWnw9@Wac}Bw$SgMi2C0hxxmJIgykG^3+sodqBlwbjSDmQnjy?ah$9?J%DK=KlTVC26}z)Nb_WRvUn|Yb9Y0qtf1- z^tI^iF~oq!u3Erc@`x-_Gweu&Fs7+l!3^UN3(Qd=-B@SYDPQ%~pW98vcz8iz%_Wg^O2g zO=@dn9_?C5n1@m6+?>SvF2f@UdhF`N8!A$d6jhv|iSjqp!5q&N++XC<4zuF!U37e2 zs5?GkKKbf`EWng{L_8I!83w$n1Qpp~4*2Jh7VQ6T@5_5+Nw)glM;I0Zk2TF=crc@v znYDv~&g{^4 z{O9`!?<4RLd?L>IMPy}GWMxFhXu9sLtEZRIJ#iwk~r-6BW{id z^Gm=y^-Im>*V}wdq82+B@meY3P*w%&X9a7=H&gx~ zBee5ctNc-c`OAk-H_Rzu9{8PU{dxoDFe(l6+jwq{1@jCCYx2|fD{J7_8!(4aX_(Kj zq=^yQ{kXXuTr+(ym*5&|Nf^6onPiTiGLs^l-NntbA~D?T7khk(Z}y0Y#JTz8)kVV! z776A-4dxMN5-Aq%Q)&v8Gm26dtnZ6mu~pSB=;nkPHFpE*r@JJZLMO7QZQDnh;AX!$ zKqcJVa1zRGcE^Y|jfg|pb91N)MpiIMN}*bIT}z3wz!MAQ;AVo^oSQGTF0@>Wse<_@ zb8K8)P@WMbv@>!du^3aU{4tinfEUl>Fc0&gg?Z$s1^e~JdxTM)tEMe5KT>93vJ;=q zR`A#ie5Es$+)Js`72iRt7LpIZhKXkzW@Rr;DLyXY?}94LQIb^37Nrc>y7&PFoRh2b zZdY8tfAA&A4~M;LotqBbx<6n(q$+A;$L0VPYuYy38(%~YZKAMcbf|~8+#Ic39zbiNU`BoXcSGUP+aed;r z4Z!^70F{P$l9`YxhIueG>E9wI!HzhTg*kL@rgFaGGcqNl z&ioELe!cM?VN{}m84o{(c``CEM`Xc>L$zV{)wJt*!QfV)_G@$B{4v8^e8NvR%vaoj zt}gr_xUCjDV&i#d{#Nt-U0~MY&KG70UZ?Gt?jpq4U|X>J~*jRV!lhG9gMv=N7T`hhB*(EdbVPG`3i z$94j(+JE-z4Zy;vG|ZXJk}fKkO-d0Fn}|a_U1%S|%$l~^rOU?Nj6K@T%`XA-cv-FQ zHX5=#}zx!~6;`PdcxcTPx$&8;cl5rD2{-8r~!0 znUUfV-7zB$Wnsp-+4mx{esz)6HElty{5eJs%jFr2OW-FpEk~wJzus zOcCYfrnq_J9B2nXHGlBy4Zy;vG|XdL$CqKQg<(X@*%omq%gz1FBkdb1ifT3BN7I&h#IScnNgHvf z=furxz&wQZLIz1^^(hN9dYg>p_CFnI0WeVYn*&rD=B%0iEu9(M%}cytY10qR%~l1Q zwNx-?23~E`&TGjWGb+SR&evKw(sxo9XYxC~}~((KZpWi8$2LVJ5d-wIk~oDqWFE zpf?&eYF!BI4sITf>_uc+Z60@&0sTll$Yap^^#(v;R2t@dY7}ei&4#@rs>czBvM}S^ z?8VJ=Xr_!K;#NQ=PAP6e2G9x2BIQpAH!nK5nP4`Ww#q%SBImEoBjtN*r+aHctrO8~ zA0O7c)x&8S0GR#e02Om{v#Q)AH8+!Qs-{icEdHEyS{AP`YRybuFo|<6f8Z3%pKu2< zkNBxa7Zt4e;hUfFb;jgo3-bXt1Ll+5{3&3b^~*beKgO>&{_-#?*0j$#HETa#uvQTS zE40ZTCfs}gbI$0MCt?1Yz?@}zSE@d|rAw;fw5?kAUP~%5VDEeaX1_T=#d~v0Xy@jJ zD&mG3aVTr-jIlSP@Yn&&_kCgh7~DM3e_(Gzq+f3U7DlCEeiMwH;VRfuh4wpu`I37? zuf%6^LltNRqYS(Vm7^212yN9Wze~7SZm4imxTs)i?Vgp;Cigzkw8@oM zj#l)$tQ-o=-z(3QpKh41xI>i={nR7B-VoYhROhOKnW&4P?)~(*1_7W#Icg_JS z&CLUwSDCqaFtAQS6?xGglsQoDf5pwid^z9J-L{rU+xf1d8<*t`+4xq=rsWQEJzH)@ zp8QPRP$dHI_Z&XmFuwxK0S>(Cg6d}VL67@sEaJt1cSU8dtD7&=4asWp!bTFS0+IBu z5#LOEv*_2v*G2^+2VN-}SpJ~EEKfJguLWl1j_>QIeS!I?JqX{l-J63hBI)Yl0A|Ts zK!97Dw$!>P<>`i5RB_U@=gaNtVM%3ud;Pna-`>tCDf5newJA;9T0!pqhrir!4p3>K zo!h+1auGQ;R~HeJU`HG(2Fz9kL**KBH5fr?7gx-r@FsD?{El#QI`Ye0@7EiEg;8mk zvu2jRGs=!1%FPN=j`QVk{a_!cDZlXOBT~SVpGh7-EY|t|EX|JKp=DxT)5FE~K_5XtR@S6ivtZ9!L zZUr@WlGd=^u{8& z6MH={AD;-O5G zv8HV!<5+0t6LX-782A)%D0`s7)rD6?q}qhZhnF;MX+e-u!YEus$`cFa652IC?Qub# zey)oOI|EvNz40DlR19-7HET989=#C{yAg-7Fyp@23uc`)NL#_Ag{3E$XDoy9#PYgf zHr#xvb)lE;IoY%o8?%0`TC9TUmf_}a7r5o=hWUy+QeLoPv%BB)aNXsP%C9#*w=gQr z%@lTlQCMh?rlvsA!+xu(q;21)S{ggaTR@i-%j$YJe^Djmj=bGh-5CrpcEq9Dn)XR< zu4nlp9#-D>*=$lPX2Of#OyY=_cf*VW)dgn$-Xp?nUH))x_Jx^3Y6eGPmiT7Ci>Djr z1l&CGbI0@RjrRzn(%k$excr@j`S6B{1oVK@zfmi%@pSnvqgH;2pIBZ8%+rC***Sc8 zT(O$Dpp3h>#fAi4N7>hQZ>u4+TX>H)Ro5J#(lC#kRprK3^^T|>M;yuuZD`uJl+gHi zwkEoSe0*%>?5u~>AnJmCmz(r&UtyRLB6S?*Y%nPj?nvq1{NkJF(vBiSz%H)2x=0y4ER-AOE5JOtuZo+3;>_)6T`j-fc#l9T zZR{L3Y}x~xj3ivTiKu0gtG;V9wJDNih~8)kc;@-sws`UKe*k`~^> zZw^ptZa!;cr}%<>e%vfcksRyKAHt=Y4=H^V>I4ReCMdEmEi`t`==7D)A`?9HDa z%vXSUkXL0sLu32)fU>_FgM%^G!JXH0_JPw@+YnGTNt(S8xNmuZZ>=KWLfOD zRZoXMa*6Qj4Vc5ISOpuJ92C4a4{YFTM3;|PJeMg2;tYaBVg)%A#FQwEV-28bakxz&swqp}R_F*QELF9`5o>+Hf{gl8uR_0YydF7IY6ahKEomiEurnD zf;nN%W-XWnZa2&cU><96wV;wx&Y0#pnzfEpiAtS^>;JXc24H@3fQnVHNz)2u!!ROx z-9{YBmzx_ZSX7wpfeKo16Qbik`}GE3VN@FCGc42njJVkxsHT1p`1QWP+@nTh_uj0N zv^Mu<*^|rey_wt!jL@DcM_h`&wGOBM$XMZYKLR zd4MUm0%_H_8NOih#PS~J=6oHgP6^CUF^kZc~w zpM7?GqiKg;T@cK2FC`I?ny<5AiFD~dDtojj(r%cI3YKs0SNp|Hwdq&Y#IH913!~C7 zk8|}7&-mF`? zRFSk0B3H^(c)DRWLVJ9HSxLZ%H&l^fR?dG6^VGmRVxe8i(+%?#cl0iT;P+AB0}rEO z73>YDL*=zM6QmS2m}3d;*8+2v`a$5=`vP;1`{tJSNJOCx^GG(hnHQ9~ zan;i!pL_T0Y@8ka=D^3n+&nZgnl!h(tiil$99Y$Q8AwMHgX zP8@j4&g}R(9jFrF=G4;)7Ip#-qtY&uLOUJ$T`TzY2Fzhp8s;;+x@aA!ykI6P zn7U|&iSyv_vY=q+>o8b zJ~j8-CjKp`$}YKfQ=UwPEfyk2Ep~ zX%_;WKZsi7R-pKrTjTPYnX{bA^T+w=;^xc-*NpK8-WKzPO1VmD^6sjwPLo$#dNgbQ zm3;9xy98wDaPVy6fzGv24*K&CpwcjpvWEA_Ff$>Ncy<45>1I~U6>+FG%-!640_NPj zYhqxYF}&vGX#uX+^TldM+59MR<9ic*CYxlnz4_*GyI%G^PbK6Bvf1gBQ51AhZpe1l zrN7}l{N?}^@6FAsa=A@LLXlqUIR%TXHjnQnJ9@L?dVa05kvvp%hNEwFNm8ftBfwk{ zhib!of}0Nu6uG%MGcbdj<>}_;HGdCu5qbZ(UM)$g7S%(K@-^t)tFslqUUOjSHO#ea zZ*oJG8ln9_nL10VJH36-*e>_9jp*ccoyc15pcdweIh0Ys`sE&JxZ^irRt^SDp)K58 zo)p>%V19B^ii1^a{9qQ*E0Z9o80I%1%ijrZKFsphgxT)R-rPJbUIFH|18?W)r{#*< z*&Bd`Q8CQT;(?Td7{f-qB#t=L)2(0W0AVXBBJ1|kk+g?2v`tPL}rmPJ&X?45K< zqA>P^nG;DV%J1Nx-7p(Xd-P)UK-9O~&X zt9{t;u!Pwt)&}>MmB1~}<1i1>S~d1jOFf!D;-a*qVO-q<2qGP`roV9H8R8*(%l|w8tjeCZcCg z#G%^ek!~wkTWG6eGE}gG_~suIE|wT7ER-AO1TYUePed*3{d(g)!l*RNZ`}et~Z~CO2pA4eD+M;AWAO0gb4In5SL^#?^SGqCWAjte znDT->P$>-U5{AFe{lt6t%>gRjn+FXQY?7LaMO2$Z)goFgx7ygLe%x{Z{;5C1yfWsB zIFwbv5E1Enpcxh-_XxFyM$;AzyZj!O$u5{j)(YlX>mp42hEcsSLfaQ+@&!}H z14(?3Da#+X$QNueN!(0BtQ!rbh?U(D?uQzxlkm{|;r(G{MruXJtj3UbR1!XKZ zN&CJk=;7(+<~4r@RXXt7oBetN<}fPOw9hY8&V;cCMqMb+P63yK=EP8Pz|F92pXBD3 zfO+U=i1h0Xn8TK5dIRP#s&n0&Tion>Zl*#eQrK73 zmow_3t@xTVlVW)tLc5k|IZOQns$XxsM;O%`BeZ>CR@*anb6_^>h`G)q4rOay^fPug zJUcba;#Q!tcdFX2^1Jf)1!h4HKRZ+~f;k1uQ~e#U9#-V-oRE7iCCOJM>*u@2qZrPY z*W{eNt!|ReZbA#d{N?}^t6)>3amhvG#NZy$un&2znS%`XWz%M;7%;AVo^a86rr7Eex4l{?-9G|jTRQ&3hmHyvkj1=y?J7%F*!T`Y+smP1Li@s zpgY^mN`KC)yG`+s?2-?P7gbVFeX99xe^XH@1Z>FoZ?_aWxvR8)H^ovp|KTt9n*&r@ zXr}|S6^qaw7?;2K@`VcOyVI7Oe!742RWVn@p)AZnns!v7eI+obGk^0)Z#PgAq2xCQ zmR`gB)+MDNQ7!tlZXN8+;saI=7(FbMdv9KYn^V8rBfs8wk1#5R`TTCE%-;O@3+)8l zJl^it8kKaz>IgRr%*H%&fmttEOqi{cP$0}yzggT04q-08o8j#bbHW6aPrJowou{8x z?@s@Gd~PkO&N)EE+}sRf9}LWuRYYte4i%f5nZp(IO>PG4Zf<^cfmt6T@JYplxy8*^ zU{fX=Ev#{bVVT_&+T__;6WSK$@~<9p^J$o00_JIp)Am%Aoz54>^Ue76#v+DMX>QJ1 znS=&rvyO;O#G&kg3VX9J%yprSA_(-m46q`u83!ykH^V%VPW-gsi>3`mY(4Q!TbOZf z_Eo_SV6NM=Wp6IO$V`eE9WW2Z)~#SjN!$_>LDYKp<}dtu<2}NtG&fI14V(7FrY|tB z{U*gwk-s11-DM{sYNhJjtbdo~Wy0_xGzxpQ8)lhBV;6UV^0Zq4 zS-})He+4iPC>!oi?U%~UkJ6alQ|8VUmA)wM9A2K=eR)XG*&mB|NOEcpPzlWD{KPQR zi4q;EM{;?XZ&w=73ZQ&o;GEb1{-fcbRp5rG*hST+qfP#s;c zW52{A`pp3&-+e(IRrl4F>|T_TdU1>`&F@sAxP|f(dRXl{ zQ)z1o@TK1zpwiqtvF9fi+UdZg%a7<>9dRfNbEx;o!3|YyZ^l8Y_?XedLbj9w|3h1@W|0?fmf15foK)__B?(Nsf$Qtc69TEy1Rad8@0~1LANzqmND)1ilzNhB^m4-QO8aqcbQvx<3 z3q~BO2D7*o_;NG(f{9y!wQ z&25*z&g@R@s|#{Zbmqzj%q^JxtYD zs3SsKV7_9uCqHdJ2wJ^27nlVHEV|vBac=fBcB+zak{!PRvjn{Mhxrv?o?I6@vV&dk zl9kF-aO#T6^wtXVsT(c)<%X))9H7$NJRCHFYf^hdwcT&-$Zd_vRnj$;DkP`cw6@pP z4Q1HqbwtEm5r=B;&0d-|XB<&JBf6EU6STC-KVsBO^o2xWxVd=^n1{<^zpZ-e*-7Hp z8;cl5rD2{78!!)Yqk=_r`G`1Fjhp4%>;g;wwqrf{UNI!Voiw8|IgQ*|Vfc z^+2}oUVNfN8DM_9N}3oI3^wi03Fb*n1#4H8>vWZG?adc=e5gqHrmfHp+M7v0(=kf% zux=eBbNpoy+JB9onDIC_XTw_k=3!Y}zn`p&dAHXH{uaO9c#kkDEwr<&VICQ!<{Dc zcf)+e1e6zyQnSrB^Zf&W?0)+7#(RWOX_yDr8X`7r`-_M<+aeC-yEixTf{`&#@y#=;2YD3c z9~Lg|4fEFp<}4+b+!yofzF`-Bz44caQE6@-H}h%JjXQ>o=)e_mC<`-GFs}m@>DQEK zSx(DziNW?Tb&rvk|6E`eO}qRX{Ii>z6M;F+ZyvYnYONf>`uwB#iOo*ch3wPWoSXgT z0E#TMhvwdqRj`Sz4I0s=5pgIBGlaGm%vuFQ#u199lACAMGB)k6GkOSTcf)Lqont=; z<|MK1RL->%Zu|Td05HEfK=sDJ?7uf#p`F#!rbB3dAH$4=a>HzHs4{|J?+9i-!m$r? zm62KRO{OyYk#6!UyocW$pkkrj%<`9K#z|;XE#Wj9m@DE?mYaiwc7vM% zIC1m9aPz0a&40pAH_RV%hbo=2xT46nN};z+Ud+3kc*zm)f%1kWw~M_SUGrbCh<owd6uVO{)9VJ zS;i2oC|d$mioC0cJvJ4A_@Uwql{wpBrW<~}0azH7hIyDa;+qGl*{pe36{JbKh+=Gi zFOtJIj53tvX6((LLc0O81)vEtUf#{k!tPZ%Syv0vwELPn{d(g)!l*RN+0^*!GB=NB zhP^ixS&eV@Y}!;V$JK+rlPpzc_gyd0@rDtHYQyZMf@w_~+3|&&_3yH&DS`lQ{?Dhl zc`e+W4zaCi*UXc73;cRx5yPk$=4Lha)D|d;C}|@OWnu0owA*>X?75kCWbxQ0lgYG% z3ii#6UPr}Oy3WkVJn}WbJbO{xX@U3fc)dD($B5pKnqSP~Siy480?eT5HwUOR%(a^e z;bxl;&P@MIlTrl19PQkkQ!=o30Q0CQZ&nW)=swp}e!T%$7?p-OZ~B4_ZEDsxbZ=JW zd~K%Ann!;5O^g~$)mYx+d$WQ$y}+#H4pu7S7h^T;KoyK`sBnyG#5eDKVNL*Z+vV@# zR-mKem48`rLvn7uCACG{gD4YEMTO}5+q45cJ1sX;tVP{C0&afA=;0f6bMqBop5Dwq z`e^RDp(*l(}7Ba zHl3CSwZPZ%e=ut0Z}x(DG%gbENcYVxx1URjnb_Ryb)e!D>6{Hr!K}<9^g9K3Ib+m} z#{DDwvxA$*H5Dvt!QAO8-|Btw(}wJV5UO!=h|nfYTcOInVCr59 z=hv(K-Mt;^M9Z(Yc@M8SK&6HDBsJC$7TUQDd?jD(HJN6q9^T`-$?l#~EnKV6YjN5p z3(0BI80LyNl!X}wDlaP-!Aw!j0yBlc))PkUgqt_~#LK&3zT%EmI_%}`W5D<8jrRzn zVwlgbq{-7<{s?CB`%<^e+^Qd_ep_JvuYF;Dd4XAfy7&-dCZ#aGV4>Vh4!ja;aTv*7 z{+=()=G;8k-mmrxQabuswf%aVMf92jRGOPdO_#siW~qqjbsNza*uWg5X%i3AflBJU zs^E1aNt5!|1m?fbPb`#MXs^M|7nt=*#Qb86&<=&!a&rS_aC0x1hr?Q7-}ZrOzM+d} zSIk^X)9&nz&n=8fb936fx)=;?3{^$P-GlqbV4KEglC1zy7hVS{&CS}glUj5GAqBfB zJ;lIqvm~P^{~j~zac)*HUxAx1p>ld9Vj4SJLi;H&>x5AR_yNpt%Xh;}Dmo=l!^w+E znv|Q>l1kSfuSaC}1!?*91~-RMX>J}5j28hPs7ATT3-(NJsEp7?wgO+6#T}o(B^Asl zWBITYBWL;NnMuo^=jRb_7MRW6JS_Lin?;qBn}X0z%EgL8sy51`*@9U8f~v8vs1j^N z#$E1ojNDKfn7!rz6(6XqZBt;L8F!M1>3<>))jl`-!b~cda>r*LR?$?{qFs7e{)E8$ zL-Nc{!FNO{+Wb~ z3Wfufm(bQpDN>tarf%%S4b{8Mq*z`z%ti&fz^s=n=DFD(s6uY2IQNKzu~R0YI?T5W zZ`m8>D<&Wnti@>;?~y0oH$Nk8etCges}PWTZzwk>fO)9zW;#ulR;5Z3zus8HFe<$_ zkEX^N!h7>zYV0KuuazPWRde|Z%vL}?*-`|7od4<(kx2h0TP_kWAK#m^*~rwPx@7s| z?>!e&7Hl$&3^ko zs5CbZnts}ELH%ZBzougp0ZuU2OMyz3f>LsiV4>VFzvS41r?rJ^-T1)Sgj~} zj^ZL$i)K=Wx@?y=-otMWP-&R6p~(*=#!h?R9Pz#(;!tfX*ps+fg!Tb9e?wnx{unUN z{9=!FG?aE)zM0?N&M7U|?(qn|O_;r6s1INszm@ULsR(Vlc{aOrIyOT4&k4+bnV)WM zeg&9EI@k66{ASZ5f{IiyN*qL;J_7_DE@8d(UC0R6gy|v|%1eZMyu3dQ-%q zYARS*&Q6sV%fO^Ua+J;1>U1SMg8MoZa%-9oyOP+n7vdm4YRHhNv-@n9nj9u zPs@KHFv~%z6rV6R%s5bGnV*BbUvI!1Mx|jsXLtNim{qI=-%C+mFxwiHKQ1um@*MHg z4RgXBD8-E5VTXJ7Jbf9V?KcNL4(8@FK2X84(~Fzw>Vkr6IGLkraip_qjgSWnrA>;j zoPzlsz&!DbR`lx)z{03B%x^+O)zj6mcl4X~Wp*rD-eu%ed{TYTFir^2>}G>NaB?+%R7W%vtJJ zLR*D4QzZAI!vV~`mJ!;1bKvbY%<0*c>9#O`{(JMsfO$x#V5$R3j-5A;?A};|sokvi zW6E|P`x^k}HwUO#Xg70qj#885FQPkU#G$Nt1WrP}+)OrY>)BbiX-lOVRIb579p~o3 zWMtj(C#u$IpX4$Oo?magM;H~uJZJ>I)+!dMVO5;Pq9`9Jn zci&1>fZ1;jP-&Palg35lcxJ4h5m_+ePIMMwn*&rD=3(>dBAuG}=7^`Dh(lSS4VX_Js2XLu${Q7dm}XdIPX9s&nOLV;%{GneHMbS^8niRF(T~fmxmonDbi2*LI2-svzL5 zvflEz?(7Yi!>BaOgC;kR$L1g%(T6_bP?npqH=k6&>Oxz4ioltG%%1fdD(uM;GKb}L z!<;~9=YEya{d(g)!l*RNXIPEh?9I5k@Dkbt^MGyIx}}vdX(1A_6!h?P!+ZspJ#VPO z#BUhYxe9FqGlce&xVe^^)o9ql)!?GzFb}Ezr-6AyC!E{8$~{2|wziZHtaeB~qF9;U zNB&#;SLQvu<^YwzY`h5MK$RPvEMn2+h(oo7wih>(xS*neVpvAk}W6Yf}L zbZ*u~KsS%eyB>)&CO$bpqeVbIg{hGeI{!B#;-R33!~C7PezTv*NF|0G_U~)|b zp*^80H3Y71Ws zznhf*N?`s~dHzd&x`a06eB%yPmOArk7L;jszT4katdyu~2T9Ukc3W z6H>G8x{~i|u<;(wPw8m-S5Rq~--OhxzCzn_vno&o@lEB%z|F`#B5=E5Hs|KCpLv9m zOK|Ncm3z7R@LFYIe&Mu_8o=JFq!h-cjfhBpn>N5DnCnp&fLGAN^15M8z|9js=i2#> zGU@kCJz`?0{N}*hvkG>84!q9==Ak_|r{lUk)x_BDQ_0+6X88RDLU8nq?%$z6* z3Vv{KGr^oNfp=c8OBlOd^+pSeZZ&NPZLhtVZm7tFB{x*c(U0w6)Ebwm!2Csdy1hq~ z6>K~x67ERBHMf)i>Td7cUK@YQZr)k@v(X!Wx!)Y1VoiJ4$k~}qjTJ1S%SXha+Aw?V z&H5q|0djQxSoa>83B2M1hJ|u)GrDm3@S=B^`GU!6t$dgDF9sF<6Z#RI8|7KV*@NgQ#g_6?OkH)|`H=IeuV zGmM?`#5%aS`3f-Sep>KF)2@H?2W>2RO=t%uS{Cz2Lwx5`W7CH4?zU-@(0&D&2Xr^H zThQ^B{H{;mMI?T`@t22DX>J}ixp`#MzeQA!BM#N(W?vOd%p)3RUHet|x)juKWdYb7 z+&syO1Td$5>d{37BX77Hy2@KEn@oXky2j0tv(sN_BU^#GZ?+->^{2}3XY??m8)m3r z=}fC&Dye3#Y>wMSRjp5(zvR{M9)5EeDwUcww;@w}-#pHr``&C-u+JUlRJb{vZXc;0 z;JWXD%C9#73!`G8Jv13*80LW$+7b1ph(pB?+B#>ah-yAJtNps1Fly!L;2L#qo(-Xr ztI9PL@k+kCw~Ia9Ic=4Vc5I80JaihH7j#>xd3q5r?Y59LUY&BqWKJRm%ba z_j^3CybhsFFeiqakJa+LlmcyTymqafEiC$Tg4qb|Sv`V%TdjAh>~(cZ_rpj39>3oB z%fqNNH;LMQ-m?N65A`Vr9Ipo}|U4wK<6W!AGFmV?` zVr6r%lKk4og|>ouZH4v)W?GAgFh8+Ck#-FlNGVWq5|Vs>be0~L|AkR2|BXC#w zjnJO>BnA~iwV8IuW$T&h*lJ)!M5B0l#pA)3+SOWa+|5&q=-n;x`>;(2!is{mWou0!{JU)iq)eO?sjnV zI4u&uJn$2!e!T%u7}eVR#j_JLy102_Z>TsTa$7C89Mwz#{t1 z0V)miIhQnndBp4Lf_PY*gt%1?e1#S4OAId-$_;bE9Vt|9`$4r>^p0iq>y7saqtY;s zN5+wptzbi2G%{k~Q^cXH(EglZp48H&Uo>s~!GFFgSiRN-No+ET7`K9aXk{ie?XP~^ zi<_sjBH@m7Zoa7&Iy0*st*eFJ{k(+0&7kTU+5R_BX>QJ%dBH|@Z;lu$5pk#(+^lOv zYN34qGs<&+xi8FSZyw&0R<*yLFDd?&@=Toi=hxc+<~4_*QttR^-Y97@9-d7G-f*EE z3+5|uGZ{NqoL~96SYDrW)b{HQz{03l)6N<$f7#5K#UfrSMI6fdf}Mu>_zji1i)8(p z^1jtouz${|m4CM{H>ZI4azmw8;JB76F=Xdu9om)NXzrcI=%>gRS&AE-G5l#Di@`9b_ z=HusPLRt#@s+L{Q;!hZ6Jh4!2n9bgt`JHJm@y&MC8!arlRl$NhI|;O{+kYOGqdHe^eyaBf<4AUa*C#HOWE8NTgvM@U+(CPp#OrK`F6FT^0NJGbZY(Z zh7pIdLK~X4m(bQRRC;gb_zNYp`FDBwLSUAva>zk)d~a4TUopYO<&W1PstVTPW?z^k zJ3fI+x&0&qFY$F={u;ln*_;0n|Llf21BX;FT~c&CO{uDMfA_wsJ@wz^E01 zUN_9cY>JLlBhv3o>(?9a5k|$_e12B2CkyS736P_}*BZ>wu={bdg83DH7i8?buZo-E z`o3rWH^1J1Igm=b6^w^wl!c1A7!1uXB1+nbLs?C`ciQy2laO-eG#8QTvYBt5=|DAx zM<*7f{0&C&xX@NGe*%~%eh~Qe#`^?Pohi(go8`XQ>)fn^YqT#ITfrpEM%9fh{~x0U zc*{RJ1@jePzC>N+#ePF&EKUK4ZbEgUI{@>W15_Gjs_0>VR(tcvx_VZR_7vFv+dFt?j2&^P z&tz{_`}MH3H~%|E(E;-?gRXY5Y4bvTwl;0A1C_R9Yi{ONJ;lu5;hUkbxS)skD9#%U#!gvX70#_17 z>6RAS+?thu`4)hn zz0rID%X>sTu9-F&;H;+MEzJ$kan8^#>U?9K26^A+0UovmW1h_6*CP{U$L`RfdC z`MM{}#aFl^?akM#J;lrP{pZ&kix@`52ddOm{$!Z*so~~YmaBJ@-TjIZT~Xx&1@=Ql zrD^;40pblK4rPUQ=z)r&E|l#{i*KF1lUj5uIW0v6D-uQz38b9dY_2Y{F_-FHRsD>e z+tuwZ+3r@W#Zl&Hd@Wc+zd1m~+-yri3O7#;H%D~Gj5t(VXrDYc*Kep8QlocdV1JZpeX`GS_tq=&m=6IF#k)-sk29%<33L+)OuAwT+qH9=1y?5T0(B z*ZdujdBm@HpkHsiM;MicIX%Dn&1P@z4Rbw{kQUXERIuW;z?|jt&4x<+lvLfPkGk#G z8!(4aX_#x(#h9CiW3yRDRF5ML)fU>mDp)j4yZ9K~JlWjOm#fX@zTfV=*)Nxm$#S*r z4y31+_B0geh~QezQ9}-C1t;?u2(PU|8KrbXPVXGh4tPzl9YlN*mARS z2VNwV#PYgf zmZBI{o_(;|li8^6KkiK`ST6#+hu<8aVxc`W$q8g{wy|^br%qEej_I>q5}GN|_fkfIU*7h5PvpWt!_@ zZZlNMPkS_NI0>a^dO$^Fl- zHvkKxVxc`Yk#Q`vCu76S4|Fe8uBc+|gO=9IJr$PMr-lADPrPBwp`LthrdvdF5t)k$ zM!y@E|C3Pzla~Me6wGUZIZNlu?doCK(@mS0*rzuZF^o#XoX;BEJhU)Jl(Z3tvO+u5 z*jeZ1ydK6bR~0amV0qnp^Gks_wcaD*+&JG_eZS4s==2eFI_-CY_b@#{-Z=-TG|ZX3 zsbFp%+sZXs?N?gYc3)oacLgQhBuh`9Yi9F@VXlZn)nE?v9-+gNBwD5e)iGbNA7J$G z@@|+Dzy>y`FxR=c?mg1nn@_|1N?^{i7ZixTnUfbru}P{AsXmk{9ib9E-Xr9v zZH%1<*$Os{S}9K~l!KcmLu}$zI`P{#{d(g)!l>Suz1hnOrf!)TW+kyvZcMdi<=+&T zU&vDm{kmaJxFglNF#BemX`SthXQy*%@J(B8MyQpw_@nSbUvPE5620 z%;<*sC3n2Q%T5>{LJuRYPcN=RYmJDO&-A_RlbS<oBT-XY16;XsG(RKxX2AN%p>UqX1#O~xw+=@_hg}c2(uB|f?hYw zbjMXB{9TZyT`X3rGJQY)-Q=EffhFVte{gQHN=@t+CIL7KLPSt{44YM?XA zI`9$zdfhNn$|ZYl9{M@g`t`W&1fHZBndDc-EKg2S) zl$)vY2l?mY+^k?W+&owoTYUk)yi-}JPgNY#KAmLr>ebm~`SY6tABToH%S@03+zQMM zRm6yxh(oo7wm;0sr(K7ciXhG+VxrB6Ls^)6-%!;<<=6@~%4RcC#%h<% zBubI~4atC^ae^Dh&($$au8({XE160h-HUN@^b~Z3(v4|UL#G$Ov#<|(c z3Z{j&cJz~$U1kK=;E9ED!<+!-i<6LEiRWVlYrOw=#OCVKxV<3(V1Be)4@Y z>DS6_mjSQCEa&9@Fu&yQp~_OfGp%25d~RV>T4<+l+qs#*t?$inFd$chso9%v7`?LM z=W(Gu9FB{GJ5+Rw5tJ9KxVzgFFNzasI{~xb9H7!LzX^H4{LjrO(>>!bc7mQ-V`L7( z!3tLyZkVBIr<1<9cUcoqNto{X<(DA>0OmIbs5H!j%-lP&3O1Y=BX>l-DdJEy6)Z5m znJywF)`D6RO+~Gt$qV+6nMuoE<)<6w*Wl)<9|RYe>E7l>hwwD7-0^j`VfNCr`G!gY zUsV>8nx>72$bZe~VMaI1F9Gw#7fi3jXQF8bo}0_ zb<%T0A$`z$vAQl6a}^xv_=op6pmOxJzXlZ_sHP1+ZAuf34iVMkh(lQw3_{zJn-5?f z)Uy=`%%wcB4sMv=5t!4-_HlVlzMXcJJ6nFe@g8AR8s=e>n+KVRor`#T7;&hramR;E zyZhYyxTH8k$^oH@=d$hVfSXwvQznxX@FKA;f^FO|o4tAJ2Z3Mj3(VU&C5-Ck=5Cmu zz|E6ck${^AEzge52n@g8fH{mxb936fp&AU0*HA=B8*wNrwBbF{4Kw8it8+8CaMIyP zC4JMadJwkR-2?38DQ?!*?cOX5^grk%jf2?ErJj+lSIU!tUG>h zm%sYntWV1@kI?mFEh4fMSnvqc^XPmMEd%E6164x> zBbdppKzNwAS=~_4?)}d4x?gC`~2JrjLTmr%o24$ z;3~`+X4OKP^zs`8W_dbb9@I4LiC1eOgga6lDwVa5@u6>+GxrtK@V>E1z|n-v2SLvu?fb9@wdMHZJo#y>k?9;No&JoGbNw0f8OjZSe~ z{}xOefVHSPO)#Khp?!Yl5hJu=9`S{l*jQ4`P)h(;t@1|&X6()Kbi@3b2~@U%W(-v) z1g+i|nDJ5L>$I9SVD_?t5f9r;LZpne+-z%eh~QezQC-nE_{VH z-B3vk6&<5gl2+mH@{a}PSMn6@cEc1}nb9E6j33kNP+;(pcF?KeDc3SryfzbY^3^NwW4f7}5u}WutrVGE` zc#kkD5!yzvK0EUWgtq_Q3~p9@jlG`=bb_1ZiRE>}yavpJJ>|sTP(nHmU0+c>O`S|v zSw2-AC`QB{PY&8Kaq-s;S4>PJH-DMYE3f(KfO(SItBawZpH{7$K@T4?ETZ2W zpwcj(pD$SLA~H;9tBXiJEo)a^`(c*2i2NRg7YpTvIR!V5%he4raP>eu&55!tl6C^q zs&}Ls=oDVl2o$O3@9rP&IwH$Met36)bG+Y4RZpRJ@1>zI=!aq_C4!*17^QFZ9{dY1&Ue@yib9-mSQG=o38-#L_@HvmfJ4r zYXqHNZv&WeE9gCkp;9pCxrvNpp*^$*su#tUi#PNyNM!yHX<)91Lp>* zSi~?Yy*Hn)1Mj0MW7wkpU3?5~9=EL2omCN9 zy*sNS0Ol4|=NzEYFb^`5YD849fno26etHpyvIi=_>~(IY7%IAS6vd0O{7DEbnLTGF zlh9ve^vZwBPdCh;USQT@8=q86n5`A87dJO-+8ipUQaIA3R0C!NzV?RMYT9M7DAZ*$ z_P6Hlb@=msx!sYT-Sfs7i|988s5Cc^h9=t^b2E9ep+m$=;)p}lxH<6LOahuOB9(s4 zSxA(F!3YPaQbOg*&WlJTv|oaob3X_!Fdu&QwV&|u#ZbZEGtz(=9-X~mP66|fJg;}U zuy5^+-OX~dpOc09E?M0sx5X)s6a3|VbAXD?BbiCjDSPwOaC5|>%MpjN+#DDxr_?RO z&Ei&|)Uw=g^A{Pt@<;gT-kV=tVAkIB3+{dxnSFe(jmHa6!cF^||#xri(naVQIOC^y%IHdHXR zOBZ$8RmRqHtUF| zpol}+y*cRIOm~lzfmeJ+$j7su$x-nPGq0H3<+zPy`VA@FtB?HMjyUxvm8Y-3G<=xzzf}1lx z2;N^-R3@Pyp!@v8d-%-(s&j?eXxf0;Q`1%vk>WE#sVKxxTeV=rMiNIn-7tR)m}fVS z+x0!Ucl0YOxBY-Lw$%sfV1n$u(m=o?m?)WVT zE-_T}5wc5gaq}==&bQ=ktUVibnJ!Z0Ph{XVD%j@_v(dC?PlUPiqX1v}%>gRS&1aY} zss*#B3Pyg~;AU!>EF`%t9{A(J&FfR#d=QZikUXdo%?2sFE4vD^l1p8r|-=pvm+1R%O%oTwUBEB;p=!hR4{`1CAhi0H(y}> zy!U1cvq~((!8JO?49boDlyJ2?-7uR2)kV|ROBPdTxAtaVP5S_5v4;`NW5dl$fmxnz zm|t^8O0?V(!xwITPTY*UDuO;WFmD8AdAec#1TeRAc2d&cb|fS=pw>sx*&Ewc7!{wJ z2hH?v_5wO03q~BOy*K-6+H_&To}H9p2IppVC219~KZUH<4MPeliJ=Z!MG!QP!uETW<6H3z6PH=lEARv0^d zxtX+TxtF3y=ZRfmldDq#V6jkcZZ_tTL2WB8cB}RL+75f9C0%MnM>?5b;XP{Id&~hU z4fAl?2xHGjCJZBD9g>Jc*&8ZcM4p7XQKnnLoXw`WSx0FAW-Jh%ZkWFYp*{2qe)H>% z_Xwmq(@;4hw8723nl?EJNhwe(zSZwcmOlt@$@=GpIf2j~>F;>IxTee$J^tz5)n?T% zeiAVI%>gPlcG~M@zHd%#P*p@0j5w6#=1?mbT~mk(rX0geQi>dfeGvhN%CByiKL$5v zewT!oWR6Z=z}IPE?k%(%iIz#f7MDLdMvd%*CRFYNMh`POV4h?)nPb}u)_EDxIvREM z#(RWOF*m;f$sAAa%?+3dT)Bu;ts2Zo`zB8;uN&r<5ZV`*^-6rE2P$8f$rnsSbpz(V z!l*%bpN9Dzz&yUCyVSdV_c6+TP=3Af9${3>%}uw0%*Ief#3tfUHSvNuzrWx2XgDVL3N(4P^m{y~1ag?1t^r;}x| z-}X&|o+N&~0azH7=H^Mea*avm7||Uw;!w|to38}sEL)QkwW?>bt>z!?DMe87!F+d5 zKPhLJf^z?+IHfiK z^P2-y8s?ErP9RYi*5xlEHW7!i+}sc5Mp6noDytgod|IZcX351%5s@>*Gh}FEnhKe<-7dEhvkO(Q^4GIE4V~NJ`rYP(+)Lu9>6TVU`mje zSBzQ-ZthG|n!>BaOX>P8UnVW~U{#ZoyIO0$>6)X^D(yEQ9PQ}51bna1^2)y5X_;kZ81XVin zGhO)g2Fzhp8s;-Jj~H$ax^Hd>Z5;xuf0vJq(EfyBF68Nk`HDMIRXINh{CdCTFozmD z54c%E<%pYShMT{U(JQ}=pKh360_K??aDKfnFb5SVs>6&rRP?*CfmwZng2GS0OJC{{1cWbr;YVPEuN|RB@b_hA)v4;P&c^A})ZvJ&(~~)vsju_5 zva+h*ymN7R=h6A2JGb9{bouY}>#cjY9$h?o_x#P2_pkMS1E1gJeMN=mczJPs@wI+_4=(QCxthS+tioeUKhMw4zIk?b z_T95@TwT9&`R={T^Q#x1z5lE8d+$Ga_TuRWPoF%Wk}dwVe1)G2-_QEwSiX7o&C9p% zU)+0eet!A!M~|OAJHPn(&!0c}uTLMpc>3|P@Mnsj;co_}egEA+Kj@QV`J=OMy>s=> ztsmpLyz}hoKYsS){OYrx|CcB4y_kML;cxZE^2dRG&?m?82WNj^Ln#g7gO8t|zxXA_ zC*li#)IP)C3S|5KF9Q9bPmbj~XMgzU?$!0>_3b#8M^8R@^8CrO_c(;d&tIHhK7R4! zudkne^d$UIe=L7>&=|rG>sbEDqq}z=l*e-C+54j-f$rN^7@~dqZv*|HPaVrYeRTJy z@?iG(KmOqS?$hU=zA)KbKY#N0#YZr&@K^OS{H;K>@9RK6=u^k?ZHz@8Og5Ic9#0MB zJp8TRSpFu^5BlU-zH#=?9^Jinn=;DAa_<@R_M<27pWpuY*{6d?B7Z*ot=?Gf1o}ar z9Lx94zVqnr!{KwGsz6i^p}bGud-_Sq+l0T>8_V55Kj>3s^hcN1Z}PF^&*c&-^2_j7 z%AetH1+IPncY%J;r^@KN7|Y$a@C$>J(_!5G@bNFgUnzfvzZJOl{m%mZpihqFTWA0L z>fZGoxLq@vtEVrXO#58^{qVPXV|g6t2Yr46KmF~qKfd_eJM!x;e$n@4;jffG!`}*A z`~LkvKj@Rsz!nDpY)@XIGY!`})&X5W7p=m&kOzI^ZM&QImnT|N2l z;n%*_XZTy;hwb}+4D^FOIhOOYKY4U2YqrZ-#+`Zi%0iw!;H=!e)#y=GkDsI z=O4k_zCZbl!r$tR<$nhHL7yDU_s_nMvBT z-?wjR4Itya=KS~e<-M!h5AVJ8_H|WX-mmH#8(ejTLIAF&s=FKbzH0Pt6Yp}``JR1U z*EhRWGGhF`TmMM`y?f{4(be6*e-oiT`GNlJoA<6BUeKSu{pkFyi|cz2-sVp{{Q1Z7 zgK!@2J+b@nFFoEnR~Hyud!ue{H0zh2=s-q5H*H-tEq=VYQEhKjgpa$Og6`95f^NaP zQE$UQ;wM4Bk$}E`3eXtw=0?-J{89%p26_w7Tg9@uQSWdkGOxQ5%_I#K=_u)1YD@;3 zp#Sy|&=20eJ|9Z^r;nfg!<$df&++;3M^8R{`s~U1n@@l7OH>Cwed6(gqyf6FUw-a_ zZXxNGk_J@h2I1qb1FAl)z0r!K!QS1dQ^i))1pVV>K)(eIPe8x*@qZJ{r2WGfPeCh+ zY6^4*&;}5eTnkiacv~sxoTic%_I0(px#~;$egb;ZroReF1N8bv(@ofPx2dac1AuC( zbY!?|Z!}c&9x^8b~?u?S|jtA{ID~}gL79Gxnq}!^l zLwLetvV?Sdqh2fgoMxcOCg?$OvVf#LU>+|4UF}}}%vEnBC$%IeKvy9W0V>qH(~#At zZB4z&zOJjAb(<*pf;K%rBhwMLFCV&~JJ@tKZ%AMiZuOZUBTN0Z{v1K?67`1{a;{mJp5z5LqaMbInEIVNnngCpxq zskiF05wRKI6@E@LnC@oH zMbhAreO-4qn^fKe{r2&a_MDZ+i;{+VuV4L%Yt!qdhNCW6Z<(Y|0+Xt>S`xOloSgi}6f~CoAKkls@!MaSG+An3u?Rn_ens5O0dcu)yfqHA+8&Xx!oKM?b zM(a${D5iA--KV4%Di_V4aKIfybnVOEx{}_(k?p9|_*s_JRDbcbsPY4vfhL zON3r;K3%qHPnsSt+BD|9TfZ>aR4sHn+OL#=CDxT`dr7yFhNkX}lFp`Z2JM9OQecPSx|45I}5ZXO1d`n4vJBC?-KM|i6fht zhI-QUctO&bLA2GY?|JIov|Wu$$BufZ`EjHv(T}Gz15Gw7Cxhg~S~WzyXL@f>njSAo z8vdwy`GpU92hg!JBr=D4X6+acf|*ym1Fa%xV~b7q)%&23HLQ74?J3P;(oi@egsd-J z&>h?ryC`4tOH~4rE_?56mNn0&y#&PLMM+Z){p6(CtZG~;Kssx^TgPJmp0?T-`^mnp zo11Mv_x=z1fK|Pt-#REGJ5JJ~n^QHiX1l3zDOCDBy+iP_%1KU(>fLDNqz^h(?@34Y zRj9Wbd4?AtMY{7b}H$q1-x>|@;tQ1i|UPpa^n{U z;hI?@gM1}A+qwpVmnEc_ou)LCG}5$k8k(v1e9*@@GLE?N)6lls0CbvI`5rCUK{cF> zGEOg$k$KL_;{{1GjhvWTwlzRYVIS6jc?4yS2`TeT#h24m(!%Ca?JD)*1by-q4na{@ ze(v2iU5yI>p|UVlQ*``W-VJDK)2y5{1U>NH=`3qza^l&o$5Tl|%&1zf{frC=SGsr)3}V9ICOQ#Xlz?#wXmQH8gB;-jb-LN3nIj{c zHL^OjY=SPl=RnOKF#F`f0os*cK|(HqZzmxa z|NeMMdtu4rDQJuxpj&@g2St+_7obY^m8?%QP7i3N-dLYToJK~LS~ey9AOSryBlCcH zJOwQy#w_bMI*@XA5fZW**T5@{5%fvGY|^Y-f0&@t!r=W=R89bzMNL0WcjyAf1uO_p zD74U}sd}6H%4w$FoMcPoB!y1UY4hAkBrPcFi4t(v?2v|7cOdN7?z#}MnUE&5sNOA# z{msp+v5KJ6o|DOpY}|W~B_Pui4uFPDuU`GYRc{mqyUsE)L?T+UID>r=A*Gq55yw`v z=|KtDcF3Ky1S}cZ?|je=K-dbQS>)6~IBZf_Xu1~*^ zoDei}Z(IN^)um7wGtfO6R^o$7pmNmzBIpHjZ_inIypWNx1l%|o8A0y=dS^2#2+-0L zWFHotQ(A0&CcBUMoS?J$^t`&amuh;v0Ghe;?$y8XBwbf%w5cpk;~|*O#+=kVdQLM* zlg(AjflV)voOr-IUI=wKm;wZPMupy3ngG-OY3vKfY;tidqXGVbU6+6r0MYjXsY*w_eQ0c zJ?;vSelI``EmavU?91XrrfActdd~#yNz>y+&|F<~GBT<+Hm=}O^@dWLOG8Rx5qnQV z8kTHPN-N%qpN=e@THc*Ewe)~_yZ{>evQYOP&%LS9*j|cDLF0P^&8E^4EjlvR$l87p zp}n<0jm%SFj~78Bo!a_wx>;>&TmXoe4EY*-W*(#Tozg1Hy}7fmtlkSq+EZbV7bT4;;Ko_Nqk8Yq zbF#DK)8vc!G@$B(U|rw(jIe?$Hf?OKWo7#yXwyH{2Q0bwNhA$ONT$12f9Xnk2TAV; zP*To)7qGJ)jwANE%bi>gKAS zoMgH8i9!}~YoEhZee2ARefL7xd8W?8+nBTC?0~T zH&n!Yc1|<(CY$A=tiN)Qkx>qX z6R5Y8fO}KRE>A;G0a{R0-jN>ydI!+v$ha;CRfcf)eMXT+Hz%D4#va(}rs{58C2{%) z^&V5<*Gf(>;>uBPg4X{<|71$N-zg8F?rE}H2fjjf$`1>JUDiA|6SNnLJzi9A*tAzf z5YRXtAWSGBU!7(!4~vDtJuPfeqOTY_d`db!{bD9)&u%@Qg4Q7Gb@mfJ8BQ*d0|Kn+OXHhq!_ zhm5%1y{uf&I~?P)vp@yEY=Mf4RU&gP)kYe`8xB! zMfHaF_FA6_8uMvf0bp=nsGL~D#(p+SPDnG*yrp{gDkojmF?cFTBL=m8?p?3ZTePP4 zhW6qaS#*Z5i!^m)Y_u)ay}P`KFfUGf()4&LX+_~3!UjnjzK{&m3ueP zZd{55^OM}V@hehV+$qnDr3l*2ygsHA!OOZlUUXz~Gm_4 zs7+jyC%XuGfsp0dt;dTt4KaBOc(m#DnwLnLS*s=|GL0(H%zGpLmo}qyx6&g&PBhD6 zEx_v-1n3s$hT;-{l4$9jwb4Pn_qiEpNfDvcbJAt|vQ8ATu>4ZDuk3vhg`N`ujk>p3 zGX0dMp}1ogJK$$Dz?Z3|u?q`$x%WOo((^Mi8F4*PE`sCc$y}<+3~~w;CTuF7(E@1B zJc~B{aG7$^*reih9GMhAoTXYyS`xCDa)xRsI6C2=om=irn%OjOi&M+5LvJWbAron6 zi*rtJLB0?!q^eaC+686ar-f=L*{qxl=F@3%GE==h5AE@S_ok#LDkmL8jY|O{5*cXR zQN9wW_Oy6dD%r(y(E_`5JYXI#0bSM3QZ2N!!?r_Q00R*x>U15~hZ-5P z7mv`%UD(vxsBjXCk+E?!er%B=p z>K$6D&@gFPnx&>t8`8{?$!-6+92~OBjW*s)%Hu_w#)xa@)MrW>=PKe70WwaTO(WcC z7M{@X1VbMgCf;csRN)i!z0`ZpZ>c(VYPo)St^+9)5d<^}pwjOxGb-D6$L3G1dn4+l zG)fw}O}03)esYqj_dL*E*5&b3(u$(>Ll*oM+9a)rfVs0R+TwBW4g$|;(o&@f8$hG= zIduk<^uJ$5(#JS5j=1(gx5z# zK1#hY;>x#atWM*=CR?>cgd6~UZO*Z3nwqQ$1r^Wu6Avu2T z@IqFLo)cWaf_$3o;fe}@%9eUknsy>E9i!0uUj)5C?tNSuswf&i_r^|Q1gAsGMM!$e z^XUb0Z!gvKcu~?AoOk*K)ETKaFO@HHj(zYl=a$pdkwGh10>*(&sk|xa%QQ|;Ey|a3 z@8cvbnUlN1f%0{QrCMA98dyTB1(It8ozp_Oh-@Y&z4nXsEi)zExN?e&OdXk54HeL+ zoP>}?$w!%648QFTNG0PpDh`gB`0_m`z|wWh&47> zIC`D^n=B2TOisonJs-5FH#V+(J}POJuPZFdhvsG^a5lB%E;hCEj26m8WM5a?ei!iO z)`kA9W7;pgtjpsC?~Mrun%sTRI0&LS^gSH>y`|#;7Ll|UmONfiZ_cv35-=p);eA=S z`c7%|dx#(EjgXZFEB)zBwOOL2$^+){6toV`i_-!cC)%{bg4Y;ob?yvVgP$PiZ2$B; z@9hEectO3TtmV|m(0n8l%ff2h0Fn{J&2zq40=>PpKqrC+%;Tl%?bW>nG~#sFL7RH- zeQqY+TU~bO0!ExJy^>;^Wn@Pb5svlV-u`KVM$ZW@)mnySy+e$*yNnh(5y)m5+RMnc zx6&61od`4>4wiL384Xzkz3O<4Y4d=NX9A%Ebjguzm#Bt%D(vxI*O3wQ8p+9eSP>YY z-P<$}%rSyVQ!&6Bk#(-wCEV5;mmBu=P z&g$OtytkKXdb|i4D7-FUN*Zrxz@<(ZIfq#{QZDN_%4t?3BfF4>ZkNcty{yaQCEgpa zgZrLm(>Avp)8+wPZJOSDz@nrdBx&f~6YZbo;C%J2(TRXdvA`PQvQF5cmC-`TLKCiHXh?cP`C9Q*Wsb0>mpn{(VA)f<(5TmuAS z1lR%82mi2a(_e$Br3}uG(+ytGi%V^qFEN%oPMBi}IHkojbY#M@z+05OSnTnlO(R`g z`ymVUKkhG$j?9#rVX04JMiSG|3Y`czAvT?BQN0&hz#DT`uchAbJ&m)Sf$ELsIa~@5 z9az?9gqeoMZgyoQG>g+@OG9jb!jY=?%sA~y)8j=+bNiehryHDIgiArA_^U!q!^&T*f7eOOk^xlj{N#kHeTnd^AoZi8@P0|@HoL$7Mir>Y?Ydz(>)v~$-QZK1pT=e zr(48nT!2cI4c?pWLzMY|W{!+o0E&`MiwLJmPN19K#ubKJ#A#dspe@j{JC5otpi`QG zCR=vO_Z`{a=mS3Hj6u(CJ)Ww!j(8#sZ96pDbY|0taMoP}_hmMn(+o8G$cvIrZF;79 z({8XFe8hemx=Y&|1G&ZAk2GF|rVbgeEmaybBvuUzfBOBOsdd|rappS~vSbp&i zOC{(P)O$4)+dz&+fX>5Lu-|*|6Le&0&&f>C-t^JqMM<-3-A_YXq@lPJ3-`?iRH2P- zPlF%dH@Vk%`ABbb+RxV;6nZ;?ieY5kNW;RVWCEYukYnvVUajJ|A8aXka z?$C*VOC*g5C9`NeDk!zeyhk(8WEZ-Nw%LmcX4>?z-WwxE-TV7qa?+u#AD4n=K?HXI zUB_d5jHbODVbeI-oMmN7PDhri_Yt7SRQPpln$u!$0gp2%c~60+oG2HCx;Jp!gUD$n zX|fA8y<4J2<|QB=FWNLhOXZx|FQBokBV_{SpekS7!IHHWp3s8#R(5H^u{-Q#p5x`B z`H~hCjn_P9b7lBxD77ST0u_N6xwnF*h1k@CG)mgoOip?&RlC!-Q~?FNY~y%u0gX-s zYm}qYvZ*DK>o^HXX%V!(Ix5?lx~XEan-;}yXi{2Y&0i#^h z3t7ADV8tUs)_nCwXyv9Vry2^-Flb)tpIB(oyLj9l4@HhNRc|;lsP}M=LiJwYz$Pyi zd%PI35U0IYM-lWIM!nuoEe$?moz1a1b=C(V%Nlaa_&?kXK+p@lo#7ZsOY@vlE&}L= zi__sG6UfkJS@7ObzI$4H4+q%{S-p44@3N)ZnKtc7)8j=+!-0G47X-}{*a|z#2Kkl| zf}{)ogpy9v(3zmUIkU$LprMBDtC$HI{oc67Fb?PdEe^8SiLlFBswN#-c@KvN%;QDx z4bWaom4HT&#>Om3wBVmisbR@x(-}=V5nu$Ih!36zC4DC;49=7^Rrn~IM$O)P|1?44 z^b1@H8VQ_Lz)^j$YD!Lv85wJ2cx`J6ouC(3%kpBe#|!Gsc+>iEy4m72Gu!C2>{x5W zq_AxX%Xa46aBgN;;UK$EF4|=^vLhrtKO=)0B2;_JI*>Ga+_(f=Li)4`+XG)qos zHqtSeIs-~NZHS$;>GCYglcvXul4cjXvja~+V}(O1C-6_0QCYdjLROC!kHrlktJej* zTVjin2h8K8j%?>oINAzZi9;(5EZGuL#5%L{oTfI-X{a9g(VuWEuyN&RM}{fz&RM{t zq}f|!Qwr`I<;+?p7eUc;nyNR`Tite;)n2D%4x%4epEo2)coK2cM09p)L)m zLh_l@Owwc**0Od>oJZzmT^=vmG!OEfP;b0xybViq2){8-7io5GDB`r8Xwz5kw0Z6b z@9o9uG0z@BBgd$nZHJUJ-mQZRN-Z@9+quD2O9rX|O(iXCdhfy1GHr;R3EFd39#28b zh~4#RfbNicx zgs*o5J)o&0!w;5Dw5h8s_dWvj7_ir|X{aYEC!;ko1&y~7+X@F4Xl(@x)@^qwEgqps z_E5b6`u8B|F?)|T4T)^VZCXG};lwhsSUTYJY+pLisRw>K^oB~6b*SC|ovu&MT+5nL z?@7=w+TC~&K|!O~FI5t#GD^Uv)O63P-Z{4eS-%;pdkbhBUth`b^}xbU8^%1ykcmG1?b@p2snpZ z?f;0oo+v|GWYrg>KG!308X%Cpk3!tg5 zPQSOP_ZE(9YXH%KWziW)dx;j7YROjbtu6rHH}6ut(_?W@1sb-u8?TWOG+Kap4dTxj zK|z*tZ-7p#p)>ovy)v)Ii;{*PUXAyW324;4*;7TItq(!&VBIR|9!r47HJMb89oHj`TjpG68l}#w&lr7`NDuLbYX-Ovn*8&Ds zPxVeSvdO7sd0B_joIkZh?hTvXj-Op5pz&^Zd8^%ZJ(UTOTzLujRW*U^&h8eau;{pbgzEs zIx-v&P>16I0MH~2(B|B7ntE^PL>TVN0_b$F<;*zkIV+DB92xW%o6+3LNrRV<;1X3v zE)!;1uw+VFd|^s6&}1_W%@^eX`s6PvQ19(5;L)ZVcyC+)2*ubJ3{VZV+&ib4dXrt0 zbQ-589a*{9?@80+#W)SKc3P?g^a_jet6^z#;G2yQo=)L?CG_44%(A?!%i~4R$eeb5 zM%LgJkGKR2Dkn)EW?6Vfv)mgVue3#}XVWt!?M*5?UI5MdPvcK58_cJ10kl+?!m1W4 z3MHDUH*C7Fe;S}qUM|uaSv>_B^9^Wta9ZlV=)u%`)43T9Y9o?{&Cp#841nsrK%1l| zO^+A6H>Z{pA*;cB8kc~kBg@x11Ye+m8+uL{4U3@Dxw6K5&&}B(46sPB>p{j;XnzC)=)Uw5~xVQ#l8zZPq zv;A`L6O{AFEL#6~3`7EvK0yW9l||ER^&@oe0O+G*LLm1AvXqrPym3mhCusQqYLgHp|Ls z2AXVo??DkEmGtS-P*hI7@NBxnTMBRu#5P8dXTtQhEa?RtnWw@YFQ~WV-i~^+{)IM4 zTq<990b9YMr|Q$-vcslv#I{ngzs~kgpQJ{HWE%5cuMW${PH%1*9^XfH<{p*7q z8N3)=dfBG4vy0|Q+EZbV7bGo%^VPfF0QBZi&{*CqdG9*g&M-4%dB8kg1kJ(upd0ji z;~IFSF@lCH#Q!qrOwuP>wdCL?K(8=!Tn*P<9ni3HWMpOaUSO8xNz>y+@6EwYfW`t| zvpqI^LPpx z-kXD)0KG$O+8sE{LZ(;j_pYmEtG)CW)UGf z-iqp-b|TCK?UjVQ7#<~!5w}j9M#5GhIl-mL2~uj#veam;7@X6rassnK zTxxxK{?t;`8>dwL)o5};(1_Ex0#s?b&_f?0{FJ7kF(+k1EH;hzL1!UrUUK3|)8i$M z3|+wEi}C=C7GPcgEk%T|trWAYBF%DdvbjFp%e~v|G|8FC$&`AJHOne!L4hXszw{)H z1rD@S#UgJ24G(BGz29GpVt>*m3D8ZyH?+-~=S~6|>doE1PV*cky+I$@#^zRl$~(zE zLJcLSnN7oyLA_VKljmU5Z|DO)WupydS#|B(bb}41xByk3k$P_=?V&Xm&n=;;dJCI2 zokeRpvb09_6?t!8y#)nc@i@L}2}w6A-hdh-}cRrH)@>P@yR>-4?%0?RrcFpn3#Hzv%Tv#bNq zU59F@oEr+L_;G`8&2xQPcqIiumvZm+^e5WLh^v*;+0THCJ~CV?ReVqT)&0{{dHjl; zrjlmuxa7UNY}?^XoA#vX@uH+LXm2|M(P1qM7XV5wvp-}ntWU#xE0-CGog0eV?A!~T zZ*A%>3t2NkdkKigQ_w)c^YfgL1<>^l6Y3o$jUPvmSEI9_D$&e)6SU;s>0FDT)2Zc5 zN9F7*OQd;cy#(pnZ%j&g0cUiyp5$ZjbfV`G^W5l&HwM1a5aH0(^1&wUoB#nP) z&Ml{zq{*gDXVvdby~@=4RE`V=>2(1EH0G7O0_dRL;Mg2{ukx5$1@#8#PIlm>C4Yim z=$wULW4s7jy!V%$r15@U*fGmRFjeY?-od6Br~5Q1 z7pYAnPUC#7&Pspi$QGdQM=| zU4=9>6am@XtVWCCnt@Jfnw;PHg^>($J%l6YQVbIPDh#8Z*Med!Po8 zjG)g1W>c!1tg{LOGp_F{mufKjtr7+`U`mLr8c9D#p2hQPjkep2}yTQ@6MKGk&8oCTGMbT5(z0kdj6Z!Z6~0$V!$+37 zi`Gk2PCRGj@uGTja1)LU&2!b-Vlw6twyeYRe?+}8bxvrOdviKg3R&xHr~FJwdn)Yl zqNFk6DMu!S6K32{3?y&{71iz{&D0wYbJ%)D^g3*3?;UJX_<2K`+op=1J4zDQF$>grwoRQ6r;zYtBKRjXQL_+8s05 zJ6r+p^4_q$DbP4$unuPorclEU%baH38)>Kr2I1>T-x_No-NxH#td$<5vytl+;+yRvZ zDnPa1#WyQi$Rb%M#TF%uxbtngMKu)H zlz<~&@pBRuN#TZ)UO>G)X?naw(v^4I9wgl&4aK#`B6kd4mXXCtrqB{evp2MNLhK@v z_B^!5OF$z|KlB_KrW;txVxkGHU`bf-80&^KJ;nz?8uRI)a!}Ig)N*FX@@7&VPeBWc zYU?{Ptm+d)UJa7u*cHXCj!L+#*{-LELIn5jy*-TEd08h~7KaOc~_kel4 zC~4Mo{oEV53A%vIkpYWMEz#y{cR9_}n`}zD*D<)xj@z5*$UG12@f5V!9**YvwdcLN z4hwjl&8MLotc>9wLI;X815Gx|MFY?aWMrN+JzkKsOd=fbjRo1NLSb<4zCy?X$KWG6 znR6p8N}8?Dcvo%e_BZurDfOOTIZ-cLJ5BC@fl?^1;FM)G1OJe%`z2Zgt&VJ!X5a*! zdheO)?Mc()CF+eu`El<}&>I-_hO&guHv7dLKo@BQZS2BsolTa8o&>a@Kow!oR!B*ZMyL#-NJR_0%-Mngo-<4T}7IK zCYzO$Y(*Qv%(3~yB%RV?$U+=T{kG1iH}y8_IhkqGM}uau!%0pE z8hb5q0kjlP#gR$=YP)JtAq})@Un9fwEKM!9OPyUbU($-g+pPo8IIW47N*ZWQ(pajE zg~34M)*lO5WYc^1W?9>O)pGv+>9LvAbex7bxDfT~d!BluT@Vv$n?|CDpm(zBt`8!o znIq$(JRR8pbhcY(-Z>|phxT|OWYHbB6QEZR^~&rQSPVX;s-RO^JerGa*=w09Ic<7@ z8kq;o<3-RIu@|SQ-Z<(SmjZeUZi z_1>WOd1LmA^*)QqNJvfQIV~n9*;Hc>dVwN>CrytRB@HpHoHP`YZlK<{f~5DI-=RWk zpe0{ZMa1U;Qgj(#;AL1UVKLih&G`@CD$$MwZe{(pn=! zlY8DKxjn2J`W1neIQ?4>blafr9onbp>{aG5A(a52G?adAg+nG`p~fFS>B!Rdi&Lec zFwL#A!U6Seu|)}&!eYHo@1P=P(>X21X}*;h2O#$)y+EUlXSW_N+BC9_#t&Kgx-63~ zQgus6`#ko9d4-JsrNp~OTrXIJi922?YPhX4-FMFM*si- literal 0 HcmV?d00001 diff --git a/data/ds.xpt b/data/ds.xpt new file mode 100644 index 0000000000000000000000000000000000000000..cd0daaa0b85054de9777580c268622c0f7edee8a GIT binary patch literal 132880 zcmd6Q-IF9qa#u@yNjf3s0K>raLFfeB=iF6hRez0u>&ot$oziu8wYsYJGR69VpLg(MIUSOdoU{R#Ic@bhr@OwX!} z>WC4_jI!PF_U??z{H1$%c({8+Jeo~UW|!`AcD%Se`3Qeb=hfx(^09kl|Mr9Y8EySI zx125=eGJ9dId}N+iU0kN?M?pHY&kmcOvgWEIlX$V*ncoOcu~8eCNr}JbmNcr*FTdw`tM(S*Sfe`bXyU z35AO#^j+`U`D0hhtLjJaUasDH`qN)};+9`}^CzEt_TBIcs-NY3e518z`JUL@x32p( zaNn`>$4{2a*^lB2mrw90Z+-TOJO9!b-VBRKZ|(HE^cTYaCH;L8Wf}bmJj(@Mi(5W> z`>ij&{m%W9C!c@%)|1Z#Urha8x@Gi(Nzb4c(|3Jx=TDw2SF_7A=PsW-d;6Vt@er#g z?|i|1{_S_%yFc;7ojm>Gv$wza)N9Y|XQ0=vewI)27p=XQAJVT+qVz1^yYr_`mM1Xf z)Q{eH>vM0s^SP%#i|4VA;Ga$J=$dEw-p*%vGwB)hVtSVM?|cXB;BKI>m0)6?!>M35!+n;yGZ~xR!!Qyq<-uhYY@!i&* zlQ+Ih z@5L+6Cz`kOiP_(M;|ux*nCiXsx5EDq{e2SUXZbV!z2IqD&%!SW57qf<{O$E#YtQn( z_4g@MzvESCm;bk@*x73REz;jTKAA6%FXpF<)u=dGj*9#H_`etxyVF`JFD@6W#qr|Q z9WTxi*q-7eRjT@-tv3=^lbJiSMD|UdAK+|U3~if)kQff zCih4C_eUlFvEi%VT*7N9eSClldO%M%{R2M`UAdcbG3-x z_OmercE6CBE|3Xd{XVx<8j{(8YNK-*S`ZjH(N*qe#8+PxWJ1Hp9ADV4Hb&Y;LP8d# z7$qYc*A@f=mKzZH%)Z9?5ES_+XbUND8va zzRIlF-{M5@d)xl+mgbulf<6a zp#hlznd1xlwfb-T5`DgMb-p})G&{LEg(=h3>!OW9!^j+8*l$0JvyC+K zJS5vVKJ-@K^Kr*XWp>0jjX~z;)Z|?yBg@$~!h$q$5ZFrMt6$-_qBJD4I>J*NY*8npFTo$T zG~d+5Ya=t8MYY-pB*p!5Tx+B7apPHm*p=g(^s9~6d{eKDcOY98<%44EM*)vC9$C)X zxZ57jM#NXY#&1PwNE`Ex79e)j8qbK=*^AOJGRLo=Uu}#W&j`t?7(Xaw=9z$OJks$j z%LvcG{XzoBJW>-MH$N+YEN7V!5|Wulcv6s=2v2T)Bdq*nZGJ|4^;_J1lm`0QP!XP( zekRC#j99FG0^Ga$=ZW`tx_Odgby%}qeI zSE_By(&{5a(Td6uuhw2^KxX^3)z1%^j}Dl)zVM1jX#m+l?Gf+0Ed!Dnwt_!yY5vON z8KU2+*pGA&mgoNhQzG?y^bqcaND%Wq-#1X&ut+6W~6E19o2jQ!t zoL+NVr6HMR9F-GfB(o7kQiWGUO2f!T{0ekV-4rqmT{Qs{kGMzE&xEgjl^}=Mr`wE6iFRLMtFd15N*8W_s&+|Og%TF-y_n-3HkbvVLY;Ol(DbR z+Su4e;p1dR$a0n$`W1W-Q~^o`p7=;)O=hq-I6=`Q6|}$NXG`-fFXN_=)@Xi&h+jc#T;p4aw{wkK_dUSF*{WR8CoG+=iHtnO$Q8i9=wpemG zJC^U*wE8#PxxEjfDYA8|51H+)RofC@U2|KdVPuXk?ALNeL>=Lp7pwzXk>@=NZs$8I?}sp^)px$uZ>FXlX~;%xZOkXagILuFej{6GKR@$)_1{EhLc3))9@TT|aj_-H8)N^s zG~cxPaWX655!(ol=c}0@6Bu{sIbXJS`Kp2bIa2-zV0?3QJ= zHFhOPsJ6iOvovJLz+@{kjLg)vjMeviT!d!~WZBA0kde&1M=X3KvPqpk>({%wFxn{b zZ7-X(*cB{BQ`HV+#8)5Swn_uG5y%FSSpqVeQx|(2BThkPW}bbn^L)wgoh^tFnw1$k z862#}yArz`57TqL`nn5b~CP;fQ;~8D|SV^#y^w>knNcW z&&AnEv*P&VYUWl8H=TWO8RLN9nu|w|m-FNK^t|~JZMo@#99eDD%RsF*!eXGhR#cVy z8S&F^aa*NfWR5TFcTRo8H|2h|9htWvl4VLmHfkfwXMP6NgGb!bM&hgAJb8VUB6xa7iD1SEM{8J=#lyAq$ZmijV$Al+SggN)>G4} z<7jQ{np3|%Uz}n?5bO|=@~P8rC$rb*?dF^P?1=l>*6|EhpQ@4g8PvNfcc`Jcgv3V+ z#5Tqwn>3X!`DJs-NwmJc@H#>(?bgOg<~!!WVl=ZDww04OZ6suljcC8Km|MQ-9q~r8 z`q=LZ*<6b2ry(ni->50{Is-4WPrrR3W|YT|-F&&kjI{fs&7(5#&kQnC1h_u)oUE-s zBfk15w^bU@Mj&&1VZSmYQhexfp0)yJ~{?NZU9mvz8elspr(NjVZ|LTnubU zkGqLRS`ZA*P0kY*g!s6%Oq0n#xtIiG6qUo-5#BbYAse-=em+q-$Y{^zJcZXCyp(p> zM!bO0fwdqj+PD`7Okf{M?1{Gg!2BFlbJ#xEZ%X;s+#J7s{KFS3Y&$x8h+S|$i0zF} zmmmCqj08y|^>com-UkU+NR!{V7L_aZt1og}rD0^QEwg^2atX-%NL@$eqL5LI3~b{) zMV8x04edL)KW<{g!bezrK{klYZuxa?^@s%tjnooJ^++R;HEVMZdR@U9sf~zLHM1Cw zWyP#SAejN#ATmopM%76ps&7m~c2LI~i(X}RW3(|;M-1EDl9}+;JKR=jhixR80h!|q z`<=zy@J-q3n+clD3pvgh5gFxmT!93NKMGd*VmDn_()_$9lI)e-8<>VAPZT2$PBgKt@#=8YVDN< zWCmo8Z_=;KZuq8Kt-c^5kJz8~AiN?{8b+40)kp57)z65J)JD6OsrL1;jtQqQ9$(IJ z48VNq&KE0pHd{4Dy!)rR`TwuXp!cR)zCH$P6yLvOc`FUb49FZ`*snGo@lDx+m^W1q znCd5vvBMDd0<8VUXk^Wt`mk5O@!BAh44KEbflMddinJ)JLvE`yATuCyd||&byXKpE zncacR%S`6fjbgTHQ|LtL>R)ibLRQJ2J)*N1;(tflDh(hzG%FDv zPS572k1;MS5!9#H08E;mFBOoJ{dJPeUhwN=ZIn%f=*z4Rf_&NT{i2B$2p@4u7F_%=6Z2qX}MhAS2u8s{jRQ z9J2A)^s`!KJydQ!Gsq0E&3t7W#u1GL6) z?dL76Ud?X=5=2fLA4K@-H(1_EyRH5h$Oe&FsGqG_eL_Z66T7n41o4VUX#kmxe)A}q z&tC125o&f?;~DW<*Qm4`*`(Q5ZnxKH!4Yc|kJLu3t<1dNXhv$`r`Oz8X&9N~3;Xr1 zj`*fA$VeOIbXiI?9V#NF0c7LMMrtcFXd|NCEek@tt{PDqMmC7dA}t6ZA*-+T`jN=6 zT7ERDXP*5=g=e0f zCn)~BAQKu!=J>*X$Fl@vbw9%>KuD`dWcB*9e)pP)vmmr$)#lGUUzH*=p&^+KwEiq) zLE8NcNa!33tUr@16Ytq%g*2$?k=vGCOqw^bTO z=J>*X``KssrZLFK2QllZ533_?t2BUYua;TA{p>kEo%e_}`A3#`O=cLGTm6jq>Te1% zpFYH%l3CMher_Sa^Bipa*^|8jT$9ny1ew|)sp`53W4wwwQ@DULn@*9E7@lE=b z*)`uZ1{v8#pRq_oc37|O@7Ffo7-U;(c+4JU@b#&Fzj~9~Dh>2AAai_SzcRbwo3aHl z0mrrl@kpqj>0a$=$VP2sIaO{_wXL0>dH(qQ-}FyhQ%bC0QN&_3Do&O-TwosygK&s* zZ9$wnolU(Tj5OL5=J(R=!ZSW!J?fgWbok0i9`Q?lonB^Y*f*^{`H8Ld)Wqwm5vASQ zNXQ)Dq+e}($v2HbMs>uyvXfT=GMt+z-qpC*s9el=23v^uVv~yzzB=N!qBI~gAai_S zzcNceMiyk3^3;jQ>RC*dt0BjBU5t)rcgOX~f|LWzVs2ScxSs{Az91o)wMObVWS#l5 zEm@Tgo2b9q((09SG05HuY}Q8NtKa9hqBPLYhRUBs%8ZcsJ)|WUlYnf`jAyy!&)`i# zA?+;2^C~N)0hs}rW8wB|8)IblheB2sb@V$w+X!Sh+0Cx=^nCSo>1RT_Wk$$ymKh-< z+gM7i9PyFJaPsy&)kb#wX1$za@q%y4RzDC)h0Ji)NUNU_U%kt1l?G%s)S2Qp2ALXm z8a~=lIYQRd$}!TS`e{KXG=QwxwRf*qzwz223q=cj#==Akgs)Bnnb0sY#~1c%8?X7M zUK{T~M&p^*>yO}VMIy8Nq*9jYYSu(ky)Fh-?fW7#q1`eYm-Tptqjr0Yq&_pq%p_(l`b|4iw&EbfS5A-# z4I`5a`t4^I{B&MsG8TJVWcwM$FCalb8*7%y^VRnWGNB=4b;iQ@jXl&i-WX(dq_*)! zIQp%9QiZR6QjiG^BXfLVzcRbwn|hhufsACPb812wiELc&57Ms>5;LAbMlke^Z4|zG z$ZthyKxRPZ_`-f=mVk_Ezg1?0R1ql+Alt1^docZMOGKk_IW~UU((0AtAQ+e$+X$Hv zU;P)6nb0t@L1cEzPv`rYZn{A4YR!TW5}Rd8Kz5M#oEj^`Z3Z5>8LUM3uOc&{0hs|= zwlc$bMo1_F@B5kXamXe%-q`1y`kLSS9o`lB`nICX^SW|XX}8P>*&s4YKxV2YQjkq* zALIZla{D{Q`Q?uPumv&hRojC28Xh*nK1S?$UEirRATuCye3O31vlo0*MrI;B)^CI% zM15mX@53W}C1at|4rB-=k8<9R7#0I7R+|cG;k8a*X$YCM`cmKcik2iPn|owsW(Iw$ zjX;9fRm*}9uhr~I!^j-pq+e~k$2YAPKL%Dq?qQc+8mV4I^`WVZSna$v2Hb<}>h3mMIolvr=6549I824@Y!t zKck3Gsg^@&KxVsjReQg+1vf@!It5$zh#A>hr3-di{(Ib3X&9N~3;Wf^8@{R6#ygPJ z+9*gBkN9UrM`WRy6xJI``=D z#q6@0pUy9@s`>fs4BIB9e3H&TlQGF_qj4M8XP&SaP0o{LwqN~aRx+hwWUj4^{p@Y~ zqkd19uh>0Zc4w^dqitGEFXBslB6c=sW?=^pR#IKXbGou+6nfDW0RqgO2v5EIL zxvkQG%!XP6pMb26g9uVZq_i7ZIjQ6NIgZq{vaX3Y0vYjYIg|#F9n@8TSw`is3sf^w zqn{BUQCk43Ujmt9we5GLzU7;8KQqag_RN!z_{^Y2Qi+dKlVB`IIn0;xmJEjzto(akJM%zcbGl z{NCB>n|PzuMj*l7f6bg)cs;95X}8P>nd6)E+s|(JrXHEK`fKAEz@Q3n@}Q&>fx!?T zQBejZ9yjZ$`<2;qi%i6_9xVV2tn+Nm&xo&<+*WBoWSyNsv;FFaxUJFvvSz1c)6cTm z9h-cR#x_EL#A|p%X&BicGP}p`{jOZhE>dWIou~MX#J_jMZIuR)HEVPGtxkHuPq)$PrB)4(=OcC#g`t@M*&y0@%U$4(k=i5i*<9AfSY#;u88vGxjMd*# z^=87k>pyO3^~$w!h*dRpSLEo^NjU$9--^->Z4_kL%1n^db;OCtYLB?zsN6H7jUn#} z76WmQCXy<=o&>BkB(s4$;sj(gQa4o-h!KBOv{7gn*@!RH@hqR5CxVNZkJ-4s=d0fn zWJ0@JMlzEfU_DYrq%?qRH)Go8@#N^vIYjdHE#7ET1 zQ9nBvC^Hx*GmoU6pCutfkXRFJ`FU3XA4DyO((Zm%H0xse-P`sVTLC{m3q?|a3}^Z@ zaS-7n;*HQoLND3929XXqw%#Tqlf?sd>B&{BK zzT-c>pJ_mVzT0}l&_4XvM8AcvKFe*DhGaHSKTAMH5gy$EmXInUr2%BtyUNgSe8oI9 zw6ScW1(ROa#atL|+%iAwT4PcDSCxiL6kyOvCkFPXunFzOEZM@y_pN%Y2+v*b% z-Z78;M$c>BOld%7`$ijKL5?5saocA&>|wRVN9_7jQa1P6APeu4N`7O@*C)Puz-^U= zkvYDwUzuI=O})(SKxRkk1Y~xlcy9d+FktAL2#@e_vzQXd9KXJPWftmZYqJi@98^7RQTI6qKD^oX%E=TBUrp zw0gA)X}~}f&iaj>*EplnfXs%P#l*<$4~NXoV)7f$sJ^jf8;RF(Old%7K$dMk^D-;F z58~H(3a^NihLF|cS-({i&)ID8cxJ){YvUP~6s*Y%yY~KdZmTqmY!I0xAoFVm>$rYA zG85O&t)F2$gWuRh3xu!U6PXDO$!wswevEAtB;l%^G#roEpelt09SxI9*nd4PrqOkkMKuIWLA}7>leG;Zg4@t5wG> znPD;DNGr*d1}q4W4I;C9JO0C6dw%|!6PLdJ1+T>=ci%^N#Of3Oo{ShuL&%KPUtTQE zmpFR$WOh7XQtI|Y%hlD%V~1a9$e$K!;8@oA`4!yd>aklrnmK9qVZL}ZyFA03f!t~Q zUH-P|5x-z$zMtvBVsgLjNDUaMNo_`I;j4ejZIySuoaSrW2I=4&i) znrsu{0W#v_>aGacATqmUMPY3W#6bi}d!1)Ava;@HWv_YaYlBRBlAq;n^fPn*nb$^~ z61L*DO1t~n1jrm;*l$0(=9_LEsRaqyM!)k(JTe;gMj2Np0SW$V*+$|cvP^<(5ShI+ zGSjW&NF8mK2`~^$^=Ct>%!sf41-Dh&p^Y9{J@f20l6ql~h3Y~4x=ypdzVOu#3NoQ# zWR5TFx1S{-tIr-uL)M%ro?j%DV^>WiRrtt$Hq@EoG2@vaS*rppVv*HrnKG4GyB-8l zxxMPQq@M{5^fPQ+JV-x_mRX5&21gHe57_rlKz2}%XZ==4-|&0)Beezu$m*~8AT%GN zUpoh67zO6JpltU1F}J6mVnIrAXLMXh^+P-^Xq4P@=de;OnA*yC=JPMAipuD zp9vE3^(87tXZ{>2BBcRj&0g&}%8XWzG+8ESBk_?|f2h6M<7DQMQ1n~<#&~3Cq1oJi z{l@3kHik16W1QMt+eVDs#8;=>R%y335;DgZ_Ukt$AS1s~GE2Qe%;oMLj?3cZZ=HgDm8Oc#qiF zM&YY>xUJG|nGrI_7xpW&8@}mQ?@Ex6%(RXee&enpQW`*3X1rz)p#iKOY2qNlYyGg& z05ZG7P;U7%jLbmRSPT275ef<~}%4`ga-NsRt2WBdAIPG6S+~WhO`{-Y6B)9;qTy8bW4lW8=|RSC=QV zty^XoM_zwSS`B%`U4Tbw{RU8*i-8AxV0T&;UUyhl8b&sV%o30p+vt%hBBcRjVBW-6z$=8#yX>FumCEAEjYr zgUIZNpKhzw7bJA*WmA({L?g@E2cf+sn%V;Dbl`OjlhTmPvi3nd5^Eb1kTs_l^}9;z znbAfQELihFD6Ze~8;P$z!EKcWWCmo8FYMRXPe5i)obpH&koJ zW+zvtSRi!paTxeDZKNIZ>bfhB43(RAp6BT;$euavA;b9@*1@!7Mtt?#A~T@@nE{#O z3;P|B*k zPux}-kQtB-BC{J-6t?=ty|NYr<^sqLXgu4c8Xn=RXWUk42wC1f2K zp-u#j>1Tq3;*GikYznfv9wbY@5xZkI{R~Knul}=WqtK8x4pb`_DKkPszP`?>6ObL$ zyBzLeP40B{DAEviT(+h8rfobj7Q~dKu8-8HY-wZ$+X%j#%3GPfJ5 zk8fHppLX5rsWEpvgh5c${0x}w@bzeC`s)&>ZkTrWJ^;-paVPqCw z4GE{+Sbg{)#8-boWF|C>Y!I0xAfrfXN!i>)WLaAf>Q~YWeU{1dYB`h!WY(O^)bARL zn11HHD|42X@YP2|8-<3E4Wf++$S6kaef>0Kdv#pD7;Twgb+{ZGzuMA#(+9cX_r5WU zS&J56wMZ+jPki-dk(tnd%z(`Ch5cIn8@_1_GV=AcUOxd@<2PpM>toi^)P8$yjHv>o z2v0GT-*{_erVEQnzpXY3l6p>^h%DndH93jxT#V=M&cL(GGLGvDvO2CWd>pcJT*vkE z>t{fMnP$_^gpZ4Z5HiOq->+?q>1TqZZ5y%v?9M7c(#CRPysO+|#IP8sBW}g6h>u5> zt;_^j-Oq%NM7C>eV{WUoPz8uR%35{A#H%N)wA%+M_v)2(*mF6%=(q1M?8dRLPaUZG zSvCwx!^j5F#uxl_-n$B~`0>d6s$_aCwXx1v^gHu>Ze+HlYJ%JlV;iZTjjM+uGoc}w4V1BnN9K25 zGbeBFS3e@igmxnvkLql0zY(5DWawIUq^7EgL+xKm!^j-Jf_^>X1Y{I%^qE1ZVgfSk z!*EZL={B#Ivxis9+0v~RI30nvdo?3Y@W-T;2%q7bPS2{VQ#U()&0WsU7OziFt!)I7 zUAwYQ_{woxr2&}%nOxYf%r5xpybofd-_|xV5@ZHZH6gob0O`2;0YN4-gsh%<=C>LW z$oAVYV$WCqNRSB)BO63!FO1B>expZH`yhfe5?PZ!%P}*EBtUo{LC=JN0iR)(> z2f^t@jYsVJ9X#S+6Kxb4MmC5x-db%mNzV=2IKoLdlX@Q>LK=&#_O6_3)}MWPx^#~g z%ZvGHdOH8{*~t$tXEQn<=L`i|%aGYmvidJAGGiRqkYQSFYro-LVdnYk+*WBwW&?Rw zAq%o*^|3W7>KhB*R}R`pysi*e8bH?Uca>j1!+Z?8t%*PpEf78~k~$u0zpI#jCP?Zv z7HP=#>-<@MR-chHwo!Ps_DTcVcu@QL`5{BU!dY4^3qrgiQW`>5dsqF|q}~|Ys7ZD* zx*Hb6)Hiwyg8Ifg_erHW^?0Z~T@sK{?YGtuV-^#MY%((AS#EKC$Os;BOB;#5`%DCq z86k7582!#-Vr-)zBOgTb)CtHYb$w%w7KF-nY=p=2YB`j4SP&G*pyWsA)cMt2L1yq1 zTiQr`#LQEW4Wf+~+yyq~)N6htAu&5Lc%<>jM(uufIa^)MX9!8S*Kr=sD&+re{+}k0&=0c|X6ZOpHq!RLT)-{h%<*Z!q6 zfGqR#JYhjv)k(xxzsK@c8b;>Y+L+H7tk6C}LLRZ-9b0%sq_i7Z(OCVm*A+j{`E_#L zm6$*3YHQvV{KUp11~TIHOh~0+WP`{o0h!-1ukhL2L}Yo}#iX*aUc?st`8JqW7U8)O*Vh*v~P z1ITvkJav{MHLV$}wGksV@rp=k0GX{x%}r+B=P&Tp*#{wB5h?9JMpm@(8?%glquREy`fNca)i?O9 zC=DZXd||&byR|Y4WSInskMQu$l$ft!U%5DB)(6QgD#vI1G`3Or>gysip#hlznd1v{ zlo@$b*pUIJJ=D92Vy}rPWJS)W%fdDy!qc*i#7C?YhXo;I*~(0i+00-9vPtbX_Pb-= zGwuT3>Kg;HKAyqnXvvKD>V(@W?e1pjW>ML7-W8Boyd%kDk7y}WTQ5+CJi}s&XcvVl^KLK?nlgGXeO8Q+FU-} zq49`?kFX$u%(Z2fPi9b%)E;pfvZlVV->Qk{wx5}>oV6gZ-6+OsWF~yXiXVChL)AAX zAoCtE&tg2%IAq0PT`QNRN8H+B$jc0CEPjLKt+c~7LS}@_@rC_b{ad~%M^XdhnIIwW z%J1otgseQMN9z1!2CKifRu4ja^}GC5ly=LEkU73EKbZ+K%E0Shfbq!2`&suhR3o*| z^CZ6d9g&&PZkZ9XY-NU73n3wy?ea=-&&MH~puXjvYGa>gLmu%>*@A>~G1#l!Mhj@~ z_Hug7ZIyP*jF36Lu-|@m#5avWMza{Pjj_n!IFIako*709us3^?froYyAF;+lkPRZU zxbe&*q4BJg%wRmSVpQ)BQsj8nFFo zY*PKIAQKu!HsTA_g5)#vr?R?&0O)%q>?}Cy&jT6ZkP{&EPXu6mRv7L)^+Td1SgZ8*(wiSN~A7QD_*MYinaa zbLtC&O!UpaFk6!fBvg368XeSUuo7Q=zaSIZjjU{JV}8Cq`c-GO?cKgUY$G9a{0h{9 z^dqy#@r;o9J<23A=n#Oon|p5FSyf; z53NLKc~`_otR4|$gJ@#{GVfi(d)*zfAj(`5_T#>uGm8~e2&M-~~68vb8vL7LruKYR}Q%5Yk+C-%tGD9eNG^(rG^RxPp5h`7p-PeRyL`nn5 znp2!}wEE-$x7K+QubB#^VPvk|&$61u5EAc$$SfuWS;lo&l#{jDT;Z$VXHh5($t>f# zD?vgT3%?^n8nUrj@pG|qpPJzxzbzll2C+FHPHtQVtzr8QN%ONKe(zhyGq&V0+ATuCyd|`egwIHFY38~lj5g$dQG=OYk;*I%bENBI*^{zZ0v3i8YGaws8W|1B- zA@l30#Umy@64_o|ub<^e4Y#9-enUHn*AZH2KpUI&)Wv?EJ1yUE=jLdE2@8g(e5T=A$;|o$V_NJX8UzN%WvOrFQfKe z6Id5hRQrNVXc*Zb+IY=R=lhxTBtPzN^s{#KI}KUR+6Y_NssbdwddY7^X+UO&^+;V5 zecDE`Z(e4`G`1qC&_?+77MbU(4+=7&VPuXk?ANq7U>39}nI-0eOf{c9qg8W9| zW07TCx#`EV_I_8W4;ks|ETtitWn8%_$b6-XL{bxwHG8`ByEga6Xrm5UG*nw{1Ty4a ztas)4>K|}hr2&}%nd1xlwfZ-F)4P0qLPl0!s{n~tL`uWRa<=-=K0BwT+PQH=O)6P^ zdzMy)Rv+fDSq%w>_{i}L$Q&z1zuFjS^$AHGNlinxXQOhLi`C+IaZ03^Jb?ESg-5@DaHf(ncW5R%U|4M^fvYXHmo=Gg+qG`WdV~!on>JLVU!k zV=uFe`kn{c%)eEY`gLuSNl4n}D}8xQMfLBG-O=ZuW!XTkN`_;w-WMmtCHWxBWLpEw7%gHuUJ)?~lcs^p^0$7l7Qw5k`&eQj+ zwl>lpW!k@#c5CCfb@s^V^cZup`MEp4x?EDXezZ7?uiH;>O+tKW#h>(HLY zCw#;?gVfJ}%qcQHh@u~vB_N|ns;+@2r18i`ZDje_MogfQr*1}S;p1XgG$uW}Rp3N<^enpEQBB0OUt8>FAzau;9=63#La z60(g=MOiemX4l?+GZxPcve1ejjMS}N=!MsH)Jg-|IMlAa3CR2^tue2(BczH*X*aS- zQTzJ&^)p|yW3suzSO1;mtu%}*+kPfUXy!SYc$txH94R8D0c6dtz4^%uwh_CnHPHg$ zHU6PAj4WH32@>jO>VptcMWi%@EaMn4kih|L=4Zl3tkOcW$t2?#u^=(~%6X&_$gt#T zG^*>aGVN!Yp67ZHJn~*Vvb_6QfwPXs4@x?5%J;iiWJS(9Eqf%Uj#&7JI0!^b$nut1 zc|f*tmwb>kWcwNSGarRBE9-=h>t_X!Wh*m5;`eW?*LmWEj=R_9LK`9DCJuto)u-Iz zp_@H?I6s~qKmHgk`I+PBce5?S#q9DJtAY?J*_eW^H#Zk-&OEPo{KwB?LUqK@K6t=Q zZGrIBl-nxp7^wxB;|u$Z5nuC7W03ib1^JCh$i_BfvHsFCkQtof*6I=Bt55P*XWfnqaEeMc|?vIOAvBxoD;j51dGNEB)qc*a9axv&v_^-*u2w(jhK_;{t zSz$fm{6=cjf3$0Oh_8NGkO>VVb8VURlNo%;H@(9L@yN&{)~bmFWaGN-D!&L12D8o; ztY71|qEUl@%z(`Ch5cHPTfQmF%oxY^c;=CjcO^3OydqK>K(?E8RXdGe&CHWW>LOx| z1$>YK$TF6hN9ND?siOtsSY-RP%=-1NE{rysNla^`_Wi6?ZA&BfSVw530c`}bL1dPI zjQW{BvrdpIBBfzu*^bog+czV%@Om@}2M9WPLSHKTCW^m0xi zE8~=J{+Lw5^W11-I8P1jGy7e6nU#kTr>c+z*)NCD#sp*(ZQ_W&LPIjkI2QvMQFRhqVUB(iACa+uZ7g>OiV@%Pd*A923o;+qm(~68 z$i}6u;gQVC)%le6#>TL=TAa=mJenO&YuPu=|Ta=yY<$iz%nyg8d&&hdBp{1J?2 zbnDLqwWP`{ogv>@#83`h(_QWaJ#y16-&~9Xt(o~e?mdyn+goRr&BfdHkWJ1Hp9ADV4 z)&IFMeMUCRbntPMGFp#Vkkxx`3SS8#rD0?_TYcJ3zxJ+xjQDlGk^laO|M&j^0o1H0 literal 0 HcmV?d00001 diff --git a/data/test_data.csv b/data/test_data.csv new file mode 100644 index 0000000..276f450 --- /dev/null +++ b/data/test_data.csv @@ -0,0 +1,7519 @@ +USUBJID,AESEQ,AESTDT,AESTDY,AEENDT,AEENDY,AETERM,AEDECOD,AEBODSYS,AESER,AEONGO,AESEV,AEREL,AEOUT,STUDYFL,TRTEMFL,SITE,SITEID,AGE,SEX,RACE,ARM,ARMCD,SBJTSTAT,RFSTDTC,RFENDTC,RFENDY,SAFFL +01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y +01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y +01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y +01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y +01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y +01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y +01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y +01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y +01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y +01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y +01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y +01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y +01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y +01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y +01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y +01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y +01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y +01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y +01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y +01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y +01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y +01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1118,1,2003,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,52,M,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-09-09,NA,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y +01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1181,1,2013-12-09,5,2013-12-09,5,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-05,2013-12-12,4,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1203,1,2013-03-21,48,2013-03-21,48,EYE LASER SURGERY,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-02-02,2013-08-03,136,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y +01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y +01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y +01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y +01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y +01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y +01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y +01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y +01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y +01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y +01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y +01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1442,1,2014-01-10,77,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-26,2014-04-26,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y +01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y +01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y +01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y +01-703-1175,1,2013-12-18,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,75,M,WHITE,Placebo,Pbo,ONGOING,2013-12-20,2013-12-31,NA,Y +01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y +01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1295,1,2013-12-28,38,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,88,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-21,2014-05-19,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y +01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y +01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y +01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y +01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y +01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y +01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y +01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y +01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y +01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y +01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y +01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y +01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y +01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y +01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y +01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y +01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y +01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y +01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y +01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y +01-704-1218,1,2012-12-30,42,NA,NA,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-19,2013-05-27,NA,Y +01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y +01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y +01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y +01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y +01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y +01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y +01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y +01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1388,1,2012-08-23,-106,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-07,2013-06-19,NA,Y +01-704-1435,1,2013-01-06,51,NA,NA,PARKINSON'S DISEASE,PARKINSON'S DISEASE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,M,WHITE,Placebo,Pbo,ONGOING,2012-11-17,2013-01-12,NA,Y +01-704-1445,1,2014-10-31,174,2014-10-31,174,COMPLETED SUICIDE,COMPLETED SUICIDE,PSYCHIATRIC DISORDERS,N,N,SEVERE,N,FATAL,Y,Y,704,704,75,M,WHITE,Placebo,Pbo,ONGOING,2014-05-11,2014-11-01,2,Y +01-705-1031,1,2013-12-25,29,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-27,2014-05-11,NA,Y +01-705-1059,1,2013-11-02,90,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,66,F,WHITE,Placebo,Pbo,ONGOING,2013-08-05,2013-12-05,NA,Y +01-705-1186,1,2014-01-26,19,NA,NA,HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATOBILIARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,84,F,WHITE,Placebo,Pbo,ONGOING,2014-01-08,2014-02-07,NA,Y +01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y +01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y +01-705-1280,1,2014-04-20,94,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-17,2014-07-25,NA,Y +01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y +01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y +01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y +01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y +01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y +01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y +01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y +01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y +01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y +01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y +01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y +01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y +01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y +01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y +01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y +01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y +01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y +01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y +01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y +01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y +01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y +01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y +01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y +01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y +01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y +01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y +01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y +01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y +01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y +01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y +01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y +01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y +01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y +01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y +01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1032,1,2013-02-26,18,2013-03-09,29,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,62,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-09,2013-03-09,0,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y +01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y +01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y +01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y +01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y +01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y +01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y +01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y +01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y +01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y +01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y +01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y +01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y +01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y +01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y +01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y +01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y +01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y +01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y +01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y +01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y +01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y +01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y +01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1372,1,2013-04-10,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-12,2013-05-10,NA,Y +01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y +01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y +01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y +01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y +01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y +01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y +01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y +01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y +01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y +01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y +01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y +01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y +01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y +01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y +01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y +01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y +01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y +01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y +01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1301,1,2013-08-30,43,NA,NA,DIABETES MELLITUS,DIABETES MELLITUS,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,62,F,WHITE,Placebo,Pbo,ONGOING,2013-07-19,2014-01-17,NA,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y +01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y +01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y +01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1424,1,2013-03-07,5,2013-03-07,5,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline High Dose,Xan_Hi,DISCONTINUED,2013-03-03,2013-03-08,2,Y +01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y +01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y +01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y +01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y +01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y +01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y +01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y +01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y +01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y +01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y +01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y +01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y +01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y +01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y +01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y +01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1083,1,2013-08-02,12,2013-08-02,12,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,FATAL,Y,Y,710,710,89,F,WHITE,Placebo,Pbo,ONGOING,2013-07-22,2013-08-03,2,Y +01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y +01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y +01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y +01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y +01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y +01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y +01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y +01-710-1187,1,2012-12-23,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-10,2013-05-12,NA,Y +01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y +01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y +01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y +01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y +01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y +01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y +01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y +01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y +01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y +01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y +01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y +01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y +01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y +01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y +01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y +01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y +01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y +01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y +01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y +01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y +01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y +01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y +01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y +01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y +01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y +01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y +01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y +01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y +01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y +01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y +01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y +01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y +01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y +01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y +01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y +01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y +01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y +01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y +01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y +01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y +01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1073,1,2014-07-14,107,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-30,2014-10-05,NA,Y +01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y +01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y +01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y +01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y +01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y +01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1425,1,2013-08-13,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,714,714,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-22,NA,Y +01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y +01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y +01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y +01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y +01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y +01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y +01-715-1207,1,2013-01-10,54,2013-01-10,54,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,78,F,WHITE,Placebo,Pbo,ONGOING,2012-11-18,2013-06-01,143,Y +01-715-1319,1,2013-03-18,30,2013-03-18,30,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-03-18,0,Y +01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y +01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y +01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y +01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y +01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y +01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y +01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y +01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y +01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y +01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y +01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y +01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y +01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y +01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y +01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y +01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y +01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y +01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y +01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y +01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y +01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y +01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y +01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y +01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y +01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y +01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y +01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y +01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y +01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y +01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y +01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y +01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y +01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y +01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y +01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y +01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y +01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y +01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y +01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1177,1,2014-08-24,-9,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,716,716,72,M,WHITE,Placebo,Pbo,ONGOING,2014-09-02,2015-03-05,NA,Y +01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y +01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y +01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y +01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1308,1,2013-09-20,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,76,F,WHITE,Placebo,Pbo,ONGOING,2013-08-28,2013-10-07,NA,Y +01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y +01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y +01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y +01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y +01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y +01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y +01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y +01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y +01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y +01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y +01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y +01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y +01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y +01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y +01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y +01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y +01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y +01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y +01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y +01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1441,1,2014-05-11,110,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Placebo,Pbo,ONGOING,2014-01-22,2014-07-22,NA,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y +01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y +01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y +01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y +01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y +01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y +01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y +01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y +01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y +01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y +01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y +01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y +01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y +01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y +01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y +01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y diff --git a/global.R b/global.R index df772e7..2bea683 100644 --- a/global.R +++ b/global.R @@ -19,6 +19,7 @@ library(tidyr) # version: 1.0.2 library(survival) # version: 3.1-8 library(survminer) # version: 0.4.6 library(fmsb) # version: 0.7.0 +library(shinyWidgets) # if function conflicts, default dplyr conflict_prefer("first", "dplyr") diff --git a/server.R b/server.R index 55a997b..0509bd3 100644 --- a/server.R +++ b/server.R @@ -1,828 +1,826 @@ -################################################################################ -# server.R -# This R Script defines the server logics for the Shiny App. -################################################################################ - -server <- function(input, output, session) { - - data <- reactiveValues(ae_test = NULL, - statistics = NULL, - statistics_soc = NULL) - - plots <- reactiveValues(volcano_plot_data = NULL, - volcano_plot = NULL, - volcano_plot_click = NULL) - - ### Data uploading ----------------------------------------------------------- - ae_test_data <- reactive({ - file <- input$file_ae_test - if (is.null(file)) return() - df <- fread(input$file_ae_test$datapath) - }) - - statistics_data <- reactive({ - file <- input$file_statistics - if (is.null(file)) return() - df <- fread(input$file_statistics$datapath) - }) - - observe({ - if (!is.null(ae_test_data())) { - data$ae_test <- ae_test_data() - } - # if (is.null(data$ae_test)){ - # filename <- paste0(getwd(),"/ae-test.csv") - # if(file.exists(filename)){ - # data$ae_test <- fread(filename) - # } else { - # shinyjs::alert(paste0("SDTM file does not exist:",filename)) - # } - # } - }) - - - ### Extract all arms --------------------------------------------------------- - ARMCD <- reactive({ - req(data$ae_test) - unique(data$ae_test$ARMCD) - }) - - - ### Definitions of UI outputs in the control panel and related logics -------- - output$summary_by_UI <- renderUI({ - req(data$ae_test) - selectInput("summary_by", "Summary By", - choices = c("Patients", "Events"), multiple = F) - }) - - output$review_by_UI <- renderUI({ - req(data$ae_test) - selectInput("review_by", "Review By", - choices = c("PT", "SOC", "Other"), multiple = F) - }) - - output$review_by_please_specify_UI <- renderUI({ - req(data$ae_test) - req(input$review_by) - if (input$review_by != "Other") return() - textInput("review_by_please_specify", "Please specify") - }) - - output$period_UI <- renderUI({ - req(data$ae_test) - selectInput("period", "Period", - choices = c("Treatment emergent", "AE during entire study", "Other"), multiple = F) - }) - - output$period_please_specify_UI <- renderUI({ - req(data$ae_test) - req(input$period) - if (input$period != "Other") return() - numericInput("period_please_specify", - HTML("Please enter residual period (in days)"), - value = 30, min = 0, max = 10^5) - }) - - output$ser_UI <- renderUI({ - req(data$ae_test) - checkboxInput("ser", "Serious adverse event", value = FALSE) - }) - - output$drug_UI <- renderUI({ - req(data$ae_test) - checkboxInput("drug", "Drug-related adverse events", value = FALSE) - }) - - output$test_UI <- renderUI({ - req(data$ae_test) - selectInput("test", "Measure of Association", - choices = c("Rate Ratio", - "Risk Ratio", - "Hazard Ratio", - "Risk Difference", - "Rate Difference"), - multiple = F) - }) - - output$treatment1_UI <- renderUI({ - req(data$ae_test) - req(ARMCD()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - div(style = 'height:100px; width:91%; overflow: scroll', - checkboxGroupInput("treatment1", "Exposed Group", - choices = ARMCD(), - selected = ARMCD()[1], - inline = F) - ) - }) - - output$treatment2_UI <- renderUI({ - req(data$ae_test) - req(ARMCD()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - div(style = 'height:100px; width:91%; overflow: scroll', - checkboxGroupInput("treatment2", "Unexposed Group", - choices = setdiff(ARMCD(), input$treatment1), - selected = setdiff(ARMCD(), input$treatment1)[1], - inline = F) - ) - }) - - output$treatment1_label_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("treatment1_label", "Label for Exposed Group") - }) - - output$treatment2_label_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("treatment2_label", "Label for Unexposed Group") - }) - - subgroup_var_choices <- reactive({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - c("No Subgroup Variable", colnames(data$ae_test)) - }) - - output$subgroup_var_UI <- renderUI({ - req(data$ae_test) - req(subgroup_var_choices()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - selectInput("subgroup_var", "Subgroup Variable", - # choices = subgroup_var_choices(), - choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"), - selected = NULL, multiple = F) - }) - - output$subgroup_vals_title_UI <- renderUI({ - req(input$subgroup_var) - if(input$subgroup_var == "No Subgroup Variable") return() - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - h5(strong("Value for Subgroup")) - }) - - output$subgroup_vals_UI <- renderUI({ - req(input$subgroup_var) - if(input$subgroup_var == "No Subgroup Variable") return() - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - req(data$ae_test) - div(style = 'height:200px; width:91%; overflow: scroll', - checkboxGroupInput("subgroup_vals", "", - choices = sort(unique(data$ae_test[[input$subgroup_var]])), - inline = F) - ) - }) - - output$X_ref_UI <- renderUI({ - req(data$ae_test) - req(input$test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - if (input$test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {xref <- 1} - if (input$test %in% c("Rate Difference", "Risk Difference")) {xref <- 0} - textInput("X_ref", "X-axis Reference Line", value = xref) - }) - - output$Y_ref_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("Y_ref", "Y-axis Reference Line", value = 0.05) - }) - - output$pvalue_option_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - selectInput("pvalue_option", "p-Value Option", - choices = c("Unadjusted", "Adjusted"), multiple = F) - }) - - - ### An essential step for obtaining statistics right after data uploading and - ### before the generation of volcano plot ------------------------------------ - observeEvent(input$obtain, { - req(input$review_by) - req(input$summary_by) - req(input$treatment1) - req(input$treatment2) - if (input$period == "Other") {req(input$period_please_specify)} - if (input$review_by == "SOC") return() - if (!is.null(statistics_data())) { - data$statistics <- statistics_data() - } - # if (is.null(data$statistics)){ - # filename <- paste0(getwd(),"/statistics.csv") - # if(file.exists(filename)){ - # data$statistics <- fread(filename) - # } else { - # shinyjs::alert(paste0("ADaM file does not exist:",filename)) - # } - # } - if (is.null(ae_test_data())) { - shinyjs::alert("Please import a SDTM dataset first!") - data$statistics <- NULL - } else { - if (input$summary_by == "Events" & input$test == "Hazard Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Difference") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Difference") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { - withProgress(data$statistics <- GetStatistics_HazardR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Difference") { - withProgress(data$statistics <- GetStatistics_RateD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Ratio") { - withProgress(data$statistics <- GetStatistics_RateR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Difference") { - withProgress(data$statistics <- GetStatistics_RiskD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Ratio") { - withProgress(data$statistics <- GetStatistics_RiskR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - } - }) - - observeEvent(input$obtain, { - req(input$review_by) - req(input$summary_by) - if (input$period == "Other") {req(input$period_please_specify)} - if (input$review_by!="SOC") return() - if (!is.null(statistics_data())) { - data$statistics_soc <- statistics_data() - } - # if (is.null(data$statistics_soc)){ - # filename <- paste0(getwd(),"/statistics-soc.csv") - # if(file.exists(filename)){ - # data$statistics_soc <- fread(filename) - # } else { - # shinyjs::alert(paste0("ADaM file does not exist:",filename)) - # } - # } - if (is.null(ae_test_data())) { - shinyjs::alert("Please import a SDTM dataset first!") - data$statistics_soc <- NULL - } else { - if (input$summary_by == "Events" & input$test == "Hazard Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Difference") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Difference") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { - withProgress(data$statistics_soc <- GetStatistics_HazardR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Difference") { - withProgress(data$statistics_soc <- GetStatistics_RateD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Ratio") { - withProgress(data$statistics_soc <- GetStatistics_RateR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Difference") { - withProgress(data$statistics_soc <- GetStatistics_RiskD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Ratio") { - withProgress(data$statistics_soc <- GetStatistics_RiskR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - } - }) - - - ### Definition of 'Reset' button UI output and its consequent triggerings ---- - output$reset_UI <- renderUI({ - req(data$ae_test) - actionButton("reset", "Reset") - }) - - observeEvent(input$reset, { - updateSelectInput(session, "summary_by", "Summary By", - choices = c("Patients", "Events")) - updateSelectInput(session, "review_by", "Review By", - choices = c("PT", "SOC", "Other")) - updateSelectInput(session, "period", "Period", - choices = c("Treatment emergent", - "AE during entire study", - "Other")) - updateCheckboxInput(session, "ser", "Serious adverse event", value = FALSE) - updateCheckboxInput(session, "drug", "Drug-related adverse events", value = FALSE) - updateSelectInput(session, "test", "Measure of Association", - choices = c("Rate Ratio", - "Risk Ratio", - "Hazard Ratio", - "Risk Difference", - "Rate Difference")) - updateCheckboxGroupInput(session, "treatment1", "Exposed Group", - choices = ARMCD(), selected = ARMCD()[1], inline = F) - updateCheckboxGroupInput(session, "treatment2", "Unexposed Group", - choices = setdiff(ARMCD(), input$treatment1), - selected = setdiff(ARMCD(), input$treatment1)[1], - inline = F) - updateTextInput(session, "treatment1_label", "Label for Exposed Group") - updateTextInput(session, "treatment2_label", "Label for Unexposed Group") - updateSelectInput(session, "subgroup_var", "Subgroup Variable", - choices = c("No Subgroup Variable", "SITE", "AGE", "SEX", "RACE"), - selected = NULL) - updateTextInput(session, "X_ref", "X-axis Reference Line", value = 1) - updateTextInput(session, "Y_ref", "Y-axis Reference Line", value = 0.05) - updateSelectInput(session, "pvalue_option", "p-Value Option", - choices = c("Unadjusted", "Adjusted")) - }) - - - ### Definition of 'Obtain Statistics' button UI output ----------------------- - output$obtain_UI <- renderUI({ - req(data$ae_test) - actionButton("obtain", "Obtain Statistics") - }) - - - ### Definition of 'Update Plot' button UI output ----------------------------- - output$update_UI <- renderUI({ - req(data$ae_test) - if (input$review_by == "PT") {req(data$statistics)} - if (input$review_by == "SOC") {req(data$statistics_soc)} - actionButton("update", "Update Plot") - }) - - - ### Check the prerequisite of customized labels for exposed/unexposed group -- - observeEvent(input$update, { - if(nchar(input$treatment1_label) == 0) { - shinyjs::alert("Please enter label for the exposed group.") - return() - } - - if(nchar(input$treatment2_label) == 0) { - shinyjs::alert("Please enter label for the unexposed group.") - return() - } - }) - - - ### Generation of volcano plot ----------------------------------------------- - observeEvent(c(input$update - # input$review_by, - # input$review_by_please_specify, - # input$period, - # input$period_please_specify, - # input$ser, - # input$drug, - # input$test, - # input$treatment1, - # input$treatment2, - # input$treatment1_label, - # input$treatment2_label, - # input$subgroup_var, - # input$subgroup_vals, - # input$X_ref, - # input$Y_ref, - # input$pvalue_option - ), { - req(data$ae_test) - if (input$review_by == "PT") {req(data$statistics)} - if (input$review_by == "SOC") {req(data$statistics_soc)} - req(input$treatment1_label) - req(input$treatment2_label) - - if(length(input$treatment1) == 0) { - shinyjs::alert("Please select an exposed group.") - return() - } - - if(length(input$treatment2) == 0) { - shinyjs::alert("Please select an unexposed group.") - return() - } - - # if(length(input$period_please_specify)>0) { - # if(!numbers_only(input$period_please_specify)) { - # shinyjs::alert("Please enter only an integer for risk period.") - # return() - # } - # } - - if(length(input$X_ref) > 0) { - X_ref <- as.numeric(input$X_ref) - if(is.na(X_ref)) { - shinyjs::alert("Please enter a numeric value for X-axis reference line.") - return() - } - } - - if(length(input$Y_ref) > 0) { - Y_ref <- as.numeric(input$Y_ref) - if(is.na(Y_ref)) { - shinyjs::alert("Please enter a numeric value for Y-axis reference line.") - return() - } else { - if (!(as.numeric(input$Y_ref) >= 0 & as.numeric(input$Y_ref) <= 1)) { - shinyjs::alert("Please enter a valid value between 0 and 1 for Y-axis reference line.") - return() - } - } - } - - plots$volcano_plot <- NULL - plots$volcano_plot_data <- NULL - plots$volcano_plot_click <- NULL - withProgress(message = 'Plotting data', value = 0, { - out <- try( - volcano.plot( - data = isolate(data$ae_test), - statistics_data = isolate(data$statistics), - statistics_soc_data = isolate(data$statistics_soc), - ser = input$ser, - drug = input$drug, - period = input$period, - residual = input$period_please_specify, - test = input$test, - Treatment1 = input$treatment1, - Treatment2 = input$treatment2, - treatment1_label = input$treatment1_label, - treatment2_label = input$treatment2_label, - subgroup_var = input$subgroup_var, - subgroup_vals = input$subgroup_vals, - X_ref = as.numeric(input$X_ref), - Y_ref = as.numeric(input$Y_ref), - X_label = paste(input$test, input$treatment1_label, "vs", input$treatment2_label), - review_by = input$review_by, - summary_by = input$summary_by, - pvalue_option = input$pvalue_option) - ) - if (!"try-error" %in% class(p)) { - - tempdata <- data$ae_test %>% - mutate_at(names(data$ae_test)[!(names(data$ae_test) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data$ae_test), ~na_if(., "")) - - if (input$summary_by == "Patients") { - N1.total <- tempdata %>% - drop_na(RFSTDTC) %>% - filter(ARMCD %in% input$treatment1) %>% - distinct(USUBJID) %>% tally() %>% as.numeric() - - N2.total <- tempdata %>% - drop_na(RFSTDTC) %>% - filter(ARMCD %in% input$treatment2) %>% - distinct(USUBJID) %>% tally() %>% as.numeric() - } - - # if (input$summary_by == "Events") { - # N1.total <- tempdata %>% - # filter(!is.na(AESTDT) | !is.na(AEDECOD)) %>% - # filter(ARMCD %in% input$treatment1) %>% - # tally() %>% as.numeric() - # N2.total <- tempdata %>% - # filter(!is.na(AESTDT) | !is.na(AEDECOD)) %>% - # filter(ARMCD %in% input$treatment2) %>% - # tally() %>% as.numeric() - # } - - if (input$summary_by == "Patients") { - text1 <- paste0("<- Favors ", input$treatment1_label, - " n=", out$N1, " (N=", N1.total, ")") - text2 <- paste0("Favors ", input$treatment2_label, - " n=", out$N2, " (N=", N2.total, ") ->") - } else { - text1 <- paste0("<- Favors ", input$treatment1_label, - " (N=", N1.total, ")") - text2 <- paste0("Favors ", input$treatment2_label, - " (N=", N2.total, ") ->") - } - - plots$volcano_plot <- out$plot - plots$volcano_plot_data <- out$data - output$volcano_plot <- renderPlotly({ - ggplotly(plots$volcano_plot,tooltip = c("label")) %>% - plotly::layout(annotations = - list(x = 0, y = 0.02, text = text1, - showarrow = F, xref = 'paper', yref = 'paper', - xanchor = 'left', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 15, color = "blue"))) %>% - plotly::layout(annotations = - list(x = .95, y = 0.02, text = text2, - showarrow = F, xref = 'paper', yref = 'paper', - xanchor = 'right', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 15, color = "blue"))) - - }) - output$volcano_plot_UI <- renderUI({ - req(plots$volcano_plot) - # req(input$treatment1_label) - # req(input$treatment2_label) - plotlyOutput("volcano_plot", height = "625px") %>% withSpinner(type = 5) - }) - } else { - #Catch Error - plots$volcano_plot <- NULL - plots$volcano_plot_data <- NULL - shinyjs::alert("Error occurred processing the selected data.") - } - }) - }) - - - ### Definitions and logics for the drilldown table from click triggering ----- - observeEvent(event_data("plotly_click"), { - plots$volcano_plot_click <- event_data("plotly_click") - }) - - volcano_plot_table <- reactive({ - req(plots$volcano_plot_click) - plots$volcano_plot$data[as.numeric(plots$volcano_plot_click$key),] %>% - inner_join(plots$volcano_plot_data) %>% - select(USUBJID, - SITE, - AGE, - SEX, - RACE, - ARM, - SBJTSTAT, - AEBODSYS, - AEDECOD, - AESTDT, - AESTDY, - AEENDT, - AESER, - AEONGO, - AESEV, - AEREL, - AEOUT, - TRTEMFL, - STUDYFL) - }) - - #List the details of filtered data that matches the selected SOC/PT - output$volcano_plot_drill <- DT::renderDataTable({ - datatable(volcano_plot_table(), extensions = 'Buttons', - colnames = c('Subject ID', - 'Site', - 'Age', - 'Sex', - 'Race', - 'Treatment', - 'Subject Status', - 'SOC', - 'PT', - 'Onset Date', - 'Time to Onset', - 'End Date', - 'Serious AE?', - 'Still Ongoing?', - 'Severity', - 'Causality', - 'Outcome', - 'Treatment Emergent?', - 'During Entire Study?'), - options = list(dom = 'Bfrtip', - buttons = I('colvis'), - #buttons = c(I('colvis'), - # 'copy', - # 'csv', - # 'excel', - # 'print', - # 'pdf'), - pageLength = 10) - - - - ) - }, server = FALSE) - - output$volcano_plot_drill_UI <- renderUI({ - req(plots$volcano_plot_click) - DT::dataTableOutput("volcano_plot_drill") - }) - - - ### Specifications on the footnote of volcano plot --------------------------- - output$footnote_UI <- renderUI({ - req(plots$volcano_plot) - - # if (input$summary_by == "Events") { - # ft <- paste0(" Note:
", - # "* N is the total number of events.") - # } - - if (input$summary_by == "Patients") { - - if (input$ser == FALSE & input$drug == FALSE) { - ftn <- "* n is the number of patients with adverse events." - } - if (input$ser == TRUE & input$drug == FALSE) { - ftn <- "* n is the number of patients with serious adverse events." - } - if (input$ser == FALSE & input$drug == TRUE) { - ftn <- "* n is the number of patients with drug-related adverse events." - } - if (input$ser == TRUE & input$drug == TRUE) { - ftn <- "* n is the number of patients with serious adverse events and drug-related adverse events." - } - - ft <- paste0(" Note:
", - "* N is the total number of treated patients.
", - ftn) - } - - return(HTML(ft)) - }) -} - - +################################################################################ +# server.R +# This R Script defines the server logics for the Shiny App. +################################################################################ + +server <- function(input, output, session) { + + data <- reactiveValues(ae_test = NULL, + statistics = NULL, + statistics_soc = NULL) + + plots <- reactiveValues(volcano_plot_data = NULL, + volcano_plot = NULL, + volcano_plot_click = NULL) + + ### Data uploading ----------------------------------------------------------- + ae_test_data <- reactive({ + # SDTM + file <- input$file_ae_test + if (is.null(file)) return() + df <- fread(input$file_ae_test$datapath) + }) + + statistics_data <- reactive({ + # ADAM + file <- input$file_statistics + if (is.null(file)) return() + df <- fread(input$file_statistics$datapath) + }) + + observe({ + #only runs for SDTM + if (!is.null(ae_test_data())) { + data$ae_test <- ae_test_data() + } + + # only runs for ADAM + # if (!is.null(statistics_data())) { + # data$ae_test <- statistics_data() + # } + + + }) + + + ### Extract all arms --------------------------------------------------------- + ARMCD <- reactive({ + req(data$ae_test) + unique(data$ae_test$ARMCD) + }) + + + ### Definitions of UI outputs in the control panel and related logics -------- + output$summary_by_UI <- renderUI({ + req(data$ae_test) + selectInput("summary_by", "Summary By", choices = c("Patients", "Events")) + }) + + output$review_by_UI <- renderUI({ + req(data$ae_test) + selectInput("review_by", "Review By", choices = c("PT", "SOC", "Other")) + }) + + output$review_by_please_specify_UI <- renderUI({ + req(data$ae_test) + req(input$review_by) + if (input$review_by != "Other") return() + textInput("review_by_please_specify", "Please specify") + }) + + output$period_UI <- renderUI({ + req(data$ae_test) + selectInput("period", "Period",choices = c("Treatment emergent", "AE during entire study", "Other")) + }) + + output$period_please_specify_UI <- renderUI({ + req(data$ae_test) + req(input$period) + if (input$period != "Other") return() + numericInput("period_please_specify", + HTML("Please enter residual period (in days)"), + value = 30, min = 0, max = 10^5) + }) + + output$ser_UI <- renderUI({ + req(data$ae_test) + checkboxInput("ser", "Serious adverse event", value = FALSE) + }) + + output$drug_UI <- renderUI({ + req(data$ae_test) + checkboxInput("drug", "Drug-related adverse events", value = FALSE) + }) + + output$test_UI <- renderUI({ + req(data$ae_test) + selectInput("test", "Measure of Association", + choices = c("Rate Ratio", + "Risk Ratio", + "Hazard Ratio", + "Risk Difference", + "Rate Difference") + ) + }) + + output$treatment1_UI <- renderUI({ + req(data$ae_test) + req(ARMCD()) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + div(style = 'height:100px; width:91%; overflow: scroll', + checkboxGroupInput("treatment1", "Exposed Group", + choices = ARMCD(), + selected = ARMCD()[1], + inline = F) + ) + }) + + output$treatment2_UI <- renderUI({ + req(data$ae_test) + req(ARMCD()) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + div(style = 'height:100px; width:91%; overflow: scroll', + checkboxGroupInput("treatment2", "Unexposed Group", + choices = setdiff(ARMCD(), input$treatment1), + selected = setdiff(ARMCD(), input$treatment1)[1], + inline = F) + ) + }) + + output$treatment1_label_UI <- renderUI({ + req(data$ae_test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + textInput("treatment1_label", "Label for Exposed Group") + }) + + output$treatment2_label_UI <- renderUI({ + req(data$ae_test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + textInput("treatment2_label", "Label for Unexposed Group") + }) + + subgroup_var_choices <- reactive({ + req(data$ae_test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + c("No Subgroup Variable", colnames(data$ae_test)) + }) + + output$subgroup_var_UI <- renderUI({ + req(data$ae_test) + req(subgroup_var_choices()) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + selectInput("subgroup_var", "Subgroup Variable", + # choices = subgroup_var_choices(), + choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"), + selected = NULL, multiple = F) + }) + + output$subgroup_vals_title_UI <- renderUI({ + req(input$subgroup_var) + if(input$subgroup_var == "No Subgroup Variable") return() + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + h5(strong("Value for Subgroup")) + }) + + output$subgroup_vals_UI <- renderUI({ + req(input$subgroup_var) + if(input$subgroup_var == "No Subgroup Variable") return() + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + req(data$ae_test) + div(style = 'height:200px; width:91%; overflow: scroll', + checkboxGroupInput("subgroup_vals", "", + choices = sort(unique(data$ae_test[[input$subgroup_var]])), + inline = F) + ) + }) + + output$X_ref_UI <- renderUI({ + req(data$ae_test) + req(input$test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + if (input$test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {xref <- 1} + if (input$test %in% c("Rate Difference", "Risk Difference")) {xref <- 0} + textInput("X_ref", "X-axis Reference Line", value = xref) + }) + + output$Y_ref_UI <- renderUI({ + req(data$ae_test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + textInput("Y_ref", "Y-axis Reference Line", value = 0.05) + }) + + output$pvalue_option_UI <- renderUI({ + req(data$ae_test) + if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", + "Rate Difference", + "Rate Ratio", + "Risk Difference", + "Risk Ratio")) return() + selectInput("pvalue_option", "p-Value Option", + choices = c("Unadjusted", "Adjusted"), multiple = F) + }) + + + ### An essential step for obtaining statistics right after data uploading and before the generation of volcano plot ------------------------------------ + observeEvent(input$obtain, { + req(input$review_by) + req(input$summary_by) + req(input$treatment1) + req(input$treatment2) + if (input$period == "Other") {req(input$period_please_specify)} + if (input$review_by == "SOC") return() + if (!is.null(statistics_data())) { + data$statistics <- statistics_data() + } + # if (is.null(data$statistics)){ + # filename <- paste0(getwd(),"/statistics.csv") + # if(file.exists(filename)){ + # data$statistics <- fread(filename) + # } else { + # shinyjs::alert(paste0("ADaM file does not exist:",filename)) + # } + # } + if (is.null(ae_test_data())) { + shinyjs::alert("Please import a SDTM dataset first!") + data$statistics <- NULL + } else { + if (input$summary_by == "Events" & input$test == "Hazard Ratio") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Rate Difference") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Rate Ratio") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Risk Difference") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Risk Ratio") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { + withProgress(data$statistics <- GetStatistics_HazardR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + FALSE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Rate Difference") { + withProgress(data$statistics <- GetStatistics_RateD(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + FALSE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Rate Ratio") { + withProgress(data$statistics <- GetStatistics_RateR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + FALSE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Risk Difference") { + withProgress(data$statistics <- GetStatistics_RiskD(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + FALSE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Risk Ratio") { + withProgress(data$statistics <- GetStatistics_RiskR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + FALSE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + } + }) + + observeEvent(input$obtain, { + req(input$review_by) + req(input$summary_by) + if (input$period == "Other") {req(input$period_please_specify)} + if (input$review_by!="SOC") return() + if (!is.null(statistics_data())) { + data$statistics_soc <- statistics_data() + } + # if (is.null(data$statistics_soc)){ + # filename <- paste0(getwd(),"/statistics-soc.csv") + # if(file.exists(filename)){ + # data$statistics_soc <- fread(filename) + # } else { + # shinyjs::alert(paste0("ADaM file does not exist:",filename)) + # } + # } + if (is.null(ae_test_data())) { + shinyjs::alert("Please import a SDTM dataset first!") + data$statistics_soc <- NULL + } else { + if (input$summary_by == "Events" & input$test == "Hazard Ratio") { + data$statistics_soc <- NULL + shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Rate Difference") { + data$statistics_soc <- NULL + shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Rate Ratio") { + data$statistics_soc <- NULL + shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Risk Difference") { + data$statistics_soc <- NULL + shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Events" & input$test == "Risk Ratio") { + data$statistics_soc <- NULL + shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", + "if data is summarized by events instead of patients!")) + } + if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { + withProgress(data$statistics_soc <- GetStatistics_HazardR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + TRUE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Rate Difference") { + withProgress(data$statistics_soc <- GetStatistics_RateD(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + TRUE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Rate Ratio") { + withProgress(data$statistics_soc <- GetStatistics_RateR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + TRUE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Risk Difference") { + withProgress(data$statistics_soc <- GetStatistics_RiskD(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + TRUE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + if (input$summary_by == "Patients" & input$test == "Risk Ratio") { + withProgress(data$statistics_soc <- GetStatistics_RiskR(ae_test_data(), + input$ser, + input$drug, + input$period, + ifelse(input$period != "Other", + NULL, input$period_please_specify), + TRUE, + input$treatment1, + input$treatment2), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } + } + }) + + + ### Definition of 'Reset' button UI output and its consequent triggerings ---- + output$reset_UI <- renderUI({ + req(data$ae_test) + actionBttn("reset", "Reset",color = "primary",style = "bordered",block=TRUE) + }) + + observeEvent(input$reset, { + updateSelectInput(session, "summary_by", "Summary By", + choices = c("Patients", "Events")) + updateSelectInput(session, "review_by", "Review By", + choices = c("PT", "SOC", "Other")) + updateSelectInput(session, "period", "Period", + choices = c("Treatment emergent", + "AE during entire study", + "Other")) + updateCheckboxInput(session, "ser", "Serious adverse event", value = FALSE) + updateCheckboxInput(session, "drug", "Drug-related adverse events", value = FALSE) + updateSelectInput(session, "test", "Measure of Association", + choices = c("Rate Ratio", + "Risk Ratio", + "Hazard Ratio", + "Risk Difference", + "Rate Difference")) + updateCheckboxGroupInput(session, "treatment1", "Exposed Group", + choices = ARMCD(), selected = ARMCD()[1], inline = F) + updateCheckboxGroupInput(session, "treatment2", "Unexposed Group", + choices = setdiff(ARMCD(), input$treatment1), + selected = setdiff(ARMCD(), input$treatment1)[1], + inline = F) + updateTextInput(session, "treatment1_label", "Label for Exposed Group") + updateTextInput(session, "treatment2_label", "Label for Unexposed Group") + updateSelectInput(session, "subgroup_var", "Subgroup Variable", + choices = c("No Subgroup Variable", "SITE", "AGE", "SEX", "RACE"), + selected = NULL) + updateTextInput(session, "X_ref", "X-axis Reference Line", value = 1) + updateTextInput(session, "Y_ref", "Y-axis Reference Line", value = 0.05) + updateSelectInput(session, "pvalue_option", "p-Value Option", + choices = c("Unadjusted", "Adjusted")) + }) + + + ### Definition of 'Obtain Statistics' button UI output ----------------------- + output$obtain_UI <- renderUI({ + req(data$ae_test) + actionBttn("obtain", "Obtain Statistics",color = "primary",style = "bordered",block=TRUE) + }) + + + ### Definition of 'Update Plot' button UI output ----------------------------- + output$update_UI <- renderUI({ + req(data$ae_test) + if (input$review_by == "PT") {req(data$statistics)} + if (input$review_by == "SOC") {req(data$statistics_soc)} + actionBttn("update", "Update Plot",color = "primary",style = "bordered",block=TRUE) + }) + + + ### Check the prerequisite of customized labels for exposed/unexposed group -- + observeEvent(input$update, { + if(nchar(input$treatment1_label) == 0) { + shinyjs::alert("Please enter label for the exposed group.") + return() + } + + if(nchar(input$treatment2_label) == 0) { + shinyjs::alert("Please enter label for the unexposed group.") + return() + } + }) + + + ### Generation of volcano plot ----------------------------------------------- + observeEvent(c(input$update + # input$review_by, + # input$review_by_please_specify, + # input$period, + # input$period_please_specify, + # input$ser, + # input$drug, + # input$test, + # input$treatment1, + # input$treatment2, + # input$treatment1_label, + # input$treatment2_label, + # input$subgroup_var, + # input$subgroup_vals, + # input$X_ref, + # input$Y_ref, + # input$pvalue_option + ), { + req(data$ae_test) + if (input$review_by == "PT") {req(data$statistics)} + if (input$review_by == "SOC") {req(data$statistics_soc)} + req(input$treatment1_label) + req(input$treatment2_label) + + if(length(input$treatment1) == 0) { + shinyjs::alert("Please select an exposed group.") + return() + } + + if(length(input$treatment2) == 0) { + shinyjs::alert("Please select an unexposed group.") + return() + } + + # if(length(input$period_please_specify)>0) { + # if(!numbers_only(input$period_please_specify)) { + # shinyjs::alert("Please enter only an integer for risk period.") + # return() + # } + # } + + if(length(input$X_ref) > 0) { + X_ref <- as.numeric(input$X_ref) + if(is.na(X_ref)) { + shinyjs::alert("Please enter a numeric value for X-axis reference line.") + return() + } + } + + if(length(input$Y_ref) > 0) { + Y_ref <- as.numeric(input$Y_ref) + if(is.na(Y_ref)) { + shinyjs::alert("Please enter a numeric value for Y-axis reference line.") + return() + } else { + if (!(as.numeric(input$Y_ref) >= 0 & as.numeric(input$Y_ref) <= 1)) { + shinyjs::alert("Please enter a valid value between 0 and 1 for Y-axis reference line.") + return() + } + } + } + + plots$volcano_plot <- NULL + plots$volcano_plot_data <- NULL + plots$volcano_plot_click <- NULL + withProgress(message = 'Plotting data', value = 0, { + out <- try( + volcano.plot( + data = isolate(data$ae_test), + statistics_data = isolate(data$statistics), + statistics_soc_data = isolate(data$statistics_soc), + ser = input$ser, + drug = input$drug, + period = input$period, + residual = input$period_please_specify, + test = input$test, + Treatment1 = input$treatment1, + Treatment2 = input$treatment2, + treatment1_label = input$treatment1_label, + treatment2_label = input$treatment2_label, + subgroup_var = input$subgroup_var, + subgroup_vals = input$subgroup_vals, + X_ref = as.numeric(input$X_ref), + Y_ref = as.numeric(input$Y_ref), + X_label = paste(input$test, input$treatment1_label, "vs", input$treatment2_label), + review_by = input$review_by, + summary_by = input$summary_by, + pvalue_option = input$pvalue_option) + ) + if (!"try-error" %in% class(p)) { + + tempdata <- data$ae_test %>% + mutate_at(names(data$ae_test)[!(names(data$ae_test) %in% c("AESEQ", "AESTDY", "AEENDY", + "AGE", "RFENDY", "SAFFN"))], + ~as.character(.)) %>% + mutate_at(names(data$ae_test), ~na_if(., "")) + + if (input$summary_by == "Patients") { + N1.total <- tempdata %>% + drop_na(RFSTDTC) %>% + filter(ARMCD %in% input$treatment1) %>% + distinct(USUBJID) %>% tally() %>% as.numeric() + + N2.total <- tempdata %>% + drop_na(RFSTDTC) %>% + filter(ARMCD %in% input$treatment2) %>% + distinct(USUBJID) %>% tally() %>% as.numeric() + } + + # if (input$summary_by == "Events") { + # N1.total <- tempdata %>% + # filter(!is.na(AESTDT) | !is.na(AEDECOD)) %>% + # filter(ARMCD %in% input$treatment1) %>% + # tally() %>% as.numeric() + # N2.total <- tempdata %>% + # filter(!is.na(AESTDT) | !is.na(AEDECOD)) %>% + # filter(ARMCD %in% input$treatment2) %>% + # tally() %>% as.numeric() + # } + + if (input$summary_by == "Patients") { + text1 <- paste0("<- Favors ", input$treatment1_label, + " n=", out$N1, " (N=", N1.total, ")") + text2 <- paste0("Favors ", input$treatment2_label, + " n=", out$N2, " (N=", N2.total, ") ->") + } else { + text1 <- paste0("<- Favors ", input$treatment1_label, + " (N=", N1.total, ")") + text2 <- paste0("Favors ", input$treatment2_label, + " (N=", N2.total, ") ->") + } + + plots$volcano_plot <- out$plot + plots$volcano_plot_data <- out$data + output$volcano_plot <- renderPlotly({ + ggplotly(plots$volcano_plot,tooltip = c("label")) %>% + plotly::layout(annotations = + list(x = 0, y = 0.02, text = text1, + showarrow = F, xref = 'paper', yref = 'paper', + xanchor = 'left', yanchor = 'bottom', xshift = 0, yshift = 0, + font = list(size = 15, color = "blue"))) %>% + plotly::layout(annotations = + list(x = .95, y = 0.02, text = text2, + showarrow = F, xref = 'paper', yref = 'paper', + xanchor = 'right', yanchor = 'bottom', xshift = 0, yshift = 0, + font = list(size = 15, color = "blue"))) + + }) + output$volcano_plot_UI <- renderUI({ + req(plots$volcano_plot) + # req(input$treatment1_label) + # req(input$treatment2_label) + plotlyOutput("volcano_plot", height = "625px") %>% withSpinner(type = 5) + }) + } else { + #Catch Error + plots$volcano_plot <- NULL + plots$volcano_plot_data <- NULL + shinyjs::alert("Error occurred processing the selected data.") + } + }) + }) + + + ### Definitions and logics for the drilldown table from click triggering ----- + observeEvent(event_data("plotly_click"), { + plots$volcano_plot_click <- event_data("plotly_click") + }) + + volcano_plot_table <- reactive({ + req(plots$volcano_plot_click) + plots$volcano_plot$data[as.numeric(plots$volcano_plot_click$key),] %>% + inner_join(plots$volcano_plot_data) %>% + select(USUBJID, + SITE, + AGE, + SEX, + RACE, + ARM, + SBJTSTAT, + AEBODSYS, + AEDECOD, + AESTDT, + AESTDY, + AEENDT, + AESER, + AEONGO, + AESEV, + AEREL, + AEOUT, + TRTEMFL, + STUDYFL) + }) + + #List the details of filtered data that matches the selected SOC/PT + output$volcano_plot_drill <- DT::renderDataTable({ + datatable(volcano_plot_table(), extensions = 'Buttons', + colnames = c('Subject ID', + 'Site', + 'Age', + 'Sex', + 'Race', + 'Treatment', + 'Subject Status', + 'SOC', + 'PT', + 'Onset Date', + 'Time to Onset', + 'End Date', + 'Serious AE?', + 'Still Ongoing?', + 'Severity', + 'Causality', + 'Outcome', + 'Treatment Emergent?', + 'During Entire Study?'), + options = list(dom = 'Bfrtip', + buttons = I('colvis'), + #buttons = c(I('colvis'), + # 'copy', + # 'csv', + # 'excel', + # 'print', + # 'pdf'), + pageLength = 10) + + + + ) + }, server = FALSE) + + output$volcano_plot_drill_UI <- renderUI({ + req(plots$volcano_plot_click) + DT::dataTableOutput("volcano_plot_drill") + }) + + + ### Specifications on the footnote of volcano plot --------------------------- + output$footnote_UI <- renderUI({ + req(plots$volcano_plot) + + # if (input$summary_by == "Events") { + # ft <- paste0(" Note:
", + # "* N is the total number of events.") + # } + + if (input$summary_by == "Patients") { + + if (input$ser == FALSE & input$drug == FALSE) { + ftn <- "* n is the number of patients with adverse events." + } + if (input$ser == TRUE & input$drug == FALSE) { + ftn <- "* n is the number of patients with serious adverse events." + } + if (input$ser == FALSE & input$drug == TRUE) { + ftn <- "* n is the number of patients with drug-related adverse events." + } + if (input$ser == TRUE & input$drug == TRUE) { + ftn <- "* n is the number of patients with serious adverse events and drug-related adverse events." + } + + ft <- paste0(" Note:
", + "* N is the total number of treated patients.
", + ftn) + } + + return(HTML(ft)) + }) +} + + diff --git a/ui.R b/ui.R index 2dde808..02560ae 100644 --- a/ui.R +++ b/ui.R @@ -1,59 +1,51 @@ -################################################################################ -# ui.R -# This R Script only defines the Web layout for the Shiny App. -################################################################################ - -ui <- pageWithSidebar( - headerPanel('Volcano Plot'), - sidebarPanel(width = 3, - useShinyjs(), - div(uiOutput("update_UI"), style = "display: inline-block"), - div(style = "display: inline-block; width: 30px"), - div(uiOutput("obtain_UI"), style = "display: inline-block"), - div(style = "display: inline-block; width: 30px"), - div(uiOutput("reset_UI"), style = "display: inline-block"), - br(), - br(), - fileInput("file_ae_test", label = h5("Import SDTM dataset"), accept = ".csv"), - br(), - fileInput("file_statistics", label = h5("Import ADaM dataset"), accept = ".csv"), - br(), - uiOutput("summary_by_UI"), - br(), - uiOutput("review_by_UI"), - uiOutput("review_by_please_specify_UI"), - br(), - uiOutput("period_UI"), - uiOutput("period_please_specify_UI"), - br(), - uiOutput("ser_UI"), - uiOutput("drug_UI"), - br(), - uiOutput("test_UI"), - br(), - uiOutput("treatment1_UI"), - br(), - uiOutput("treatment2_UI"), - br(), - uiOutput("treatment1_label_UI"), - br(), - uiOutput("treatment2_label_UI"), - br(), - uiOutput("subgroup_var_UI"), - uiOutput("subgroup_vals_title_UI"), - uiOutput("subgroup_vals_UI"), - uiOutput("X_ref_UI"), - uiOutput("Y_ref_UI"), - uiOutput("pvalue_option_UI") - ), - mainPanel( - uiOutput("volcano_plot_UI"), - br(), - div(uiOutput("footnote_UI"), - style = "font-size: 12px; white-space: pre"), - br(), - uiOutput("volcano_plot_drill_UI") - ) -) - - +################################################################################ +# ui.R +# This R Script only defines the Web layout for the Shiny App. +################################################################################ + +ui <- fluidPage( + tags$head(tags$style(HTML("hr {border-top: 1px solid #999999;}"))), # horizontal line option + headerPanel('Volcano Plot'), + useShinyjs(), + sidebarPanel(width=4,align="center", + column(width=6,uiOutput("update_UI"),uiOutput("obtain_UI")), + column(width=6,uiOutput("reset_UI")),hr(), + fluidRow( + column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="md")), + column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) + ), hr(), + fluidRow( + column(width=6, uiOutput("summary_by_UI") ), + column(width=6, uiOutput("review_by_UI"),uiOutput("review_by_please_specify_UI") ) + ), hr(), + fluidRow( + column(width=6,uiOutput("period_UI"), uiOutput("period_please_specify_UI")), + column(width=6, uiOutput("ser_UI"), uiOutput("drug_UI") ) + ),hr(), + fluidRow( + column(width=6,uiOutput("treatment1_UI"), uiOutput("treatment1_label_UI"), ), + column(width=6, uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI") ) + ),hr(), + uiOutput("test_UI"), + uiOutput("subgroup_var_UI"), + uiOutput("subgroup_vals_title_UI"), + uiOutput("subgroup_vals_UI"), + wellPanel(align="center",dropdown(label="Plot Options",icon = icon("chart-bar"), width = "600px",size="lg",style="stretch",status="primary", + wellPanel(fluidRow( + column(width=4,uiOutput("X_ref_UI")), + column(width=4,uiOutput("Y_ref_UI")), + column(width=4,uiOutput("pvalue_option_UI")) + )))) + + ), + mainPanel( + uiOutput("volcano_plot_UI"), + br(), + div(uiOutput("footnote_UI"), + style = "font-size: 12px; white-space: pre"), + br(), + uiOutput("volcano_plot_drill_UI") + ) +) + + diff --git a/volcano-plot.Rproj b/volcano-plot.Rproj new file mode 100644 index 0000000..066341e --- /dev/null +++ b/volcano-plot.Rproj @@ -0,0 +1,13 @@ +Version: 1.0 + +RestoreWorkspace: Default +SaveWorkspace: Default +AlwaysSaveHistory: Default + +EnableCodeIndexing: Yes +UseSpacesForTab: Yes +NumSpacesForTab: 4 +Encoding: UTF-8 + +RnwWeave: Sweave +LaTeX: pdfLaTeX From 73e42597eeaf05fd4c92617cde3de51c69d8ad9a Mon Sep 17 00:00:00 2001 From: Isaac Zhao Date: Tue, 16 Jun 2020 21:24:27 -0400 Subject: [PATCH 03/15] test --- ui.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/ui.R b/ui.R index 02560ae..ced10ea 100644 --- a/ui.R +++ b/ui.R @@ -2,7 +2,7 @@ # ui.R # This R Script only defines the Web layout for the Shiny App. ################################################################################ - +# test ui <- fluidPage( tags$head(tags$style(HTML("hr {border-top: 1px solid #999999;}"))), # horizontal line option headerPanel('Volcano Plot'), From 119e8eafecc0cf6f2b1f6141cc7e0dd7b6b4097b Mon Sep 17 00:00:00 2001 From: Isaac Zhao Date: Tue, 16 Jun 2020 21:26:32 -0400 Subject: [PATCH 04/15] fixed SDTM ADAM toggle size to be valid option --- ui.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/ui.R b/ui.R index ced10ea..859171b 100644 --- a/ui.R +++ b/ui.R @@ -11,7 +11,7 @@ ui <- fluidPage( column(width=6,uiOutput("update_UI"),uiOutput("obtain_UI")), column(width=6,uiOutput("reset_UI")),hr(), fluidRow( - column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="md")), + column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="medium")), column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) ), hr(), fluidRow( From 75ac90f8f24e87c500c2b012f7b0088281153700 Mon Sep 17 00:00:00 2001 From: Isaac Zhao Date: Tue, 16 Jun 2020 21:27:02 -0400 Subject: [PATCH 05/15] fixed SDTM ADAM toggle to be valid option --- ui.R | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/ui.R b/ui.R index 859171b..bc70787 100644 --- a/ui.R +++ b/ui.R @@ -11,7 +11,7 @@ ui <- fluidPage( column(width=6,uiOutput("update_UI"),uiOutput("obtain_UI")), column(width=6,uiOutput("reset_UI")),hr(), fluidRow( - column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="medium")), + column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="normal")), column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) ), hr(), fluidRow( From acdfd4d1dc3d2f9d6ad780a0cbc58fad64fbeeb3 Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Tue, 16 Jun 2020 22:18:26 -0400 Subject: [PATCH 06/15] Update README.md add example display screenshot --- README.md | 3 +++ 1 file changed, 3 insertions(+) diff --git a/README.md b/README.md index 823aca3..6eb55b3 100644 --- a/README.md +++ b/README.md @@ -5,3 +5,6 @@ Original Developers - Ke Xiao (Boehringer Ingelheim) - Hong Wang (Boehringer Ingelheim) - Dennis o'Brien (Boehringer Ingelheim) + + +![image](https://user-images.githubusercontent.com/62663896/84847440-318cb080-b01f-11ea-8d22-b3820905db2c.png) From 229bec3650f2809d11c5dfb8f16f659920e30ebb Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Tue, 16 Jun 2020 22:25:31 -0400 Subject: [PATCH 07/15] fixed issue #18 and removed test_data duplicates issue #18 fixed by replacing all rbind with row_bind, made all date variables using as.Date. --- GetStatistics.R | 13 +- data/Get Test Data.Rmd | 22 +- data/test_data.csv | 7577 ++++------------------------------------ server.R | 18 +- ui.R | 19 +- volcano_plot.R | 374 +- 6 files changed, 845 insertions(+), 7178 deletions(-) diff --git a/GetStatistics.R b/GetStatistics.R index ba09c97..6d6073f 100644 --- a/GetStatistics.R +++ b/GetStatistics.R @@ -67,7 +67,7 @@ GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - extension <- rbind(events, censors) %>% + extension <- bind_rows(events, censors) %>% group_by(USUBJID) %>% mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% rowwise() %>% @@ -77,7 +77,7 @@ GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, mutate(AVAL = ADT - STARTDT + 1) %>% distinct() - data.extend <- rbind(data.extend, extension) + data.extend <- bind_rows(data.extend, extension) } data.extend <- data.extend %>% @@ -188,7 +188,7 @@ GetStatistics_RateD <- function(data, ser, drug, period, residual, soc,treatment AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - extension <- rbind(events, censors) %>% + extension <- bind_rows(events, censors) %>% group_by(USUBJID) %>% mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% rowwise() %>% @@ -198,7 +198,7 @@ GetStatistics_RateD <- function(data, ser, drug, period, residual, soc,treatment mutate(AVAL = ADT - STARTDT + 1) %>% distinct() - data.extend <- rbind(data.extend, extension) + data.extend <- bind_rows(data.extend, extension) } data.extend.summary <- data.extend %>% @@ -328,7 +328,8 @@ GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatmen AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - extension <- rbind(events, censors) %>% + #extension <- bind_rows(events, censors) %>% + extension <- bind_rows(events, censors) %>% group_by(USUBJID) %>% mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% rowwise() %>% @@ -338,7 +339,7 @@ GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatmen mutate(AVAL = ADT - STARTDT + 1) %>% distinct() - data.extend <- rbind(data.extend, extension) + data.extend <- bind_rows(data.extend, extension) } data.extend.summary <- data.extend %>% diff --git a/data/Get Test Data.Rmd b/data/Get Test Data.Rmd index 907353d..ace4f4e 100644 --- a/data/Get Test Data.Rmd +++ b/data/Get Test Data.Rmd @@ -49,9 +49,29 @@ match_vars no_vars = all_vars[which(!all_vars %in% colnames(test_data))] no_vars -test_data2 = test_data %>% select(match_vars) +test_data2 = test_data %>% select(match_vars) %>% group_by_all() %>% slice(1) %>% group_by() %>% as.data.frame() %>% + mutate(AESTDT = as.Date(AESTDT), AEENDT = as.Date(AEENDT), RFSTDTC = as.Date(RFSTDTC), RFENDTC = as.Date(RFENDTC)) write_csv(test_data2, path="data/test_data.csv") ``` + + +Load test data +```{r} + +setwd("~/Desktop/volcano-plot") +library(scales); library(dplyr); library(tidyr); library(tibble); library(stringr); library(ggplot2); library(cowplot); library(ggpubr) +select <- dplyr::select; rename <- dplyr::rename; mutate <- dplyr::mutate; +summarize <- dplyr::summarize; arrange <- dplyr::arrange; slice <- dplyr::slice; filter <- dplyr::filter; recode<-dplyr::recode +style <- plotly::style +``` + + +```{r} +library(data.table) + +test_data = fread("data/test_data.csv") %>% as.data.frame() %>% + mutate(AESTDT = as.Date(AESTDT), AEENDT = as.Date(AEENDT), RFSTDTC = as.Date(RFSTDTC), RFENDTC = as.Date(RFENDTC)) +``` \ No newline at end of file diff --git a/data/test_data.csv b/data/test_data.csv index 276f450..620c0bc 100644 --- a/data/test_data.csv +++ b/data/test_data.csv @@ -1,2951 +1,449 @@ USUBJID,AESEQ,AESTDT,AESTDY,AEENDT,AEENDY,AETERM,AEDECOD,AEBODSYS,AESER,AEONGO,AESEV,AEREL,AEOUT,STUDYFL,TRTEMFL,SITE,SITEID,AGE,SEX,RACE,ARM,ARMCD,SBJTSTAT,RFSTDTC,RFENDTC,RFENDY,SAFFL 01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y -01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y -01-701-1015,1,2014-01-03,2,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y -01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y -01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y 01-701-1015,2,2014-01-03,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,NA,Y 01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y -01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y -01-701-1015,3,2014-01-09,8,2014-01-11,10,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,63,F,WHITE,Placebo,Pbo,ONGOING,2014-01-02,2014-07-02,173,Y -01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y 01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,2,2012-08-07,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y -01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y -01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y -01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y +01-701-1023,3,2012-08-26,22,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,NA,Y 01-701-1023,4,2012-08-07,3,2012-08-30,26,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,64,M,WHITE,Placebo,Pbo,DISCONTINUED,2012-08-05,2012-09-02,4,Y 01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y -01-701-1028,1,2013-07-21,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y 01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y -01-701-1028,2,2013-08-08,21,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-19,2014-01-14,NA,Y -01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y 01-701-1034,1,2014-08-27,58,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y 01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y -01-701-1034,2,2014-11-02,125,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-07-01,2014-12-30,NA,Y -01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y -01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y -01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y 01-701-1047,2,2013-02-12,1,2013-02-12,1,HIATUS HERNIA,HIATUS HERNIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,46,Y 01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1047,3,2013-03-06,23,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y +01-701-1047,4,2013-03-10,27,NA,NA,BUNDLE BRANCH BLOCK LEFT,BUNDLE BRANCH BLOCK LEFT,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,F,WHITE,Placebo,Pbo,DISCONTINUED,2013-02-12,2013-03-29,NA,Y 01-701-1097,1,2014-01-03,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y 01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,2,2014-02-20,51,2014-02-20,51,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,140,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y -01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y +01-701-1097,3,2014-02-20,51,2014-02-22,53,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,138,Y +01-701-1097,4,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y 01-701-1097,5,2014-03-21,80,2014-03-21,80,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,111,Y 01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,6,2014-03-31,90,2014-03-31,90,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,101,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y 01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1097,7,2014-04-19,109,2014-04-20,110,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,81,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1097,8,2014-04-19,109,2014-04-22,112,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,9,2014-04-19,109,2014-04-22,112,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,79,Y +01-701-1097,10,2014-02-21,52,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-01,2014-07-09,NA,Y 01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y 01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,3,2012-07-08,-61,NA,NA,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y +01-701-1111,4,2012-09-02,-5,2012-09-07,1,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y 01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y 01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1111,5,2012-09-02,-5,2012-09-07,1,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,11,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,6,2012-09-07,1,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,7,2012-09-13,7,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y +01-701-1111,8,2012-09-13,7,NA,NA,CELLULITIS,CELLULITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2012-09-17,NA,Y 01-701-1115,1,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y 01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,2,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,4,2012-12-26,27,2012-12-26,27,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,29,Y +01-701-1115,5,2012-12-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y 01-701-1115,6,2012-12-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y 01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1115,7,2013-01-14,46,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y -01-701-1118,1,2003,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,52,M,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-09-09,NA,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y +01-701-1115,8,2013-01-19,51,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1115,9,2013-01-19,51,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-01-23,NA,Y +01-701-1118,1,NA,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,52,M,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-09-09,NA,Y +01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y +01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y +01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y 01-701-1130,5,2014-05-09,84,2014-05-09,84,EYE ALLERGY,EYE ALLERGY,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y 01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,6,2014-05-22,97,NA,NA,EYE PRURITUS,EYE PRURITUS,EYE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,4,2014-05-09,84,2014-05-09,84,EYE SWELLING,EYE SWELLING,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,100,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y 01-701-1130,7,2014-05-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,2,2014-03-09,23,2014-03-09,23,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,161,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1130,3,2014-03-09,23,2014-03-16,30,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,154,Y -01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1130,8,2014-05-22,97,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,84,M,WHITE,Placebo,Pbo,ONGOING,2014-02-15,2014-08-16,NA,Y 01-701-1133,1,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y 01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,2,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y +01-701-1133,3,2012-12-27,61,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y 01-701-1133,4,2012-12-27,61,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-28,2013-04-29,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y +01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y 01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y 01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,3,2013-06-01,13,2013-06-02,14,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,5,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,6,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,7,2013-06-10,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,8,2013-06-10,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,9,2013-06-22,34,NA,NA,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,10,2013-06-26,38,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,4,2013-06-03,15,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1146,2,2013-05-16,-4,2013-06-02,14,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,29,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y +01-701-1146,11,2013-06-26,38,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-20,2013-06-30,NA,Y 01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y 01-701-1148,1,2013-08-25,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y 01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y 01-701-1148,2,2013-08-25,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y +01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y 01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y 01-701-1148,6,2013-12-17,117,2013-12-17,117,CALCULUS URETHRAL,CALCULUS URETHRAL,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,8,2012-02,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y 01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y 01-701-1148,7,2014-01-03,134,2014-01-03,134,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,49,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,5,2013-12-15,115,2013-12-17,117,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,66,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1148,4,2013-10-12,51,2013-11-10,80,LOWER RESPIRATORY TRACT INFECTION,LOWER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,103,Y -01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y +01-701-1148,8,NA,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,8,NA,NA,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,9,2013-07-29,-25,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y +01-701-1148,10,2014-02-12,174,NA,NA,ACTINIC KERATOSIS,ACTINIC KERATOSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-23,2014-02-20,NA,Y 01-701-1153,2,2013-10-13,21,2013-11-06,45,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-04-01,147,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,4,2002,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y 01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y 01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y -01-701-1180,2,2013-02-12,1,2013-02-12,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,40,Y +01-701-1180,4,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,4,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,5,2013-03-06,23,2013-03-07,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,17,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,6,2013-02-15,4,2013-03-19,36,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,5,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,7,2013-03-19,36,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,8,2013-03-19,36,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y +01-701-1180,9,2013-03-19,36,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-12,2013-03-23,NA,Y 01-701-1181,1,2013-12-09,5,2013-12-09,5,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-05,2013-12-12,4,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,1,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,2,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,3,2013-02-16,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,4,2013-02-16,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,5,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,6,2013-03-04,18,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y +01-701-1188,7,2013-03-21,35,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y 01-701-1188,8,2013-03-21,35,NA,NA,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-15,2013-03-25,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,4,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,9,2010-06,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y 01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y 01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,1,2012-08-03,13,2012-08-03,13,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,171,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,4,NA,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,4,NA,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y 01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y 01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1192,5,2012-08-07,17,2012-09-14,55,SECRETION DISCHARGE,SECRETION DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y -01-701-1203,1,2013-03-21,48,2013-03-21,48,EYE LASER SURGERY,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-02-02,2013-08-03,136,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,6,2012-08-07,17,2012-09-14,55,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,129,Y +01-701-1192,9,NA,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,9,NA,NA,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,10,2012-09-07,48,2012-10-06,77,PNEUMONIA,PNEUMONIA,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,107,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,11,2012-09-07,48,2012-09-30,71,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,113,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,13,2012-12-05,137,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,14,2012-12-05,137,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,NA,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1192,15,2012-12-05,137,2012-12-16,148,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-22,2013-01-20,36,Y +01-701-1203,1,2013-03-21,48,2013-03-21,48,EYE LASER SURGERY,EYE LASER SURGERY,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-02-02,2013-08-03,136,Y 01-701-1211,1,2012-11-16,2,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y 01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,2,2012-11-21,7,2012-11-21,7,JOINT DISLOCATION,JOINT DISLOCATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,55,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y 01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,3,2012-11-21,7,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y -01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,4,2012-11-22,8,NA,NA,INCONTINENCE,INCONTINENCE,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,5,2012-11-29,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y 01-701-1211,6,2012-12-09,25,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,7,2013-01-11,58,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y +01-701-1211,8,2013-01-11,58,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,NA,Y 01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1211,9,2013-01-14,61,2013-01-14,61,SUDDEN DEATH,SUDDEN DEATH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,N,FATAL,Y,Y,701,701,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-15,2013-01-14,0,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y -01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y 01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,1,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,9,2014-03,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,10,2014-04,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y 01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,2,2014-01-12,2,NA,NA,SKIN ODOUR ABNORMAL,SKIN ODOUR ABNORMAL,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y -01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,3,2014-01-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,5,2014-01-20,10,2014-02-08,29,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,154,Y +01-701-1239,6,2014-01-12,2,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y 01-701-1239,8,2014-02-20,41,2014-03-12,61,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,122,Y +01-701-1239,9,NA,NA,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1239,10,NA,NA,NA,NA,HORDEOLUM,HORDEOLUM,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-11,2014-07-11,NA,Y +01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y 01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,9,2014-03-12,34,2014-03-27,49,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y 01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,10,2014-03-12,34,2014-03-27,49,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,80,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y 01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,11,2014-02-13,7,2014-06-03,117,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y +01-701-1275,12,2014-02-24,18,2014-06-12,126,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y +01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y 01-701-1275,14,2014-02-24,18,2014-06-03,117,PAROSMIA,PAROSMIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y 01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,15,2014-02-24,18,2014-06-12,126,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,3,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,13,2014-02-24,18,2014-06-03,117,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,12,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1275,2,2014-02-23,17,2014-02-23,17,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,AMERICAN INDIAN OR ALASKA NATIVE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-07,2014-06-14,112,Y -01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y 01-701-1287,2,2014-02-22,29,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y +01-701-1287,3,2014-03-09,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y 01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y -01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y -01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y -01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y -01-701-1287,5,2014-07-09,166,2014-07-12,169,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,15,Y -01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1287,1,2014-01-26,2,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-25,2014-07-26,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y 01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y -01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y -01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y -01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y -01-701-1294,1,2013-03-22,-2,2013-03-23,-1,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,84,Y 01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,2,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,3,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,4,2013-05-19,57,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y +01-701-1294,5,2013-05-19,57,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y 01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1294,6,2013-06-10,79,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-06-14,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,1,2013-08-30,2,NA,NA,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y -01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,9,2013-09-02,5,2013-09-03,6,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,64,Y +01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,11,2013-09-04,7,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,14,2013-09-30,33,NA,NA,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,15,2013-09-05,8,2013-10-08,41,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,29,Y +01-701-1302,16,2013-10-15,48,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,17,2013-10-15,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,21,2013-10-24,57,NA,NA,FEELING ABNORMAL,FEELING ABNORMAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,13,2013-09-15,18,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,2,2013-08-30,2,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y 01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,22,2013-10-24,57,NA,NA,LISTLESS,LISTLESS,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,8,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,18,2013-09-02,5,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,10,2013-09-02,5,NA,NA,MYALGIA,MYALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,5,2013-09-01,4,NA,NA,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,4,2013-08-31,3,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,6,2013-09-02,5,NA,NA,PHARYNGOLARYNGEAL PAIN,PHARYNGOLARYNGEAL PAIN,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,7,2013-09-02,5,NA,NA,PRODUCTIVE COUGH,PRODUCTIVE COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,19,2013-10-23,56,NA,NA,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,20,2013-10-23,56,NA,NA,RHINITIS,RHINITIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1302,3,2013-08-30,2,NA,NA,STOMACH DISCOMFORT,STOMACH DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1302,23,2013-10-24,57,NA,NA,LIBIDO DECREASED,LIBIDO DECREASED,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,61,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-29,2013-11-05,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,3,2014-06-23,33,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,4,2014-06-23,33,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,5,2014-06-23,33,NA,NA,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,2,2014-05-13,-9,NA,NA,CYST,CYST,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,6,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,7,2014-07-04,44,NA,NA,DEPRESSED MOOD,DEPRESSED MOOD,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y 01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,8,2014-09-12,114,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1317,1,2014-05-13,-9,NA,NA,ONYCHOMYCOSIS,ONYCHOMYCOSIS,INFECTIONS AND INFESTATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y -01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y -01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y -01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y -01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1317,9,2014-11-03,166,NA,NA,DYSPHONIA,DYSPHONIA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-22,2014-11-20,NA,Y +01-701-1324,1,2012-10-22,21,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y +01-701-1324,2,2012-12-02,62,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,NA,Y 01-701-1324,4,2012-12-25,85,2013-01-16,107,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-02,2013-04-02,77,Y +01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y 01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,2,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y +01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y 01-701-1341,4,2013-01-26,22,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y 01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,5,2013-01-26,22,2013-01-30,26,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,1,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,NA,Y -01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1341,3,2013-01-26,22,2013-01-30,26,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,701,701,51,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-05,2013-02-07,9,Y -01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y 01-701-1360,1,2013-08-02,3,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y 01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1360,2,2013-08-02,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y 01-701-1360,3,2013-08-05,6,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-31,2013-08-14,NA,Y -01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y +01-701-1363,2,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,2,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y 01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y 01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,3,2013-07-16,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y -01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y -01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y +01-701-1363,4,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y +01-701-1363,4,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y 01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y 01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y -01-701-1363,6,2013-10-13,137,2013-10-15,139,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,44,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,2,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,4,1986,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,NA,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1363,1,2013-06-14,16,2013-06-15,17,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,81,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-05-30,2013-11-27,166,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y -01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y +01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y 01-701-1383,3,2013-03-23,48,2013-03-26,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,134,Y +01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y 01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,5,2013-04-12,68,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y 01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,6,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,2,2013-02-07,4,2013-02-07,4,APPLICATION SITE PAIN,APPLICATION SITE PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,1,2013-02-07,4,2013-02-07,4,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,181,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,4,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y 01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,7,2013-03-23,48,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y -01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y +01-701-1383,8,2013-04-12,68,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,NA,Y 01-701-1383,9,2013-05-07,93,2013-05-24,110,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,75,Y 01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,10,2013-06-24,141,2013-06-24,141,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y 01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1383,11,2013-06-24,141,2013-06-24,141,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,44,Y -01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y +01-701-1383,12,2013-07-17,164,2013-07-26,173,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,701,701,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-04,2013-08-06,12,Y 01-701-1387,1,2014-03-18,7,2014-03-18,7,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y 01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y -01-701-1387,2,2014-03-18,7,2014-03-18,7,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,87,F,WHITE,Placebo,Pbo,ONGOING,2014-03-12,2014-03-25,8,Y 01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y -01-701-1392,2,2013-03-16,140,2013-03-21,145,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,78,M,WHITE,Placebo,Pbo,ONGOING,2012-10-28,2013-04-28,39,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y -01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y -01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y -01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y 01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y -01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y -01-701-1415,2,2013-10-21,29,2013-11-04,43,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,141,Y -01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y -01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y -01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y -01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y -01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,3,2013-12-02,71,NA,NA,MICTURITION URGENCY,MICTURITION URGENCY,RENAL AND URINARY DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,NA,Y 01-701-1415,5,2014-01-21,121,2014-02-10,141,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,43,Y +01-701-1415,6,2014-03-09,168,2014-03-09,168,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,85,M,WHITE,Placebo,Pbo,ONGOING,2013-09-23,2014-03-24,16,Y 01-701-1442,1,2014-01-10,77,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,57,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-26,2014-04-26,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,1,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,2,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,4,2013-01-19,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y 01-701-1444,5,2013-01-19,15,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y +01-701-1444,6,2013-02-04,31,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y 01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,7,2013-02-04,31,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y 01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,8,2013-02-08,35,2013-02-08,35,PARAESTHESIA,PARAESTHESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,6,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-701-1444,3,2013-01-19,15,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,701,701,63,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-02-13,NA,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y +01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y 01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y 01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,6,2013-07-07,-19,2013-07-26,1,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y 01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y 01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,8,2013-09-02,39,2013-09-06,43,RECTAL HAEMORRHAGE,RECTAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,73,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y +01-702-1082,9,2013-09-09,46,2013-09-24,61,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,55,Y 01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y 01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,10,2013-10-12,79,2013-10-31,98,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,18,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,4,2013-07-07,-19,2013-07-24,-2,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,117,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-702-1082,5,2013-07-07,-19,2013-07-26,1,WHITE BLOOD CELL COUNT INCREASED,WHITE BLOOD CELL COUNT INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,702,702,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-26,2013-11-17,115,Y -01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y 01-703-1042,1,2013-03-04,3,2013-03-05,4,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,180,Y 01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y -01-703-1042,2,2013-03-05,4,2013-03-06,5,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,64,M,WHITE,Placebo,Pbo,ONGOING,2013-03-02,2013-08-31,179,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y -01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y 01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y 01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y -01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y -01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y -01-703-1076,1,2013-11-16,23,2013-11-16,23,BIOPSY PROSTATE,BIOPSY PROSTATE,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,39,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,3,2007,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,2,2013-11-20,27,NA,NA,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,NA,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,3,NA,NA,NA,NA,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLAEMIA,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,4,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,5,2013-11-23,30,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y 01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y 01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1076,6,2013-11-25,32,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y -01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y +01-703-1076,7,2013-11-23,30,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2013-12-24,NA,Y 01-703-1086,2,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y 01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,3,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y -01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y 01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y -01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y -01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y -01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y -01-703-1086,5,2012-10-09,38,2012-10-15,44,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,71,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y +01-703-1086,6,2012-09-13,12,2013-01-02,123,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,71,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-02,2012-12-24,-9,Y 01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y 01-703-1100,1,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y 01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y 01-703-1100,3,2013-04-05,24,2013-04-16,35,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,152,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y 01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y 01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,4,2013-04-25,44,2013-04-25,44,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,143,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y +01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y 01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y 01-703-1100,8,2013-02-28,-13,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y 01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y 01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,9,2013-07-17,127,2013-09-14,186,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,0,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1100,5,2013-05-27,76,2013-06-03,83,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,84,F,WHITE,Placebo,Pbo,ONGOING,2013-03-13,2013-09-14,104,Y -01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y 01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,1,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y 01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,2,2013-03-16,25,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y 01-703-1119,3,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y 01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y -01-703-1119,4,2013-05-04,74,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-20,2013-06-13,NA,Y 01-703-1175,1,2013-12-18,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,75,M,WHITE,Placebo,Pbo,ONGOING,2013-12-20,2013-12-31,NA,Y 01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,1,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y 01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,2,2013-10-31,15,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y 01-703-1182,3,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y 01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1182,4,2013-11-22,37,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-17,2013-12-12,NA,Y -01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y +01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y 01-703-1210,2,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y 01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,3,2013-05-04,50,NA,NA,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1210,1,2013-04-02,18,NA,NA,DISORIENTATION,DISORIENTATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,72,F,WHITE,Placebo,Pbo,ONGOING,2013-03-16,2013-09-06,NA,Y -01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y +01-703-1258,2,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,2,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y +01-703-1258,5,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y +01-703-1258,5,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y 01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y 01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,6,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y 01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y 01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,7,2012-09-04,47,2013-01-25,190,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,-4,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,2,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,5,2001,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,NA,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y -01-703-1258,3,2012-08-11,23,2012-08-19,31,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-07-20,2013-01-21,156,Y 01-703-1295,1,2013-12-28,38,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,88,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-21,2014-05-19,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,3,1992,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y +01-703-1299,3,NA,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,3,NA,NA,NA,NA,GLAUCOMA,GLAUCOMA,EYE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,4,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,5,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,6,2013-03-01,171,NA,NA,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,7,2013-03-01,171,NA,NA,TACHYCARDIA,TACHYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1299,2,2012-09-27,16,2012-10-06,25,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,159,Y -01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y +01-703-1299,8,2013-03-13,183,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,81,F,WHITE,Placebo,Pbo,TREATMENT COMPLETED,2012-09-12,2013-03-13,NA,Y 01-703-1335,2,2014-03-15,-2,2014-03-30,14,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,703,703,67,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-17,2014-05-24,56,Y -01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y -01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y -01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y -01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y -01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y -01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y 01-703-1403,2,2012-12-13,2,2012-12-14,3,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y 01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,3,2012-12-13,2,2012-12-14,3,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,6,Y -01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y -01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y -01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y -01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y +01-703-1403,4,2012-12-15,4,2012-12-16,5,CHEST DISCOMFORT,CHEST DISCOMFORT,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,4,Y 01-703-1403,5,2012-12-12,1,2012-12-19,8,WEIGHT DECREASED,WEIGHT DECREASED,INVESTIGATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,703,703,67,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-12,2012-12-19,0,Y 01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y -01-703-1439,1,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y 01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y -01-703-1439,2,2014-04-24,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,703,703,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-03-12,2014-09-11,NA,Y -01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y 01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y -01-704-1008,1,2013-01-30,18,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y -01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y -01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y -01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y 01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y -01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y -01-704-1008,2,2013-02-21,40,2013-02-21,40,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,5,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1008,3,2013-02-25,44,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-13,2013-02-25,NA,Y 01-704-1009,1,2013-09-05,10,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y +01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y 01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,4,2013-09-05,10,2013-09-27,32,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,6,Y -01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y -01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y -01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y -01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y -01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y +01-704-1009,5,2013-09-17,22,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y 01-704-1009,6,2013-09-22,27,2013-09-23,28,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,10,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1009,3,2013-09-14,19,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,83,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-27,2013-10-02,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y 01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,1,2014-02-27,7,2014-03-06,14,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,126,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y +01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y 01-704-1010,3,2014-07-05,135,2014-07-06,136,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y 01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,4,2014-07-06,136,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y 01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,5,2014-07-06,136,NA,NA,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1010,2,2014-07-05,135,2014-07-06,136,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,4,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1010,6,2014-07-06,136,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y +01-704-1010,7,2014-07-06,136,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Placebo,Pbo,ONGOING,2014-02-21,2014-07-09,NA,Y 01-704-1017,1,2013-10-19,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y 01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1017,2,2013-10-19,14,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1017,3,2013-11-01,27,2013-11-08,34,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,17,Y +01-704-1017,4,2013-11-01,27,NA,NA,CARDIAC DISORDER,CARDIAC DISORDER,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,NA,Y +01-704-1017,7,2013-11-05,31,2013-11-22,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y +01-704-1017,8,2013-11-05,31,2013-11-22,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-06,2013-11-24,3,Y 01-704-1025,1,2013-09-28,2,2013-09-30,4,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1025,2,2013-09-28,2,2013-09-30,4,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,61,Y +01-704-1025,5,2013-10-11,15,2013-10-25,29,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,36,Y +01-704-1025,6,2013-10-25,29,2013-11-29,64,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROME,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-27,2013-11-29,0,Y +01-704-1065,1,2013-10-26,3,NA,NA,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y 01-704-1065,3,2013-10-27,4,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,4,2013-11-09,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y 01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,7,2013-11-17,25,2013-11-17,25,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y 01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,8,2013-11-17,25,2013-11-17,25,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,38,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,6,2013-11-09,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,5,2013-11-09,17,NA,NA,MALAISE,MALAISE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,2,2013-10-27,4,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y +01-704-1065,9,2013-12-15,53,2013-12-15,53,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,10,Y 01-704-1065,10,2013-12-24,62,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,75,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-24,2013-12-24,NA,Y -01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y -01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y -01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y -01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y -01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y -01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y -01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y -01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y -01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y -01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y -01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y -01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y -01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y -01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y -01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y -01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y -01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y -01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y -01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y -01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y -01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y -01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y -01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y -01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y -01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y -01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y -01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y -01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y -01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y -01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y -01-704-1218,1,2012-12-30,42,NA,NA,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-19,2013-05-27,NA,Y -01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y -01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y -01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y -01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1074,1,2014-01-22,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1074,2,2014-02-09,19,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-22,2014-03-31,NA,Y +01-704-1093,2,2013-03-30,16,2013-04-13,30,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,69,Y +01-704-1093,3,2013-05-04,51,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1093,4,2013-05-04,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-03-15,2013-06-20,NA,Y +01-704-1114,1,2013-02-21,30,2013-02-23,32,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,136,Y +01-704-1114,2,2013-02-23,32,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,3,2013-03-23,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,4,2013-03-23,60,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,NA,Y +01-704-1114,5,2013-06-07,136,2013-06-13,142,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-23,2013-07-08,26,Y +01-704-1120,1,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,3,2013-12-23,22,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,4,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,5,2014-01-27,57,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,NA,Y +01-704-1120,6,2013-12-28,27,2014-02-03,64,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-02,2014-02-03,0,Y +01-704-1135,1,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1135,2,2013-12-08,39,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-31,2014-05-16,NA,Y +01-704-1164,2,2012-09-27,9,2012-10-07,19,INFLUENZA,INFLUENZA,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,180,Y +01-704-1164,3,2013-02-04,139,2013-02-13,148,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,67,F,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-04-04,51,Y +01-704-1218,1,2012-12-30,42,NA,NA,BLOOD GLUCOSE INCREASED,BLOOD GLUCOSE INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-19,2013-05-27,NA,Y +01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,1,2013-08-14,-11,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1241,2,2013-09-28,35,NA,NA,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-25,2013-10-31,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,2,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y +01-704-1266,5,2013-10-27,15,2013-11-08,27,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,29,Y 01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y 01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y -01-704-1266,10,2013-11-09,28,2013-12-04,53,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,3,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,12,2013-10-17,5,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,13,2013-11-08,27,2013-12-06,55,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,0,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y +01-704-1266,14,2013-11-15,34,2013-12-14,63,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-8,Y 01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y 01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,15,2013-11-15,34,2013-12-23,72,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1266,1,2013-10-06,-7,NA,NA,SEASONAL ALLERGY,SEASONAL ALLERGY,IMMUNE SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,NA,Y -01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y -01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y -01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y -01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y +01-704-1266,16,2013-12-06,55,2013-12-23,72,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-13,2013-12-06,-17,Y 01-704-1323,1,2013-07-30,23,2013-08-03,27,VIRAL INFECTION,VIRAL INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,6,Y -01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y -01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y -01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y +01-704-1323,2,2013-08-04,28,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,3,2013-08-04,28,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y +01-704-1323,4,2013-08-04,28,NA,NA,OEDEMA,OEDEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-08,2013-08-08,NA,Y 01-704-1325,1,2014-05-23,31,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1325,2,2014-07-04,73,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,81,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-04-23,2014-08-06,NA,Y 01-704-1332,1,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y +01-704-1332,4,2014-02-03,57,NA,NA,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,NA,Y 01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1332,5,2013-12-10,2,2014-02-24,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y -01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y -01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1332,6,2014-01-18,41,2014-02-24,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,704,704,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-09,2014-02-16,-8,Y 01-704-1351,3,2013-10-27,16,2014-04-04,175,POLLAKIURIA,POLLAKIURIA,RENAL AND URINARY DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y +01-704-1351,4,2013-10-27,16,2014-04-04,175,FLATULENCE,FLATULENCE,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,704,704,70,M,WHITE,Placebo,Pbo,ONGOING,2013-10-12,2014-04-18,15,Y 01-704-1388,1,2012-08-23,-106,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,704,704,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-07,2013-06-19,NA,Y 01-704-1435,1,2013-01-06,51,NA,NA,PARKINSON'S DISEASE,PARKINSON'S DISEASE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,704,704,74,M,WHITE,Placebo,Pbo,ONGOING,2012-11-17,2013-01-12,NA,Y 01-704-1445,1,2014-10-31,174,2014-10-31,174,COMPLETED SUICIDE,COMPLETED SUICIDE,PSYCHIATRIC DISORDERS,N,N,SEVERE,N,FATAL,Y,Y,704,704,75,M,WHITE,Placebo,Pbo,ONGOING,2014-05-11,2014-11-01,2,Y @@ -2953,4567 +451,706 @@ USUBJID,AESEQ,AESTDT,AESTDY,AEENDT,AEENDY,AETERM,AEDECOD,AEBODSYS,AESER,AEONGO,A 01-705-1059,1,2013-11-02,90,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,66,F,WHITE,Placebo,Pbo,ONGOING,2013-08-05,2013-12-05,NA,Y 01-705-1186,1,2014-01-26,19,NA,NA,HYPERBILIRUBINAEMIA,HYPERBILIRUBINAEMIA,HEPATOBILIARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,84,F,WHITE,Placebo,Pbo,ONGOING,2014-01-08,2014-02-07,NA,Y 01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y -01-705-1199,2,2013-09-17,2,2013-09-29,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-09-29,0,Y 01-705-1280,1,2014-04-20,94,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,56,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-17,2014-07-25,NA,Y -01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y 01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,1,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y +01-705-1281,2,2014-01-30,64,NA,NA,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y 01-705-1281,3,2014-01-30,64,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,73,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-28,2014-03-17,NA,Y -01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y -01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y -01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y 01-705-1292,1,2013-10-28,15,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y -01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1292,2,2014-02-13,123,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,60,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-14,2014-05-14,NA,Y 01-705-1303,2,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y -01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y +01-705-1303,3,2014-02-05,52,2014-03-03,78,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y 01-705-1303,4,2014-02-05,52,2014-03-03,78,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,705,705,72,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-02,92,Y 01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y -01-705-1310,1,2013-11-14,13,NA,NA,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y -01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y 01-705-1310,2,2014-01-09,69,NA,NA,WOUND HAEMORRHAGE,WOUND HAEMORRHAGE,VASCULAR DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,74,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-11-02,2014-01-23,NA,Y -01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y -01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y 01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y -01-705-1349,1,2013-04-08,30,2013-04-08,30,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,154,Y -01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y -01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y -01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y -01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y 01-705-1349,2,2013-04-11,33,2013-04-11,33,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,151,Y -01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y +01-705-1349,3,2013-08-25,169,NA,NA,VENTRICULAR HYPERTROPHY,VENTRICULAR HYPERTROPHY,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y +01-705-1349,4,2013-08-25,169,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,86,F,WHITE,Placebo,Pbo,ONGOING,2013-03-10,2013-09-08,NA,Y 01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y 01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y -01-705-1393,1,2012-09-19,13,2012-09-24,18,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,150,Y -01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y 01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y 01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y -01-705-1393,3,2013-01-21,137,2013-01-24,140,COLON CANCER,COLON CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,SEVERE,N,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,28,Y -01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y 01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y 01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y -01-705-1393,4,2011-12-05,-277,2013-02-20,167,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-07,2013-02-20,0,Y -01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y -01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y 01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y 01-705-1431,1,2013-06-22,-1,NA,NA,RASH ERYTHEMATOUS,RASH ERYTHEMATOUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,1,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,7,2012-05,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y +01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y +01-705-1431,2,2013-07-04,12,2013-07-06,14,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,705,705,68,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-23,2013-12-19,167,Y +01-706-1041,1,NA,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,1,NA,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y 01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y 01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,2,2014-01-07,8,2014-01-08,9,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,203,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y 01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y 01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,5,2014-01-14,15,2014-01-28,29,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,183,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y +01-706-1041,7,NA,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y +01-706-1041,7,NA,NA,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,NA,Y 01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y 01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,8,2014-01-15,16,2014-07-29,211,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y 01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y 01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y -01-706-1041,9,2014-03-04,64,2014-07-29,211,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,706,706,64,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-12-31,2014-07-29,0,Y 01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y -01-706-1049,1,2013-06-03,21,2013-06-03,21,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,23,Y -01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y 01-706-1049,2,2013-06-18,36,2013-06-18,36,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,706,706,60,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-14,2013-06-25,8,Y 01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,6,2012-09-15,1,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y 01-706-1384,7,2012-09-15,1,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,8,2012-09-15,1,2012-09-29,15,EXCORIATION,EXCORIATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y +01-706-1384,9,2012-09-23,9,2012-09-29,15,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y 01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-706-1384,10,2012-09-23,9,2012-09-29,15,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,706,706,74,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-15,2012-09-29,0,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y 01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,4,2013-11-26,30,2013-12-09,43,BLOOD CREATINE PHOSPHOKINASE INCREASED,BLOOD CREATINE PHOSPHOKINASE INCREASED,INVESTIGATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,140,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y 01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,5,2013-12-03,37,2013-12-10,44,POSTNASAL DRIP,POSTNASAL DRIP,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,139,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y 01-707-1206,6,2013-11-25,29,2013-12-23,57,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,126,Y -01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y -01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y -01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y -01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y +01-707-1206,8,2014-02-08,104,2014-02-22,118,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,707,707,65,M,WHITE,Placebo,Pbo,ONGOING,2013-10-28,2014-04-27,65,Y 01-708-1019,1,2013-12-31,12,2013-12-31,12,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,24,Y 01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,2,2014-01-01,13,2014-01-01,13,STUPOR,STUPOR,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y 01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,3,2014-01-01,13,2014-01-01,13,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y -01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y 01-708-1019,4,2014-01-01,13,2014-01-01,13,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y +01-708-1019,5,2014-01-01,13,2014-01-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-12-20,2014-01-23,23,Y 01-708-1032,1,2013-02-26,18,2013-03-09,29,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,62,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-09,2013-03-09,0,Y 01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,2,2013-05-23,15,2013-05-23,15,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,173,Y -01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y -01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y -01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y -01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y 01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y -01-708-1084,4,2013-06-09,32,2013-06-09,32,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,156,Y -01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y -01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y -01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y 01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y -01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y -01-708-1084,6,2013-06-23,46,2013-06-23,46,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-11-11,142,Y -01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y -01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y -01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y -01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y -01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y +01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y 01-708-1087,3,2013-02-04,106,2013-02-08,110,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,80,Y 01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,4,2013-02-16,118,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,NA,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,2,2013-01-19,90,2013-01-19,90,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,100,Y -01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y -01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y -01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y -01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y -01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y 01-708-1087,6,2013-03-16,146,2013-03-16,146,HEART RATE IRREGULAR,HEART RATE IRREGULAR,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2012-10-22,2013-04-28,44,Y 01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y -01-708-1158,1,2014-02-25,18,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,NA,Y -01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y 01-708-1158,2,2014-03-22,43,2014-03-22,43,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,81,F,WHITE,Placebo,Pbo,ONGOING,2014-02-08,2014-03-22,0,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y -01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y 01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y 01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,1,2013-12-19,-10,NA,NA,FLANK PAIN,FLANK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y 01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y 01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y -01-708-1178,2,2014-03-01,63,2014-03-08,70,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,30,Y 01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y 01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1178,4,2014-03-09,71,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,NA,Y -01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,5,2014-03-09,71,2014-04-06,99,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,0,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,6,2014-03-24,86,2014-03-26,88,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,7,2014-03-24,86,2014-03-26,88,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,12,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,8,2014-03-24,86,2014-03-28,90,CYSTITIS,CYSTITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,10,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y +01-708-1178,9,2014-03-24,86,2014-03-24,86,ALCOHOL USE,ALCOHOL USE,SOCIAL CIRCUMSTANCES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,77,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-29,2014-04-06,14,Y 01-708-1213,2,2013-02-22,14,2013-02-22,14,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-09,2013-02-26,5,Y -01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y -01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y -01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y -01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y -01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y 01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1216,1,2012-11-06,14,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y 01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1216,3,2012-11-22,30,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,NA,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1216,4,2012-11-06,14,2012-12-13,51,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,78,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-24,2012-12-06,-7,Y 01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y +01-708-1253,4,2013-05-06,-1,2013-05-16,10,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,5,2013-05-06,-1,2013-05-16,10,CONJUNCTIVITIS,CONJUNCTIVITIS,EYE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,174,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,6,2013-05-07,1,2013-05-10,4,HEART RATE INCREASED,HEART RATE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,180,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y +01-708-1253,8,2013-06-07,32,2013-06-07,32,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,M,WHITE,Placebo,Pbo,ONGOING,2013-05-07,2013-11-05,152,Y 01-708-1272,1,2013-02-11,6,2013-02-11,6,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,53,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y 01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,2,2013-02-18,13,2013-02-18,13,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,46,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y -01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,4,2013-02-27,22,2013-02-27,22,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,37,Y +01-708-1272,8,2013-03-01,24,2013-03-07,30,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y 01-708-1272,9,2013-03-01,24,2013-03-07,30,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,10,2013-03-07,30,2013-03-07,30,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,29,Y +01-708-1272,11,2013-03-19,42,2013-03-19,42,HOT FLUSH,HOT FLUSH,VASCULAR DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,17,Y 01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1272,12,2013-02-21,16,2013-03-20,43,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-06,2013-04-04,16,Y -01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y 01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,1,2013-09-12,3,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y -01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y 01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1286,2,2013-09-23,14,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,NA,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y -01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y +01-708-1286,3,2014-02-18,162,2014-02-18,162,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1286,4,2014-02-18,162,2014-02-18,162,CONSTIPATION,CONSTIPATION,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,80,F,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-09-10,2014-03-08,19,Y +01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y 01-708-1296,4,2013-09-04,83,2013-09-18,97,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,86,Y 01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,6,2013-10-04,113,2013-10-30,139,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,44,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y -01-708-1296,2,2013-06-27,14,2013-06-27,14,ATRIAL HYPERTROPHY,ATRIAL HYPERTROPHY,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,169,Y 01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1296,7,2013-12-07,177,2013-12-07,177,PAIN IN EXTREMITY,PAIN IN EXTREMITY,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,57,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2013-06-14,2013-12-12,6,Y -01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y 01-708-1297,1,2013-04-02,68,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y 01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1297,2,2013-04-02,68,NA,NA,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y 01-708-1297,3,2013-05-08,104,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,61,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-25,2013-05-08,NA,Y -01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y -01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y 01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y -01-708-1316,1,2014-01-29,160,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y -01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1316,2,2014-02-15,177,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,74,F,WHITE,Placebo,Pbo,ONGOING,2013-08-23,2014-03-01,NA,Y 01-708-1336,1,2012-12-18,12,2012-12-18,12,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,170,Y +01-708-1336,2,2013-01-12,37,2013-01-12,37,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,145,Y 01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1336,3,2013-02-02,58,2013-02-02,58,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,124,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1336,6,2013-04-10,125,2013-06-05,181,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1336,7,2013-04-10,125,2013-06-05,181,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-07,2013-06-05,0,Y +01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y +01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y 01-708-1347,7,2013-06-13,55,2013-06-25,67,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y 01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,8,2013-06-13,55,2013-06-25,67,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,6,2013-06-13,55,2013-06-25,67,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1347,5,2013-06-13,55,2013-06-25,67,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,61,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-20,2013-06-18,-7,Y -01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y -01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y -01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y -01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y 01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y -01-708-1348,2,2013-08-18,14,2013-08-31,27,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,167,Y -01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y -01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y +01-708-1348,3,2013-12-01,119,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-05,2014-02-13,NA,Y 01-708-1353,2,2013-08-18,46,2013-09-10,69,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y 01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y -01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y -01-708-1353,3,2013-08-28,56,2013-09-10,69,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,87,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-04,2013-09-10,0,Y 01-708-1372,1,2013-04-10,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,708,708,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-12,2013-05-10,NA,Y 01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y -01-708-1406,2,2014-06-16,173,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,71,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-26,2014-07-02,NA,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y 01-708-1428,2,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,3,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y 01-708-1428,4,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,5,2013-12-10,32,2013-12-21,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y +01-708-1428,6,2013-12-10,32,2013-12-21,43,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y 01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,7,2013-12-10,32,2013-12-21,43,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,42,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-708-1428,1,2013-11-22,14,2013-11-22,14,EPISTAXIS,EPISTAXIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,708,708,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-11-09,2014-01-31,71,Y -01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y -01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y -01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y -01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y -01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y -01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y -01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y +01-709-1007,2,2012-08-16,17,2012-08-19,20,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,14,Y 01-709-1007,3,2012-08-21,22,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,NA,Y 01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y -01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y -01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y -01-709-1007,4,2012-08-30,31,2012-08-30,31,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,54,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-07-31,2012-09-01,3,Y -01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y 01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,1,2012-12-27,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y -01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y 01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1020,2,2013-01-03,34,2013-01-11,42,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y +01-709-1020,3,2013-01-03,34,2013-01-11,42,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,142,Y +01-709-1020,4,2013-01-15,46,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-01,2013-06-01,NA,Y 01-709-1029,2,2013-01-17,24,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y 01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,4,2013-01-09,16,2013-02-19,57,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,128,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,5,2013-01-24,31,2013-02-27,65,MUSCLE SPASMS,MUSCLE SPASMS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,120,Y 01-709-1029,8,2013-03-20,86,2013-04-16,113,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y +01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y 01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,12,2013-05-15,142,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y +01-709-1029,13,2013-05-12,139,2013-05-19,146,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y 01-709-1029,14,2013-05-12,139,2013-05-19,146,PHARYNGEAL ERYTHEMA,PHARYNGEAL ERYTHEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,39,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,9,2013-03-20,86,2013-04-16,113,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,72,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y 01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1029,15,2013-06-12,170,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y -01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y -01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y -01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1029,16,2013-06-19,177,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-25,2013-06-26,NA,Y 01-709-1081,1,2014-04-07,80,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y +01-709-1081,2,2014-05-01,104,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,86,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-18,2014-05-10,NA,Y 01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y -01-709-1088,1,2014-05-08,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y -01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y 01-709-1088,2,2014-08-02,113,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Placebo,Pbo,ONGOING,2014-04-12,2014-10-09,NA,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y -01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y 01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,2,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y 01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,3,2013-11-12,19,NA,NA,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1099,4,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,5,2013-11-06,13,2013-11-17,24,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,160,Y +01-709-1099,6,2013-11-12,19,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,7,2013-11-12,19,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,NA,Y +01-709-1099,8,2014-03-23,150,2014-03-23,150,ACROCHORDON EXCISION,ACROCHORDON EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,79,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-25,2014-04-25,34,Y +01-709-1102,1,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y 01-709-1102,2,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y +01-709-1102,3,2013-02-11,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y 01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,4,2013-02-11,28,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,NA,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y -01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y -01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y -01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y 01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y -01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y -01-709-1102,5,2013-03-20,65,2013-03-26,71,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,6,Y -01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y +01-709-1102,6,2013-03-26,71,2013-03-27,72,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-01-15,2013-03-31,5,Y +01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y 01-709-1168,5,2013-09-06,36,2013-10-11,71,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y 01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,6,2013-09-06,36,2013-10-11,71,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,-14,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1168,2,2013-08-17,16,2013-09-06,36,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-02,2013-09-27,22,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y 01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,1,2013-03-06,3,2013-03-06,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,112,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y +01-709-1217,2,2013-03-20,17,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y +01-709-1217,3,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y 01-709-1217,4,2013-03-27,24,2013-03-27,24,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,91,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y 01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,5,2013-03-30,27,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,NA,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y -01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,7,2013-04-01,29,2013-04-11,39,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,76,Y 01-709-1217,9,2013-05-17,75,2013-05-18,76,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,39,Y +01-709-1217,10,2013-03-26,23,2013-06-18,107,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y 01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1217,11,2013-05-27,85,2013-06-18,107,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-04,2013-06-25,8,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y 01-709-1238,2,2013-05-30,16,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y 01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,3,2013-05-30,16,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,1,2013-05-28,14,2013-05-28,14,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,72,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y +01-709-1238,4,2013-05-30,16,NA,NA,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y 01-709-1238,5,2013-05-31,17,2013-05-31,17,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,69,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y +01-709-1238,6,2013-06-09,26,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y 01-709-1238,7,2013-06-09,26,NA,NA,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,NA,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y +01-709-1238,8,2013-06-28,45,2013-06-28,45,SKIN LESION EXCISION,SKIN LESION EXCISION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,69,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-15,2013-08-07,41,Y +01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y +01-709-1259,3,2013-03-14,48,NA,NA,BLOOD URINE PRESENT,BLOOD URINE PRESENT,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,NA,Y +01-709-1259,4,2013-03-17,51,2013-03-17,51,CYSTOSCOPY,CYSTOSCOPY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,89,Y +01-709-1259,5,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,6,2013-03-17,51,2013-03-30,64,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERPLASIA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,76,Y +01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y 01-709-1259,8,2013-04-13,78,2013-04-14,79,DEHYDRATION,DEHYDRATION,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y 01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,9,2013-04-13,78,2013-04-14,79,HYPOTENSION,HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,2,2013-02-05,11,2013-02-13,19,LOCALISED INFECTION,LOCALISED INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,121,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y 01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,11,2013-04-20,85,2013-06-13,139,ORTHOSTATIC HYPOTENSION,ORTHOSTATIC HYPOTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,0,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1259,7,2013-04-13,78,2013-04-14,79,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-26,2013-06-13,61,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y -01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y 01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,1,2013-04-14,22,NA,NA,HEMIANOPIA HOMONYMOUS,HEMIANOPIA HOMONYMOUS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y -01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y 01-709-1285,4,2013-05-19,57,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,NA,Y +01-709-1285,5,2013-04-19,27,2013-05-31,69,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y +01-709-1285,6,2013-04-19,27,2013-05-31,69,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,87,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-03-24,2013-05-31,0,Y 01-709-1301,1,2013-08-30,43,NA,NA,DIABETES MELLITUS,DIABETES MELLITUS,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,62,F,WHITE,Placebo,Pbo,ONGOING,2013-07-19,2014-01-17,NA,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y 01-709-1306,2,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y 01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,6,2014-05-20,107,2014-05-23,110,DRUG ERUPTION,DRUG ERUPTION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,34,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,1,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y 01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1306,7,2014-04-20,77,2014-06-23,141,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y +01-709-1306,8,2014-04-20,77,2014-06-23,141,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1306,9,2014-05-04,91,2014-06-23,141,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,60,F,WHITE,Placebo,Pbo,ONGOING,2014-02-03,2014-06-25,3,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y +01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y 01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y 01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,5,2013-06-19,1,2013-06-20,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y 01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y 01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,6,2013-06-19,1,2013-06-20,2,NIGHTMARE,NIGHTMARE,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,183,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y 01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y 01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,7,2013-06-20,2,NA,NA,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,8,2013-06-26,8,2013-06-26,8,BIOPSY,BIOPSY,INVESTIGATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,177,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,10,2013-06-10,-9,2013-07-01,13,RASH MACULO-PAPULAR,RASH MACULO-PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,11,2013-07-01,13,2013-07-01,13,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,172,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y +01-709-1309,12,2013-07-04,16,2013-07-04,16,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOUS ANGIITIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,169,Y 01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y 01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,13,2013-06-18,-1,2013-07-16,28,RASH PAPULAR,RASH PAPULAR,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,157,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1309,4,2013-06-19,1,2013-06-19,1,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,184,Y -01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,14,2013-07-28,40,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y +01-709-1309,15,2013-09-06,80,NA,NA,FEELING COLD,FEELING COLD,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-19,2013-12-19,NA,Y 01-709-1312,1,2014-05-17,28,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y 01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y -01-709-1312,2,2014-10-19,183,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,68,F,WHITE,Placebo,Pbo,ONGOING,2014-04-20,2014-10-19,NA,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y -01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y 01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,1,2013-05-01,27,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y 01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,2,2013-05-01,27,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y 01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1326,3,2013-05-21,47,2013-05-21,47,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y -01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y -01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y -01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y -01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y -01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y -01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y -01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y -01-709-1339,1,2011-11,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y -01-709-1424,1,2013-03-07,5,2013-03-07,5,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline High Dose,Xan_Hi,DISCONTINUED,2013-03-03,2013-03-08,2,Y -01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y -01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y -01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y -01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y -01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y -01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y -01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y -01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y -01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y -01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y -01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y -01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y -01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y -01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y -01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y -01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y -01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-709-1326,4,2013-05-21,47,2013-05-21,47,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,135,Y +01-709-1326,5,2013-06-07,64,2013-06-17,74,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,108,Y +01-709-1326,6,2013-07-12,99,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-05,2013-10-02,NA,Y +01-709-1329,1,2013-08-25,11,2013-08-25,11,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1329,2,2013-08-25,11,2013-08-25,11,PYREXIA,PYREXIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,709,709,70,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-29,5,Y +01-709-1339,1,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,1,NA,NA,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1339,2,2013-05-12,141,NA,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,BLOOD ALKALINE PHOSPHATASE INCREASED,INVESTIGATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,709,709,81,M,WHITE,Placebo,Pbo,ONGOING,2012-12-23,2013-06-24,NA,Y +01-709-1424,1,2013-03-07,5,2013-03-07,5,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,709,709,77,M,WHITE,Xanomeline High Dose,Xan_Hi,DISCONTINUED,2013-03-03,2013-03-08,2,Y +01-710-1002,2,2014-01-16,3,2014-01-20,7,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHAEMIC ATTACK,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,88,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-01-18,-2,Y +01-710-1006,1,2013-02-18,9,2013-02-19,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,173,Y +01-710-1006,2,2013-03-01,20,NA,NA,SALIVARY HYPERSECRETION,SALIVARY HYPERSECRETION,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,3,2013-03-01,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,4,2013-04-16,66,2013-04-16,66,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,117,Y +01-710-1006,5,2013-04-17,67,2013-04-19,69,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,114,Y +01-710-1006,6,2013-04-17,67,2013-04-17,67,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,116,Y +01-710-1006,7,2013-05-18,98,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,9,2013-06-29,140,2013-07-04,145,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,38,Y +01-710-1006,10,2013-08-08,180,2013-08-08,180,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,3,Y +01-710-1006,11,2013-08-08,180,NA,NA,FACIAL BONES FRACTURE,FACIAL BONES FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1006,12,2013-08-08,180,NA,NA,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-10,2013-08-10,NA,Y +01-710-1021,1,2013-10-10,14,2013-10-10,14,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,34,Y +01-710-1021,3,2013-10-21,25,2013-10-31,35,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-09-27,2013-11-12,13,Y +01-710-1027,3,2014-05-09,71,2014-06-01,94,HAEMOPTYSIS,HAEMOPTYSIS,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,90,Y +01-710-1027,4,2014-05-23,85,2014-06-20,113,RALES,RALES,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,M,WHITE,Placebo,Pbo,ONGOING,2014-02-28,2014-08-29,71,Y +01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y 01-710-1045,5,2013-07-02,30,2013-07-09,37,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,40,Y +01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y 01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,10,2013-07-02,30,2013-08-17,76,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y 01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,11,2013-07-22,50,2013-08-17,76,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y +01-710-1045,12,2013-08-03,62,2013-08-17,76,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y 01-710-1045,13,2013-08-13,72,2013-08-17,76,SKIN EXFOLIATION,SKIN EXFOLIATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,9,2013-07-02,30,2013-08-17,76,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,0,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1045,1,2013-06-22,20,2013-06-22,20,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-06-03,2013-08-17,57,Y -01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y 01-710-1053,3,2013-01-28,34,2013-02-11,48,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y 01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1053,4,2013-01-28,34,2013-02-11,48,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,84,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-12-26,2013-02-15,5,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y -01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y +01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y +01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y 01-710-1060,4,2013-01-21,21,2013-01-21,21,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,166,Y 01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,5,2013-01-23,23,2013-01-23,23,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,164,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y 01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,6,2013-01-31,31,2013-01-31,31,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,156,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y 01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,7,2013-02-08,39,2013-02-08,39,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,148,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y 01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,8,2013-02-09,40,2013-02-09,40,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,147,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,3,2013-01-04,4,2013-01-15,15,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,172,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1060,1,2013-01-02,2,2013-01-02,2,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,82,M,WHITE,Placebo,Pbo,ONGOING,2013-01-01,2013-07-05,185,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y -01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y 01-710-1070,2,2012-12-12,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y +01-710-1070,3,2012-12-12,96,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y 01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,4,2012-12-12,96,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1070,1,2012-10-06,29,NA,NA,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,NA,Y -01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y -01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y -01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y -01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y +01-710-1070,5,2013-01-22,137,2013-01-25,140,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,30,Y +01-710-1070,6,2013-02-05,151,2013-02-10,156,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL HAEMORRHAGE,GASTROINTESTINAL DISORDERS,N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,85,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-09-08,2013-02-23,14,Y 01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y -01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,4,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,5,1977,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y -01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,1,2013-12-12,26,2013-12-12,26,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,158,Y 01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,2,2013-12-27,41,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,3,2014-01-12,57,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,NA,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,4,NA,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,NA,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y +01-710-1077,5,NA,NA,NA,NA,ARTHRITIS,ARTHRITIS,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,76,F,WHITE,Placebo,Pbo,ONGOING,2013-11-17,2014-05-18,NA,Y 01-710-1083,1,2013-08-02,12,2013-08-02,12,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,FATAL,Y,Y,710,710,89,F,WHITE,Placebo,Pbo,ONGOING,2013-07-22,2013-08-03,2,Y -01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y 01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,1,2013-10-13,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y -01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,2,2013-10-13,3,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y 01-710-1137,3,2013-11-04,25,NA,NA,VERTIGO,VERTIGO,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y +01-710-1137,4,2013-11-13,34,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-10-11,2013-11-13,NA,Y 01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,1,2012-10-04,3,2012-10-06,5,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y -01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y -01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y -01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y -01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y -01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y -01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y -01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y -01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y -01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y -01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y -01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y +01-710-1142,2,2012-10-04,3,2012-10-06,5,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,18,Y +01-710-1142,3,2012-10-14,13,2012-10-14,13,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,10,Y +01-710-1142,4,2012-10-19,18,2012-10-19,18,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1142,5,2012-10-19,18,2012-10-19,18,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,76,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-02,2012-10-23,5,Y +01-710-1154,1,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y +01-710-1154,2,2014-04-18,21,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,84,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-29,2014-05-09,NA,Y 01-710-1166,1,2013-03-19,110,2013-03-19,110,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y 01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,2,2013-03-19,110,2013-03-19,110,SKIN LACERATION,SKIN LACERATION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y 01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,3,2013-03-19,110,2013-03-19,110,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,12,Y -01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y +01-710-1166,4,2013-03-19,110,2013-03-20,111,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y 01-710-1166,5,2013-03-20,111,2013-03-20,111,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-11-30,2013-03-30,11,Y -01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y -01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y -01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y 01-710-1183,1,2014-03-10,115,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y +01-710-1183,2,2014-03-10,115,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,80,F,WHITE,Placebo,Pbo,ONGOING,2013-11-16,2014-05-17,NA,Y 01-710-1187,1,2012-12-23,44,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-10,2013-05-12,NA,Y -01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y -01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y 01-710-1235,1,2012-11-22,58,2012-12-14,80,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,104,Y 01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1235,2,2013-01-13,110,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y -01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y -01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y -01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y +01-710-1235,3,2013-01-29,126,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,56,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-26,2013-03-27,NA,Y 01-710-1249,1,2014-02-11,46,2014-02-11,46,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,138,Y 01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y -01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y -01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y -01-710-1249,2,2014-02-18,53,2014-02-18,53,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,131,Y -01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y +01-710-1249,3,2014-02-23,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y 01-710-1249,4,2014-04-24,118,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-28,2014-06-28,NA,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y 01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,1,2013-07-03,21,2013-07-05,23,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,100,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y 01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,2,2013-08-21,70,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y 01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1264,3,2013-08-21,70,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,NA,Y -01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y +01-710-1264,4,2013-09-29,109,2013-09-29,109,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,5,2013-09-29,109,2013-09-29,109,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,14,Y +01-710-1264,6,2013-10-09,119,2013-10-09,119,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,7,2013-10-09,119,2013-10-09,119,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,4,Y +01-710-1264,8,2013-10-11,121,2013-10-11,121,COLD SWEAT,COLD SWEAT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y +01-710-1264,9,2013-10-11,121,2013-10-11,121,CHILLS,CHILLS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,78,M,WHITE,Placebo,Pbo,ONGOING,2013-06-13,2013-10-12,2,Y 01-710-1270,1,2014-02-23,12,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y 01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y -01-710-1270,2,2014-02-23,12,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-02-12,2014-03-01,NA,Y -01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y +01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y +01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y 01-710-1271,3,2012-11-21,56,2012-11-26,61,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y 01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y -01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y -01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y -01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y -01-710-1271,4,2012-11-22,57,NA,NA,CARDIAC FAILURE CONGESTIVE,CARDIAC FAILURE CONGESTIVE,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,NA,Y -01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,1,2012-11-21,56,2012-11-21,56,DYSPNOEA,DYSPNOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y 01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,5,2012-11-22,57,2012-11-26,61,HYPONATRAEMIA,HYPONATRAEMIA,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,7,Y -01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1271,2,2012-11-21,56,2012-11-21,56,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,710,710,86,F,WHITE,Placebo,Pbo,ONGOING,2012-09-27,2012-12-02,12,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y -01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y 01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,1,2013-01-13,21,2013-01-19,27,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,44,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y +01-710-1278,4,2013-02-24,63,2013-02-26,65,BURNING SENSATION,BURNING SENSATION,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,6,Y 01-710-1278,5,2013-03-02,69,2013-03-02,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,2,Y -01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y -01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1278,6,2013-02-07,46,2013-03-03,70,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y +01-710-1278,7,2013-02-24,63,2013-03-03,70,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-24,2013-03-03,0,Y 01-710-1300,1,2013-01-31,48,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,2,2013-02-10,58,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,3,2013-02-10,58,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y +01-710-1300,4,2013-02-13,61,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-15,2013-02-19,NA,Y 01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y -01-710-1314,2,2013-05-20,27,2013-05-24,31,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,78,F,WHITE,Placebo,Pbo,ONGOING,2013-04-24,2013-05-25,2,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y 01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y 01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y -01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y -01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y -01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y -01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y -01-710-1315,1,2013-02-26,-1,2013-02-26,-1,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,141,Y 01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y 01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,5,2013-05-14,77,2013-07-07,131,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y 01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y 01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1315,6,2013-06-18,112,2013-07-07,131,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y -01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y +01-710-1315,7,2013-06-18,112,2013-07-07,131,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,710,710,83,F,WHITE,Placebo,Pbo,ONGOING,2013-02-27,2013-07-16,10,Y 01-710-1354,1,2012-12-30,50,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y 01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y -01-710-1354,2,2013-02-14,96,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-11-11,2013-05-01,NA,Y -01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y 01-710-1358,1,2012-12-22,97,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y -01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y -01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y -01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y -01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y -01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y +01-710-1358,2,2012-12-22,97,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1358,3,2013-01-24,130,NA,NA,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-17,2013-03-12,NA,Y +01-710-1368,2,2014-03-26,155,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y 01-710-1368,3,2014-03-26,155,NA,NA,PSYCHOMOTOR HYPERACTIVITY,PSYCHOMOTOR HYPERACTIVITY,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1368,4,2013-12-25,64,2014-04-24,184,HIP FRACTURE,HIP FRACTURE,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,710,710,88,F,WHITE,Placebo,Pbo,ONGOING,2013-10-23,2014-04-24,0,Y +01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y 01-710-1385,3,2012-11-26,29,NA,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,ATRIOVENTRICULAR BLOCK FIRST DEGREE,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y 01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,4,2012-12-18,51,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y 01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,5,2012-12-27,60,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1385,2,2012-11-12,15,2012-11-13,16,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,98,Y -01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y -01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y -01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y -01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y -01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y -01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y -01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-710-1385,6,2012-12-27,60,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,7,2013-02-18,113,NA,NA,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y +01-710-1385,8,2013-02-18,113,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,710,710,77,M,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2012-10-29,2013-02-18,NA,Y 01-710-1408,2,2013-01-31,27,2013-02-09,36,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,154,Y +01-710-1408,4,2013-02-24,51,2013-05-31,147,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,710,710,80,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-05,2013-07-12,43,Y 01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,1,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y 01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,2,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y +01-711-1012,3,2013-04-16,14,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y 01-711-1012,5,2013-04-27,25,NA,NA,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,NA,Y -01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y -01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y -01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y -01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y -01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1012,6,2013-04-29,27,2013-05-01,29,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,2,Y +01-711-1012,7,2013-04-16,14,2013-05-02,30,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,67,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-03,2013-05-02,0,Y 01-711-1036,1,2012-07-29,1,NA,NA,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1036,3,2012-08-12,15,NA,NA,GLOSSITIS,GLOSSITIS,GASTROINTESTINAL DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,NA,Y +01-711-1036,4,2012-08-04,7,2012-08-12,15,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,70,M,BLACK OR AFRICAN AMERICAN,Placebo,Pbo,ONGOING,2012-07-29,2013-02-10,183,Y +01-711-1143,1,NA,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,1,NA,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y 01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y 01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,3,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y 01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y 01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,6,2013-04-28,26,2013-05-11,39,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,22,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,2,2013-04-11,9,NA,NA,PARAESTHESIA ORAL,PARAESTHESIA ORAL,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y -01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y 01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y 01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,7,2013-04-29,27,2013-05-15,43,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,18,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y -01-711-1143,1,2007-10,NA,NA,NA,TINNITUS,TINNITUS,EAR AND LABYRINTH DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,8,2013-05-18,46,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,11,2013-05-27,55,2013-05-31,59,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,2,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,12,2013-05-30,58,NA,NA,CONJUNCTIVAL HAEMORRHAGE,CONJUNCTIVAL HAEMORRHAGE,EYE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y +01-711-1143,13,2013-06-01,60,NA,NA,CERUMEN IMPACTION,CERUMEN IMPACTION,EAR AND LABYRINTH DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,NA,Y 01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y 01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1143,14,2013-05-28,56,2013-06-01,60,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,711,711,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,DISCONTINUED,2013-04-03,2013-06-01,0,Y -01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y -01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y -01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y -01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y 01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y 01-711-1433,1,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y 01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y -01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y 01-711-1433,2,2012-07-23,-188,NA,NA,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y +01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y +01-711-1433,3,2013-02-05,10,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,711,711,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-27,2013-02-06,NA,Y 01-713-1043,1,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y 01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,4,2013-09-26,12,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,NA,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y 01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,5,2013-10-11,27,2013-10-11,27,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y -01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y 01-713-1043,6,2013-10-11,27,2013-10-11,27,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,165,Y +01-713-1043,7,2014-03-08,175,2014-03-08,175,CATARACT OPERATION,CATARACT OPERATION,SURGICAL AND MEDICAL PROCEDURES,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,713,713,78,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-15,2014-03-24,17,Y 01-713-1073,1,2014-07-14,107,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-30,2014-10-05,NA,Y +01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y 01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y -01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y -01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y -01-713-1141,3,2013-06-30,31,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,NA,Y -01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y 01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,4,2013-07-01,32,2013-07-15,46,DELIRIUM,DELIRIUM,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1141,2,2013-06-21,22,2013-07-15,46,RASH PRURITIC,RASH PRURITIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,79,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-31,2013-08-06,23,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y +01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y 01-713-1179,4,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y +01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y 01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,6,2013-09-05,28,NA,NA,ASTHENIA,ASTHENIA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,2,2013-08-22,14,2013-08-22,14,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,168,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y 01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,7,2013-09-12,35,NA,NA,DYSPEPSIA,DYSPEPSIA,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,1,2013-08-19,11,2013-08-23,15,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,167,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y 01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,9,2013-10-10,63,2013-10-13,66,GASTROENTERITIS VIRAL,GASTROENTERITIS VIRAL,INFECTIONS AND INFESTATIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,116,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y 01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,10,2013-10-10,63,NA,NA,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,NA,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,5,2013-08-28,20,2013-09-08,31,URINARY TRACT INFECTION,URINARY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,151,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y 01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1179,13,2013-11-23,107,2013-12-02,116,VAGINAL MYCOSIS,VAGINAL MYCOSIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y -01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y -01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y -01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1179,14,2013-11-23,107,2013-12-02,116,CERVICITIS,CERVICITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,66,Y +01-713-1179,15,2013-10-10,63,2014-01-18,163,PELVIC PAIN,PELVIC PAIN,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,64,F,WHITE,Placebo,Pbo,ONGOING,2013-08-09,2014-02-05,19,Y +01-713-1209,1,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,2,2013-06-02,7,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,3,2013-05-30,4,NA,NA,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1209,4,2013-10-31,158,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,77,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-27,2013-11-22,NA,Y +01-713-1256,2,2012-10-30,42,2012-10-31,43,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,M,WHITE,Placebo,Pbo,ONGOING,2012-09-19,2013-03-25,146,Y +01-713-1269,1,2014-02-02,7,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,2,2014-04-18,82,NA,NA,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y 01-713-1269,3,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y +01-713-1269,4,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y 01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1269,5,2014-06-01,126,NA,NA,SHOULDER PAIN,SHOULDER PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y -01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y +01-713-1269,6,2014-07-10,165,NA,NA,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,713,713,73,M,WHITE,Placebo,Pbo,ONGOING,2014-01-27,2014-07-28,NA,Y 01-713-1448,3,2014-03-19,60,2014-05-23,125,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y 01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-713-1448,4,2014-03-27,68,2014-05-23,125,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,713,713,71,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-19,2014-05-17,-6,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y 01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,2,2014-05-26,40,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y -01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,4,2014-06-04,49,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,NA,Y +01-714-1035,5,2014-05-26,40,2014-06-04,49,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,135,Y 01-714-1035,6,2014-06-04,49,2014-06-17,62,SUPRAVENTRICULAR EXTRASYSTOLES,SUPRAVENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,122,Y +01-714-1035,7,2014-07-18,93,2014-07-24,99,BRONCHITIS,BRONCHITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,88,F,WHITE,Placebo,Pbo,ONGOING,2014-04-17,2014-10-16,85,Y +01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y 01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,3,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y 01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,4,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y +01-714-1068,5,2013-09-20,44,NA,NA,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y 01-714-1068,6,2013-09-20,44,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,NA,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1068,2,2013-08-12,5,2013-08-22,15,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-08-08,2013-10-16,56,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y +01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y 01-714-1195,5,2013-05-17,22,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y 01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,6,2013-05-12,17,2013-07-17,83,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y 01-714-1195,7,2013-05-12,17,2013-07-17,83,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1195,4,2013-05-14,19,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y +01-714-1195,8,2013-05-13,18,2013-07-17,83,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,99,Y +01-714-1195,9,2013-07-25,91,2013-08-06,103,DYSURIA,DYSURIA,RENAL AND URINARY DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,75,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-26,2013-10-23,79,Y 01-714-1288,1,2013-12-13,10,2013-12-13,10,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,187,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,2,2013-12-14,11,2013-12-15,12,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,185,Y 01-714-1288,3,2014-01-11,39,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y 01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,4,2014-01-22,50,2014-01-25,53,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y -01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1288,5,2014-01-22,50,2014-01-25,53,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,144,Y +01-714-1288,7,2014-03-08,95,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y +01-714-1288,8,2014-02-24,83,2014-04-08,126,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,71,Y +01-714-1288,9,2014-05-27,175,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,77,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-04,2014-06-17,NA,Y 01-714-1375,3,2013-03-30,33,2013-04-06,40,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,155,Y +01-714-1375,4,2013-04-04,38,2013-04-15,49,EAR PAIN,EAR PAIN,EAR AND LABYRINTH DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,146,Y +01-714-1375,5,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,6,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,7,2013-05-29,93,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y +01-714-1375,8,2013-06-16,111,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,714,714,78,F,WHITE,Placebo,Pbo,ONGOING,2013-02-26,2013-09-07,NA,Y 01-714-1425,1,2013-08-13,-2,NA,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,ATRIOVENTRICULAR BLOCK SECOND DEGREE,CARDIAC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,714,714,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-08-15,2013-08-22,NA,Y -01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y -01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y -01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y -01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y -01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y 01-715-1107,2,2013-05-13,77,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,NA,Y +01-715-1107,3,2013-05-07,71,2013-05-21,85,DERMATITIS CONTACT,DERMATITIS CONTACT,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-26,2013-05-13,-8,Y 01-715-1207,1,2013-01-10,54,2013-01-10,54,NEPHROLITHIASIS,NEPHROLITHIASIS,RENAL AND URINARY DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,78,F,WHITE,Placebo,Pbo,ONGOING,2012-11-18,2013-06-01,143,Y 01-715-1319,1,2013-03-18,30,2013-03-18,30,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,65,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-03-18,0,Y -01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y 01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y -01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y -01-715-1321,2,2014-03-14,32,2014-03-14,32,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,40,Y -01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y +01-715-1321,3,2014-04-21,70,NA,NA,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y 01-715-1321,4,2014-04-22,71,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,715,715,75,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-02-11,2014-04-22,NA,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y 01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,1,2013-07-08,3,2013-07-08,3,PALPITATIONS,PALPITATIONS,CARDIAC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y -01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y -01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y -01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y -01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y -01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y +01-715-1405,2,2013-07-08,3,2013-07-08,3,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,3,2013-07-08,3,2013-07-08,3,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y +01-715-1405,4,2013-07-08,3,2013-07-08,3,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,6,Y 01-715-1405,6,2013-07-13,8,2013-07-13,8,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,715,715,69,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-06,2013-07-13,0,Y -01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y -01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y -01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y 01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y -01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y -01-716-1024,2,2012-08-20,43,2012-09-27,81,NASOPHARYNGITIS,NASOPHARYNGITIS,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,116,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y +01-716-1024,3,2012-12-16,161,NA,NA,EMPHYSEMA,EMPHYSEMA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,87,F,WHITE,Placebo,Pbo,ONGOING,2012-07-09,2013-01-20,NA,Y +01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y +01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y 01-716-1026,4,2014-07-16,106,2014-07-25,115,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,84,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y 01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,5,2014-07-31,121,NA,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y 01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,6,2014-04-18,17,2014-07-31,121,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,78,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,1,2014-04-17,16,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1026,2,2014-04-17,16,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,NA,Y -01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y -01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y -01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y -01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y -01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y +01-716-1026,7,2014-08-15,136,2014-08-27,148,EAR INFECTION,EAR INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,73,F,WHITE,Placebo,Pbo,ONGOING,2014-04-02,2014-10-16,51,Y 01-716-1044,2,2013-05-21,25,2013-05-26,30,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,162,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y +01-716-1044,3,2013-10-15,172,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Placebo,Pbo,ONGOING,2013-04-27,2013-11-03,NA,Y 01-716-1063,1,2013-05-09,1,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y -01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,2,2013-07-01,54,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y 01-716-1063,4,2013-07-04,57,2013-07-28,81,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,32,Y +01-716-1063,6,2013-07-31,84,NA,NA,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,NA,Y 01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1063,7,2013-07-28,81,2013-07-31,84,RESTLESSNESS,RESTLESSNESS,PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-05-09,2013-08-28,29,Y -01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y -01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y -01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y 01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y -01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y -01-716-1071,1,2013-07-13,36,NA,NA,HYPERSOMNIA,HYPERSOMNIA,NERVOUS SYSTEM DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y -01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y -01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y +01-716-1071,2,2013-07-13,36,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,NA,Y 01-716-1071,3,2013-07-31,54,2013-07-31,54,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-06-08,2013-08-01,2,Y 01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,1,2013-01-19,32,NA,NA,ATRIAL FLUTTER,ATRIAL FLUTTER,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y 01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,2,2013-01-19,32,NA,NA,BUNDLE BRANCH BLOCK RIGHT,BUNDLE BRANCH BLOCK RIGHT,CARDIAC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y 01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1094,3,2013-01-19,32,NA,NA,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,82,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-12-19,2013-01-26,NA,Y -01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y -01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y -01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y -01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y +01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y 01-716-1103,2,2014-07-09,112,2014-07-16,119,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,67,Y -01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y -01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y -01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y -01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y -01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y -01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y 01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,3,2014-07-09,112,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1103,1,2014-07-09,112,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,NA,Y -01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y +01-716-1103,5,2014-08-17,151,2014-08-24,158,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,716,716,79,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-03-20,2014-09-20,28,Y 01-716-1108,1,2013-04-12,60,NA,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,ELECTROCARDIOGRAM ST SEGMENT DEPRESSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y 01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y -01-716-1108,2,2013-05-01,79,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,86,F,WHITE,Placebo,Pbo,ONGOING,2013-02-12,2013-08-10,NA,Y -01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y -01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y -01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y +01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y 01-716-1151,3,2013-03-15,43,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y 01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y -01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y -01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y -01-716-1151,4,2013-02-19,19,2013-03-22,50,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOMA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,78,Y -01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y -01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y -01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y -01-716-1151,2,2013-03-15,43,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-02-01,2013-06-07,NA,Y 01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,2,2013-10-25,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y 01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,3,2013-10-25,24,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,NA,Y -01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y -01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y 01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y -01-716-1157,4,2013-10-17,16,2013-11-04,34,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,85,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-10-02,2014-04-05,153,Y -01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y -01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y -01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y 01-716-1160,1,2013-05-09,35,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y -01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y -01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y -01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y -01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y -01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y -01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1160,2,2013-05-09,35,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,83,F,WHITE,Placebo,Pbo,ONGOING,2013-04-05,2013-10-11,NA,Y 01-716-1167,1,2012-11-17,41,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y 01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1167,2,2012-11-17,41,NA,NA,SWELLING,SWELLING,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y -01-716-1177,1,2014-08-24,-9,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,716,716,72,M,WHITE,Placebo,Pbo,ONGOING,2014-09-02,2015-03-05,NA,Y -01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y -01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y -01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y -01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y -01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1167,3,2012-12-03,57,NA,NA,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,NA,Y +01-716-1167,5,2013-03-10,154,2013-04-10,185,HYPERSENSITIVITY,HYPERSENSITIVITY,IMMUNE SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,716,716,68,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-10-08,2013-04-13,4,Y +01-716-1177,1,2014-08-24,-9,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,716,716,72,M,WHITE,Placebo,Pbo,ONGOING,2014-09-02,2015-03-05,NA,Y +01-716-1189,1,2012-11-24,47,NA,NA,HALLUCINATION,HALLUCINATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,2,2012-11-24,47,NA,NA,DELUSION,DELUSION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,3,2013-01-05,89,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1189,4,2013-02-07,122,NA,NA,PROSTATE CANCER,PROSTATE CANCER,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)",N,Y,SEVERE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,81,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-10-09,2013-03-03,NA,Y +01-716-1229,1,2013-02-20,1,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y +01-716-1229,2,2013-03-06,15,NA,NA,BLOOD CHOLESTEROL INCREASED,BLOOD CHOLESTEROL INCREASED,INVESTIGATIONS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,73,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-20,2013-04-02,NA,Y 01-716-1298,4,2013-04-22,15,2013-07-06,90,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y 01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y -01-716-1298,5,2013-04-22,15,2013-07-06,90,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y +01-716-1298,6,2013-06-08,62,2013-07-06,90,BLISTER,BLISTER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,76,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-04-08,2013-07-06,0,Y 01-716-1308,1,2013-09-20,24,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,76,F,WHITE,Placebo,Pbo,ONGOING,2013-08-28,2013-10-07,NA,Y 01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y -01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y -01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y -01-716-1311,2,2014-07-22,70,2014-08-02,81,ABDOMINAL PAIN,ABDOMINAL PAIN,GASTROINTESTINAL DISORDERS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,60,Y -01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y -01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y -01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y -01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y -01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y -01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y -01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y 01-716-1311,3,2014-08-02,81,NA,NA,ULCER,ULCER,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,NA,Y -01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y -01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y -01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y +01-716-1311,4,2014-05-28,15,2014-09-22,132,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-05-14,2014-09-30,9,Y 01-716-1364,1,2013-08-18,46,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y -01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y +01-716-1364,2,2013-09-02,61,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,84,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-07-04,2014-01-09,NA,Y 01-716-1373,1,2012-12-14,1,NA,NA,COGNITIVE DISORDER,COGNITIVE DISORDER,NERVOUS SYSTEM DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y 01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y -01-716-1373,2,2012-12-15,2,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,74,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-14,2013-02-28,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y 01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,2,2013-05-05,1,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,7,2013-07,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y 01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,3,2013-05-05,1,2013-05-07,3,URTICARIA,URTICARIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,198,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1418,8,2013-07,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y -01-716-1441,1,2014-05-11,110,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Placebo,Pbo,ONGOING,2014-01-22,2014-07-22,NA,Y -01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y -01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y -01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y -01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y -01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y -01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,1,2013-05,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y +01-716-1418,4,2013-05-07,3,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,NA,Y +01-716-1418,7,NA,NA,2013-09-26,145,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,56,Y +01-716-1418,8,NA,NA,2013-10-04,153,VISION BLURRED,VISION BLURRED,EYE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,48,Y +01-716-1418,10,2013-09-26,145,2013-11-11,191,HEADACHE,HEADACHE,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,80,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-05,2013-11-20,10,Y +01-716-1441,1,2014-05-11,110,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,85,M,WHITE,Placebo,Pbo,ONGOING,2014-01-22,2014-07-22,NA,Y +01-716-1447,1,2014-01-01,17,NA,NA,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,2,2014-01-14,30,NA,NA,ERYTHEMA,ERYTHEMA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,3,2014-01-14,30,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,4,2014-03-14,89,NA,NA,ELECTROCARDIOGRAM T WAVE INVERSION,ELECTROCARDIOGRAM T WAVE INVERSION,INVESTIGATIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,NA,Y +01-716-1447,5,2014-04-05,111,2014-04-09,115,CHEST PAIN,CHEST PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,716,716,72,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-12-16,2014-06-17,70,Y +01-717-1004,1,NA,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,1,NA,NA,NA,NA,ENURESIS,ENURESIS,RENAL AND URINARY DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,5,2014-01-15,2,NA,NA,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,7,2014-01-15,2,NA,NA,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,8,2014-01-15,2,NA,NA,IRRITABILITY,IRRITABILITY,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,9,2014-01-15,2,2014-02-08,26,RHINORRHOEA,RHINORRHOEA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,159,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y +01-717-1004,10,2014-01-13,-1,2014-02-10,28,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,157,Y 01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y 01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,11,2014-01-15,2,2014-02-09,27,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,158,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y +01-717-1004,12,2014-01-15,2,2014-02-18,36,COUGH,COUGH,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,149,Y 01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y 01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,14,2014-03-09,55,2014-03-15,61,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,124,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,15,2014-04-08,85,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y 01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y 01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,16,2014-04-21,98,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y +01-717-1004,17,2014-05-21,128,NA,NA,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,NA,Y 01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y 01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1004,19,2014-06-03,141,2014-06-10,148,WOUND,WOUND,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2014-01-14,2014-07-16,37,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y +01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y 01-717-1109,3,2014-02-15,20,2014-02-17,22,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,162,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y +01-717-1109,4,2014-02-20,25,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y 01-717-1109,5,2014-02-22,27,NA,NA,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y 01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,6,2014-03-04,37,NA,NA,PRURITUS GENERALISED,PRURITUS GENERALISED,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,2,2014-02-15,20,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y 01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1109,7,2014-04-18,82,NA,NA,VENTRICULAR EXTRASYSTOLES,VENTRICULAR EXTRASYSTOLES,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,NA,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y -01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y +01-717-1109,8,2014-01-29,3,2014-07-16,171,INCREASED APPETITE,INCREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,84,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2014-01-27,2014-07-28,13,Y +01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y 01-717-1174,2,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y -01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y -01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y -01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y -01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y +01-717-1174,3,2013-04-17,86,2013-04-19,88,INSOMNIA,INSOMNIA,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,97,Y 01-717-1174,4,2013-04-25,94,2013-04-26,95,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,90,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,1,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y 01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1174,5,2013-01-26,5,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y -01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y -01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y -01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y +01-717-1174,6,2013-02-03,13,NA,NA,PRURITUS,PRURITUS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,73,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-01-22,2013-07-24,NA,Y 01-717-1201,1,2013-12-19,1,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y -01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y -01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y -01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y -01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y -01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y -01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y -01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y -01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y -01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y +01-717-1201,2,2014-01-15,28,NA,NA,ALOPECIA,ALOPECIA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,85,F,WHITE,Placebo,Pbo,ONGOING,2013-12-19,2014-02-21,NA,Y 01-717-1344,1,2014-02-01,22,2014-02-06,27,NASAL CONGESTION,NASAL CONGESTION,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,37,Y -01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y +01-717-1344,3,2014-02-01,22,2014-02-18,39,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,25,Y 01-717-1344,4,2014-02-28,49,2014-03-01,50,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y 01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1344,5,2014-02-28,49,2014-03-01,50,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,64,F,WHITE,Placebo,Pbo,ONGOING,2014-01-11,2014-03-14,14,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,1,1994-04,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,1,NA,NA,NA,NA,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y 01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y 01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,2,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y -01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,3,2013-05-29,29,NA,NA,OEDEMA PERIPHERAL,OEDEMA PERIPHERAL,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,5,2013-05-23,23,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,NA,Y +01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y 01-717-1357,6,2013-07-07,68,2013-07-08,69,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,105,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,7,2013-07-22,83,2013-07-22,83,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,91,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,8,2013-08-10,102,2013-08-10,102,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,72,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y +01-717-1357,9,2013-06-11,42,2013-10-15,168,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,77,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-05-01,2013-10-20,6,Y 01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,2,2013-09-15,15,2013-09-16,16,ANXIETY,ANXIETY,PSYCHIATRIC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,170,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y -01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y +01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y +01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y 01-717-1446,7,2014-01-13,135,2014-01-14,136,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,50,Y 01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,8,2014-01-28,150,NA,NA,PAIN,PAIN,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,6,2013-10-07,37,2013-10-11,41,RASH,RASH,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,145,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y 01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,9,2013-10-06,36,2014-03-03,184,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,2,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-717-1446,3,2013-09-19,19,NA,NA,SKIN IRRITATION,SKIN IRRITATION,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,717,717,75,F,WHITE,Xanomeline Low Dose,Xan_Lo,TREATMENT COMPLETED,2013-09-01,2014-03-04,NA,Y -01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y 01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y -01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y -01-718-1066,1,2013-07-16,10,2013-07-20,14,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,11,Y -01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y -01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,2,2013-07-18,12,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y 01-718-1066,3,2013-07-30,24,NA,NA,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1066,4,2013-07-30,24,NA,NA,INFLAMMATION,INFLAMMATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-07,2013-07-30,NA,Y +01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y 01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,2,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y 01-718-1079,3,2012-10-05,17,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1079,1,2012-10-05,17,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,67,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2012-09-19,2012-11-06,NA,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y -01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y -01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y -01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y 01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y -01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y -01-718-1101,1,2013-03-06,18,2013-03-06,18,VOMITING,VOMITING,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,150,Y -01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y -01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y -01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y -01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y -01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y +01-718-1101,4,2013-04-13,56,2013-05-12,85,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,83,Y +01-718-1101,5,2013-07-06,140,NA,NA,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,CARDIAC DISORDERS,N,Y,MILD,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,NA,Y +01-718-1101,6,2013-04-14,57,2013-07-06,140,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,M,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-17,2013-08-02,28,Y 01-718-1139,2,2013-06-03,16,2013-07-16,59,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,125,Y +01-718-1139,3,2013-11-16,182,2013-11-16,182,DIARRHOEA,DIARRHOEA,GASTROINTESTINAL DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,77,M,WHITE,Placebo,Pbo,ONGOING,2013-05-19,2013-11-17,2,Y 01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,3,2013-03-15,56,2013-03-15,56,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,139,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y 01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,4,2013-02-16,29,2013-03-17,58,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,137,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y 01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1150,5,2013-03-06,47,2013-03-26,67,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY TRACT INFECTION,INFECTIONS AND INFESTATIONS,N,N,MODERATE,N,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,128,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y +01-718-1150,7,2013-06-09,142,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,8,2013-06-16,149,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1150,9,2013-05-10,112,2013-07-07,170,BRADYCARDIA,BRADYCARDIA,CARDIAC DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,25,Y +01-718-1150,10,2013-07-31,194,NA,NA,SINUS BRADYCARDIA,SINUS BRADYCARDIA,CARDIAC DISORDERS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,73,F,WHITE,Placebo,Pbo,ONGOING,2013-01-19,2013-07-31,NA,Y +01-718-1170,1,2013-10-07,22,2013-10-07,22,DIZZINESS,DIZZINESS,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,28,Y +01-718-1170,2,2013-10-11,26,2013-10-12,27,HYPERHIDROSIS,HYPERHIDROSIS,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,3,2013-10-11,26,2013-10-12,27,BODY TEMPERATURE INCREASED,BODY TEMPERATURE INCREASED,INVESTIGATIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,4,2013-10-11,26,2013-10-12,27,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,23,Y +01-718-1170,5,2013-10-12,27,2013-10-13,28,SYNCOPE,SYNCOPE,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,22,Y +01-718-1170,6,2013-10-16,31,NA,NA,AGITATION,AGITATION,PSYCHIATRIC DISORDERS,N,Y,SEVERE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,80,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-16,2013-11-03,NA,Y 01-718-1250,1,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y 01-718-1250,3,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y +01-718-1250,6,2013-10-09,19,2013-11-15,56,BALANCE DISORDER,BALANCE DISORDER,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y 01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,7,2013-10-15,25,2013-11-02,43,CONTUSION,CONTUSION,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,99,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y 01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,8,2013-11-15,56,2013-11-15,56,COORDINATION ABNORMAL,COORDINATION ABNORMAL,NERVOUS SYSTEM DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,86,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1250,2,2013-10-09,19,2013-10-09,19,FALL,FALL,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,123,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1250,9,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y +01-718-1250,11,2013-12-29,100,2014-02-19,152,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,82,F,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-09-21,2014-02-08,-11,Y 01-718-1254,1,2013-07-13,4,NA,NA,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y 01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,3,2013-07-25,16,2013-07-25,16,ARTHRALGIA,ARTHRALGIA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,169,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y -01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,4,2013-08-13,35,NA,NA,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLOURATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,5,2013-08-13,35,NA,NA,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y 01-718-1254,7,2013-09-03,56,2013-09-19,72,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,113,Y +01-718-1254,8,2013-10-31,114,NA,NA,FOOD CRAVING,FOOD CRAVING,METABOLISM AND NUTRITION DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y +01-718-1254,9,2013-10-31,114,NA,NA,DYSPHAGIA,DYSPHAGIA,GASTROINTESTINAL DISORDERS,N,Y,MODERATE,NA,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,78,M,WHITE,Xanomeline Low Dose,Xan_Lo,ONGOING,2013-07-10,2014-01-09,NA,Y 01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,1,2013-03-23,51,2013-03-25,53,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y 01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,2,2013-03-23,51,2013-03-25,53,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,38,Y -01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y 01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1328,3,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y 01-718-1328,4,2013-04-02,61,2013-04-21,80,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,86,M,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-02-01,2013-05-01,11,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,3,1982,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y +01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y 01-718-1355,2,2013-03-08,9,2013-03-22,23,SKIN ULCER,SKIN ULCER,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,161,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,NA,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,3,NA,NA,NA,NA,DERMATITIS ATOPIC,DERMATITIS ATOPIC,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,4,2013-04-17,49,NA,NA,CONFUSIONAL STATE,CONFUSIONAL STATE,PSYCHIATRIC DISORDERS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,5,2013-04-27,59,2013-04-27,59,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,125,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,6,2013-05-12,74,2013-05-12,74,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,110,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,7,2013-05-16,78,2013-05-16,78,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,106,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y +01-718-1355,8,2013-05-20,82,2013-05-20,82,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,102,Y 01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y 01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1355,9,2013-05-25,87,NA,NA,SOMNOLENCE,SOMNOLENCE,NERVOUS SYSTEM DISORDERS,N,Y,MODERATE,N,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y -01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,10,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,11,2013-06-23,116,2013-08-13,167,APPLICATION SITE REACTION,APPLICATION SITE REACTION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,17,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,N,N,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y +01-718-1355,13,2013-08-15,169,2013-08-29,183,HYPERTENSION,HYPERTENSION,VASCULAR DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,79,M,WHITE,Placebo,Pbo,ONGOING,2013-02-28,2013-08-29,0,Y 01-718-1371,1,2013-05-09,14,2013-05-11,16,FATIGUE,FATIGUE,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y -01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y -01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y 01-718-1371,2,2013-05-09,14,2013-05-11,16,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MILD,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,90,Y +01-718-1371,3,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y 01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1371,4,2013-06-02,38,2013-06-05,41,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,PARTIAL SEIZURES WITH SECONDARY GENERALISATION,NERVOUS SYSTEM DISORDERS,Y,N,SEVERE,N,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,65,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y +01-718-1371,5,2013-06-02,38,2013-06-03,39,"HALLUCINATION, VISUAL","HALLUCINATION, VISUAL",PSYCHIATRIC DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,67,Y +01-718-1371,6,2013-05-24,29,NA,NA,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MODERATE,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,69,F,WHITE,Xanomeline High Dose,Xan_Hi,ONGOING,2013-04-26,2013-08-08,NA,Y 01-718-1427,1,2012-12-18,2,2012-12-18,2,BACK PAIN,BACK PAIN,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,63,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y 01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,2,2012-12-26,10,2012-12-26,10,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,55,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y 01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,4,2013-01-03,18,2013-01-09,24,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,41,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y -01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,5,2013-01-05,20,2013-01-05,20,LETHARGY,LETHARGY,NERVOUS SYSTEM DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,45,Y 01-718-1427,6,2013-01-16,31,2013-01-16,31,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,34,Y +01-718-1427,7,2013-01-01,16,2013-01-19,34,AMNESIA,AMNESIA,NERVOUS SYSTEM DISORDERS,N,N,MILD,N,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,31,Y 01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,8,2013-01-21,36,2013-01-24,39,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,SEVERE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,26,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y -01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y +01-718-1427,10,2013-01-27,42,2013-01-27,42,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,23,Y +01-718-1427,11,2013-01-27,42,2013-01-28,43,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,22,Y +01-718-1427,12,2013-01-29,44,NA,NA,APPLICATION SITE DERMATITIS,APPLICATION SITE DERMATITIS,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,N,Y,MILD,Y,NOT RECOVERED/NOT RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,NA,Y +01-718-1427,15,2013-02-04,50,2013-02-25,71,DECREASED APPETITE,DECREASED APPETITE,METABOLISM AND NUTRITION DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y 01-718-1427,16,2013-02-04,50,2013-02-25,71,NAUSEA,NAUSEA,GASTROINTESTINAL DISORDERS,N,N,MODERATE,Y,RECOVERED/RESOLVED,Y,Y,718,718,74,F,BLACK OR AFRICAN AMERICAN,Xanomeline High Dose,Xan_Hi,ONGOING,2012-12-17,2013-02-18,-7,Y diff --git a/server.R b/server.R index 0509bd3..9f12b6f 100644 --- a/server.R +++ b/server.R @@ -18,7 +18,8 @@ server <- function(input, output, session) { # SDTM file <- input$file_ae_test if (is.null(file)) return() - df <- fread(input$file_ae_test$datapath) + df <- fread(input$file_ae_test$datapath)%>% as.data.frame() %>% + mutate(AESTDT = as.Date(AESTDT), AEENDT = as.Date(AEENDT), RFSTDTC = as.Date(RFSTDTC), RFENDTC = as.Date(RFENDTC)) }) statistics_data <- reactive({ @@ -484,7 +485,7 @@ server <- function(input, output, session) { ### Definition of 'Reset' button UI output and its consequent triggerings ---- output$reset_UI <- renderUI({ req(data$ae_test) - actionBttn("reset", "Reset",color = "primary",style = "bordered",block=TRUE) + actionBttn("reset", "Reset Options",color = "primary",style = "bordered",block=TRUE) }) observeEvent(input$reset, { @@ -637,7 +638,7 @@ server <- function(input, output, session) { subgroup_vals = input$subgroup_vals, X_ref = as.numeric(input$X_ref), Y_ref = as.numeric(input$Y_ref), - X_label = paste(input$test, input$treatment1_label, "vs", input$treatment2_label), + X_label = paste(input$test, input$treatment1_label, "vs.", input$treatment2_label), review_by = input$review_by, summary_by = input$summary_by, pvalue_option = input$pvalue_option) @@ -688,24 +689,27 @@ server <- function(input, output, session) { plots$volcano_plot <- out$plot plots$volcano_plot_data <- out$data output$volcano_plot <- renderPlotly({ - ggplotly(plots$volcano_plot,tooltip = c("label")) %>% + output = ggplotly(plots$volcano_plot,tooltip = c("label")) %>% plotly::layout(annotations = list(x = 0, y = 0.02, text = text1, showarrow = F, xref = 'paper', yref = 'paper', xanchor = 'left', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 15, color = "blue"))) %>% + font = list(size = 12, color = "blue"))) %>% plotly::layout(annotations = list(x = .95, y = 0.02, text = text2, showarrow = F, xref = 'paper', yref = 'paper', xanchor = 'right', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 15, color = "blue"))) + font = list(size = 12, color = "blue"))) + + output$x$layout$legend$font$size=8.5 # change legend text size + output }) output$volcano_plot_UI <- renderUI({ req(plots$volcano_plot) # req(input$treatment1_label) # req(input$treatment2_label) - plotlyOutput("volcano_plot", height = "625px") %>% withSpinner(type = 5) + plotlyOutput("volcano_plot", height = "650px") %>% withSpinner(type = 5) }) } else { #Catch Error diff --git a/ui.R b/ui.R index bc70787..6ae634f 100644 --- a/ui.R +++ b/ui.R @@ -2,14 +2,17 @@ # ui.R # This R Script only defines the Web layout for the Shiny App. ################################################################################ -# test +# test# ui <- fluidPage( tags$head(tags$style(HTML("hr {border-top: 1px solid #999999;}"))), # horizontal line option headerPanel('Volcano Plot'), useShinyjs(), sidebarPanel(width=4,align="center", - column(width=6,uiOutput("update_UI"),uiOutput("obtain_UI")), - column(width=6,uiOutput("reset_UI")),hr(), + fluidRow( + column(width=4,uiOutput("obtain_UI")), + column(width=4,uiOutput("update_UI")), + column(width=4,uiOutput("reset_UI")) + ),hr(), fluidRow( column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="normal")), column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) @@ -30,12 +33,14 @@ ui <- fluidPage( uiOutput("subgroup_var_UI"), uiOutput("subgroup_vals_title_UI"), uiOutput("subgroup_vals_UI"), - wellPanel(align="center",dropdown(label="Plot Options",icon = icon("chart-bar"), width = "600px",size="lg",style="stretch",status="primary", - wellPanel(fluidRow( + #wellPanel(align="center", + #dropdown(label="Plot Options",icon = icon("chart-bar"), width = "600px",size="lg",style="stretch",status="primary", + #wellPanel(fluidRow( + fluidRow( column(width=4,uiOutput("X_ref_UI")), column(width=4,uiOutput("Y_ref_UI")), - column(width=4,uiOutput("pvalue_option_UI")) - )))) + column(width=4,uiOutput("pvalue_option_UI"))) + #)))) ), mainPanel( diff --git a/volcano_plot.R b/volcano_plot.R index dd996bb..1c8a19f 100644 --- a/volcano_plot.R +++ b/volcano_plot.R @@ -1,187 +1,187 @@ -################################################################################ -# volcano_plot.R -# 1 Function: Generation of volcano plot along with specifications. -################################################################################ - -volcano.plot <- function(data, - statistics_data, - statistics_soc_data, - ser, - drug, - period, - residual, - test, - Treatment1, - Treatment2, - treatment1_label, - treatment2_label, - subgroup_var, - subgroup_vals, - X_ref, - Y_ref, - X_label, - review_by, - summary_by, - pvalue_option) -{ - assign("data", data, envir = .GlobalEnv) - assign("statistics_data", statistics_data, envir = .GlobalEnv) - assign("statistics_soc_data", statistics_soc_data, envir = .GlobalEnv) - assign("ser", ser, envir = .GlobalEnv) - assign("drug", drug, envir = .GlobalEnv) - assign("period", period, envir = .GlobalEnv) - assign("residual", residual, envir = .GlobalEnv) - assign("test", test, envir = .GlobalEnv) - assign("Treatment1", Treatment1, envir = .GlobalEnv) - assign("Treatment2", Treatment2, envir = .GlobalEnv) - assign("treatment1_label", treatment1_label, envir = .GlobalEnv) - assign("treatment2_label", treatment2_label, envir = .GlobalEnv) - assign("subgroup_var", subgroup_var, envir = .GlobalEnv) - assign("subgroup_vals", subgroup_vals, envir = .GlobalEnv) - assign("X_ref", X_ref, envir = .GlobalEnv) - assign("Y_ref", Y_ref, envir = .GlobalEnv) - assign("X_label", X_label, envir = .GlobalEnv) - assign("review_by", review_by, envir = .GlobalEnv) - assign("summary_by", summary_by, envir = .GlobalEnv) - assign("pvalue_option", pvalue_option, envir = .GlobalEnv) - - ### Data pre-processing & data imputation ------------------------------------ - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - - ### Filtering based on selected treatment groups ----------------------------- - data <- data %>% - filter(ARMCD %in% c(Treatment1, Treatment2)) - - - ### Filtering based on subgroup variable ------------------------------------- - if (subgroup_var != "No Subgroup Variable") { - data <- filter(data, length(subgroup_vals) == 0 | get(subgroup_var) %in% subgroup_vals) - } - - - ### Filtering based on other options from control panel ---------------------- - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } - - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((as.Date(AESTDT) > as.Date(RFSTDTC)) & (as.Date(AESTDT) < (as.Date(RFENDTC) + residual))) - } - - - ### Calculation of lowercase n ----------------------------------------------- - TRT_N <- data %>% - filter(!is.na(AEDECOD)) %>% - group_by(ARMCD) %>% - {if (summary_by == "Patients") filter(., !is.na(RFSTDTC)) else .} %>% - {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% - {if (summary_by == "Events") summarise(., N = n()) else .} - - N1 <- sum(subset(TRT_N, ARMCD %in% Treatment1)$N) - N2 <- sum(subset(TRT_N, ARMCD %in% Treatment2)$N) - - - ### Data preparation for the next step of data integration ------------------- - PT_N <- data %>% - filter(!is.na(AEDECOD) & !is.na(RFSTDTC)) %>% - group_by(AEDECOD, ARMCD) %>% - {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% - {if (summary_by == "Events") summarise(., N = n()) else .} - - SOC_N <- data %>% - filter(!is.na(AEDECOD) & !is.na(RFSTDTC)) %>% - group_by(AEBODSYS, ARMCD) %>% - {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% - {if (summary_by == "Events") summarise(., N = n()) else .} - - - ### Integration of data for the purpose of graph & listing presentation ------ - if (review_by == "SOC") { - statistics_data <- statistics_soc_data %>% - inner_join(data %>% select(ARMCD, AEBODSYS) %>% unique()) %>% - inner_join(SOC_N) %>% - mutate(N1 = (ARMCD %in% Treatment1) * N, - N2 = (ARMCD %in% Treatment2) * N, - pvalue = TESTP, - Summary = paste0("\nSOC:", AEBODSYS, - "\n<", N1, ",", N2,">", - "\n", test, ":", TEST, - "\np-Value:", pvalue)) - } else { - statistics_data <- statistics_data %>% - inner_join(data %>% select(ARMCD, AEBODSYS, AEDECOD) %>% unique()) %>% - inner_join(PT_N) %>% - mutate(N1 = (ARMCD %in% Treatment1) * N, - N2 = (ARMCD %in% Treatment2) * N, - pvalue = TESTP, - Summary = paste0("\nSOC:", AEBODSYS, - "\nPT:", AEDECOD, " <", N1, ",", N2, ">", - "\n", test, ":", TEST, - "\np-Value:", pvalue)) - } - - - ### Construction of volcano plot --------------------------------------------- - if (dim(statistics_data)[1] == 0) { - p <- ggplot() + - annotate("text", x = 4, y = 25, size = 8, label = "No data selected for plot.") + - theme_bw() + - theme(panel.grid.major = element_blank(), - panel.grid.minor = element_blank(), - axis.title.x = element_blank(), - axis.text.x = element_blank(), - axis.ticks.x = element_blank(), - axis.title.y = element_blank(), - axis.text.y = element_blank(), - axis.ticks.y = element_blank()) - return(list(plot = p, data = data)) - } - breaks <- c(Y_ref, 0, .00001, .0001, .001, .01, .1, 1) - key <- row.names(statistics_data) - - # pt_size <- statistics_data %>% - # mutate('N3' = N1+N2) %>% - # select('N3') - pt_size <- statistics_data %>% - mutate('N3' = N1 + N2) - - if (test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {x_L <- 0; x_U <- 2 * X_ref} - if (test == "Rate Difference") { - x_L <- min(statistics_data$TEST, na.rm = TRUE) - 1 - x_U <- max(statistics_data$TEST, na.rm = TRUE) + 1 - } - if (test == "Risk Difference") {x_L <- X_ref - 1; x_U <- X_ref + 1} - - p <- ggplot(statistics_data, aes(TEST, pvalue, label = Summary, color = AEBODSYS, key = key)) + - # geom_point() + - geom_point(size = pt_size$N3) + - geom_hline(aes(yintercept = Y_ref), color = 'grey30', linetype = "dotted") + - geom_vline(aes(xintercept = X_ref), color = 'grey30', linetype = "dotted") + - theme_bw() + - xlim(x_L, x_U) + - xlab(X_label) + - scale_y_continuous(trans = reverselog_trans(10), breaks = breaks, labels = fmt_dcimals()) + - coord_cartesian(ylim = c(0.00001, 1)) - return(list(plot = p, data = data, N1 = N1, N2 = N2)) -} - - +################################################################################ +# volcano_plot.R +# 1 Function: Generation of volcano plot along with specifications. +################################################################################ + +volcano.plot <- function(data, + statistics_data, + statistics_soc_data, + ser, + drug, + period, + residual, + test, + Treatment1, + Treatment2, + treatment1_label, + treatment2_label, + subgroup_var, + subgroup_vals, + X_ref, + Y_ref, + X_label, + review_by, + summary_by, + pvalue_option) +{ + assign("data", data, envir = .GlobalEnv) + assign("statistics_data", statistics_data, envir = .GlobalEnv) + assign("statistics_soc_data", statistics_soc_data, envir = .GlobalEnv) + assign("ser", ser, envir = .GlobalEnv) + assign("drug", drug, envir = .GlobalEnv) + assign("period", period, envir = .GlobalEnv) + assign("residual", residual, envir = .GlobalEnv) + assign("test", test, envir = .GlobalEnv) + assign("Treatment1", Treatment1, envir = .GlobalEnv) + assign("Treatment2", Treatment2, envir = .GlobalEnv) + assign("treatment1_label", treatment1_label, envir = .GlobalEnv) + assign("treatment2_label", treatment2_label, envir = .GlobalEnv) + assign("subgroup_var", subgroup_var, envir = .GlobalEnv) + assign("subgroup_vals", subgroup_vals, envir = .GlobalEnv) + assign("X_ref", X_ref, envir = .GlobalEnv) + assign("Y_ref", Y_ref, envir = .GlobalEnv) + assign("X_label", X_label, envir = .GlobalEnv) + assign("review_by", review_by, envir = .GlobalEnv) + assign("summary_by", summary_by, envir = .GlobalEnv) + assign("pvalue_option", pvalue_option, envir = .GlobalEnv) + + ### Data pre-processing & data imputation ------------------------------------ + data <- data %>% + mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", + "AGE", "RFENDY", "SAFFN"))], + ~as.character(.)) %>% + mutate_at(names(data), ~na_if(., "")) %>% + mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% + mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + + + ### Filtering based on selected treatment groups ----------------------------- + data <- data %>% + filter(ARMCD %in% c(Treatment1, Treatment2)) + + + ### Filtering based on subgroup variable ------------------------------------- + if (subgroup_var != "No Subgroup Variable") { + data <- filter(data, length(subgroup_vals) == 0 | get(subgroup_var) %in% subgroup_vals) + } + + + ### Filtering based on other options from control panel ---------------------- + if (ser == TRUE) { + data <- data %>% filter(AESER == "Y") + } + + if (drug == TRUE) { + data <- data %>% filter(AEREL == "Y") + } + + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + } + + if (period == "AE during entire study") { + data <- data %>% filter(STUDYFL == "Y") + } + + if (period == "Other") { + data <- data %>% filter((as.Date(AESTDT) > as.Date(RFSTDTC)) & (as.Date(AESTDT) < (as.Date(RFENDTC) + residual))) + } + + + ### Calculation of lowercase n ----------------------------------------------- + TRT_N <- data %>% + filter(!is.na(AEDECOD)) %>% + group_by(ARMCD) %>% + {if (summary_by == "Patients") filter(., !is.na(RFSTDTC)) else .} %>% + {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% + {if (summary_by == "Events") summarise(., N = n()) else .} + + N1 <- sum(subset(TRT_N, ARMCD %in% Treatment1)$N) + N2 <- sum(subset(TRT_N, ARMCD %in% Treatment2)$N) + + + ### Data preparation for the next step of data integration ------------------- + PT_N <- data %>% + filter(!is.na(AEDECOD) & !is.na(RFSTDTC)) %>% + group_by(AEDECOD, ARMCD) %>% + {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% + {if (summary_by == "Events") summarise(., N = n()) else .} + + SOC_N <- data %>% + filter(!is.na(AEDECOD) & !is.na(RFSTDTC)) %>% + group_by(AEBODSYS, ARMCD) %>% + {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% + {if (summary_by == "Events") summarise(., N = n()) else .} + + + ### Integration of data for the purpose of graph & listing presentation ------ + if (review_by == "SOC") { + statistics_data <- statistics_soc_data %>% + inner_join(data %>% select(ARMCD, AEBODSYS) %>% unique()) %>% + inner_join(SOC_N) %>% + mutate(N1 = (ARMCD %in% Treatment1) * N, + N2 = (ARMCD %in% Treatment2) * N, + pvalue = TESTP, + Summary = paste0("\nSOC:", AEBODSYS, + "\n<", N1, ",", N2,">", + "\n", test, ":", TEST, + "\np-Value:", pvalue)) + } else { + statistics_data <- statistics_data %>% + inner_join(data %>% select(ARMCD, AEBODSYS, AEDECOD) %>% unique()) %>% + inner_join(PT_N) %>% + mutate(N1 = (ARMCD %in% Treatment1) * N, + N2 = (ARMCD %in% Treatment2) * N, + pvalue = TESTP, + Summary = paste0("\nSOC:", AEBODSYS, + "\nPT:", AEDECOD, " <", N1, ",", N2, ">", + "\n", test, ":", TEST, + "\np-Value:", pvalue)) + } + + + ### Construction of volcano plot --------------------------------------------- + if (dim(statistics_data)[1] == 0) { + p <- ggplot() + + annotate("text", x = 4, y = 25, size = 8, label = "No data selected for plot.") + + theme_bw() + + theme(panel.grid.major = element_blank(), + panel.grid.minor = element_blank(), + axis.title.x = element_blank(), + axis.text.x = element_blank(), + axis.ticks.x = element_blank(), + axis.title.y = element_blank(), + axis.text.y = element_blank(), + axis.ticks.y = element_blank()) + return(list(plot = p, data = data)) + } + breaks <- c(Y_ref, 0, .00001, .0001, .001, .01, .1, 1) + key <- row.names(statistics_data) + + # pt_size <- statistics_data %>% + # mutate('N3' = N1+N2) %>% + # select('N3') + pt_size <- statistics_data %>% + mutate('N3' = N1 + N2) + + if (test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {x_L <- 0; x_U <- 2 * X_ref} + if (test == "Rate Difference") { + x_L <- min(statistics_data$TEST, na.rm = TRUE) - 1 + x_U <- max(statistics_data$TEST, na.rm = TRUE) + 1 + } + if (test == "Risk Difference") {x_L <- X_ref - 1; x_U <- X_ref + 1} + + p <- ggplot(statistics_data, aes(TEST, pvalue, label = Summary, fill = AEBODSYS, key = key)) + + # geom_point() + + geom_point(size = pt_size$N3, pch=21, alpha=0.8) + + geom_hline(aes(yintercept = Y_ref), color = 'grey30', linetype = "dotted") + + geom_vline(aes(xintercept = X_ref), color = 'grey30', linetype = "dotted") + + theme_bw() + + xlim(x_L, x_U) + + xlab(X_label) + + scale_y_continuous(trans = reverselog_trans(10), breaks = breaks, labels = fmt_dcimals()) + + coord_cartesian(ylim = c(0.00001, 1)) + return(list(plot = p, data = data, N1 = N1, N2 = N2)) +} + + From 672637b63b0341d1329285d6a0f075c610e3b6d8 Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 8 Jul 2020 02:33:02 -0400 Subject: [PATCH 08/15] Update README.md --- README.md | 3 ++- 1 file changed, 2 insertions(+), 1 deletion(-) diff --git a/README.md b/README.md index 6eb55b3..81dbf57 100644 --- a/README.md +++ b/README.md @@ -7,4 +7,5 @@ Original Developers - Dennis o'Brien (Boehringer Ingelheim) -![image](https://user-images.githubusercontent.com/62663896/84847440-318cb080-b01f-11ea-8d22-b3820905db2c.png) +![image](https://user-images.githubusercontent.com/62663896/86885438-4ced5780-c0c3-11ea-9ee7-b87aba9295f5.png) + From 02cabcea1a2cc91950ba04f515abda2c3f0d3f7e Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 8 Jul 2020 02:35:33 -0400 Subject: [PATCH 09/15] Simplified UI/Server code, Fix issue #19-21 --- GetStatistics.R | 22 ++---- global.R | 6 +- server.R | 173 +++++++++--------------------------------------- ui.R | 85 +++++++++++++----------- volcano_plot.R | 45 ++++++------- 5 files changed, 109 insertions(+), 222 deletions(-) diff --git a/GetStatistics.R b/GetStatistics.R index 6d6073f..81499ed 100644 --- a/GetStatistics.R +++ b/GetStatistics.R @@ -271,23 +271,15 @@ GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatmen mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } + if (ser == TRUE) {data <- data %>% filter(AESER == "Y") } - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - } + if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } - if (period == "AE during entire study") { + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + }else if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { + }else if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } @@ -328,7 +320,6 @@ GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatmen AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% {if (soc == TRUE) mutate(., AEDECOD = NA) else .} - #extension <- bind_rows(events, censors) %>% extension <- bind_rows(events, censors) %>% group_by(USUBJID) %>% mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% @@ -359,6 +350,7 @@ GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatmen {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% distinct(USUBJID, .keep_all = TRUE) %>% {if (soc == FALSE) summarise(., + AESEV=first(AESEV), AEBODSYS = first(AEBODSYS), COUNT1 = sum(ARMCD %in% treatment1), COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% diff --git a/global.R b/global.R index 2bea683..29e636b 100644 --- a/global.R +++ b/global.R @@ -39,9 +39,9 @@ source("GetStatistics.R") # Check that it doesn't match any non-number numbers_only <- function(x) !grepl("\\D", x) -fmt_dcimals <- function(decimals = 0) { - function(x) format(x, nsmall = decimals, scientific = FALSE) -} +# fmt_dcimals <- function(decimals = 0) { +# function(x) format(x, nsmall = decimals, scientific = FALSE) +# } reverselog_trans <- function(base = exp(1)) { trans <- function(x) -log(x, base) diff --git a/server.R b/server.R index 9f12b6f..17fc1f5 100644 --- a/server.R +++ b/server.R @@ -4,6 +4,7 @@ ################################################################################ server <- function(input, output, session) { + data <- reactiveValues(ae_test = NULL, statistics = NULL, @@ -22,25 +23,23 @@ server <- function(input, output, session) { mutate(AESTDT = as.Date(AESTDT), AEENDT = as.Date(AEENDT), RFSTDTC = as.Date(RFSTDTC), RFENDTC = as.Date(RFENDTC)) }) + # what is statistics_data used for? statistics_data <- reactive({ - # ADAM file <- input$file_statistics if (is.null(file)) return() df <- fread(input$file_statistics$datapath) }) + # once data is loaded, all other inputs are loaded + output$fileUploaded <- reactive({ return(!is.null(ae_test_data())) }) + outputOptions(output, 'fileUploaded', suspendWhenHidden=FALSE) + + observe({ #only runs for SDTM if (!is.null(ae_test_data())) { data$ae_test <- ae_test_data() } - - # only runs for ADAM - # if (!is.null(statistics_data())) { - # data$ae_test <- statistics_data() - # } - - }) @@ -52,16 +51,6 @@ server <- function(input, output, session) { ### Definitions of UI outputs in the control panel and related logics -------- - output$summary_by_UI <- renderUI({ - req(data$ae_test) - selectInput("summary_by", "Summary By", choices = c("Patients", "Events")) - }) - - output$review_by_UI <- renderUI({ - req(data$ae_test) - selectInput("review_by", "Review By", choices = c("PT", "SOC", "Other")) - }) - output$review_by_please_specify_UI <- renderUI({ req(data$ae_test) req(input$review_by) @@ -69,10 +58,6 @@ server <- function(input, output, session) { textInput("review_by_please_specify", "Please specify") }) - output$period_UI <- renderUI({ - req(data$ae_test) - selectInput("period", "Period",choices = c("Treatment emergent", "AE during entire study", "Other")) - }) output$period_please_specify_UI <- renderUI({ req(data$ae_test) @@ -83,27 +68,6 @@ server <- function(input, output, session) { value = 30, min = 0, max = 10^5) }) - output$ser_UI <- renderUI({ - req(data$ae_test) - checkboxInput("ser", "Serious adverse event", value = FALSE) - }) - - output$drug_UI <- renderUI({ - req(data$ae_test) - checkboxInput("drug", "Drug-related adverse events", value = FALSE) - }) - - output$test_UI <- renderUI({ - req(data$ae_test) - selectInput("test", "Measure of Association", - choices = c("Rate Ratio", - "Risk Ratio", - "Hazard Ratio", - "Risk Difference", - "Rate Difference") - ) - }) - output$treatment1_UI <- renderUI({ req(data$ae_test) req(ARMCD()) @@ -143,7 +107,7 @@ server <- function(input, output, session) { "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - textInput("treatment1_label", "Label for Exposed Group") + textInput("treatment1_label", "Label for Exposed Group", value="Exposed") }) output$treatment2_label_UI <- renderUI({ @@ -153,93 +117,24 @@ server <- function(input, output, session) { "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - textInput("treatment2_label", "Label for Unexposed Group") - }) - - subgroup_var_choices <- reactive({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - c("No Subgroup Variable", colnames(data$ae_test)) + textInput("treatment2_label", "Label for Unexposed Group",value="Unexposed") }) - output$subgroup_var_UI <- renderUI({ - req(data$ae_test) - req(subgroup_var_choices()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - selectInput("subgroup_var", "Subgroup Variable", - # choices = subgroup_var_choices(), - choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"), - selected = NULL, multiple = F) - }) - output$subgroup_vals_title_UI <- renderUI({ - req(input$subgroup_var) - if(input$subgroup_var == "No Subgroup Variable") return() - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - h5(strong("Value for Subgroup")) - }) output$subgroup_vals_UI <- renderUI({ - req(input$subgroup_var) if(input$subgroup_var == "No Subgroup Variable") return() if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", "Rate Difference", "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - req(data$ae_test) - div(style = 'height:200px; width:91%; overflow: scroll', - checkboxGroupInput("subgroup_vals", "", + div(style = 'height:130px; width:91%; overflow: scroll', + checkboxGroupInput("subgroup_vals", "Value for Subgroup", choices = sort(unique(data$ae_test[[input$subgroup_var]])), inline = F) ) }) - - output$X_ref_UI <- renderUI({ - req(data$ae_test) - req(input$test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - if (input$test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {xref <- 1} - if (input$test %in% c("Rate Difference", "Risk Difference")) {xref <- 0} - textInput("X_ref", "X-axis Reference Line", value = xref) - }) - - output$Y_ref_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("Y_ref", "Y-axis Reference Line", value = 0.05) - }) - - output$pvalue_option_UI <- renderUI({ - req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - selectInput("pvalue_option", "p-Value Option", - choices = c("Unadjusted", "Adjusted"), multiple = F) - }) ### An essential step for obtaining statistics right after data uploading and before the generation of volcano plot ------------------------------------ @@ -595,26 +490,26 @@ server <- function(input, output, session) { # } # } - if(length(input$X_ref) > 0) { - X_ref <- as.numeric(input$X_ref) - if(is.na(X_ref)) { - shinyjs::alert("Please enter a numeric value for X-axis reference line.") - return() - } - } - - if(length(input$Y_ref) > 0) { - Y_ref <- as.numeric(input$Y_ref) - if(is.na(Y_ref)) { - shinyjs::alert("Please enter a numeric value for Y-axis reference line.") - return() - } else { - if (!(as.numeric(input$Y_ref) >= 0 & as.numeric(input$Y_ref) <= 1)) { - shinyjs::alert("Please enter a valid value between 0 and 1 for Y-axis reference line.") - return() - } - } - } + # if(length(input$X_ref) > 0) { + # X_ref <- as.numeric(input$X_ref) + # if(is.na(X_ref)) { + # shinyjs::alert("Please enter a numeric value for X-axis reference line.") + # return() + # } + # } + # + # if(length(input$Y_ref) > 0) { + # Y_ref <- as.numeric(input$Y_ref) + # if(is.na(Y_ref)) { + # shinyjs::alert("Please enter a numeric value for Y-axis reference line.") + # return() + # } else { + # if (!(as.numeric(input$Y_ref) >= 0 & as.numeric(input$Y_ref) <= 1)) { + # shinyjs::alert("Please enter a valid value between 0 and 1 for Y-axis reference line.") + # return() + # } + # } + # } plots$volcano_plot <- NULL plots$volcano_plot_data <- NULL @@ -632,8 +527,6 @@ server <- function(input, output, session) { test = input$test, Treatment1 = input$treatment1, Treatment2 = input$treatment2, - treatment1_label = input$treatment1_label, - treatment2_label = input$treatment2_label, subgroup_var = input$subgroup_var, subgroup_vals = input$subgroup_vals, X_ref = as.numeric(input$X_ref), @@ -706,11 +599,11 @@ server <- function(input, output, session) { }) output$volcano_plot_UI <- renderUI({ - req(plots$volcano_plot) + req(plots$volcano_plot) # req(input$treatment1_label) # req(input$treatment2_label) plotlyOutput("volcano_plot", height = "650px") %>% withSpinner(type = 5) - }) + }) } else { #Catch Error plots$volcano_plot <- NULL diff --git a/ui.R b/ui.R index 6ae634f..1c38f15 100644 --- a/ui.R +++ b/ui.R @@ -5,49 +5,58 @@ # test# ui <- fluidPage( tags$head(tags$style(HTML("hr {border-top: 1px solid #999999;}"))), # horizontal line option - headerPanel('Volcano Plot'), + fluidRow(align="center",h1("Volcano Plot")), useShinyjs(), - sidebarPanel(width=4,align="center", - fluidRow( - column(width=4,uiOutput("obtain_UI")), - column(width=4,uiOutput("update_UI")), - column(width=4,uiOutput("reset_UI")) - ),hr(), - fluidRow( - column(width=6,radioGroupButtons("data_type","Type:",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="normal")), - column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) - ), hr(), - fluidRow( - column(width=6, uiOutput("summary_by_UI") ), - column(width=6, uiOutput("review_by_UI"),uiOutput("review_by_please_specify_UI") ) - ), hr(), - fluidRow( - column(width=6,uiOutput("period_UI"), uiOutput("period_please_specify_UI")), - column(width=6, uiOutput("ser_UI"), uiOutput("drug_UI") ) - ),hr(), - fluidRow( - column(width=6,uiOutput("treatment1_UI"), uiOutput("treatment1_label_UI"), ), - column(width=6, uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI") ) - ),hr(), - uiOutput("test_UI"), - uiOutput("subgroup_var_UI"), - uiOutput("subgroup_vals_title_UI"), - uiOutput("subgroup_vals_UI"), - #wellPanel(align="center", - #dropdown(label="Plot Options",icon = icon("chart-bar"), width = "600px",size="lg",style="stretch",status="primary", - #wellPanel(fluidRow( - fluidRow( - column(width=4,uiOutput("X_ref_UI")), - column(width=4,uiOutput("Y_ref_UI")), - column(width=4,uiOutput("pvalue_option_UI"))) - #)))) - + + fluidRow( + column(width=4, + wellPanel( + fluidRow( + column(width=1), + column(width=4,radioGroupButtons("data_type","Type: (Doesn't work yet)",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="normal")), + column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) + )))), + conditionalPanel(condition = "output.fileUploaded", + sidebarPanel(width=4,align="center", + fluidRow( + column(width=4,uiOutput("obtain_UI")), + column(width=4,uiOutput("update_UI")), + column(width=4,uiOutput("reset_UI")) + ), hr(), + fluidRow( + column(width=4,selectInput("summary_by", "Summary By", choices = c("Patients", "Events"))), + column(width=4,selectInput("review_by", "Review By", choices = c("PT", "SOC", "Other")),uiOutput("review_by_please_specify_UI")), + column(width=4,selectInput("period", "Period",choices = c("Treatment emergent", "AE during entire study", "Other")), uiOutput("period_please_specify_UI")), + ), + fluidRow( + column(width=6, checkboxInput("ser", "Serious adverse event", value = FALSE)), + column(width=6,checkboxInput("drug", "Drug-related adverse events", value = FALSE)) + ),hr(), + fluidRow( + column(width=6,uiOutput("treatment1_UI"), uiOutput("treatment1_label_UI"), ), + column(width=6,uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI") ) + ),hr(), + fluidRow( + selectInput("test", "Measure of Association", choices = c("Rate Ratio", "Risk Ratio", "Hazard Ratio", "Risk Difference", "Rate Difference")), + selectInput("subgroup_var", "Subgroup Variable", choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"),selected = "No Subgroup Variable"), uiOutput("subgroup_vals_UI") + ),br(),hr(), + fluidRow( + column(width=6,numericInput("X_ref", "X-axis Reference Lines", value = 0) ), + column(width=6,numericInput("Y_ref", "Y-axis Reference Line", value = 0.05)) + ), + fluidRow( + column(width=6,selectInput("pvalue_option", "p-Value Option",choices = c("Unadjusted", "Adjusted"), selected="Unadjusted")), + column(width=6,selectInput("color_option", label="Color",choices=c("Body System or Organ Class","Severity"),selected="Body/Organ")) + ) + + ) + ), mainPanel( uiOutput("volcano_plot_UI"), + br(), - div(uiOutput("footnote_UI"), - style = "font-size: 12px; white-space: pre"), + div(uiOutput("footnote_UI"),style = "font-size: 12px; white-space: pre"), br(), uiOutput("volcano_plot_drill_UI") ) diff --git a/volcano_plot.R b/volcano_plot.R index 1c8a19f..fc7ec55 100644 --- a/volcano_plot.R +++ b/volcano_plot.R @@ -13,8 +13,6 @@ volcano.plot <- function(data, test, Treatment1, Treatment2, - treatment1_label, - treatment2_label, subgroup_var, subgroup_vals, X_ref, @@ -34,8 +32,6 @@ volcano.plot <- function(data, assign("test", test, envir = .GlobalEnv) assign("Treatment1", Treatment1, envir = .GlobalEnv) assign("Treatment2", Treatment2, envir = .GlobalEnv) - assign("treatment1_label", treatment1_label, envir = .GlobalEnv) - assign("treatment2_label", treatment2_label, envir = .GlobalEnv) assign("subgroup_var", subgroup_var, envir = .GlobalEnv) assign("subgroup_vals", subgroup_vals, envir = .GlobalEnv) assign("X_ref", X_ref, envir = .GlobalEnv) @@ -94,7 +90,7 @@ volcano.plot <- function(data, group_by(ARMCD) %>% {if (summary_by == "Patients") filter(., !is.na(RFSTDTC)) else .} %>% {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% - {if (summary_by == "Events") summarise(., N = n()) else .} + {if (summary_by == "Events") summarise(., N = n()) else .} N1 <- sum(subset(TRT_N, ARMCD %in% Treatment1)$N) N2 <- sum(subset(TRT_N, ARMCD %in% Treatment2)$N) @@ -155,32 +151,29 @@ volcano.plot <- function(data, axis.ticks.y = element_blank()) return(list(plot = p, data = data)) } - breaks <- c(Y_ref, 0, .00001, .0001, .001, .01, .1, 1) + key <- row.names(statistics_data) - # pt_size <- statistics_data %>% - # mutate('N3' = N1+N2) %>% - # select('N3') - pt_size <- statistics_data %>% - mutate('N3' = N1 + N2) - - if (test %in% c("Hazard Ratio", "Rate Ratio", "Risk Ratio")) {x_L <- 0; x_U <- 2 * X_ref} - if (test == "Rate Difference") { - x_L <- min(statistics_data$TEST, na.rm = TRUE) - 1 - x_U <- max(statistics_data$TEST, na.rm = TRUE) + 1 + # adjusted p value + if (pvalue_option=="Unadjusted"){ + statistics_data$my_pvalue = statistics_data$pvalue + } else{ + statistics_data$my_pvalue = p.adjust(statistics_data$pvalue, method="fdr") } - if (test == "Risk Difference") {x_L <- X_ref - 1; x_U <- X_ref + 1} - p <- ggplot(statistics_data, aes(TEST, pvalue, label = Summary, fill = AEBODSYS, key = key)) + - # geom_point() + - geom_point(size = pt_size$N3, pch=21, alpha=0.8) + - geom_hline(aes(yintercept = Y_ref), color = 'grey30', linetype = "dotted") + - geom_vline(aes(xintercept = X_ref), color = 'grey30', linetype = "dotted") + + p <- ggplot(statistics_data, aes(TEST, my_pvalue, label = Summary, fill = AEBODSYS, key = key)) + + geom_point(aes(size=N), pch=21, alpha=0.65) + + geom_hline(yintercept = Y_ref, color = 'grey30', linetype = "dotted") + + geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0), color = 'grey30', linetype = "dotted") + + geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0)+c(-X_ref,X_ref), color = 'grey30', linetype = "dotted") + theme_bw() + - xlim(x_L, x_U) + - xlab(X_label) + - scale_y_continuous(trans = reverselog_trans(10), breaks = breaks, labels = fmt_dcimals()) + - coord_cartesian(ylim = c(0.00001, 1)) + scale_x_continuous(X_label,expand = expansion(mult = c(0.05, 0.05)))+ + scale_y_continuous(ifelse(pvalue_option=="Unadjusted","-log10(p-value)","-log10(adj. p-value)"), + trans = reverselog_trans(10), + breaks = as.numeric(paste0("1e-",0:20)), + labels = as.character(0:20), + expand = expansion(mult = c(0.05, 0.05)))+ + scale_size_continuous(range = c(2, 15)) return(list(plot = p, data = data, N1 = N1, N2 = N2)) } From fd7b55ea34cee59b7be55e6f87b1e1e3fdf2ed9e Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 8 Jul 2020 14:05:12 -0400 Subject: [PATCH 10/15] Fix issue #22 -log10 transformation toggle --- server.R | 10 ++++++---- ui.R | 29 +++++++++++++++-------------- volcano_plot.R | 25 +++++++++++++++++++------ 3 files changed, 40 insertions(+), 24 deletions(-) diff --git a/server.R b/server.R index 17fc1f5..0dbad7c 100644 --- a/server.R +++ b/server.R @@ -107,7 +107,7 @@ server <- function(input, output, session) { "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - textInput("treatment1_label", "Label for Exposed Group", value="Exposed") + textInput("treatment1_label", "Label for Exposed Group", value="Exposed",width="75%") }) output$treatment2_label_UI <- renderUI({ @@ -117,7 +117,7 @@ server <- function(input, output, session) { "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - textInput("treatment2_label", "Label for Unexposed Group",value="Unexposed") + textInput("treatment2_label", "Label for Unexposed Group",value="Unexposed",width="75%") }) @@ -129,7 +129,7 @@ server <- function(input, output, session) { "Rate Ratio", "Risk Difference", "Risk Ratio")) return() - div(style = 'height:130px; width:91%; overflow: scroll', + div(style = 'height:100px; width:91%; overflow: scroll', checkboxGroupInput("subgroup_vals", "Value for Subgroup", choices = sort(unique(data$ae_test[[input$subgroup_var]])), inline = F) @@ -534,7 +534,9 @@ server <- function(input, output, session) { X_label = paste(input$test, input$treatment1_label, "vs.", input$treatment2_label), review_by = input$review_by, summary_by = input$summary_by, - pvalue_option = input$pvalue_option) + pvalue_adjustment = input$pvalue_adjustment, + pvalue_label = input$pvalue_label + ) ) if (!"try-error" %in% class(p)) { diff --git a/ui.R b/ui.R index 1c38f15..7b4bcf3 100644 --- a/ui.R +++ b/ui.R @@ -7,17 +7,16 @@ ui <- fluidPage( tags$head(tags$style(HTML("hr {border-top: 1px solid #999999;}"))), # horizontal line option fluidRow(align="center",h1("Volcano Plot")), useShinyjs(), - - fluidRow( column(width=4, wellPanel( fluidRow( column(width=1), column(width=4,radioGroupButtons("data_type","Type: (Doesn't work yet)",choices=c("SDTM","ADaM"), selected="SDTM", status="primary", size="normal")), column(width=6,fileInput("file_ae_test", label = "Import dataset (.csv)", accept = ".csv")) - )))), + )), conditionalPanel(condition = "output.fileUploaded", - sidebarPanel(width=4,align="center", + wellPanel( + fluidRow(align="center", fluidRow( column(width=4,uiOutput("obtain_UI")), column(width=4,uiOutput("update_UI")), @@ -37,22 +36,24 @@ ui <- fluidPage( column(width=6,uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI") ) ),hr(), fluidRow( - selectInput("test", "Measure of Association", choices = c("Rate Ratio", "Risk Ratio", "Hazard Ratio", "Risk Difference", "Rate Difference")), - selectInput("subgroup_var", "Subgroup Variable", choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"),selected = "No Subgroup Variable"), uiOutput("subgroup_vals_UI") + selectInput("test", "Measure of Association", choices = c("Rate Ratio", "Risk Ratio", "Hazard Ratio", "Risk Difference", "Rate Difference"), width="75%"), + selectInput("subgroup_var", "Subgroup Variable", choices = c("No Subgroup Variable", "SITE", "SEX", "RACE"),selected = "No Subgroup Variable", width="75%"), uiOutput("subgroup_vals_UI") ),br(),hr(), fluidRow( - column(width=6,numericInput("X_ref", "X-axis Reference Lines", value = 0) ), - column(width=6,numericInput("Y_ref", "Y-axis Reference Line", value = 0.05)) + column(width=6,numericInput("X_ref", "X-axis Reference Lines", value = 0,width="75%") ), + column(width=6,numericInput("Y_ref", "Y-axis Reference Line", value = 0.05,width="75%")) ), fluidRow( - column(width=6,selectInput("pvalue_option", "p-Value Option",choices = c("Unadjusted", "Adjusted"), selected="Unadjusted")), - column(width=6,selectInput("color_option", label="Color",choices=c("Body System or Organ Class","Severity"),selected="Body/Organ")) + column(width=6,selectInput("pvalue_adjustment", "P-value Adjustment",choices = c("Unadjusted", "Adjusted"), selected="Unadjusted",width="75%")), + column(width=6,selectInput("pvalue_label", "P-value Transformation",choices = c("None", "-log10"), selected="-log10",width="75%")) + ), + fluidRow(align="center", + selectInput("color_option", label="Color",choices=c("Body System or Organ Class","Severity"),selected="Body/Organ",width="50%") ) - + )) ) - - ), - mainPanel( + ), + column(width=8, uiOutput("volcano_plot_UI"), br(), diff --git a/volcano_plot.R b/volcano_plot.R index fc7ec55..21c8a12 100644 --- a/volcano_plot.R +++ b/volcano_plot.R @@ -20,7 +20,8 @@ volcano.plot <- function(data, X_label, review_by, summary_by, - pvalue_option) + pvalue_adjustment, + pvalue_label) { assign("data", data, envir = .GlobalEnv) assign("statistics_data", statistics_data, envir = .GlobalEnv) @@ -39,7 +40,8 @@ volcano.plot <- function(data, assign("X_label", X_label, envir = .GlobalEnv) assign("review_by", review_by, envir = .GlobalEnv) assign("summary_by", summary_by, envir = .GlobalEnv) - assign("pvalue_option", pvalue_option, envir = .GlobalEnv) + assign("pvalue_adjustment", pvalue_adjustment, envir = .GlobalEnv) + assign("pvalue_label", pvalue_label, envir = .GlobalEnv) ### Data pre-processing & data imputation ------------------------------------ data <- data %>% @@ -155,7 +157,7 @@ volcano.plot <- function(data, key <- row.names(statistics_data) # adjusted p value - if (pvalue_option=="Unadjusted"){ + if (pvalue_adjustment=="Unadjusted"){ statistics_data$my_pvalue = statistics_data$pvalue } else{ statistics_data$my_pvalue = p.adjust(statistics_data$pvalue, method="fdr") @@ -168,12 +170,23 @@ volcano.plot <- function(data, geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0)+c(-X_ref,X_ref), color = 'grey30', linetype = "dotted") + theme_bw() + scale_x_continuous(X_label,expand = expansion(mult = c(0.05, 0.05)))+ - scale_y_continuous(ifelse(pvalue_option=="Unadjusted","-log10(p-value)","-log10(adj. p-value)"), + scale_size_continuous(range = c(2, 15)) + + if (pvalue_label=="-log10"){ + p=p+ scale_y_continuous(ifelse(pvalue_adjustment=="Unadjusted","-log10(p-value)","-log10(adj. p-value)"), trans = reverselog_trans(10), breaks = as.numeric(paste0("1e-",0:20)), labels = as.character(0:20), - expand = expansion(mult = c(0.05, 0.05)))+ - scale_size_continuous(range = c(2, 15)) + expand = expansion(mult = c(0.05, 0.05))) + } else if (pvalue_label=="None"){ + p=p+ scale_y_continuous(ifelse(pvalue_adjustment=="Unadjusted","P-value","Adj. p-value"), + trans = reverselog_trans(10), + breaks = c(Y_ref, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1), + labels = as.character(c(Y_ref, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1)), + expand = expansion(mult = c(0.05, 0.05))) + + } + return(list(plot = p, data = data, N1 = N1, N2 = N2)) } From f12cd0f7178c634a6fcf4d3f9925201c4fdb84b8 Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 8 Jul 2020 14:05:48 -0400 Subject: [PATCH 11/15] Update README.md --- README.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/README.md b/README.md index 81dbf57..6e9525e 100644 --- a/README.md +++ b/README.md @@ -7,5 +7,5 @@ Original Developers - Dennis o'Brien (Boehringer Ingelheim) -![image](https://user-images.githubusercontent.com/62663896/86885438-4ced5780-c0c3-11ea-9ee7-b87aba9295f5.png) +![image](https://user-images.githubusercontent.com/62663896/86954516-1ac01200-c124-11ea-8acf-dba461f2aa02.png) From 7a88b95d125c1cccaa70e6d9fb61695a3cee723a Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 12 Aug 2020 12:47:32 -0400 Subject: [PATCH 12/15] Update README.md --- README.md | 10 +--------- 1 file changed, 1 insertion(+), 9 deletions(-) diff --git a/README.md b/README.md index 6e9525e..2c5f537 100644 --- a/README.md +++ b/README.md @@ -1,11 +1,3 @@ # volcano-plot -Original Developers - -- Ke Xiao (Boehringer Ingelheim) -- Hong Wang (Boehringer Ingelheim) -- Dennis o'Brien (Boehringer Ingelheim) - - -![image](https://user-images.githubusercontent.com/62663896/86954516-1ac01200-c124-11ea-8acf-dba461f2aa02.png) - +![image](https://user-images.githubusercontent.com/62663896/90043322-efd45b00-dc99-11ea-834c-5633c91ea41d.png) From 53faacd7122137d7c308a6d9a53bbec665155ee2 Mon Sep 17 00:00:00 2001 From: isaaczhao-alk <62663896+isaaczhao-alk@users.noreply.github.com> Date: Wed, 12 Aug 2020 12:51:34 -0400 Subject: [PATCH 13/15] Greatly simplified redundant code and simplified UI. Minor performance improvements --- GetStatistics.R | 623 +++++++++++++--------------------------------- server.R | 640 ++++++++++++------------------------------------ ui.R | 30 +-- volcano_plot.R | 139 +++++------ 4 files changed, 409 insertions(+), 1023 deletions(-) diff --git a/GetStatistics.R b/GetStatistics.R index 81499ed..b2cc1a0 100644 --- a/GetStatistics.R +++ b/GetStatistics.R @@ -3,9 +3,8 @@ # 5 Functions: Obtain statistics for further TLG outputs. ################################################################################ -### Hazard Ratio (Cox's Proportional Hazards Model) ---------------------------- -GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { + +GetStatistics_all = function(data, ae_filter, period, residual, soc, treatment1, treatment2, test) { if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} @@ -20,15 +19,28 @@ GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD), AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - if (ser == TRUE) { data <- data %>% filter(AESER == "Y") } - if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } + ## DOESN'T CALCULATION OF N HAVE TO GO AFTER FILTERS??? + if (test%in% c("Risk Ratio","Risk Difference")){ + N1.total <- length(unique((data %>% filter(ARMCD %in% treatment1))$USUBJID)) + N2.total <- length(unique((data %>% filter(ARMCD %in% treatment2))$USUBJID)) + } - if (period == "Treatment emergent") { data <- data %>% filter(TRTEMFL == "Y") } - if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") } + # filter data for seriousness, drug-related, and severity + if (length(ae_filter)>0){ + if ("Serious" %in% ae_filter) { data <- data %>% filter(AESER == "Y") } + if ("Drug-related" %in% ae_filter) { data <- data %>% filter(AEREL == "Y") } + if (sum(c("Mild","Moderate","Severe") %in% ae_filter)>0){ + severity_filter = ae_filter[which(ae_filter%in% c("Mild","Moderate","Severe"))] + data = data %>% filter(AESEV %in% severity_filter) + } + } - if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } + # filter data for ae timeframe + if (period == "Treatment emergent") { data <- data %>% filter(TRTEMFL == "Y") } + else if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") } + else if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) @@ -48,9 +60,7 @@ GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% mutate(CNSR = 0) - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } + if (soc == FALSE) {aebodsys <- unique(events$AEBODSYS)} censors <- data %>% filter(!(USUBJID %in% events$USUBJID)) %>% @@ -80,477 +90,194 @@ GetStatistics_HazardR <- function(data, ser, drug, period, residual, soc, data.extend <- bind_rows(data.extend, extension) } - data.extend <- data.extend %>% - mutate(TRT = ifelse(ARMCD %in% treatment1, 1, 0)) - - getHazardRatio <- function(time, delta, trt) { - fit <- coxph(Surv(time, delta) ~ trt) - S <- summary(fit) - - HR <- unname(exp(fit$coefficients)) - HRP <- S$coefficients[5] - - output <- c(HR, HRP) - return(output) - } - - result <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Rate Difference (Large Sample Approximation by CLT) ------------------------ -GetStatistics_RateD <- function(data, ser, drug, period, residual, soc,treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - TDDT <- Sys.Date() # use today's date for convenience - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY","AGE", "RFENDY", "SAFFN"))],~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(STARTDT = RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) + data.extend <- data.extend %>% mutate(TRT = ifelse(ARMCD %in% treatment1, 1, 0)) - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") + if (test %in% c("Rate Difference", "Rate Ratio")){ + data.extend.summary <- data.extend %>% + mutate(AVAL = as.numeric(AVAL)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% + {if (soc == TRUE) summarise(., + SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), + SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} } - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + if (test %in% c("Rate Difference", "Rate Ratio","Risk Difference","Risk Ratio")){ + data.summary <- data %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + distinct(USUBJID, .keep_all = TRUE) %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + {if (soc == TRUE) summarise(., + COUNT1 = sum(ARMCD %in% treatment1), + COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% + na.omit() } - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - data.extend <- NULL - if (soc == FALSE) { - ae.list <- na.omit(unique(data$AEDECOD)) - } else { - ae.list <- na.omit(unique(data$AEBODSYS)) - } - for (ae in ae.list) { - - events <- data %>% - {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% - {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% - mutate(CNSR = 0) - - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } else {} - - censors <- data %>% - filter(!(USUBJID %in% events$USUBJID)) %>% - mutate(CNSR = 1) %>% - group_by(USUBJID) %>% - summarise_all(list(first)) %>% - {if (soc == FALSE) mutate(., - AEDECOD = ae, - AEBODSYS = aebodsys) else .} %>% - {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% - mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, - AEENDT = NA, AEENDY = NA, AETERM = NA, - AESER = NA, AEONGO = NA, AESEV = NA, - AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% - {if (soc == TRUE) mutate(., AEDECOD = NA) else .} + ### Hazard Ratio (Cox's Proportional Hazards Model) ---------------------------- + if (test=="Hazard Ratio"){ + getHazardRatio <- function(time, delta, trt) { + fit <- coxph(Surv(time, delta) ~ trt) + S <- summary(fit) + + HR <- unname(exp(fit$coefficients)) + HRP <- S$coefficients[5] + + output <- c(HR, HRP) + return(output) + } - extension <- bind_rows(events, censors) %>% - group_by(USUBJID) %>% - mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% + result <- data.extend %>% + mutate(AVAL = as.numeric(AVAL)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getHazardRatio(AVAL, CNSR, TRT), + collapse = " ")) else .} %>% rowwise() %>% - mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% - mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% - ungroup() %>% - mutate(AVAL = ADT - STARTDT + 1) %>% - distinct() - - data.extend <- bind_rows(data.extend, extension) + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) } - data.extend.summary <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% - {if (soc == TRUE) summarise(., - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - na.omit() - - getRateDifference <- function(count1, count2, saval1, saval2) { - r <- ratedifference(a = count1, b = count2, PT1 = saval1, PT0 = saval2) - RD <- r$estimate - RDP <- r$p.value - - output <- c(RD, RDP) - return(output) - } - - result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Rate Ratio (Large Sample Approximation by CLT) ----------------------------- -GetStatistics_RateR <- function(data, ser, drug, period, residual, soc, treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - TDDT <- Sys.Date() # use today's date for convenience - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY","AGE", "RFENDY", "SAFFN"))], ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(STARTDT = RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - if (ser == TRUE) {data <- data %>% filter(AESER == "Y") } - - if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") - }else if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - }else if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) - } - - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - - data.extend <- NULL - if (soc == FALSE) { - ae.list <- na.omit(unique(data$AEDECOD)) - } else { - ae.list <- na.omit(unique(data$AEBODSYS)) - } - - for (ae in ae.list) { - - events <- data %>% - {if (soc == FALSE) filter(., AEDECOD == ae) else .} %>% - {if (soc == TRUE) filter(., AEBODSYS == ae) else .} %>% - mutate(CNSR = 0) - - if (soc == FALSE) { - aebodsys <- unique(events$AEBODSYS) - } else {} - - censors <- data %>% - filter(!(USUBJID %in% events$USUBJID)) %>% - mutate(CNSR = 1) %>% - group_by(USUBJID) %>% - summarise_all(list(first)) %>% - {if (soc == FALSE) mutate(., - AEDECOD = ae, - AEBODSYS = aebodsys) else .} %>% - {if (soc == TRUE) mutate(., AEBODSYS = ae) else .} %>% - mutate(AESEQ = NA, AESTDT = NA, AESTDY = NA, - AEENDT = NA, AEENDY = NA, AETERM = NA, - AESER = NA, AEONGO = NA, AESEV = NA, - AEREL = NA, AEOUT = NA, STUDYFL = NA, TRTEMFL = NA) %>% - {if (soc == TRUE) mutate(., AEDECOD = NA) else .} + ### Rate Difference (Large Sample Approximation by CLT) ------------------------ + else if (test=="Rate Difference"){ + getRateDifference <- function(count1, count2, saval1, saval2) { + r <- ratedifference(a = count1, b = count2, PT1 = saval1, PT0 = saval2) + RD <- r$estimate + RDP <- r$p.value + + output <- c(RD, RDP) + return(output) + } - extension <- bind_rows(events, censors) %>% - group_by(USUBJID) %>% - mutate(ADT = ifelse(CNSR == 1, min(RFENDTC + 30, TDDT), NA)) %>% + result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRateDifference(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% rowwise() %>% - mutate(ADT = ifelse(CNSR == 0, min(AESTDT, na.rm = TRUE), ADT)) %>% - mutate(ADT = as.Date(ADT, origin = "1970-01-01")) %>% - ungroup() %>% - mutate(AVAL = ADT - STARTDT + 1) %>% - distinct() - - data.extend <- bind_rows(data.extend, extension) + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) } - data.extend.summary <- data.extend %>% - mutate(AVAL = as.numeric(AVAL)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} %>% - {if (soc == TRUE) summarise(., - SAVAL1 = sum((ARMCD %in% treatment1) * AVAL), - SAVAL2 = sum((ARMCD %in% treatment2) * AVAL)) else .} - - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AESEV=first(AESEV), - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - na.omit() - - getRateRatio <- function(count1, count2, saval1, saval2) { - r <- rateratio(a = count1, b = count2, PT1 = saval1, PT0 = saval2) - RR <- r$estimate - RRP <- r$p.value - - output <- c(RR, RRP) - return(output) - } - - result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Risk Difference (Large Sample Approximation by CLT) ------------------------ -GetStatistics_RiskD <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", - "AGE", "RFENDY", "SAFFN"))], - ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - N1.total <- data %>% - filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - N2.total <- data %>% - filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - if (ser == TRUE) { data <- data %>% filter(AESER == "Y") } - - if (drug == TRUE) { data <- data %>% filter(AEREL == "Y") } - - if (period == "Treatment emergent") { data <- data %>% filter(TRTEMFL == "Y") } - - if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") } - - if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) } - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - - if (nrow(data) == 0) {return(NULL)} - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} - - getRiskDifference <- function(count1, count2) { - r <- riskdifference(a = count1, b = count2, N1 = N1.total, N0 = N2.total) - RD <- r$estimate - RDP <- r$p.value + ### Rate Ratio (Large Sample Approximation by CLT) ----------------------------- + else if (test=="Rate Ratio"){ + getRateRatio <- function(count1, count2, saval1, saval2) { + r <- rateratio(a = count1, b = count2, PT1 = saval1, PT0 = saval2) + RR <- r$estimate + RRP <- r$p.value + + output <- c(RR, RRP) + return(output) + } - output <- c(RD, RDP) - return(output) - } - - result <- data.summary %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRiskDifference(COUNT1, COUNT2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRiskDifference(COUNT1, COUNT2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) - - return(result) -} - - -### Risk Ratio (Large Sample Approximation by CLT) ----------------------------- -GetStatistics_RiskR <- function(data, ser, drug, period, residual, soc, - treatment1, treatment2) { - - if (is.null(treatment1) | is.null(treatment2)) {return(NULL)} - - data <- data %>% - mutate_at(names(data)[!(names(data) %in% c("AESEQ", "AESTDY", "AEENDY", "AGE", "RFENDY", "SAFFN"))], ~as.character(.)) %>% - mutate_at(names(data), ~na_if(., "")) %>% - mutate_at(c("AESTDT", "AEENDT", "RFSTDTC", "RFENDTC"), ~as.Date(.)) %>% - drop_na(RFSTDTC) %>% - mutate(AEDECOD = ifelse(!is.na(AESTDT) & is.na(AEDECOD), "Not yet coded", AEDECOD)) %>% - mutate(AESTDT = ifelse(is.na(AESTDT) & !is.na(AEDECOD), RFSTDTC, AESTDT)) - - N1.total <- data %>% - filter(ARMCD %in% treatment1) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - N2.total <- data %>% - filter(ARMCD %in% treatment2) %>% distinct(USUBJID) %>% - tally() %>% as.numeric() - - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") - } - - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") + result <- cbind(data.summary, data.extend.summary %>% select(SAVAL1, SAVAL2)) %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRateRatio(COUNT1, COUNT2, SAVAL1, SAVAL2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) } - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - if (period == "Other") { - data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + ### Risk Difference (Large Sample Approximation by CLT) ------------------------ + else if (test=="Risk Difference"){ + getRiskDifference <- function(count1, count2) { + r <- riskdifference(a = count1, b = count2, N1 = N1.total, N0 = N2.total) + RD <- r$estimate + RDP <- r$p.value + + output <- c(RD, RDP) + return(output) + } + + result <- data.summary %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRiskDifference(COUNT1, COUNT2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRiskDifference(COUNT1, COUNT2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) } - data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) - if (nrow(data) == 0) {return(NULL)} - data.summary <- data %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - distinct(USUBJID, .keep_all = TRUE) %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} %>% - {if (soc == TRUE) summarise(., - COUNT1 = sum(ARMCD %in% treatment1), - COUNT2 = sum(ARMCD %in% treatment2)) else .} - - getRiskRatio <- function(count1, count2) { - r <- riskratio(X = count1, Y = count2, m1 = N1.total, m2 = N2.total) - RR <- r$estimate - RRP <- r$p.value + ### Risk Ratio (Large Sample Approximation by CLT) ----------------------------- + else if (test=="Risk Ratio"){ + # NEED N1 AND N2 + getRiskRatio <- function(count1, count2) { + r <- riskratio(X = count1, Y = count2, m1 = N1.total, m2 = N2.total) + RR <- r$estimate + RRP <- r$p.value + + output <- c(RR, RRP) + return(output) + } - output <- c(RR, RRP) - return(output) + result <- data.summary %>% + {if (soc == FALSE) group_by(., AEDECOD) else .} %>% + {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% + {if (soc == FALSE) summarise(., + AEBODSYS = first(AEBODSYS), + RESULT = paste(getRiskRatio(COUNT1, COUNT2), + collapse = " ")) else .} %>% + {if (soc == TRUE) summarise(., + RESULT = paste(getRiskRatio(COUNT1, COUNT2), + collapse = " ")) else .} %>% + rowwise() %>% + mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), + TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% + select(-RESULT) %>% + mutate(LOGPTEST = -log(TESTP)) } - result <- data.summary %>% - {if (soc == FALSE) group_by(., AEDECOD) else .} %>% - {if (soc == TRUE) group_by(., AEBODSYS) else .} %>% - {if (soc == FALSE) summarise(., - AEBODSYS = first(AEBODSYS), - RESULT = paste(getRiskRatio(COUNT1, COUNT2), - collapse = " ")) else .} %>% - {if (soc == TRUE) summarise(., - RESULT = paste(getRiskRatio(COUNT1, COUNT2), - collapse = " ")) else .} %>% - rowwise() %>% - mutate(TEST = as.numeric(unlist(strsplit(RESULT, " "))[1]), - TESTP = as.numeric(unlist(strsplit(RESULT, " "))[2])) %>% - select(-RESULT) %>% - mutate(LOGPTEST = -log(TESTP)) return(result) } - diff --git a/server.R b/server.R index 0dbad7c..20b5dbf 100644 --- a/server.R +++ b/server.R @@ -4,7 +4,7 @@ ################################################################################ server <- function(input, output, session) { - + data <- reactiveValues(ae_test = NULL, statistics = NULL, @@ -41,15 +41,15 @@ server <- function(input, output, session) { data$ae_test <- ae_test_data() } }) - - + + ### Extract all arms --------------------------------------------------------- ARMCD <- reactive({ req(data$ae_test) unique(data$ae_test$ARMCD) }) - - + + ### Definitions of UI outputs in the control panel and related logics -------- output$review_by_please_specify_UI <- renderUI({ req(data$ae_test) @@ -58,7 +58,7 @@ server <- function(input, output, session) { textInput("review_by_please_specify", "Please specify") }) - + output$period_please_specify_UI <- renderUI({ req(data$ae_test) req(input$period) @@ -70,14 +70,9 @@ server <- function(input, output, session) { output$treatment1_UI <- renderUI({ req(data$ae_test) - req(ARMCD()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() + req(input$summary_by != "Events") div(style = 'height:100px; width:91%; overflow: scroll', - checkboxGroupInput("treatment1", "Exposed Group", + checkboxGroupInput("treatment1", "Group A", choices = ARMCD(), selected = ARMCD()[1], inline = F) @@ -86,295 +81,93 @@ server <- function(input, output, session) { output$treatment2_UI <- renderUI({ req(data$ae_test) - req(ARMCD()) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() + req(input$summary_by != "Events") div(style = 'height:100px; width:91%; overflow: scroll', - checkboxGroupInput("treatment2", "Unexposed Group", - choices = setdiff(ARMCD(), input$treatment1), - selected = setdiff(ARMCD(), input$treatment1)[1], - inline = F) + checkboxGroupInput("treatment2", "Group B", + choices = setdiff(ARMCD(), input$treatment1), + selected = setdiff(ARMCD(), input$treatment1)[1], + inline = F) ) }) output$treatment1_label_UI <- renderUI({ req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("treatment1_label", "Label for Exposed Group", value="Exposed",width="75%") + req(input$summary_by != "Events") + textInput("treatment1_label", "Label for Group A", value="Exposed",width="75%") }) - + output$treatment2_label_UI <- renderUI({ req(data$ae_test) - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() - textInput("treatment2_label", "Label for Unexposed Group",value="Unexposed",width="75%") + req(input$summary_by != "Events") + textInput("treatment2_label", "Label for Group B",value="Unexposed",width="75%") }) - - + + output$subgroup_vals_UI <- renderUI({ if(input$subgroup_var == "No Subgroup Variable") return() - if(input$summary_by == "Events" & input$test %in% c("Hazard Ratio", - "Rate Difference", - "Rate Ratio", - "Risk Difference", - "Risk Ratio")) return() + req(input$summary_by != "Events") div(style = 'height:100px; width:91%; overflow: scroll', - checkboxGroupInput("subgroup_vals", "Value for Subgroup", - choices = sort(unique(data$ae_test[[input$subgroup_var]])), - inline = F) + checkboxGroupInput("subgroup_vals", "Value for Subgroup", + choices = sort(unique(data$ae_test[[input$subgroup_var]])), + inline = F) ) }) - - + + ### An essential step for obtaining statistics right after data uploading and before the generation of volcano plot ------------------------------------ observeEvent(input$obtain, { - req(input$review_by) - req(input$summary_by) req(input$treatment1) req(input$treatment2) if (input$period == "Other") {req(input$period_please_specify)} - if (input$review_by == "SOC") return() - if (!is.null(statistics_data())) { - data$statistics <- statistics_data() - } - # if (is.null(data$statistics)){ - # filename <- paste0(getwd(),"/statistics.csv") - # if(file.exists(filename)){ - # data$statistics <- fread(filename) - # } else { - # shinyjs::alert(paste0("ADaM file does not exist:",filename)) - # } - # } - if (is.null(ae_test_data())) { - shinyjs::alert("Please import a SDTM dataset first!") - data$statistics <- NULL - } else { - if (input$summary_by == "Events" & input$test == "Hazard Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Difference") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Difference") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Ratio") { - data$statistics <- NULL - shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { - withProgress(data$statistics <- GetStatistics_HazardR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Difference") { - withProgress(data$statistics <- GetStatistics_RateD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Ratio") { - withProgress(data$statistics <- GetStatistics_RateR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Difference") { - withProgress(data$statistics <- GetStatistics_RiskD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Ratio") { - withProgress(data$statistics <- GetStatistics_RiskR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - FALSE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } + if (input$review_by != "SOC"){ + if (!is.null(statistics_data())) { data$statistics <- statistics_data() } + else if(!is.null(statistics_data())) {data$statistics_soc <- statistics_data() } } - }) - - observeEvent(input$obtain, { - req(input$review_by) - req(input$summary_by) - if (input$period == "Other") {req(input$period_please_specify)} - if (input$review_by!="SOC") return() - if (!is.null(statistics_data())) { - data$statistics_soc <- statistics_data() + + if (input$summary_by == "Events") { + data$statistics <- NULL + shinyjs::alert(paste0("Error: ",input$test, "cannot be obtained if data is summarized by events instead of patients!")) } - # if (is.null(data$statistics_soc)){ - # filename <- paste0(getwd(),"/statistics-soc.csv") - # if(file.exists(filename)){ - # data$statistics_soc <- fread(filename) - # } else { - # shinyjs::alert(paste0("ADaM file does not exist:",filename)) - # } - # } - if (is.null(ae_test_data())) { - shinyjs::alert("Please import a SDTM dataset first!") - data$statistics_soc <- NULL - } else { - if (input$summary_by == "Events" & input$test == "Hazard Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Hazard Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Difference") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Rate Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Rate Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Rate Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Difference") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Risk Difference cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Events" & input$test == "Risk Ratio") { - data$statistics_soc <- NULL - shinyjs::alert(paste0("Error: Risk Ratio cannot be obtained ", - "if data is summarized by events instead of patients!")) - } - if (input$summary_by == "Patients" & input$test == "Hazard Ratio") { - withProgress(data$statistics_soc <- GetStatistics_HazardR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Difference") { - withProgress(data$statistics_soc <- GetStatistics_RateD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Rate Ratio") { - withProgress(data$statistics_soc <- GetStatistics_RateR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Difference") { - withProgress(data$statistics_soc <- GetStatistics_RiskD(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) - } - if (input$summary_by == "Patients" & input$test == "Risk Ratio") { - withProgress(data$statistics_soc <- GetStatistics_RiskR(ae_test_data(), - input$ser, - input$drug, - input$period, - ifelse(input$period != "Other", - NULL, input$period_please_specify), - TRUE, - input$treatment1, - input$treatment2), - message = "Executing data pre-processing...", - detail = "This step should take a while.", - min = 0, max = 1, value = 1) + + if (input$summary_by == "Patients"){ + if (input$review_by != "SOC"){ + + withProgress(data$statistics <- GetStatistics_all(data = ae_test_data(), + ae_filter = input$ae_filter, + period = input$period, + residual = ifelse(input$period != "Other",NULL, input$period_please_specify), + soc = FALSE, + treatment1= input$treatment1, + treatment2 = input$treatment2, + test = input$test + ), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + } else if (input$review_by == "SOC"){ + + withProgress(data$statistics_soc <- GetStatistics_all(data = ae_test_data(), + ae_filter = input$ae_filter, + period = input$period, + residual = ifelse(input$period != "Other",NULL, input$period_please_specify), + soc = FALSE, + treatment1= input$treatment1, + treatment2 = input$treatment2, + test = input$test + ), + message = "Executing data pre-processing...", + detail = "This step should take a while.", + min = 0, max = 1, value = 1) + + + } } - }) + + + + }) ### Definition of 'Reset' button UI output and its consequent triggerings ---- @@ -383,38 +176,22 @@ server <- function(input, output, session) { actionBttn("reset", "Reset Options",color = "primary",style = "bordered",block=TRUE) }) + observeEvent(input$reset, { - updateSelectInput(session, "summary_by", "Summary By", - choices = c("Patients", "Events")) - updateSelectInput(session, "review_by", "Review By", - choices = c("PT", "SOC", "Other")) - updateSelectInput(session, "period", "Period", - choices = c("Treatment emergent", - "AE during entire study", - "Other")) + updateSelectInput(session, "summary_by", "Summary By", choices = c("Patients", "Events")) + updateSelectInput(session, "review_by", "Review By", choices = c("PT", "SOC", "Other")) + updateSelectInput(session, "period", "Period", choices = c("Treatment emergent", "AE during entire study", "Other")) updateCheckboxInput(session, "ser", "Serious adverse event", value = FALSE) updateCheckboxInput(session, "drug", "Drug-related adverse events", value = FALSE) - updateSelectInput(session, "test", "Measure of Association", - choices = c("Rate Ratio", - "Risk Ratio", - "Hazard Ratio", - "Risk Difference", - "Rate Difference")) - updateCheckboxGroupInput(session, "treatment1", "Exposed Group", - choices = ARMCD(), selected = ARMCD()[1], inline = F) - updateCheckboxGroupInput(session, "treatment2", "Unexposed Group", - choices = setdiff(ARMCD(), input$treatment1), - selected = setdiff(ARMCD(), input$treatment1)[1], - inline = F) - updateTextInput(session, "treatment1_label", "Label for Exposed Group") - updateTextInput(session, "treatment2_label", "Label for Unexposed Group") - updateSelectInput(session, "subgroup_var", "Subgroup Variable", - choices = c("No Subgroup Variable", "SITE", "AGE", "SEX", "RACE"), - selected = NULL) - updateTextInput(session, "X_ref", "X-axis Reference Line", value = 1) - updateTextInput(session, "Y_ref", "Y-axis Reference Line", value = 0.05) - updateSelectInput(session, "pvalue_option", "p-Value Option", - choices = c("Unadjusted", "Adjusted")) + updateSelectInput(session, "test", "Measure of Association", choices = c("Rate Ratio", "Risk Ratio", "Hazard Ratio", "Risk Difference", "Rate Difference")) + updateCheckboxGroupInput(session, "treatment1", "Group A", choices = ARMCD(), selected = ARMCD()[1], inline = F) + updateCheckboxGroupInput(session, "treatment2", "Group B", choices = setdiff(ARMCD(), input$treatment1), selected = setdiff(ARMCD(), input$treatment1)[1], inline = F) + updateTextInput(session, "treatment1_label", "Label for Group A") + updateTextInput(session, "treatment2_label", "Label for Group B") + updateSelectInput(session, "subgroup_var", "Subgroup Variable", choices = c("No Subgroup Variable", "SITE", "AGE", "SEX", "RACE"), selected = "No Subgroup Variable") + updatenumericInput(session, "X_ref", "X-axis Reference Line", value = 1) + updatenumericInput(session, "Y_ref", "Y-axis Reference Line", value = 0.05) + updateSelectInput(session, "pvalue_option", "p-Value Option", choices = c("Unadjusted", "Adjusted")) }) @@ -432,41 +209,15 @@ server <- function(input, output, session) { if (input$review_by == "SOC") {req(data$statistics_soc)} actionBttn("update", "Update Plot",color = "primary",style = "bordered",block=TRUE) }) - - ### Check the prerequisite of customized labels for exposed/unexposed group -- - observeEvent(input$update, { - if(nchar(input$treatment1_label) == 0) { - shinyjs::alert("Please enter label for the exposed group.") - return() - } - - if(nchar(input$treatment2_label) == 0) { - shinyjs::alert("Please enter label for the unexposed group.") - return() - } - }) ### Generation of volcano plot ----------------------------------------------- observeEvent(c(input$update - # input$review_by, - # input$review_by_please_specify, - # input$period, - # input$period_please_specify, - # input$ser, - # input$drug, - # input$test, - # input$treatment1, - # input$treatment2, - # input$treatment1_label, - # input$treatment2_label, - # input$subgroup_var, - # input$subgroup_vals, - # input$X_ref, - # input$Y_ref, - # input$pvalue_option - ), { + # input$X_ref, + # input$Y_ref, + # input$pvalue_option + ), { req(data$ae_test) if (input$review_by == "PT") {req(data$statistics)} if (input$review_by == "SOC") {req(data$statistics_soc)} @@ -474,68 +225,37 @@ server <- function(input, output, session) { req(input$treatment2_label) if(length(input$treatment1) == 0) { - shinyjs::alert("Please select an exposed group.") + shinyjs::alert("Please select Group A.") return() } if(length(input$treatment2) == 0) { - shinyjs::alert("Please select an unexposed group.") + shinyjs::alert("Please select Group B.") return() } - - # if(length(input$period_please_specify)>0) { - # if(!numbers_only(input$period_please_specify)) { - # shinyjs::alert("Please enter only an integer for risk period.") - # return() - # } - # } - # if(length(input$X_ref) > 0) { - # X_ref <- as.numeric(input$X_ref) - # if(is.na(X_ref)) { - # shinyjs::alert("Please enter a numeric value for X-axis reference line.") - # return() - # } - # } - # - # if(length(input$Y_ref) > 0) { - # Y_ref <- as.numeric(input$Y_ref) - # if(is.na(Y_ref)) { - # shinyjs::alert("Please enter a numeric value for Y-axis reference line.") - # return() - # } else { - # if (!(as.numeric(input$Y_ref) >= 0 & as.numeric(input$Y_ref) <= 1)) { - # shinyjs::alert("Please enter a valid value between 0 and 1 for Y-axis reference line.") - # return() - # } - # } - # } - + plots$volcano_plot <- NULL plots$volcano_plot_data <- NULL - plots$volcano_plot_click <- NULL withProgress(message = 'Plotting data', value = 0, { out <- try( volcano.plot( - data = isolate(data$ae_test), - statistics_data = isolate(data$statistics), - statistics_soc_data = isolate(data$statistics_soc), - ser = input$ser, - drug = input$drug, - period = input$period, - residual = input$period_please_specify, - test = input$test, - Treatment1 = input$treatment1, - Treatment2 = input$treatment2, - subgroup_var = input$subgroup_var, - subgroup_vals = input$subgroup_vals, - X_ref = as.numeric(input$X_ref), - Y_ref = as.numeric(input$Y_ref), - X_label = paste(input$test, input$treatment1_label, "vs.", input$treatment2_label), - review_by = input$review_by, - summary_by = input$summary_by, - pvalue_adjustment = input$pvalue_adjustment, - pvalue_label = input$pvalue_label + data = isolate(data$ae_test), + statistics_data = isolate(data$statistics), + statistics_soc_data = isolate(data$statistics_soc), + ae_filter = input$ae_filter, + period = input$period, + residual = input$period_please_specify, + test = input$test, + treatment1 = input$treatment1, + treatment2 = input$treatment2, + subgroup_var = input$subgroup_var, + subgroup_vals = input$subgroup_vals, + X_ref = as.numeric(input$X_ref), + X_label = paste(input$test, input$treatment1_label, "vs.", input$treatment2_label), + review_by = input$review_by, + summary_by = input$summary_by, + pvalue_label = input$pvalue_label ) ) if (!"try-error" %in% class(p)) { @@ -584,17 +304,17 @@ server <- function(input, output, session) { plots$volcano_plot <- out$plot plots$volcano_plot_data <- out$data output$volcano_plot <- renderPlotly({ - output = ggplotly(plots$volcano_plot,tooltip = c("label")) %>% + output = ggplotly(plots$volcano_plot,tooltip = c("label"), source="volcano_plot") %>% plotly::layout(annotations = - list(x = 0, y = 0.02, text = text1, - showarrow = F, xref = 'paper', yref = 'paper', - xanchor = 'left', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 12, color = "blue"))) %>% + list(x = 0, y = 0.02, text = text1, + showarrow = F, xref = 'paper', yref = 'paper', + xanchor = 'left', yanchor = 'bottom', xshift = 0, yshift = 0, + font = list(size = 12, color = "blue"))) %>% plotly::layout(annotations = - list(x = .95, y = 0.02, text = text2, - showarrow = F, xref = 'paper', yref = 'paper', - xanchor = 'right', yanchor = 'bottom', xshift = 0, yshift = 0, - font = list(size = 12, color = "blue"))) + list(x = .95, y = 0.02, text = text2, + showarrow = F, xref = 'paper', yref = 'paper', + xanchor = 'right', yanchor = 'bottom', xshift = 0, yshift = 0, + font = list(size = 12, color = "blue"))) output$x$layout$legend$font$size=8.5 # change legend text size output @@ -602,8 +322,6 @@ server <- function(input, output, session) { }) output$volcano_plot_UI <- renderUI({ req(plots$volcano_plot) - # req(input$treatment1_label) - # req(input$treatment2_label) plotlyOutput("volcano_plot", height = "650px") %>% withSpinner(type = 5) }) } else { @@ -614,112 +332,68 @@ server <- function(input, output, session) { } }) }) - - ### Definitions and logics for the drilldown table from click triggering ----- - observeEvent(event_data("plotly_click"), { - plots$volcano_plot_click <- event_data("plotly_click") - }) - volcano_plot_table <- reactive({ - req(plots$volcano_plot_click) - plots$volcano_plot$data[as.numeric(plots$volcano_plot_click$key),] %>% - inner_join(plots$volcano_plot_data) %>% - select(USUBJID, - SITE, - AGE, - SEX, - RACE, - ARM, - SBJTSTAT, - AEBODSYS, - AEDECOD, - AESTDT, - AESTDY, - AEENDT, - AESER, - AEONGO, - AESEV, - AEREL, - AEOUT, - TRTEMFL, - STUDYFL) - }) - #List the details of filtered data that matches the selected SOC/PT output$volcano_plot_drill <- DT::renderDataTable({ - datatable(volcano_plot_table(), extensions = 'Buttons', - colnames = c('Subject ID', - 'Site', - 'Age', - 'Sex', - 'Race', - 'Treatment', - 'Subject Status', - 'SOC', - 'PT', - 'Onset Date', - 'Time to Onset', - 'End Date', - 'Serious AE?', - 'Still Ongoing?', - 'Severity', - 'Causality', - 'Outcome', - 'Treatment Emergent?', - 'During Entire Study?'), - options = list(dom = 'Bfrtip', - buttons = I('colvis'), - #buttons = c(I('colvis'), - # 'copy', - # 'csv', - # 'excel', - # 'print', - # 'pdf'), - pageLength = 10) - - - - ) + s=event_data("plotly_click",source="volcano_plot") + req(length(s)>0) + + volcano_plot_table = plots$volcano_plot$data[as.numeric(s$key),] %>% + inner_join(plots$volcano_plot_data) %>% + select(USUBJID, SITE, AGE, SEX, RACE, ARM, SBJTSTAT, AEBODSYS, AEDECOD, AESTDT, AESTDY, AEENDT, AESER, AEONGO, + AESEV, AEREL, AEOUT,TRTEMFL, STUDYFL) + + datatable(volcano_plot_table, extensions = 'Buttons', + colnames = c('Subject ID', 'Site', 'Age', 'Sex', 'Race', 'Treatment', 'Subject Status', 'SOC', + 'PT', 'Onset Date', 'Time to Onset', 'End Date','Serious AE?','Still Ongoing?','Severity', + 'Causality','Outcome', 'Treatment Emergent?','During Entire Study?'), + options = list(dom = 'Bfrtip', buttons = I('colvis'), pageLength = 10) + ) }, server = FALSE) - output$volcano_plot_drill_UI <- renderUI({ - req(plots$volcano_plot_click) - DT::dataTableOutput("volcano_plot_drill") - }) ### Specifications on the footnote of volcano plot --------------------------- - output$footnote_UI <- renderUI({ + output$footnote_UI <- renderText({ req(plots$volcano_plot) - # if (input$summary_by == "Events") { - # ft <- paste0(" Note:
", - # "* N is the total number of events.") - # } + if (input$summary_by == "Events") { + ft <- paste0(" Note:
", + "* N is the total number of events.
", + "Dashed horizontal line represents p-value of 0.05
", + "Dotted horizontal line represents FDR adjsuted p-value of approximately 0.05") + } if (input$summary_by == "Patients") { - - if (input$ser == FALSE & input$drug == FALSE) { - ftn <- "* n is the number of patients with adverse events." - } - if (input$ser == TRUE & input$drug == FALSE) { - ftn <- "* n is the number of patients with serious adverse events." - } - if (input$ser == FALSE & input$drug == TRUE) { - ftn <- "* n is the number of patients with drug-related adverse events." - } - if (input$ser == TRUE & input$drug == TRUE) { - ftn <- "* n is the number of patients with serious adverse events and drug-related adverse events." + if (is.null(input$ae_filter)){ + ftn = "* n is the number of patients with adverse events." + } else{ + + ae_filter_name = tolower(input$ae_filter) + if (length(ae_filter_name)<=1){ + ftn <- paste("* n is the number of patients with ",ae_filter_name,"adverse events.") + } + else if (length(ae_filter_name)>1){ + ftn <- paste0("* n is the number of patients with ",paste0(ae_filter_name[-length(ae_filter_name)],collapse=", "), " and ", ae_filter_name[length(ae_filter_name)], " adverse events.") + } } - ft <- paste0(" Note:
", "* N is the total number of treated patients.
", - ftn) + ftn, "
", + "Dashed horizontal line represents p-value of 0.05
", + "Dotted horizontal line represents FDR adjsuted p-value of approximately 0.05" + ) + } return(HTML(ft)) }) + + + + + } diff --git a/ui.R b/ui.R index 7b4bcf3..ae0852d 100644 --- a/ui.R +++ b/ui.R @@ -23,17 +23,16 @@ ui <- fluidPage( column(width=4,uiOutput("reset_UI")) ), hr(), fluidRow( - column(width=4,selectInput("summary_by", "Summary By", choices = c("Patients", "Events"))), - column(width=4,selectInput("review_by", "Review By", choices = c("PT", "SOC", "Other")),uiOutput("review_by_please_specify_UI")), - column(width=4,selectInput("period", "Period",choices = c("Treatment emergent", "AE during entire study", "Other")), uiOutput("period_please_specify_UI")), + column(width=6,selectInput("summary_by", "Summary By", choices = c("Patients", "Events"), width="75%")), + column(width=6,selectInput("review_by", "Review By", choices = c("PT", "SOC", "Other"), width="75%"), uiOutput("review_by_please_specify_UI")), ), fluidRow( - column(width=6, checkboxInput("ser", "Serious adverse event", value = FALSE)), - column(width=6,checkboxInput("drug", "Drug-related adverse events", value = FALSE)) + column(width=6,selectInput("period", "Period",choices = c("Treatment emergent", "AE during entire study", "Other"), width="75%"), uiOutput("period_please_specify_UI")), + column(width=6,selectInput("ae_filter", "Adverse Event filter(s)", choices=c("Serious","Drug-related","Mild","Moderate","Severe"), selected=NULL, multiple=TRUE, width="75%") ),hr(), fluidRow( - column(width=6,uiOutput("treatment1_UI"), uiOutput("treatment1_label_UI"), ), - column(width=6,uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI") ) + column(width=6,uiOutput("treatment1_UI"), uiOutput("treatment1_label_UI")), + column(width=6,uiOutput("treatment2_UI"), uiOutput("treatment2_label_UI")) ),hr(), fluidRow( selectInput("test", "Measure of Association", choices = c("Rate Ratio", "Risk Ratio", "Hazard Ratio", "Risk Difference", "Rate Difference"), width="75%"), @@ -41,25 +40,20 @@ ui <- fluidPage( ),br(),hr(), fluidRow( column(width=6,numericInput("X_ref", "X-axis Reference Lines", value = 0,width="75%") ), - column(width=6,numericInput("Y_ref", "Y-axis Reference Line", value = 0.05,width="75%")) - ), - fluidRow( - column(width=6,selectInput("pvalue_adjustment", "P-value Adjustment",choices = c("Unadjusted", "Adjusted"), selected="Unadjusted",width="75%")), column(width=6,selectInput("pvalue_label", "P-value Transformation",choices = c("None", "-log10"), selected="-log10",width="75%")) - ), - fluidRow(align="center", - selectInput("color_option", label="Color",choices=c("Body System or Organ Class","Severity"),selected="Body/Organ",width="50%") + ) )) ) - ), + )), column(width=8, uiOutput("volcano_plot_UI"), - + br(), - div(uiOutput("footnote_UI"),style = "font-size: 12px; white-space: pre"), + div(htmlOutput("footnote_UI"),style = "font-size: 12px; white-space: pre"), + htmlOutput("test"), br(), - uiOutput("volcano_plot_drill_UI") + DT::dataTableOutput("volcano_plot_drill") ) ) diff --git a/volcano_plot.R b/volcano_plot.R index 21c8a12..2c8d880 100644 --- a/volcano_plot.R +++ b/volcano_plot.R @@ -6,42 +6,23 @@ volcano.plot <- function(data, statistics_data, statistics_soc_data, - ser, - drug, + ae_filter, period, residual, test, - Treatment1, - Treatment2, + treatment1, + treatment2, subgroup_var, subgroup_vals, X_ref, - Y_ref, X_label, review_by, summary_by, - pvalue_adjustment, - pvalue_label) + pvalue_label + ) { - assign("data", data, envir = .GlobalEnv) - assign("statistics_data", statistics_data, envir = .GlobalEnv) - assign("statistics_soc_data", statistics_soc_data, envir = .GlobalEnv) - assign("ser", ser, envir = .GlobalEnv) - assign("drug", drug, envir = .GlobalEnv) - assign("period", period, envir = .GlobalEnv) - assign("residual", residual, envir = .GlobalEnv) - assign("test", test, envir = .GlobalEnv) - assign("Treatment1", Treatment1, envir = .GlobalEnv) - assign("Treatment2", Treatment2, envir = .GlobalEnv) - assign("subgroup_var", subgroup_var, envir = .GlobalEnv) - assign("subgroup_vals", subgroup_vals, envir = .GlobalEnv) - assign("X_ref", X_ref, envir = .GlobalEnv) - assign("Y_ref", Y_ref, envir = .GlobalEnv) - assign("X_label", X_label, envir = .GlobalEnv) - assign("review_by", review_by, envir = .GlobalEnv) - assign("summary_by", summary_by, envir = .GlobalEnv) - assign("pvalue_adjustment", pvalue_adjustment, envir = .GlobalEnv) - assign("pvalue_label", pvalue_label, envir = .GlobalEnv) + + ### Data pre-processing & data imputation ------------------------------------ data <- data %>% @@ -54,8 +35,7 @@ volcano.plot <- function(data, ### Filtering based on selected treatment groups ----------------------------- - data <- data %>% - filter(ARMCD %in% c(Treatment1, Treatment2)) + data <- data %>% filter(ARMCD %in% c(treatment1, treatment2)) ### Filtering based on subgroup variable ------------------------------------- @@ -65,27 +45,33 @@ volcano.plot <- function(data, ### Filtering based on other options from control panel ---------------------- - if (ser == TRUE) { - data <- data %>% filter(AESER == "Y") - } - - if (drug == TRUE) { - data <- data %>% filter(AEREL == "Y") + # filter data for seriousness, drug-related, and severity + if (length(ae_filter)>0){ + if ("Serious" %in% ae_filter) { data <- data %>% filter(AESER == "Y") } + if ("Drug-related" %in% ae_filter) { data <- data %>% filter(AEREL == "Y") } + if (sum(c("Mild","Moderate","Severe") %in% ae_filter)>0){ + severity_filter = ae_filter[which(ae_filter%in% c("Mild","Moderate","Severe"))] + data = data %>% filter(AESEV %in% severity_filter) + } } - if (period == "Treatment emergent") { - data <- data %>% filter(TRTEMFL == "Y") + # filter data for ae timeframe + if (period == "Treatment emergent") { + data <- data %>% filter(TRTEMFL == "Y") + } else if (period == "AE during entire study") { data <- data %>% filter(STUDYFL == "Y") + } else if (period == "Other") { data <- data %>% filter((AESTDT > RFSTDTC) & (AESTDT < (RFENDTC + residual))) + } + + # filter data for seriousness, drug-related, and severity + if (length(ae_filter)>0){ + if ("Serious" %in% ae_filter) { data <- data %>% filter(AESER == "Y") } + if ("Drug-related" %in% ae_filter) { data <- data %>% filter(AEREL == "Y") } + if (sum(c("Mild","Moderate","Severe") %in% ae_filter)>0){ + severity_filter = ae_filter[which(ae_filter%in% c("Mild","Moderate","Severe"))] + data = data %>% filter(AESEV %in% severity_filter) + } } - if (period == "AE during entire study") { - data <- data %>% filter(STUDYFL == "Y") - } - - if (period == "Other") { - data <- data %>% filter((as.Date(AESTDT) > as.Date(RFSTDTC)) & (as.Date(AESTDT) < (as.Date(RFENDTC) + residual))) - } - - ### Calculation of lowercase n ----------------------------------------------- TRT_N <- data %>% filter(!is.na(AEDECOD)) %>% @@ -94,8 +80,8 @@ volcano.plot <- function(data, {if (summary_by == "Patients") summarise(., N = length(unique((USUBJID)))) else .} %>% {if (summary_by == "Events") summarise(., N = n()) else .} - N1 <- sum(subset(TRT_N, ARMCD %in% Treatment1)$N) - N2 <- sum(subset(TRT_N, ARMCD %in% Treatment2)$N) + N1 <- sum(subset(TRT_N, ARMCD %in% treatment1)$N) + N2 <- sum(subset(TRT_N, ARMCD %in% treatment2)$N) ### Data preparation for the next step of data integration ------------------- @@ -114,32 +100,35 @@ volcano.plot <- function(data, ### Integration of data for the purpose of graph & listing presentation ------ if (review_by == "SOC") { - statistics_data <- statistics_soc_data %>% + statistics_data <- statistics_soc_data %>% group_by() %>% inner_join(data %>% select(ARMCD, AEBODSYS) %>% unique()) %>% inner_join(SOC_N) %>% mutate(N1 = (ARMCD %in% Treatment1) * N, N2 = (ARMCD %in% Treatment2) * N, pvalue = TESTP, + adjpvalue = p.adjust(pvalue, method="fdr"), Summary = paste0("\nSOC:", AEBODSYS, - "\n<", N1, ",", N2,">", + "\n","n=",ifelse(N1==0,N2,N1), "\n", test, ":", TEST, - "\np-Value:", pvalue)) + "\np-Value:", round(pvalue,4))) } else { - statistics_data <- statistics_data %>% + statistics_data <- statistics_data %>% group_by() %>% inner_join(data %>% select(ARMCD, AEBODSYS, AEDECOD) %>% unique()) %>% inner_join(PT_N) %>% - mutate(N1 = (ARMCD %in% Treatment1) * N, - N2 = (ARMCD %in% Treatment2) * N, + mutate(N1 = (ARMCD %in% treatment1) * N, + N2 = (ARMCD %in% treatment2) * N, pvalue = TESTP, - Summary = paste0("\nSOC:", AEBODSYS, - "\nPT:", AEDECOD, " <", N1, ",", N2, ">", + adjpvalue = p.adjust(pvalue, method="fdr"), + Summary = paste0("\n SOC:", AEBODSYS, + "\n PT:", AEDECOD, + "\n n=",ifelse(N1==0,N2,N1), "\n", test, ":", TEST, - "\np-Value:", pvalue)) + "\n p-value:", round(pvalue,4)," (adj. p-value: ", round(adjpvalue,4))) } ### Construction of volcano plot --------------------------------------------- - if (dim(statistics_data)[1] == 0) { + if (nrow(statistics_data) == 0) { p <- ggplot() + annotate("text", x = 4, y = 25, size = 8, label = "No data selected for plot.") + theme_bw() + @@ -154,35 +143,37 @@ volcano.plot <- function(data, return(list(plot = p, data = data)) } - key <- row.names(statistics_data) - # adjusted p value - if (pvalue_adjustment=="Unadjusted"){ - statistics_data$my_pvalue = statistics_data$pvalue - } else{ - statistics_data$my_pvalue = p.adjust(statistics_data$pvalue, method="fdr") - } + statistics_data = statistics_data %>% filter(TEST!=Inf) + + key <- row.names(statistics_data) + + pvalue_adj0.05 = (statistics_data %>% group_by() %>% filter(adjpvalue<=0.05) %>% arrange(desc(adjpvalue)) %>% slice(1))$pvalue + - p <- ggplot(statistics_data, aes(TEST, my_pvalue, label = Summary, fill = AEBODSYS, key = key)) + - geom_point(aes(size=N), pch=21, alpha=0.65) + - geom_hline(yintercept = Y_ref, color = 'grey30', linetype = "dotted") + - geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0), color = 'grey30', linetype = "dotted") + - geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0)+c(-X_ref,X_ref), color = 'grey30', linetype = "dotted") + - theme_bw() + + p <- ggplot(statistics_data, aes(TEST, pvalue, label = Summary, key = key)) + + geom_point(aes(size=N), pch=21, alpha=0.5, fill="skyblue2") + + geom_hline(yintercept = 0.05, color = 'grey30', linetype = "dashed") + + geom_hline(yintercept = pvalue_adj0.05, color = 'grey30', linetype = "dotted") + + geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0), color = 'grey30', linetype = "dashed") + + geom_vline(xintercept = ifelse(grepl("Ratio",test),1,0)+c(-X_ref,X_ref), color = 'grey30', linetype = "dashed") + + theme_classic() + + background_grid(major = "xy", minor = "none", color.major="grey92")+ + theme(legend.position = "none")+ scale_x_continuous(X_label,expand = expansion(mult = c(0.05, 0.05)))+ scale_size_continuous(range = c(2, 15)) if (pvalue_label=="-log10"){ - p=p+ scale_y_continuous(ifelse(pvalue_adjustment=="Unadjusted","-log10(p-value)","-log10(adj. p-value)"), + p=p+ scale_y_continuous("-log10(p-value)", trans = reverselog_trans(10), breaks = as.numeric(paste0("1e-",0:20)), labels = as.character(0:20), expand = expansion(mult = c(0.05, 0.05))) } else if (pvalue_label=="None"){ - p=p+ scale_y_continuous(ifelse(pvalue_adjustment=="Unadjusted","P-value","Adj. p-value"), + p=p+ scale_y_continuous("P-value", trans = reverselog_trans(10), - breaks = c(Y_ref, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1), - labels = as.character(c(Y_ref, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1)), + breaks = c(0.05, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1), + labels = as.character(c(0.05, 0, .000000001,.00000001,.0000001,.000001,.00001,.00001, .0001, .001, .01, .1, 1)), expand = expansion(mult = c(0.05, 0.05))) } From 8b312d79caec475a782fded9a853f326ab62d466 Mon Sep 17 00:00:00 2001 From: jwildfire Date: Thu, 13 Aug 2020 09:38:31 -0400 Subject: [PATCH 14/15] Update README.md --- README.md | 2 ++ 1 file changed, 2 insertions(+) diff --git a/README.md b/README.md index 2c5f537..be7620c 100644 --- a/README.md +++ b/README.md @@ -1,3 +1,5 @@ # volcano-plot ![image](https://user-images.githubusercontent.com/62663896/90043322-efd45b00-dc99-11ea-834c-5633c91ea41d.png) + +Thanks to the team at Boehringer Ingelheim for developing and releasing the initial code for this tool. In particular, thanks to, Hong Wang, Ke Xiao and Dennis O'Brien. From 5ca01360e6030dfd55d200b076bed0760ee58746 Mon Sep 17 00:00:00 2001 From: jwildfire Date: Thu, 13 Aug 2020 09:38:43 -0400 Subject: [PATCH 15/15] Update global.R --- global.R | 3 +-- 1 file changed, 1 insertion(+), 2 deletions(-) diff --git a/global.R b/global.R index 29e636b..3176fe0 100644 --- a/global.R +++ b/global.R @@ -20,7 +20,7 @@ library(survival) # version: 3.1-8 library(survminer) # version: 0.4.6 library(fmsb) # version: 0.7.0 library(shinyWidgets) - +library(cowplot) # if function conflicts, default dplyr conflict_prefer("first", "dplyr") select <- dplyr::select; rename <- dplyr::rename; mutate <- dplyr::mutate; summarize <- dplyr::summarize; arrange <- dplyr::arrange; slice <- dplyr::slice; filter <- dplyr::filter; recode<-dplyr::recode @@ -51,4 +51,3 @@ reverselog_trans <- function(base = exp(1)) { domain = c(1e-100, Inf)) } -